gene_name,interaction_types,drug_claim_primary_name,interaction_group_score,TARGET_NAME,TARGET_CLASS,ACT_VALUE,drug_approved,drug_avr_mass,drug_predicted_logp,drug_rule_of_five,drug_nr_targets,drug_nr_enzymes,drug_nr_carriers,drug_nr_transporters,POLAR_SURFACE_AREA,ROTATABLE_BOND_COUNT,HYDROGEN_BOND_DONORS,HYDROGEN_BOND_ACCEPTORS,RING_COUNT,ATOM_COUNT,FORMAL_CHARGE,CHIRAL_CENTER_COUNT
OPRK1,agonist,hydromorphone,0.71,Kappa-type opioid receptor,GPCR,8.55,True,285.3377,1.6227496759764108,True,3,3,1,0,49.77,0,1,4,5,40,0,4.0
OPRD1,agonist,hydromorphone,1.51,Delta-type opioid receptor,GPCR,7.42,True,285.3377,1.6227496759764108,True,3,3,1,0,49.77,0,1,4,5,40,0,4.0
ADRB3,antagonist,alprenolol,0.55,Beta-3 adrenergic receptor,GPCR,6.86,False,249.3486,2.6927899056666664,True,4,1,0,0,41.49,8,2,3,1,41,0,1.0
ADRA1B,antagonist,prazosin,0.43,Alpha-1B adrenergic receptor,GPCR,9.08,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
ADRA2B,antagonist,prazosin,0.33,Alpha-2B adrenergic receptor,GPCR,7.89,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
KCNH2,inhibitor,prazosin,0.04,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.8,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
ADRA1D,antagonist,prazosin,0.43,Alpha-1D adrenergic receptor,GPCR,9.7,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
ADRA1A,antagonist,prazosin,0.29,Alpha-1A adrenergic receptor,GPCR,10.4,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
ADRA2A,binder,prazosin,0.16,Alpha-2A adrenergic receptor,GPCR,6.68,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
ADRA2C,antagonist,prazosin,0.04,Alpha-2C adrenergic receptor,GPCR,7.62,True,383.4011,1.6505164626666664,True,7,0,1,4,106.95,4,1,8,4,49,0,0.0
CHRM3,antagonist,ipratropium,0.27,Muscarinic acetylcholine receptor M3,GPCR,9.2924,True,332.463,-1.8177126204717453,True,3,0,2,2,46.53,5,1,3,3,54,1,5.0
CHRM2,antagonist,ipratropium,0.37,Muscarinic acetylcholine receptor M2,GPCR,8.8239,True,332.463,-1.8177126204717453,True,3,0,2,2,46.53,5,1,3,3,54,1,5.0
CHRM5,antagonist,ipratropium,0.08,Muscarinic acetylcholine receptor M5,GPCR,8.7696,True,332.463,-1.8177126204717453,True,3,0,2,2,46.53,5,1,3,3,54,1,5.0
CHRM4,antagonist,ipratropium,0.08,Muscarinic acetylcholine receptor M4,GPCR,9.1805,True,332.463,-1.8177126204717453,True,3,0,2,2,46.53,5,1,3,3,54,1,5.0
ESR1,agonist,diethylstilbestrol,0.1,Estrogen receptor,Nuclear hormone receptor,9.66,True,268.356,5.193882748,False,9,6,1,5,40.46,4,2,2,2,40,0,0.0
ESR2,agonist,diethylstilbestrol,0.07,Estrogen receptor beta,Nuclear hormone receptor,9.2,True,268.356,5.193882748,False,9,6,1,5,40.46,4,2,2,2,40,0,0.0
ESRRG,agonist,diethylstilbestrol,0.93,Estrogen-related receptor gamma,Nuclear hormone receptor,5.3,True,268.356,5.193882748,False,9,6,1,5,40.46,4,2,2,2,40,0,0.0
FLT4,inhibitor,lenvatinib,0.27,Vascular endothelial growth factor receptor 3,Kinase,8.28399658203125,True,426.86,2.5216067953333337,True,10,8,0,8,115.57,6,3,5,4,49,0,0.0
KIT,inhibitor,lenvatinib,0.16,Mast/stem cell growth factor receptor Kit,Kinase,7.0,True,426.86,2.5216067953333337,True,10,8,0,8,115.57,6,3,5,4,49,0,0.0
PDGFRA,inhibitor,lenvatinib,0.18,Platelet-derived growth factor receptor alpha,Kinase,7.2924299240112305,True,426.86,2.5216067953333337,True,10,8,0,8,115.57,6,3,5,4,49,0,0.0
CYP17A1,inhibitor,ketoconazole,0.31,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,7.28,True,531.431,4.191597861333333,False,7,18,2,3,69.06,7,0,7,5,64,0,2.0
KCNA10,blocker,ketoconazole,0.31,Potassium voltage-gated channel subfamily A member 10,Ion channel,6.3,True,531.431,4.191597861333333,False,7,18,2,3,69.06,7,0,7,5,64,0,2.0
CYP21A2,inhibitor,ketoconazole,4.37,Cytochrome P450 21,Enzyme,5.05,True,531.431,4.191597861333333,False,7,18,2,3,69.06,7,0,7,5,64,0,2.0
NR1I2,antagonist,ketoconazole,0.04,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,,True,531.431,4.191597861333333,False,7,18,2,3,69.06,7,0,7,5,64,0,2.0
KCNH2,inhibitor,ketoconazole,0.01,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.72,True,531.431,4.191597861333333,False,7,18,2,3,69.06,7,0,7,5,64,0,2.0
AR,antagonist,mifepristone,0.01,Androgen receptor,Nuclear hormone receptor,8.33,True,429.5937,5.133287652333334,False,4,5,0,5,40.54,2,1,3,5,67,0,5.0
NR1I2,agonist,mifepristone,0.06,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,5.0,True,429.5937,5.133287652333334,False,4,5,0,5,40.54,2,1,3,5,67,0,5.0
PTGER3,agonist,dinoprostone,2.67,Prostaglandin E2 receptor EP3 subtype,GPCR,9.48,True,352.4651,3.2252701369999994,True,5,0,0,16,94.83,12,3,4,1,57,0,4.0
PTGDR2,agonist,dinoprostone,0.55,Prostaglandin D2 receptor 2,GPCR,5.3,True,352.4651,3.2252701369999994,True,5,0,0,16,94.83,12,3,4,1,57,0,4.0
HTR6,antagonist,zotepine,0.14,5-hydroxytryptamine receptor 6,GPCR,8.3,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR7,antagonist,zotepine,0.11,5-hydroxytryptamine receptor 7,GPCR,8.4,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR2C,antagonist,zotepine,0.03,5-hydroxytryptamine receptor 2C,GPCR,8.54,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
DRD4,antagonist,zotepine,0.05,D(4) dopamine receptor,GPCR,7.41,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR1E,antagonist,zotepine,0.1,5-hydroxytryptamine receptor 1E,GPCR,6.5,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR1D,antagonist,zotepine,0.05,5-hydroxytryptamine receptor 1D,GPCR,9.3,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR1A,antagonist,zotepine,0.02,5-hydroxytryptamine receptor 1A,GPCR,6.48,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
DRD2,antagonist,zotepine,0.05,D(2) dopamine receptor,GPCR,7.96,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
SLC6A2,antagonist,zotepine,0.09,Sodium-dependent noradrenaline transporter,Transporter,7.15,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
DRD1,antagonist,zotepine,0.02,D(1A) dopamine receptor,GPCR,7.54,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HRH1,antagonist,zotepine,0.02,Histamine H1 receptor,GPCR,9.21,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
DRD3,antagonist,zotepine,0.04,D(3) dopamine receptor,GPCR,8.19,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
HTR1B,antagonist,zotepine,0.05,5-hydroxytryptamine receptor 1B,GPCR,7.2,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
SLC6A4,antagonist,zotepine,0.08,Sodium-dependent serotonin transporter,Transporter,6.82102298736572,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
ADRA2B,antagonist,zotepine,0.04,Alpha-2B adrenergic receptor,GPCR,8.2725772857666,True,331.86,4.510560188,True,7,2,0,0,12.47,4,0,3,3,40,0,0.0
TUBB,inhibitor,paclitaxel,0.14,Tubulin beta chain,Structural,8.05,True,853.9061,3.5388400199999985,False,6,6,0,6,221.29,10,4,14,7,113,0,11.0
NR1I2,inducer,paclitaxel,0.02,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,5.3,True,853.9061,3.5388400199999985,False,6,6,0,6,221.29,10,4,14,7,113,0,11.0
KIT,inhibitor,sorafenib,0.26,Mast/stem cell growth factor receptor Kit,Kinase,7.8,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
FLT3,antagonist,sorafenib,0.29,Receptor-type tyrosine-protein kinase FLT3,Kinase,8.35,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
FLT1,inhibitor,sorafenib,0.07,Vascular endothelial growth factor receptor 1,Kinase,7.51,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
DDR2,inhibitor,sorafenib,0.07,Discoidin domain-containing receptor 2,Kinase,8.18,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
BRAF,inhibitor,sorafenib,0.26,Serine/threonine-protein kinase B-raf,Kinase,7.66,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
CDK19,inhibitor,sorafenib,0.06,Cyclin-dependent kinase 19,Kinase,6.6,True,464.825,4.343329760666666,True,10,11,0,6,92.35,5,3,4,3,48,0,0.0
HTR2C,antagonist,duloxetine,0.02,5-hydroxytryptamine receptor 2C,GPCR,6.0,True,297.415,4.197729191333333,True,3,6,2,1,21.26,6,1,3,3,40,0,1.0
SLC6A3,inhibitor,duloxetine,0.2,Sodium-dependent dopamine transporter,Transporter,6.62,True,297.415,4.197729191333333,True,3,6,2,1,21.26,6,1,3,3,40,0,1.0
HTR6,antagonist,duloxetine,0.05,5-hydroxytryptamine receptor 6,GPCR,6.4,True,297.415,4.197729191333333,True,3,6,2,1,21.26,6,1,3,3,40,0,1.0
HTR2A,antagonist,duloxetine,0.01,5-hydroxytryptamine receptor 2A,GPCR,6.3,True,297.415,4.197729191333333,True,3,6,2,1,21.26,6,1,3,3,40,0,1.0
ADRB2,agonist,salmeterol,1.32,Beta-2 adrenergic receptor,GPCR,9.41,True,415.5656,3.6146962067229897,True,3,4,2,3,81.95,16,4,5,2,67,0,1.0
ADRB3,inverse agonist,salmeterol,0.44,Beta-3 adrenergic receptor,GPCR,6.0,True,415.5656,3.6146962067229897,True,3,4,2,3,81.95,16,4,5,2,67,0,1.0
DRD1,antagonist,asenapine,0.06,D(1A) dopamine receptor,GPCR,8.7,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR2A,antagonist,asenapine,0.08,5-hydroxytryptamine receptor 2A,GPCR,9.61,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
DRD3,antagonist,asenapine,0.13,D(3) dopamine receptor,GPCR,9.06,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR2C,antagonist,asenapine,0.1,5-hydroxytryptamine receptor 2C,GPCR,9.93,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR2B,antagonist,asenapine,0.13,5-hydroxytryptamine receptor 2B,GPCR,9.8,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR6,antagonist,asenapine,0.25,5-hydroxytryptamine receptor 6,GPCR,9.22,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HRH1,antagonist,asenapine,0.07,Histamine H1 receptor,GPCR,9.0,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR5A,antagonist,asenapine,0.61,5-hydroxytryptamine receptor 5A,GPCR,8.6,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
ADRB2,antagonist,asenapine,0.05,Beta-2 adrenergic receptor,GPCR,5.3010299960000005,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR1B,agonist,asenapine,0.17,5-hydroxytryptamine receptor 1B,GPCR,8.4,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR1E,agonist,asenapine,0.07,5-hydroxytryptamine receptor 1E,GPCR,8.0,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
ADRA2A,antagonist,asenapine,0.06,Alpha-2A adrenergic receptor,GPCR,8.187086642999999,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR1D,agonist,asenapine,0.04,5-hydroxytryptamine receptor 1D,GPCR,8.4,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
ADRB1,antagonist,asenapine,0.06,Beta-1 adrenergic receptor,GPCR,5.3010299960000005,True,401.84,3.724606573666666,True,20,4,2,0,12.47,0,0,2,4,36,0,2.0
HTR2A,antagonist,promazine,0.13,5-hydroxytryptamine receptor 2A,GPCR,7.7959,True,284.4190000000001,3.930955566,True,6,5,0,0,6.48,4,0,3,3,40,0,0.0
DRD2,antagonist,promazine,0.12,D(2) dopamine receptor,GPCR,6.7037,True,284.4190000000001,3.930955566,True,6,5,0,0,6.48,4,0,3,3,40,0,0.0
CHRM1,antagonist,promazine,0.12,Muscarinic acetylcholine receptor M1,GPCR,6.825,True,284.4190000000001,3.930955566,True,6,5,0,0,6.48,4,0,3,3,40,0,0.0
DRD3,antagonist,promazine,0.03,D(3) dopamine receptor,GPCR,6.7986,True,284.4190000000001,3.930955566,True,6,5,0,0,6.48,4,0,3,3,40,0,0.0
JAK2,inhibitor,ruxolitinib,2.91,Tyrosine-protein kinase JAK2,Kinase,10.44,True,306.365,2.4793218340000003,True,2,1,0,0,83.18,4,1,5,4,41,0,1.0
TYK2,inhibitor,ruxolitinib,0.14,Non-receptor tyrosine-protein kinase TYK2,Kinase,9.3,True,306.365,2.4793218340000003,True,2,1,0,0,83.18,4,1,5,4,41,0,1.0
JAK1,inhibitor,ruxolitinib,1.86,Tyrosine-protein kinase JAK1,Kinase,10.05,True,306.365,2.4793218340000003,True,2,1,0,0,83.18,4,1,5,4,41,0,1.0
PDGFRB,inhibitor,pazopanib,0.1,Platelet-derived growth factor receptor beta,Kinase,8.7,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
PDGFRA,inhibitor,pazopanib,0.11,Platelet-derived growth factor receptor alpha,Kinase,8.31,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
KIT,inhibitor,pazopanib,0.1,Mast/stem cell growth factor receptor Kit,Kinase,8.74,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
FGFR1,inhibitor,pazopanib,0.05,Fibroblast growth factor receptor 1,Kinase,6.0,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
FGFR3,inhibitor,pazopanib,0.12,Fibroblast growth factor receptor 3,Kinase,6.21,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
ITK,inhibitor,pazopanib,0.11,Tyrosine-protein kinase ITK/TSK,Kinase,,True,437.518,3.548707246333334,True,10,4,0,4,119.03,5,2,8,4,54,0,0.0
FLT1,inhibitor,vandetanib,0.06,Vascular endothelial growth factor receptor 1,Kinase,6.59,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
SRC,inhibitor,vandetanib,0.01,Proto-oncogene tyrosine-protein kinase Src,Kinase,7.15,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
FLT4,inhibitor,vandetanib,0.06,Vascular endothelial growth factor receptor 3,Kinase,6.52,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EGFR,inhibitor,vandetanib,0.15,Epidermal growth factor receptor,Kinase,8.32,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHB1,inhibitor,vandetanib,0.26,Ephrin type-B receptor 1,Kinase,6.54,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA4,inhibitor,vandetanib,0.52,Ephrin type-A receptor 4,Kinase,5.8,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
TEK,inhibitor,vandetanib,0.09,Angiopoietin-1 receptor,Kinase,6.0,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
PTK6,inhibitor,vandetanib,0.21,Protein-tyrosine kinase 6,Kinase,7.48,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA8,inhibitor,vandetanib,0.34,Ephrin type-A receptor 8,Kinase,7.04,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHB4,inhibitor,vandetanib,0.07,Ephrin type-B receptor 4,Kinase,6.28,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA5,inhibitor,vandetanib,0.21,Ephrin type-A receptor 5,Kinase,6.62,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
ERBB3,inhibitor,vandetanib,0.03,Receptor tyrosine-protein kinase erbB-3,Kinase,6.8,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA2,inhibitor,vandetanib,0.05,Ephrin type-A receptor 2,Kinase,5.96,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHB2,inhibitor,vandetanib,0.26,Ephrin type-B receptor 2,Kinase,6.36,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA1,inhibitor,vandetanib,0.52,Ephrin type-A receptor 1,Kinase,6.64,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
ERBB4,inhibitor,vandetanib,0.03,Receptor tyrosine-protein kinase erbB-4,Kinase,6.32,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
ERBB2,inhibitor,vandetanib,0.01,Receptor tyrosine-protein kinase erbB-2,Kinase,5.59,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHB6,inhibitor,vandetanib,0.52,Ephrin type-B receptor 6,Kinase,7.12,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA3,inhibitor,vandetanib,0.21,Ephrin type-A receptor 3,Kinase,5.74,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA7,inhibitor,vandetanib,0.26,Ephrin type-A receptor 7,Kinase,5.62,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
EPHA6,inhibitor,vandetanib,0.34,Ephrin type-A receptor 6,Kinase,7.3,True,475.354,4.542964749666666,True,5,3,2,4,59.51,6,1,6,4,54,0,0.0
HTR2A,agonist,lisuride,0.07,5-hydroxytryptamine receptor 2A,GPCR,9.061480275,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR1A,agonist,lisuride,0.22,5-hydroxytryptamine receptor 1A,GPCR,9.4,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR1B,agonist,lisuride,0.13,5-hydroxytryptamine receptor 1B,GPCR,7.7,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR2C,agonist,lisuride,0.1,5-hydroxytryptamine receptor 2C,GPCR,8.3,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
DRD5,antagonist,lisuride,0.27,D(1B) dopamine receptor,GPCR,8.5,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR2B,antagonist,lisuride,0.12,5-hydroxytryptamine receptor 2B,GPCR,8.48945499,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
DRD2,agonist,lisuride,0.11,D(2) dopamine receptor,GPCR,9.3,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
DRD3,agonist,lisuride,0.1,D(3) dopamine receptor,GPCR,8.77,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR1D,agonist,lisuride,0.15,5-hydroxytryptamine receptor 1D,GPCR,9.0,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
ADRA2C,antagonist,lisuride,0.1,Alpha-2C adrenergic receptor,GPCR,9.203425667000001,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
DRD4,agonist,lisuride,0.14,D(4) dopamine receptor,GPCR,8.3,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
ADRA1A,antagonist,lisuride,0.02,Alpha-1A adrenergic receptor,GPCR,8.3,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
HTR6,agonist,lisuride,0.07,5-hydroxytryptamine receptor 6,GPCR,8.258848401,True,338.4466,2.1692287139999995,True,15,1,0,0,51.37,3,2,2,4,51,0,2.0
DDR1,antagonist,imatinib,1.88,Epithelial discoidin domain-containing receptor 1,Kinase,9.15,True,493.6027,4.377673055,True,9,9,2,6,86.28,7,2,7,5,68,0,0.0
DDR2,inhibitor,imatinib,0.09,Discoidin domain-containing receptor 2,Kinase,7.82,True,493.6027,4.377673055,True,9,9,2,6,86.28,7,2,7,5,68,0,0.0
,antagonist,niclosamide,,SARS-CoV-2,Virus,6.55,True,327.12,3.9096388419999997,True,1,2,0,0,92.47,3,2,4,2,29,0,0.0
CHRM1,inhibitor,escitalopram,0.04,Muscarinic acetylcholine receptor M1,GPCR,5.905878404,True,324.3919,3.764304206333334,True,11,4,0,1,36.26,5,0,3,3,45,0,1.0
ADRA1A,inhibitor,escitalopram,0.05,Alpha-1A adrenergic receptor,GPCR,5.412289035,True,324.3919,3.764304206333334,True,11,4,0,1,36.26,5,0,3,3,45,0,1.0
SLC6A4,inhibitor,escitalopram,0.32,Sodium-dependent serotonin transporter,Transporter,8.9586,True,324.3919,3.764304206333334,True,11,4,0,1,36.26,5,0,3,3,45,0,1.0
SLC6A2,inhibitor,escitalopram,0.08,Sodium-dependent noradrenaline transporter,Transporter,5.186152246,True,324.3919,3.764304206333334,True,11,4,0,1,36.26,5,0,3,3,45,0,1.0
HRH1,inhibitor,escitalopram,0.05,Histamine H1 receptor,GPCR,5.705533774,True,324.3919,3.764304206333334,True,11,4,0,1,36.26,5,0,3,3,45,0,1.0
HRH1,antagonist,doxepin,0.21,Histamine H1 receptor,GPCR,9.75,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HRH2,antagonist,doxepin,0.26,Histamine H2 receptor,GPCR,5.736127323,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
ADRA1D,antagonist,doxepin,0.13,Alpha-1D adrenergic receptor,GPCR,7.366531544,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR2C,antagonist,doxepin,0.07,5-hydroxytryptamine receptor 2C,GPCR,7.0,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
CHRM5,antagonist,doxepin,0.14,Muscarinic acetylcholine receptor M5,GPCR,7.1249,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
SLC6A4,inhibitor,doxepin,0.16,Sodium-dependent serotonin transporter,Transporter,7.17,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HRH4,binder,doxepin,0.07,Histamine H4 receptor,GPCR,6.79,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
ADRA1A,antagonist,doxepin,0.05,Alpha-1A adrenergic receptor,GPCR,7.6289,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
CHRM1,antagonist,doxepin,0.09,Muscarinic acetylcholine receptor M1,GPCR,7.4202,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR2B,antagonist,doxepin,0.12,5-hydroxytryptamine receptor 2B,GPCR,7.2,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR2A,antagonist,doxepin,0.06,5-hydroxytryptamine receptor 2A,GPCR,7.45,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
SLC6A2,inhibitor,doxepin,0.18,Sodium-dependent noradrenaline transporter,Transporter,7.53,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR6,binder,doxepin,0.05,5-hydroxytryptamine receptor 6,GPCR,6.98,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR1A,antagonist,doxepin,0.05,5-hydroxytryptamine receptor 1A,GPCR,6.5376,True,279.3761,3.8399740746666673,True,19,5,2,1,12.47,3,0,2,3,42,0,0.0
HTR2C,antagonist,ziprasidone,0.11,5-hydroxytryptamine receptor 2C,GPCR,8.89,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HRH1,antagonist,ziprasidone,0.05,Histamine H1 receptor,GPCR,7.33,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
DRD2,antagonist,ziprasidone,0.09,D(2) dopamine receptor,GPCR,8.32,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR2A,antagonist,ziprasidone,0.09,5-hydroxytryptamine receptor 2A,GPCR,9.4,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
ADRA2B,antagonist,ziprasidone,0.04,Alpha-2B adrenergic receptor,GPCR,7.3187589645385716,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR3A,antagonist,ziprasidone,0.08,5-hydroxytryptamine receptor 3A,Ion channel,6.4,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
CHRM4,antagonist,ziprasidone,0.04,Muscarinic acetylcholine receptor M4,GPCR,5.795880017000001,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
CHRM1,antagonist,ziprasidone,0.02,Muscarinic acetylcholine receptor M1,GPCR,6.55,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
DRD5,antagonist,ziprasidone,0.09,D(1B) dopamine receptor,GPCR,6.81815624237061,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
ADRA2C,antagonist,ziprasidone,0.03,Alpha-2C adrenergic receptor,GPCR,7.11350917816162,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
ADRA1B,antagonist,ziprasidone,0.03,Alpha-1B adrenergic receptor,GPCR,8.04575729370117,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR1E,antagonist,ziprasidone,0.14,5-hydroxytryptamine receptor 1E,GPCR,6.44,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR1A,agonist,ziprasidone,0.12,5-hydroxytryptamine receptor 1A,GPCR,8.47,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR7,antagonist,ziprasidone,0.17,5-hydroxytryptamine receptor 7,GPCR,8.3,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
CHRM3,antagonist,ziprasidone,0.02,Muscarinic acetylcholine receptor M3,GPCR,5.0,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR1B,agonist,ziprasidone,0.08,5-hydroxytryptamine receptor 1B,GPCR,8.3,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
CHRM2,antagonist,ziprasidone,0.03,Muscarinic acetylcholine receptor M2,GPCR,5.522878745,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
CHRM5,antagonist,ziprasidone,0.04,Muscarinic acetylcholine receptor M5,GPCR,5.795880017000001,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
ADRA2A,antagonist,ziprasidone,0.02,Alpha-2A adrenergic receptor,GPCR,6.3,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
SLC6A4,inhibitor,ziprasidone,0.02,Sodium-dependent serotonin transporter,Transporter,7.0,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR6,antagonist,ziprasidone,0.06,5-hydroxytryptamine receptor 6,GPCR,7.22,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
HTR5A,antagonist,ziprasidone,0.29,5-hydroxytryptamine receptor 5A,GPCR,6.53610706329346,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
DRD1,antagonist,ziprasidone,0.02,D(1A) dopamine receptor,GPCR,8.02,True,412.936,4.304046458666667,True,26,2,2,1,48.47,4,1,5,5,49,0,0.0
AR,agonist,testosterone undecanoate,0.06,Androgen receptor,Nuclear hormone receptor,,True,456.711,8.063633875,False,3,15,2,10,43.37,10,0,3,4,81,0,6.0
BRAF,inhibitor,dasatinib,0.15,Serine/threonine-protein kinase B-raf,Kinase,6.3,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
CSF1R,inhibitor,dasatinib,0.01,Macrophage colony-stimulating factor 1 receptor,Kinase,9.24,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
HCK,inhibitor,dasatinib,0.06,Tyrosine-protein kinase HCK,Kinase,9.46,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
KIT,inhibitor,dasatinib,0.36,Mast/stem cell growth factor receptor Kit,Kinase,9.24,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
PDGFRB,inhibitor,dasatinib,0.1,Platelet-derived growth factor receptor beta,Kinase,9.2,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
LCK,multitarget,dasatinib,0.08,Tyrosine-protein kinase Lck,Kinase,9.7,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
SRC,inhibitor,dasatinib,0.16,Proto-oncogene tyrosine-protein kinase Src,Kinase,9.68,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
YES1,inhibitor,dasatinib,0.03,Tyrosine-protein kinase Yes,Kinase,9.52,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
FRK,inhibitor,dasatinib,0.07,Tyrosine-protein kinase FRK,Kinase,9.51,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
FGR,inhibitor,dasatinib,0.21,Tyrosine-protein kinase Fgr,Kinase,9.3,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
BLK,inhibitor,dasatinib,0.02,Tyrosine-protein kinase Blk,Kinase,9.68,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
SIK3,inhibitor,dasatinib,0.24,Serine/threonine-protein kinase SIK3,Kinase,7.55,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
SIK1,inhibitor,dasatinib,0.18,Serine/threonine-protein kinase SIK1,Kinase,8.41,True,488.006,3.820938309438929,True,23,6,0,2,106.51,7,3,9,4,59,0,0.0
ADRB2,antagonist,labetalol,0.29,Beta-2 adrenergic receptor,GPCR,7.958607315,True,328.4055,1.8865051835138016,True,3,5,2,1,95.58,8,4,4,2,48,0,2.0
ADRA1D,antagonist,labetalol,0.06,Alpha-1D adrenergic receptor,GPCR,7.638272164,True,328.4055,1.8865051835138016,True,3,5,2,1,95.58,8,4,4,2,48,0,2.0
ADA,inhibitor,pentostatin,12.91,Adenosine deaminase,Enzyme,10.8,True,268.2691,-2.016391028,True,1,0,0,0,112.13,2,4,8,3,35,0,4.0
SLC6A2,inhibitor,nortriptyline,0.3,Sodium-dependent noradrenaline transporter,Transporter,8.3595,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
DRD2,antagonist,nortriptyline,0.02,D(2) dopamine receptor,GPCR,5.590066877000001,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
HTR2A,antagonist,nortriptyline,0.05,5-hydroxytryptamine receptor 2A,GPCR,7.3565,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
HTR1A,antagonist,nortriptyline,0.06,5-hydroxytryptamine receptor 1A,GPCR,6.5086,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
ADRA1D,antagonist,nortriptyline,0.07,Alpha-1D adrenergic receptor,GPCR,6.910094889,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
CHRM1,antagonist,nortriptyline,0.03,Muscarinic acetylcholine receptor M1,GPCR,7.3979,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
ADRA2A,antagonist,nortriptyline,0.04,Alpha-2A adrenergic receptor,GPCR,6.560667306,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
HTR2C,"negative modulator,antagonist",nortriptyline,0.06,5-hydroxytryptamine receptor 2C,GPCR,8.0,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
KCNJ10,blocker,nortriptyline,0.3,ATP-sensitive inward rectifier potassium channel 10,Ion channel,4.79587984085083,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
HRH1,antagonist,nortriptyline,0.05,Histamine H1 receptor,GPCR,8.0325,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
ADRA1A,antagonist,nortriptyline,0.05,Alpha-1A adrenergic receptor,GPCR,7.2596,True,263.3767,4.426486977666667,True,15,6,2,2,12.03,3,1,1,3,41,0,0.0
DPP4,inhibitor,omarigliptin,1.47,Dipeptidyl peptidase 4,Enzyme,9.09691047668457,False,398.43,0.10002736666666716,True,0,0,0,0,90.45,3,1,7,4,47,0,3.0
CCR5,antagonist,maraviroc,23.39,C-C chemokine receptor type 5,GPCR,7.6,True,513.6655,3.626210654333332,False,1,1,0,0,63.05,8,1,5,5,78,0,4.0
KDR,inhibitor,sunitinib,0.25,Vascular endothelial growth factor receptor 2,Kinase,9.7,True,398.4738,2.9273768136666662,True,8,3,0,4,77.23,7,3,3,3,56,0,0.0
PDGFRB,inhibitor,sunitinib,0.23,Platelet-derived growth factor receptor beta,Kinase,10.12,True,398.4738,2.9273768136666662,True,8,3,0,4,77.23,7,3,3,3,56,0,0.0
KIT,inhibitor,sunitinib,0.64,Mast/stem cell growth factor receptor Kit,Kinase,9.68,True,398.4738,2.9273768136666662,True,8,3,0,4,77.23,7,3,3,3,56,0,0.0
FGFR1,inhibitor,sunitinib,0.01,Fibroblast growth factor receptor 1,Kinase,6.28,True,398.4738,2.9273768136666662,True,8,3,0,4,77.23,7,3,3,3,56,0,0.0
HTR2C,antagonist,sertindole,0.14,5-hydroxytryptamine receptor 2C,GPCR,9.7,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR6,antagonist,sertindole,0.29,5-hydroxytryptamine receptor 6,GPCR,8.3,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
KCNH2,inhibitor,sertindole,0.07,Potassium voltage-gated channel subfamily H member 2,Ion channel,8.57,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HRH1,antagonist,sertindole,0.02,Histamine H1 receptor,GPCR,9.29,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR1E,antagonist,sertindole,0.09,5-hydroxytryptamine receptor 1E,GPCR,6.4,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR1F,antagonist,sertindole,0.1,5-hydroxytryptamine receptor 1F,GPCR,6.4,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR1A,antagonist,sertindole,0.02,5-hydroxytryptamine receptor 1A,GPCR,7.48,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
DRD4,antagonist,sertindole,0.04,D(4) dopamine receptor,GPCR,7.96,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR1B,antagonist,sertindole,0.04,5-hydroxytryptamine receptor 1B,GPCR,7.25,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
HTR1D,antagonist,sertindole,0.04,5-hydroxytryptamine receptor 1D,GPCR,7.2,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
DRD3,antagonist,sertindole,0.03,D(3) dopamine receptor,GPCR,8.59,True,440.941,3.7738,True,8,2,0,0,40.51,5,1,3,5,57,0,0.0
AVPR2,antagonist,tolvaptan,5.61,Vasopressin V2 receptor,GPCR,9.0,True,448.941,5.350183720333334,False,2,1,0,1,69.64,3,2,3,4,57,0,1.0
AVPR1A,antagonist,tolvaptan,2.37,Vasopressin V1a receptor,GPCR,7.9,True,448.941,5.350183720333334,False,2,1,0,1,69.64,3,2,3,4,57,0,1.0
FRK,inhibitor,nintedanib,0.08,Tyrosine-protein kinase FRK,Kinase,5.57,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
PDGFRA,inhibitor,nintedanib,0.3,Platelet-derived growth factor receptor alpha,Kinase,7.744727611541751,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FGFR2,inhibitor,nintedanib,0.47,Fibroblast growth factor receptor 2,Kinase,6.46,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FGR,inhibitor,nintedanib,0.26,Tyrosine-protein kinase Fgr,Kinase,6.52,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
LYN,inhibitor,nintedanib,0.23,Tyrosine-protein kinase Lyn,Kinase,6.03,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
HCK,inhibitor,nintedanib,0.11,Tyrosine-protein kinase HCK,Kinase,5.28,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FGFR1,inhibitor,nintedanib,0.3,Fibroblast growth factor receptor 1,Kinase,7.4202165603637695,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FGFR4,inhibitor,nintedanib,0.16,Fibroblast growth factor receptor 4,Kinase,5.74,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
LCK,inhibitor,nintedanib,0.15,Tyrosine-protein kinase Lck,Kinase,8.21,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
SRC,inhibitor,nintedanib,0.11,Proto-oncogene tyrosine-protein kinase Src,Kinase,6.24,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
YES1,inhibitor,nintedanib,0.01,Tyrosine-protein kinase Yes,Kinase,7.1,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FLT3,inhibitor,nintedanib,0.11,Receptor-type tyrosine-protein kinase FLT3,Kinase,9.38,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
BLK,inhibitor,nintedanib,0.07,Tyrosine-protein kinase Blk,Kinase,6.42,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
FYN,inhibitor,nintedanib,0.07,Tyrosine-protein kinase Fyn,Kinase,6.2,True,539.6248,2.7898566030000005,False,12,5,1,3,94.55,7,1,7,5,73,0,0.0
DRD3,antagonist,remoxipride,0.11,D(3) dopamine receptor,GPCR,5.34,True,371.269,2.341989283666666,True,5,4,1,0,50.8,6,1,4,2,45,0,1.0
DRD4,antagonist,remoxipride,0.16,D(4) dopamine receptor,GPCR,5.41,True,371.269,2.341989283666666,True,5,4,1,0,50.8,6,1,4,2,45,0,1.0
SIGMAR1,antagonist,remoxipride,0.77,Sigma non-opioid intracellular receptor 1,Membrane receptor,7.26,True,371.269,2.341989283666666,True,5,4,1,0,50.8,6,1,4,2,45,0,1.0
NR3C2,agonist,budesonide,0.15,Mineralocorticoid receptor,Nuclear hormone receptor,7.85,True,430.5339,2.733890000333333,True,2,9,2,4,93.06,4,2,6,5,65,0,9.0
PGR,agonist,budesonide,0.06,Progesterone receptor,Transcription factor,7.5686362360000015,True,430.5339,2.733890000333333,True,2,9,2,4,93.06,4,2,6,5,65,0,9.0
IGF1R,inhibitor,brigatinib,0.54,Insulin-like growth factor 1 receptor,Kinase,7.13667726516724,True,584.1,3.6589999999999967,False,9,3,0,5,85.86,8,2,9,5,79,0,0.0
FLT3,inhibitor,brigatinib,0.17,Receptor-type tyrosine-protein kinase FLT3,Kinase,8.6777811050415,True,584.1,3.6589999999999967,False,9,3,0,5,85.86,8,2,9,5,79,0,0.0
INSR,binder,brigatinib,0.17,Insulin receptor,Kinase,6.79587984085083,True,584.1,3.6589999999999967,False,9,3,0,5,85.86,8,2,9,5,79,0,0.0
PTGS1,inhibitor,suprofen,2.84,Prostaglandin G/H synthase 1,Enzyme,5.96,True,260.308,3.526214794,True,2,3,1,1,54.37,4,1,3,2,30,0,1.0
RXRG,agonist,alitretinoin,4.34,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,6.66,True,300.4351,5.014367711,False,9,0,2,1,37.3,5,1,1,1,50,0,0.0
RARB,agonist,alitretinoin,3.47,Retinoic acid receptor beta,Nuclear hormone receptor,7.3,True,300.4351,5.014367711,False,9,0,2,1,37.3,5,1,1,1,50,0,0.0
RXRB,agonist,alitretinoin,3.25,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,6.7,True,300.4351,5.014367711,False,9,0,2,1,37.3,5,1,1,1,50,0,0.0
RARG,agonist,alitretinoin,2.15,Retinoic acid receptor gamma,Nuclear hormone receptor,7.13,True,300.4351,5.014367711,False,9,0,2,1,37.3,5,1,1,1,50,0,0.0
CA1,inhibitor,methocarbamol,1.17,Carbonic anhydrase 1,Enzyme,7.6,True,241.2405,0.4450462073333332,True,1,0,0,0,91.01,6,2,5,1,32,0,1.0
CHRM5,antagonist,hexocyclium,0.14,Muscarinic acetylcholine receptor M5,GPCR,8.4,True,317.496,-0.992857414471746,True,4,0,0,0,23.47,4,1,2,3,56,1,1.0
CHRM2,antagonist,hexocyclium,0.28,Muscarinic acetylcholine receptor M2,GPCR,7.6,True,317.496,-0.992857414471746,True,4,0,0,0,23.47,4,1,2,3,56,1,1.0
CHRM3,antagonist,hexocyclium,0.25,Muscarinic acetylcholine receptor M3,GPCR,8.9,True,317.496,-0.992857414471746,True,4,0,0,0,23.47,4,1,2,3,56,1,1.0
CHRM1,antagonist,hexocyclium,0.15,Muscarinic acetylcholine receptor M1,GPCR,,True,317.496,-0.992857414471746,True,4,0,0,0,23.47,4,1,2,3,56,1,1.0
CHRM4,antagonist,hexocyclium,0.42,Muscarinic acetylcholine receptor M4,GPCR,8.3,True,317.496,-0.992857414471746,True,4,0,0,0,23.47,4,1,2,3,56,1,1.0
NPR1,agonist,nesiritide,11.36,Atrial natriuretic peptide receptor 1,Enzyme,,True,3464.0,,False,3,0,0,0,1522.74,87,52,53,4,483,0,28.0
ADRB2,partial agonist,acebutolol,0.46,Beta-2 adrenergic receptor,GPCR,6.4,True,336.4259,1.5346815706666663,True,2,1,0,1,87.66,10,3,5,1,52,0,1.0
PGR,agonist,fluticasone propionate,,Progesterone receptor,Nuclear hormone receptor,9.77,True,500.571,3.718004615666666,False,4,4,2,2,80.67,4,1,6,4,65,0,9.0
NR3C2,agonist,fluticasone propionate,,Mineralocorticoid receptor,Nuclear hormone receptor,6.83,True,500.571,3.718004615666666,False,4,4,2,2,80.67,4,1,6,4,65,0,9.0
KCNK10,activator,halothane,0.44,Potassium channel subfamily K member 10,Ion channel,,True,197.382,2.11935513,True,17,5,1,0,0.0,0,0,0,0,8,0,1.0
KCNK9,binder,halothane,0.83,Potassium channel subfamily K member 9,Ion channel,,True,197.382,2.11935513,True,17,5,1,0,0.0,0,0,0,0,8,0,1.0
KCNK3,activator,halothane,0.73,Potassium channel subfamily K member 3,Ion channel,,True,197.382,2.11935513,True,17,5,1,0,0.0,0,0,0,0,8,0,1.0
KCNK2,activator,halothane,0.24,Potassium channel subfamily K member 2,Ion channel,,True,197.382,2.11935513,True,17,5,1,0,0.0,0,0,0,0,8,0,1.0
NR3C2,agonist,desoxycorticosterone pivalate,6.86,Mineralocorticoid receptor,Nuclear hormone receptor,11.0,False,414.586,5.572018192333333,False,1,1,0,0,60.44,3,0,4,4,68,0,6.0
SV2A,modulator,levetiracetam,22.32,Synaptic vesicle glycoprotein 2A,Transporter,6.099999904632571,True,170.21200000000005,-0.5936059006666665,True,2,0,0,1,63.4,3,1,2,1,26,0,1.0
ASIC3,blocker,amiloride,0.39,Acid-sensing ion channel 3,Ion channel,5.36,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
ASIC1,blocker,amiloride,5.05,Acid-sensing ion channel 1,Ion channel,5.0,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
SLC9A5,inhibitor,amiloride,3.16,Sodium/hydrogen exchanger 5,Unclassified,4.68,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
SCNN1A,inhibitor,amiloride,7.1,Amiloride-sensitive sodium channel subunit alpha,Ion channel,6.11,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
ASIC2,inhibitor,amiloride,4.42,Acid-sensing ion channel 2,Ion channel,4.6,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
PLAU,inhibitor,amiloride,0.46,Urokinase-type plasminogen activator,Enzyme,5.16,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
SLC9A1,inhibitor,amiloride,6.31,Sodium/hydrogen exchanger 1,Transporter,4.22,True,229.627,-0.4954324606666666,True,9,2,0,2,156.79,1,5,6,1,23,0,0.0
DRD2,antagonist,olanzapine,0.16,D(2) dopamine receptor,GPCR,8.5229,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
ADRA1A,antagonist,olanzapine,0.02,Alpha-1A adrenergic receptor,GPCR,7.7212,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
HTR2C,antagonist,olanzapine,0.18,5-hydroxytryptamine receptor 2C,GPCR,7.9586,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
DRD5,antagonist,olanzapine,0.11,D(1B) dopamine receptor,GPCR,7.0458,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
DRD4,antagonist,olanzapine,0.08,D(4) dopamine receptor,GPCR,8.7959,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
HTR3A,antagonist,olanzapine,0.05,5-hydroxytryptamine receptor 3A,Ion channel,6.6946,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
HRH1,antagonist,olanzapine,0.05,Histamine H1 receptor,GPCR,8.1549,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
CHRM1,antagonist,olanzapine,0.04,Muscarinic acetylcholine receptor M1,GPCR,7.506,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
ADRB1,inhibitor,olanzapine,0.01,Beta-1 adrenergic receptor,GPCR,5.3010299960000005,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
HTR1D,agonist,olanzapine,0.04,5-hydroxytryptamine receptor 1D,GPCR,6.1207,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
CHRM4,antagonist,olanzapine,0.06,Muscarinic acetylcholine receptor M4,GPCR,7.6819,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
DRD3,antagonist,olanzapine,0.07,D(3) dopamine receptor,GPCR,8.0969,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
HTR1F,agonist,olanzapine,0.03,5-hydroxytryptamine receptor 1F,GPCR,6.5086,True,312.432,3.3884950820000004,True,20,8,2,1,30.87,0,1,5,4,42,0,0.0
GABRA1,positive modulator,eszopiclone,0.2,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,7.300000190734861,True,388.80800000000005,0.8065430329999994,True,5,2,0,0,96.35,2,1,7,4,44,0,1.0
GABRA2,agonist,eszopiclone,0.18,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,6.94,True,388.80800000000005,0.8065430329999994,True,5,2,0,0,96.35,2,1,7,4,44,0,1.0
GABRA4,positive modulator,eszopiclone,0.04,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,6.99,True,388.80800000000005,0.8065430329999994,True,5,2,0,0,96.35,2,1,7,4,44,0,1.0
HTR2A,antagonist,mianserin,0.06,5-hydroxytryptamine receptor 2A,GPCR,8.17,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HRH1,antagonist,mianserin,0.07,Histamine H1 receptor,GPCR,9.2454,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR6,binder,mianserin,0.08,5-hydroxytryptamine receptor 6,GPCR,7.1748,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
DRD2,antagonist,mianserin,0.02,D(2) dopamine receptor,GPCR,5.66,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR1F,binder,mianserin,0.07,5-hydroxytryptamine receptor 1F,GPCR,8.06,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR2C,antagonist,mianserin,0.08,5-hydroxytryptamine receptor 2C,GPCR,8.5204,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HRH4,binder,mianserin,0.06,Histamine H4 receptor,GPCR,6.1249,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA2C,antagonist,mianserin,0.02,Alpha-2C adrenergic receptor,GPCR,8.4202,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
SLC6A4,inhibitor,mianserin,0.05,Sodium-dependent serotonin transporter,Transporter,5.3979401588439915,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR7,antagonist,mianserin,0.1,5-hydroxytryptamine receptor 7,GPCR,7.06,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR2B,binder,mianserin,0.05,5-hydroxytryptamine receptor 2B,GPCR,8.12,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
SLC6A2,inhibitor,mianserin,0.05,Sodium-dependent noradrenaline transporter,Transporter,7.1487,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
HTR1A,blocker,mianserin,0.01,5-hydroxytryptamine receptor 1A,GPCR,6.13,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA1D,antagonist,mianserin,0.03,Alpha-1D adrenergic receptor,GPCR,7.5,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA2B,antagonist,mianserin,0.02,Alpha-2B adrenergic receptor,GPCR,7.5686,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
DRD1,binder,mianserin,0.02,D(1A) dopamine receptor,GPCR,6.0,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA1A,antagonist,mianserin,0.02,Alpha-1A adrenergic receptor,GPCR,7.37,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
SLC6A3,binder,mianserin,0.05,Sodium-dependent dopamine transporter,Transporter,5.02687215805054,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
DRD3,binder,mianserin,0.02,D(3) dopamine receptor,GPCR,5.55,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA1B,antagonist,mianserin,0.02,Alpha-1B adrenergic receptor,GPCR,7.4,True,264.3648,3.8311976519999993,True,20,4,0,0,6.48,0,0,2,4,40,0,1.0
ADRA2C,agonist,guanfacine,0.08,Alpha-2C adrenergic receptor,GPCR,5.68,True,246.093,1.7370317963333333,True,2,2,0,3,78.97,2,3,2,1,24,0,0.0
ADRA2B,binder,guanfacine,0.26,Alpha-2B adrenergic receptor,GPCR,5.9257,True,246.093,1.7370317963333333,True,2,2,0,3,78.97,2,3,2,1,24,0,0.0
NR3C1,agonist,desoximetasone,0.74,Glucocorticoid receptor,Nuclear hormone receptor,8.931814138,True,376.4617,2.3510410726666664,True,1,0,0,0,74.6,2,2,4,4,56,0,8.0
,modulator,deferasirox,,iron,Inorganic material,,True,373.3615,4.744616195333334,True,1,6,0,0,108.47,4,3,6,4,43,0,0.0
PDE3B,inhibitor,theophylline,0.15,Uncharacterized protein,Enzyme,4.11,True,180.164,-0.7693216573333334,True,14,7,0,1,72.68,0,1,5,2,21,0,0.0
ADORA2A,antagonist,theophylline,0.19,Adenosine A2a receptor,Unclassified,4.89,True,180.164,-0.7693216573333334,True,14,7,0,1,72.68,0,1,5,2,21,0,0.0
PDE3A,inhibitor,theophylline,0.51,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,3.85,True,180.164,-0.7693216573333334,True,14,7,0,1,72.68,0,1,5,2,21,0,0.0
ADORA3,antagonist,theophylline,0.09,Adenosine receptor A3,GPCR,7.85,True,180.164,-0.7693216573333334,True,14,7,0,1,72.68,0,1,5,2,21,0,0.0
HRH4,inverse agonist,pheniramine,1.08,Histamine H4 receptor,GPCR,5.37840843200684,True,240.3434,2.9809062386666665,True,3,0,0,0,16.13,5,0,2,2,38,0,1.0
ADRB2,antagonist,levobunolol,1.27,Beta-2 adrenergic receptor,GPCR,9.262807357,True,291.3853,2.1826746933333334,True,2,1,0,0,58.56,5,2,4,2,46,0,1.0
ADRB3,antagonist,levobunolol,0.36,Beta-3 adrenergic receptor,GPCR,6.59345982,True,291.3853,2.1826746933333334,True,2,1,0,0,58.56,5,2,4,2,46,0,1.0
,negative modulator,methoxsalen,,DNA,DNA,,True,216.192,1.7848117503333332,True,1,4,0,0,52.58,1,0,4,3,24,0,0.0
HTR2A,antagonist,clozapine,0.06,5-hydroxytryptamine receptor 2A,GPCR,8.3,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR1E,agonist,clozapine,0.06,5-hydroxytryptamine receptor 1E,GPCR,6.4,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA1B,antagonist,clozapine,0.02,Alpha-1B adrenergic receptor,GPCR,7.98,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR2B,antagonist,clozapine,0.01,5-hydroxytryptamine receptor 2B,GPCR,8.26,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HRH4,antagonist,clozapine,0.16,Histamine H4 receptor,GPCR,8.23,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
CHRM4,antagonist,clozapine,0.02,Muscarinic acetylcholine receptor M4,GPCR,7.2218,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HRH1,antagonist,clozapine,0.03,Histamine H1 receptor,GPCR,9.2,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR6,antagonist,clozapine,0.04,5-hydroxytryptamine receptor 6,GPCR,7.95,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR3A,antagonist,clozapine,0.06,5-hydroxytryptamine receptor 3A,Ion channel,7.28,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR1D,agonist,clozapine,0.03,5-hydroxytryptamine receptor 1D,GPCR,6.4,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
CHRM2,antagonist,clozapine,0.01,Muscarinic acetylcholine receptor M2,GPCR,7.3,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA2C,antagonist,clozapine,0.01,Alpha-2C adrenergic receptor,GPCR,8.54,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
CHRM1,allosteric modulator,clozapine,0.01,Muscarinic acetylcholine receptor M1,GPCR,8.1813,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR1F,agonist,clozapine,0.02,5-hydroxytryptamine receptor 1F,GPCR,6.9,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR5A,antagonist,clozapine,0.04,5-hydroxytryptamine receptor 5A,GPCR,6.0,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA2B,antagonist,clozapine,0.02,Alpha-2B adrenergic receptor,GPCR,7.42,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA2A,antagonist,clozapine,0.01,Alpha-2A adrenergic receptor,GPCR,7.1541,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
CHRM5,antagonist,clozapine,0.02,Muscarinic acetylcholine receptor M5,GPCR,7.7916,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA1A,antagonist,clozapine,0.01,Alpha-1A adrenergic receptor,GPCR,8.1,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
DRD5,antagonist,clozapine,0.02,D(1B) dopamine receptor,GPCR,6.5941,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
ADRA1D,antagonist,clozapine,0.01,Alpha-1D adrenergic receptor,GPCR,7.7,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR1B,antagonist,clozapine,0.03,5-hydroxytryptamine receptor 1B,GPCR,6.2,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
CHRM3,antagonist,clozapine,0.01,Muscarinic acetylcholine receptor M3,GPCR,7.5911,True,326.823,3.400241024333333,True,27,10,0,1,30.87,0,1,4,4,42,0,0.0
HTR2B,agonist,pergolide,0.27,5-hydroxytryptamine receptor 2B,GPCR,8.2,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA2A,agonist,pergolide,0.09,Alpha-2A adrenergic receptor,GPCR,7.3,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR1A,agonist,pergolide,0.08,5-hydroxytryptamine receptor 1A,GPCR,8.5,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA1A,agonist,pergolide,0.04,Alpha-1A adrenergic receptor,GPCR,5.98,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR2C,agonist,pergolide,0.12,5-hydroxytryptamine receptor 2C,GPCR,6.5,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR1B,agonist,pergolide,0.16,5-hydroxytryptamine receptor 1B,GPCR,6.6,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR2A,agonist,pergolide,0.1,5-hydroxytryptamine receptor 2A,GPCR,8.1,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
DRD5,agonist,pergolide,0.26,D(1B) dopamine receptor,GPCR,6.76,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
DRD4,agonist,pergolide,0.17,D(4) dopamine receptor,GPCR,7.25,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR1D,agonist,pergolide,0.19,5-hydroxytryptamine receptor 1D,GPCR,7.9,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
DRD3,agonist,pergolide,0.16,D(3) dopamine receptor,GPCR,9.0,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA2B,agonist,pergolide,0.1,Alpha-2B adrenergic receptor,GPCR,7.5,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA1D,agonist,pergolide,0.09,Alpha-1D adrenergic receptor,GPCR,6.1284270639999985,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA2C,agonist,pergolide,0.09,Alpha-2C adrenergic receptor,GPCR,7.2,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
ADRA1B,agonist,pergolide,0.06,Alpha-1B adrenergic receptor,GPCR,6.16,True,314.488,4.225289858,True,15,1,0,0,19.03,4,1,2,4,48,0,3.0
HTR1E,antagonist,fluspirilene,0.07,5-hydroxytryptamine receptor 1E,GPCR,5.6,True,475.5727,5.778034304,False,3,1,0,0,35.58,7,1,3,5,66,0,0.0
HTR2A,antagonist,fluspirilene,0.04,5-hydroxytryptamine receptor 2A,GPCR,8.0,True,475.5727,5.778034304,False,3,1,0,0,35.58,7,1,3,5,66,0,0.0
HRH1,antagonist,fluspirilene,0.01,Histamine H1 receptor,GPCR,7.9,True,475.5727,5.778034304,False,3,1,0,0,35.58,7,1,3,5,66,0,0.0
HTR1A,antagonist,fluspirilene,0.02,5-hydroxytryptamine receptor 1A,GPCR,7.2,True,475.5727,5.778034304,False,3,1,0,0,35.58,7,1,3,5,66,0,0.0
HTR1D,antagonist,fluspirilene,0.04,5-hydroxytryptamine receptor 1D,GPCR,6.0,True,475.5727,5.778034304,False,3,1,0,0,35.58,7,1,3,5,66,0,0.0
PTGS2,inhibitor,mesalazine,0.2,Prostaglandin G/H synthase 2,Enzyme,,True,153.1354,-0.28978240563320434,True,8,1,0,0,83.55,1,3,3,1,18,0,0.0
PTGS1,inhibitor,tolmetin,1.2,Prostaglandin G/H synthase 1,Enzyme,6.27,True,257.2845,2.7273309576666667,True,2,2,1,1,59.3,4,1,3,2,34,0,0.0
PTGS2,inhibitor,meloxicam,1.48,Prostaglandin G/H synthase 2,Enzyme,6.8,True,351.401,1.6005813606666672,True,2,4,1,2,96.44,2,1,6,3,36,0,0.0
PTGS1,inhibitor,meloxicam,0.62,Prostaglandin G/H synthase 1,Enzyme,5.85,True,351.401,1.6005813606666672,True,2,4,1,2,96.44,2,1,6,3,36,0,0.0
MET,inhibitor,crizotinib,1.42,Hepatocyte growth factor receptor,Kinase,9.26,True,450.337,3.5741167396666658,True,2,4,0,1,77.99,5,2,6,4,52,0,1.0
EDNRA,antagonist,ambrisentan,9.97,Endothelin-1 receptor,GPCR,9.65,True,378.42800000000005,3.499580326970246,True,2,6,0,3,81.54,7,1,5,3,50,0,1.0
EDNRB,antagonist,ambrisentan,12.05,Endothelin B receptor,GPCR,6.98,True,378.42800000000005,3.499580326970246,True,2,6,0,3,81.54,7,1,5,3,50,0,1.0
SLCO2B1,inhibitor,erlotinib,0.04,Solute carrier organic anion transporter family member 2B1,Unclassified,6.28,True,393.4357,3.2009875863333344,True,2,8,2,3,74.73,10,1,7,3,52,0,0.0
EGFR,inhibitor,erlotinib,1.05,Epidermal growth factor receptor,Kinase,9.22,True,393.4357,3.2009875863333344,True,2,8,2,3,74.73,10,1,7,3,52,0,0.0
HTR2C,"antagonist,binder",imipramine,0.04,5-hydroxytryptamine receptor 2C,GPCR,6.7959,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
CHRM5,antagonist,imipramine,0.04,Muscarinic acetylcholine receptor M5,GPCR,7.0809,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
HRH1,antagonist,imipramine,0.02,Histamine H1 receptor,GPCR,7.6138,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
ADRA1A,antagonist,imipramine,0.03,Alpha-1A adrenergic receptor,GPCR,7.4949,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
KCNH1,blocker,imipramine,0.44,Potassium voltage-gated channel subfamily H member 1,Ion channel,5.7,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
SLC6A4,inhibitor,imipramine,0.22,Sodium-dependent serotonin transporter,Transporter,8.8539,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
CHRM2,antagonist,imipramine,0.04,Muscarinic acetylcholine receptor M2,GPCR,8.08,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
SLC6A3,inhibitor,imipramine,0.04,Sodium-dependent dopamine transporter,Transporter,5.07058095932007,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
HTR2A,antagonist,imipramine,0.03,5-hydroxytryptamine receptor 2A,GPCR,6.8249,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
DRD2,binder,imipramine,0.02,D(2) dopamine receptor,GPCR,6.1733,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
CHRM4,antagonist,imipramine,0.04,Muscarinic acetylcholine receptor M4,GPCR,6.9508,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
CHRM1,antagonist,imipramine,0.02,Muscarinic acetylcholine receptor M1,GPCR,7.3768,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
CHRM3,antagonist,imipramine,0.03,Muscarinic acetylcholine receptor M3,GPCR,7.2218,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
HTR1A,activator,imipramine,0.02,5-hydroxytryptamine receptor 1A,GPCR,5.23657178878784,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
KCNH2,inhibitor,imipramine,0.01,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.9,True,280.4073,4.278568794333332,True,24,8,2,4,6.48,4,0,2,3,45,0,0.0
HRH1,antagonist,mepyramine,0.49,Histamine H1 receptor,GPCR,9.5,True,285.384,3.0435211516666665,True,1,1,0,2,28.6,7,0,4,2,44,0,0.0
ABCC5,inhibitor,sildenafil,0.49,Multidrug resistance-associated protein 5,Transporter,5.92,True,474.576,1.8692007716666668,True,3,7,0,5,113.42,7,1,8,4,63,0,0.0
SLCO1B3,inhibitor,sildenafil,0.16,Solute carrier organic anion transporter family member 1B3,Transporter,6.1,True,474.576,1.8692007716666668,True,3,7,0,5,113.42,7,1,8,4,63,0,0.0
PDE5A,inhibitor,sildenafil,2.1,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,9.0,True,474.576,1.8692007716666668,True,3,7,0,5,113.42,7,1,8,4,63,0,0.0
PDE6C,inhibitor,sildenafil,1.46,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,7.41,True,474.576,1.8692007716666668,True,3,7,0,5,113.42,7,1,8,4,63,0,0.0
ADRB2,agonist,indacaterol,0.52,Beta-2 adrenergic receptor,GPCR,7.8,True,392.4907,3.2633259742508973,True,1,2,0,1,85.35,6,4,4,4,57,0,1.0
CA7,inhibitor,ethoxzolamide,1.09,Carbonic anhydrase 7,Enzyme,9.15,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA2,inhibitor,ethoxzolamide,0.23,Carbonic anhydrase,Unclassified,6.98,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA9,inhibitor,ethoxzolamide,0.26,Carbonic anhydrase 9,Enzyme,7.47,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA4,inhibitor,ethoxzolamide,0.57,Carbonic anhydrase 4,Enzyme,7.03,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA5A,inhibitor,ethoxzolamide,0.55,"Carbonic anhydrase 5A, mitochondrial",Enzyme,7.6,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA3,inhibitor,ethoxzolamide,0.94,Carbonic anhydrase 3,Enzyme,5.02,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA13,inhibitor,ethoxzolamide,2.18,Carbonic anhydrase 13,Enzyme,7.89,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA5B,inhibitor,ethoxzolamide,1.46,"Carbonic anhydrase 5B, mitochondrial",Enzyme,7.72,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA14,inhibitor,ethoxzolamide,0.62,Carbonic anhydrase 14,Enzyme,8.6,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA12,inhibitor,ethoxzolamide,0.87,Carbonic anhydrase 12,Enzyme,7.66,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
CA6,inhibitor,ethoxzolamide,0.55,Carbonic anhydrase 6,Enzyme,7.48,False,258.317,1.602889229,True,5,0,0,1,82.28,3,1,5,2,26,0,0.0
HTR1A,antagonist,nefazodone,0.05,5-hydroxytryptamine receptor 1A,GPCR,7.0969,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
HTR2C,antagonist,nefazodone,0.12,5-hydroxytryptamine receptor 2C,GPCR,7.1426675039999985,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
SLC6A4,inhibitor,nefazodone,0.38,Sodium-dependent serotonin transporter,Transporter,6.699,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
SLC6A2,inhibitor,nefazodone,0.44,Sodium-dependent noradrenaline transporter,Transporter,6.4437,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
ADRA1A,antagonist,nefazodone,0.11,Alpha-1A adrenergic receptor,GPCR,7.7892,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
HTR2A,antagonist,nefazodone,0.24,5-hydroxytryptamine receptor 2A,GPCR,8.0,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
SLC6A3,inhibitor,nefazodone,0.09,Sodium-dependent dopamine transporter,Transporter,6.4437,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
CYP3A4,inhibitor,nefazodone,0.0,Cytochrome P450 3A4,Enzyme,6.0,True,470.007,4.652967894333333,True,10,4,0,4,55.53,10,0,7,4,65,0,0.0
ADRB2,antagonist,metoprolol,0.22,Beta-2 adrenergic receptor,GPCR,6.3,True,267.3639,1.7586571139999996,True,2,2,1,1,50.72,9,2,4,1,44,0,1.0
,inhibitor,gefitinib,,Cruzipain,Enzyme,4.06,True,446.902,3.750953734666667,True,1,6,2,2,68.74,8,1,7,4,55,0,0.0
ERBB3,inhibitor,gefitinib,0.11,Receptor tyrosine-protein kinase erbB-3,Kinase,6.1,True,446.902,3.750953734666667,True,1,6,2,2,68.74,8,1,7,4,55,0,0.0
DRD2,antagonist,propiomazine,0.16,D(2) dopamine receptor,GPCR,,True,340.482,4.545754217333334,True,6,0,0,0,23.55,5,0,4,3,48,0,1.0
HTR2A,antagonist,propiomazine,0.19,5-hydroxytryptamine receptor 2A,GPCR,,True,340.482,4.545754217333334,True,6,0,0,0,23.55,5,0,4,3,48,0,1.0
OPRK1,antagonist,buprenorphine,0.32,Kappa-type opioid receptor,GPCR,9.01,True,467.6401,3.5498807580676903,True,4,8,0,2,62.16,4,2,5,8,75,0,7.0
SCN9A,blocker,phenytoin,0.02,Sodium channel protein type 9 subunit alpha,Ion channel,,True,252.268,2.1479203806666667,True,10,20,2,3,58.2,2,2,2,3,31,0,0.0
SCN2A,inhibitor,phenytoin,0.17,Sodium channel protein type 2 subunit alpha,Ion channel,4.9,True,252.268,2.1479203806666667,True,10,20,2,3,58.2,2,2,2,3,31,0,0.0
SCN8A,inhibitor,phenytoin,0.07,Sodium channel protein type 8 subunit alpha,Ion channel,,True,252.268,2.1479203806666667,True,10,20,2,3,58.2,2,2,2,3,31,0,0.0
SCN4A,blocker,phenytoin,0.02,Sodium channel protein type 4 subunit alpha,Ion channel,4.62,True,252.268,2.1479203806666667,True,10,20,2,3,58.2,2,2,2,3,31,0,0.0
HTR2C,antagonist,metergoline,0.02,5-hydroxytryptamine receptor 2C,GPCR,9.3,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR1E,antagonist,metergoline,0.09,5-hydroxytryptamine receptor 1E,GPCR,6.1,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR2B,antagonist,metergoline,0.04,5-hydroxytryptamine receptor 2B,GPCR,8.8,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR1F,antagonist,metergoline,0.1,5-hydroxytryptamine receptor 1F,GPCR,6.5,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR6,antagonist,metergoline,0.06,5-hydroxytryptamine receptor 6,GPCR,7.4,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR5A,antagonist,metergoline,0.18,5-hydroxytryptamine receptor 5A,GPCR,6.2,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR1D,antagonist,metergoline,0.04,5-hydroxytryptamine receptor 1D,GPCR,9.2,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR7,antagonist,metergoline,0.05,5-hydroxytryptamine receptor 7,GPCR,8.2,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR1B,antagonist,metergoline,0.04,5-hydroxytryptamine receptor 1B,GPCR,7.2,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
HTR2A,antagonist,metergoline,0.02,5-hydroxytryptamine receptor 2A,GPCR,8.6,True,403.526,3.9869860276666658,True,1,0,0,0,46.5,4,1,4,5,59,0,3.0
CYSLTR1,antagonist,montelukast,2.37,Cysteinyl leukotriene receptor 1,GPCR,9.3,True,586.183,8.493533064849995,False,2,5,0,1,70.42,12,2,4,5,77,0,1.0
SIGMAR1,antagonist,fluvoxamine,0.18,Sigma non-opioid intracellular receptor 1,Membrane receptor,7.44,True,318.34,2.7953195803333326,True,2,8,0,2,56.84,9,1,4,1,43,0,0.0
SLC6A4,inhibitor,fluvoxamine,0.64,Sodium-dependent serotonin transporter,Transporter,8.51,True,318.34,2.7953195803333326,True,2,8,0,2,56.84,9,1,4,1,43,0,0.0
SLC5A8,inhibitor,ibuprofen,0.45,Sodium-coupled monocarboxylate transporter 1,Transporter,4.2,True,206.2808,3.843558199333335,True,10,9,1,8,37.3,4,1,1,1,33,0,1.0
ASIC1,blocker,ibuprofen,0.27,Acid-sensing ion channel 1,Ion channel,3.53,True,206.2808,3.843558199333335,True,10,9,1,8,37.3,4,1,1,1,33,0,1.0
DRD3,antagonist,haloperidol,0.06,D(3) dopamine receptor,GPCR,8.52,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
DRD2,inverse agonist,haloperidol,0.18,D(2) dopamine receptor,GPCR,9.15,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
DRD4,antagonist,haloperidol,0.02,D(4) dopamine receptor,GPCR,9.42021656036377,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
DRD5,antagonist,haloperidol,0.02,D(1B) dopamine receptor,GPCR,7.52,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
KCNH1,blocker,haloperidol,0.06,Potassium voltage-gated channel subfamily H member 1,Ion channel,6.2,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
HTR2A,antagonist,haloperidol,0.02,5-hydroxytryptamine receptor 2A,GPCR,7.0,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
HTR1D,antagonist,haloperidol,0.01,5-hydroxytryptamine receptor 1D,GPCR,6.6,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
HTR1A,antagonist,haloperidol,0.01,5-hydroxytryptamine receptor 1A,GPCR,5.55,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
HTR2B,antagonist,haloperidol,0.01,5-hydroxytryptamine receptor 2B,GPCR,6.1,True,375.864,3.6611138006666666,True,18,10,0,1,40.54,6,1,3,3,49,0,0.0
CHRM4,antagonist,maprotiline,0.12,Muscarinic acetylcholine receptor M4,GPCR,7.236572006,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
CHRM5,antagonist,maprotiline,0.11,Muscarinic acetylcholine receptor M5,GPCR,6.93930216,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
HRH1,antagonist,maprotiline,0.05,Histamine H1 receptor,GPCR,8.7773,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
HTR2A,binder,maprotiline,0.02,5-hydroxytryptamine receptor 2A,GPCR,6.9208,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
CHRM1,antagonist,maprotiline,0.06,Muscarinic acetylcholine receptor M1,GPCR,6.844663963,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
DRD2,binder,maprotiline,0.02,D(2) dopamine receptor,GPCR,6.1772,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
CHRM2,antagonist,maprotiline,0.08,Muscarinic acetylcholine receptor M2,GPCR,6.1643094289999985,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
CHRM3,antagonist,maprotiline,0.07,Muscarinic acetylcholine receptor M3,GPCR,7.0,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
HTR2C,binder,maprotiline,0.04,5-hydroxytryptamine receptor 2C,GPCR,7.387216143,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
ADRA1A,antagonist,maprotiline,0.04,Alpha-1A adrenergic receptor,GPCR,9.854,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
ADRA2A,antagonist,maprotiline,0.04,Alpha-2A adrenergic receptor,GPCR,6.164943898,True,277.4033,4.372104774333334,True,13,2,1,0,12.03,4,1,1,5,44,0,0.0
ESR1,agonist,stanozolol,0.08,Estrogen receptor,Nuclear hormone receptor,7.494850022,True,328.4916,3.807240012,True,2,0,0,0,48.91,0,2,2,5,56,0,7.0
AR,agonist,stanozolol,0.11,Androgen receptor,Nuclear hormone receptor,,True,328.4916,3.807240012,True,2,0,0,0,48.91,0,2,2,5,56,0,7.0
ADRB2,agonist,bambuterol,1.56,Beta-2 adrenergic receptor,GPCR,,False,367.44,1.3973544953333334,True,1,1,0,0,91.34,5,2,6,1,55,0,1.0
BCHE,inhibitor,bambuterol,0.77,Cholinesterase,Enzyme,8.5,False,367.44,1.3973544953333334,True,1,1,0,0,91.34,5,2,6,1,55,0,1.0
GRIA2,allosteric modulator,cyclothiazide,0.12,Glutamate receptor 2,Ion channel,5.65,True,389.878,0.9439138553333332,True,5,0,0,1,118.36,2,3,5,4,40,0,4.0
GRIA1,allosteric modulator,cyclothiazide,0.17,Glutamate receptor 1,Ion channel,5.7,True,389.878,0.9439138553333332,True,5,0,0,1,118.36,2,3,5,4,40,0,4.0
GRIA4,allosteric modulator,cyclothiazide,0.26,Glutamate receptor 4,Ion channel,5.41,True,389.878,0.9439138553333332,True,5,0,0,1,118.36,2,3,5,4,40,0,4.0
SLC12A3,inhibitor,cyclothiazide,0.63,Solute carrier family 12 member 3,Transporter,,True,389.878,0.9439138553333332,True,5,0,0,1,118.36,2,3,5,4,40,0,4.0
GRIA3,allosteric modulator,cyclothiazide,0.2,Glutamate receptor 3,Ion channel,4.86,True,389.878,0.9439138553333332,True,5,0,0,1,118.36,2,3,5,4,40,0,4.0
SLC6A3,inhibitor,trimipramine,0.1,Sodium-dependent dopamine transporter,Transporter,5.42250823974609,True,294.4338,4.7578923536666675,True,18,3,0,1,6.48,4,0,2,3,48,0,1.0
HRH1,antagonist,trimipramine,0.03,Histamine H1 receptor,GPCR,8.85387229919434,True,294.4338,4.7578923536666675,True,18,3,0,1,6.48,4,0,2,3,48,0,1.0
SMO,antagonist,vismodegib,25.25,Smoothened homolog,GPCR,7.79,True,421.297,3.9289317773333328,True,1,4,2,2,76.13,4,1,4,3,41,0,0.0
ADRA1B,agonist,phenylephrine,0.22,Alpha-1B adrenergic receptor,GPCR,6.9,True,167.205,-0.07016072310749852,True,3,4,0,0,52.49,3,3,3,1,25,0,1.0
ADRA1A,agonist,phenylephrine,0.16,Alpha-1A adrenergic receptor,GPCR,5.3,True,167.205,-0.07016072310749852,True,3,4,0,0,52.49,3,3,3,1,25,0,1.0
HTR2A,antagonist,chlorpromazine,0.04,5-hydroxytryptamine receptor 2A,GPCR,8.1,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
HTR6,antagonist,chlorpromazine,0.08,5-hydroxytryptamine receptor 6,GPCR,7.44,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
DRD4,antagonist,chlorpromazine,0.08,D(4) dopamine receptor,GPCR,7.69,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
DRD1,inhibitor,chlorpromazine,0.03,D(1A) dopamine receptor,GPCR,7.19,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
CHRM1,antagonist,chlorpromazine,0.02,Muscarinic acetylcholine receptor M1,GPCR,7.6020598411560085,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
ADRA1B,antagonist,chlorpromazine,0.03,Alpha-1B adrenergic receptor,GPCR,9.09151458740234,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
KCNH2,inhibitor,chlorpromazine,0.01,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.83,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
ADRA1A,inhibitor,chlorpromazine,0.02,Alpha-1A adrenergic receptor,GPCR,9.552841969,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
HTR2C,antagonist,chlorpromazine,0.03,5-hydroxytryptamine receptor 2C,GPCR,7.4,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
ADRA2A,inhibitor,chlorpromazine,0.03,Alpha-2A adrenergic receptor,GPCR,6.2,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
ADRA2B,antagonist,chlorpromazine,0.02,Alpha-2B adrenergic receptor,GPCR,7.6,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
DRD3,inhibitor,chlorpromazine,0.06,D(3) dopamine receptor,GPCR,8.54,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
HRH1,antagonist,chlorpromazine,0.05,Histamine H1 receptor,GPCR,8.2,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
HRH4,binder,chlorpromazine,0.08,Histamine H4 receptor,GPCR,6.87,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
CHRM3,antagonist,chlorpromazine,0.02,Muscarinic acetylcholine receptor M3,GPCR,7.25091361999512,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
DRD5,antagonist,chlorpromazine,0.12,D(1B) dopamine receptor,GPCR,6.93,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
ADRA2C,antagonist,chlorpromazine,0.01,Alpha-2C adrenergic receptor,GPCR,7.1,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
HTR1A,antagonist,chlorpromazine,0.04,5-hydroxytryptamine receptor 1A,GPCR,6.17,True,318.8640000000001,4.535000242333334,True,24,5,1,2,6.48,4,0,3,3,40,0,0.0
PTGS1,inhibitor,phenylbutazone,0.26,Prostaglandin G/H synthase 1,Enzyme,5.52,True,308.3743,4.135797765666666,True,3,2,0,3,47.16,5,1,4,3,43,0,0.0
GLUD2,substrate,glutamic acid,2.71,"Glutamate dehydrogenase 2, mitochondrial",Enzyme,,True,147.1293,-3.2414470759830487,True,62,0,0,4,100.62,4,3,3,0,19,0,1.0
CHRM4,antagonist,umeclidinium,0.35,Muscarinic acetylcholine receptor M4,GPCR,10.3,True,428.595,0.6822211795282553,True,5,1,0,1,29.46,8,1,2,6,66,1,0.0
CHRM3,antagonist,umeclidinium,0.2,Muscarinic acetylcholine receptor M3,GPCR,10.221848487854,True,428.595,0.6822211795282553,True,5,1,0,1,29.46,8,1,2,6,66,1,0.0
CHRM1,antagonist,umeclidinium,0.19,Muscarinic acetylcholine receptor M1,GPCR,9.79588031768799,True,428.595,0.6822211795282553,True,5,1,0,1,29.46,8,1,2,6,66,1,0.0
CHRM2,antagonist,umeclidinium,0.24,Muscarinic acetylcholine receptor M2,GPCR,9.82390880584717,True,428.595,0.6822211795282553,True,5,1,0,1,29.46,8,1,2,6,66,1,0.0
DRD2,antagonist,sulpiride,0.23,D(2) dopamine receptor,GPCR,8.12,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
DRD3,antagonist,sulpiride,0.28,D(3) dopamine receptor,GPCR,8.1,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
CA2,inhibitor,sulpiride,0.13,Carbonic anhydrase 2,Enzyme,7.3979,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
CA3,inhibitor,sulpiride,0.68,Carbonic anhydrase 3,Enzyme,4.97,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
CA1,inhibitor,sulpiride,0.12,Carbonic anhydrase 1,Enzyme,5.92,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
CA7,inhibitor,sulpiride,0.3,Carbonic anhydrase 7,Enzyme,8.44,True,341.426,0.2187704497017608,True,4,1,0,0,101.73,6,2,5,2,46,0,1.0
ADRB2,antagonist,betaxolol,0.52,Beta-2 adrenergic receptor,GPCR,6.18,True,307.4278,2.539234387333333,True,2,2,0,0,50.72,11,2,4,2,51,0,1.0
HTR1A,antagonist,mesoridazine,0.05,5-hydroxytryptamine receptor 1A,GPCR,6.98,True,386.574,3.5745034059999994,True,2,1,0,0,23.55,4,0,4,4,52,0,2.0
DRD3,antagonist,mesoridazine,0.07,D(3) dopamine receptor,GPCR,8.58502674102783,True,386.574,3.5745034059999994,True,2,1,0,0,23.55,4,0,4,4,52,0,2.0
DRD1,antagonist,mesoridazine,0.04,D(1A) dopamine receptor,GPCR,6.99,True,386.574,3.5745034059999994,True,2,1,0,0,23.55,4,0,4,4,52,0,2.0
HTR2C,antagonist,mesoridazine,0.06,5-hydroxytryptamine receptor 2C,GPCR,6.804100513458249,True,386.574,3.5745034059999994,True,2,1,0,0,23.55,4,0,4,4,52,0,2.0
TRPM2,blocker,flufenamic acid,,Transient receptor potential cation channel subfamily M member 2,Ion channel,4.15,True,281.2299,5.248602981,False,6,0,1,1,49.33,3,2,2,2,30,0,0.0
KCNT2,activator,flufenamic acid,,Potassium channel subfamily T member 2,Ion channel,8.85,True,281.2299,5.248602981,False,6,0,1,1,49.33,3,2,2,2,30,0,0.0
TRPM5,blocker,flufenamic acid,,Transient receptor potential cation channel subfamily M member 5,Ion channel,4.6198,True,281.2299,5.248602981,False,6,0,1,1,49.33,3,2,2,2,30,0,0.0
SLC12A3,inhibitor,hydrochlorothiazide,1.02,Solute carrier family 12 member 3,Transporter,7.01,True,297.7390000000001,-0.5756177763333332,True,2,0,1,4,118.36,1,3,5,2,25,0,0.0
KCNMA1,inhibitor,hydrochlorothiazide,0.26,Calcium-activated potassium channel subunit alpha-1,Ion channel,,True,297.7390000000001,-0.5756177763333332,True,2,0,1,4,118.36,1,3,5,2,25,0,0.0
DRD2,antagonist,metoclopramide,0.23,D(2) dopamine receptor,GPCR,7.1,True,299.796,1.3972700643333331,True,4,3,1,1,67.59,7,2,4,1,42,0,0.0
CHRM1,agonist,metoclopramide,0.19,Muscarinic acetylcholine receptor M1,GPCR,,True,299.796,1.3972700643333331,True,4,3,1,1,67.59,7,2,4,1,42,0,0.0
HTR3A,agonist,metoclopramide,0.19,5-hydroxytryptamine receptor 3A,Ion channel,6.699,True,299.796,1.3972700643333331,True,4,3,1,1,67.59,7,2,4,1,42,0,0.0
HTR4,agonist,metoclopramide,0.46,5-hydroxytryptamine receptor 4,GPCR,6.0,True,299.796,1.3972700643333331,True,4,3,1,1,67.59,7,2,4,1,42,0,0.0
CA6,inhibitor,zonisamide,1.15,Carbonic anhydrase 6,Enzyme,7.05,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA13,inhibitor,zonisamide,4.61,Carbonic anhydrase 13,Enzyme,6.37,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA9,inhibitor,zonisamide,0.54,Carbonic anhydrase 9,Enzyme,8.301,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA3,inhibitor,zonisamide,0.77,Carbonic anhydrase 3,Enzyme,5.07,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA2,inhibitor,zonisamide,0.2,Carbonic anhydrase,Unclassified,6.19,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA5A,inhibitor,zonisamide,1.34,"Carbonic anhydrase 5A, mitochondrial",Enzyme,7.7,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA12,inhibitor,zonisamide,0.82,Carbonic anhydrase 12,Enzyme,4.96,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA4,inhibitor,zonisamide,0.4,Carbonic anhydrase 4,Enzyme,5.07,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA7,inhibitor,zonisamide,0.67,Carbonic anhydrase 7,Enzyme,6.93,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
MAOB,inhibitor,zonisamide,0.18,Amine oxidase [flavin-containing] B,Enzyme,5.51,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA14,inhibitor,zonisamide,0.66,Carbonic anhydrase 14,Enzyme,5.28,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
CA5B,inhibitor,zonisamide,3.58,"Carbonic anhydrase 5B, mitochondrial",Enzyme,5.22,True,212.226,0.1106864246666666,True,31,5,0,1,86.19,2,1,4,2,22,0,0.0
PTGS1,antagonist,loxoprofen,0.52,Prostaglandin G/H synthase 1,Enzyme,5.19,True,246.3016,3.345719083333334,True,2,3,0,0,54.37,4,1,2,2,36,0,2.0
PTGS2,antagonist,loxoprofen,0.46,Prostaglandin G/H synthase 2,Enzyme,5.0,True,246.3016,3.345719083333334,True,2,3,0,0,54.37,4,1,2,2,36,0,2.0
PRKCG,inhibitor,ruboxistaurin,0.32,Protein kinase C gamma type,Kinase,6.52,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
PIM2,inhibitor,ruboxistaurin,1.01,Serine/threonine-protein kinase pim-2,Kinase,6.89,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
PRKCD,inhibitor,ruboxistaurin,0.23,Protein kinase C delta type,Kinase,8.44,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
PRKCA,inhibitor,ruboxistaurin,0.28,Protein kinase C alpha type,Kinase,6.44,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
PRKCB,inhibitor,ruboxistaurin,1.16,Protein kinase C beta type,Kinase,8.33,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
PIM1,inhibitor,ruboxistaurin,0.17,Serine/threonine-protein kinase pim-1,Kinase,7.3,False,468.5469,2.97802764225088,True,0,0,0,0,68.5,2,1,6,6,63,0,1.0
HTR1F,agonist,sumatriptan,1.26,5-hydroxytryptamine receptor 1F,GPCR,7.59,True,295.4,0.7419288613400098,True,4,1,0,4,65.2,6,2,3,2,41,0,0.0
HTR5A,agonist,sumatriptan,0.19,5-hydroxytryptamine receptor 5A,GPCR,6.3,True,295.4,0.7419288613400098,True,4,1,0,4,65.2,6,2,3,2,41,0,0.0
HTR1E,agonist,sumatriptan,0.09,5-hydroxytryptamine receptor 1E,GPCR,5.26,True,295.4,0.7419288613400098,True,4,1,0,4,65.2,6,2,3,2,41,0,0.0
HTR7,antagonist,sumatriptan,0.05,5-hydroxytryptamine receptor 7,GPCR,6.0,True,295.4,0.7419288613400098,True,4,1,0,4,65.2,6,2,3,2,41,0,0.0
HTR6,antagonist,sumatriptan,0.06,5-hydroxytryptamine receptor 6,GPCR,5.6,True,295.4,0.7419288613400098,True,4,1,0,4,65.2,6,2,3,2,41,0,0.0
MAOA,antagonist,phenelzine,0.92,Amine oxidase [flavin-containing] A,Enzyme,6.835647144,True,136.1943,1.2030200426666668,True,7,10,0,0,38.05,3,2,2,1,22,0,0.0
AOC3,inhibitor,phenelzine,4.46,Membrane primary amine oxidase,Enzyme,7.7,True,136.1943,1.2030200426666668,True,7,10,0,0,38.05,3,2,2,1,22,0,0.0
CYP2C8,inhibitor,phenelzine,0.12,Cytochrome P450 2C8,Enzyme,5.14,True,136.1943,1.2030200426666668,True,7,10,0,0,38.05,3,2,2,1,22,0,0.0
SLC6A3,inhibitor,phenelzine,0.04,Sodium-dependent dopamine transporter,Transporter,5.07572078704834,True,136.1943,1.2030200426666668,True,7,10,0,0,38.05,3,2,2,1,22,0,0.0
TXK,inhibitor,bosutinib,0.41,Tyrosine-protein kinase TXK,Kinase,7.14,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
STK4,inhibitor,bosutinib,0.82,Serine/threonine-protein kinase 4,Kinase,6.72,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
HCK,inhibitor,bosutinib,0.21,Tyrosine-protein kinase HCK,Kinase,8.47,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
CAMK2G,inhibitor,bosutinib,0.35,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,5.44,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
MAP2K1,inhibitor,bosutinib,0.09,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,7.72,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
SIK2,inhibitor,bosutinib,0.22,Serine/threonine-protein kinase SIK2,Kinase,7.54,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
FRK,inhibitor,bosutinib,0.08,Tyrosine-protein kinase FRK,Kinase,8.85,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
SIK3,inhibitor,bosutinib,0.82,Serine/threonine-protein kinase SIK3,Kinase,7.19,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
MAP2K2,inhibitor,bosutinib,0.11,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,8.0,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
TNK2,inhibitor,bosutinib,0.11,Activated CDC42 kinase 1,Kinase,7.54,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
CAMK1D,inhibitor,bosutinib,0.22,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,6.26,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
FYN,inhibitor,bosutinib,0.06,Tyrosine-protein kinase Fyn,Kinase,7.96,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
SIK1,inhibitor,bosutinib,0.62,Serine/threonine-protein kinase SIK1,Kinase,7.52,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
STK10,inhibitor,bosutinib,0.82,Serine/threonine-protein kinase 10,Kinase,8.15,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
MAP3K2,inhibitor,bosutinib,1.65,Mitogen-activated protein kinase kinase kinase 2,Kinase,7.52,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
STK24,inhibitor,bosutinib,1.23,Serine/threonine-protein kinase 24,Kinase,6.42,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
MAP4K5,inhibitor,bosutinib,0.07,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,9.3,True,530.446,4.087721830999999,False,10,2,0,1,82.88,9,1,8,4,65,0,0.0
ADRA1B,agonist,epinephrine,0.13,Alpha-1B adrenergic receptor,GPCR,,True,183.2044,-0.4295292850171321,True,8,4,0,2,72.72,3,4,4,1,26,0,1.0
ADRA1A,agonist,epinephrine,0.09,Alpha-1A adrenergic receptor,GPCR,5.7,True,183.2044,-0.4295292850171321,True,8,4,0,2,72.72,3,4,4,1,26,0,1.0
ADRA2C,agonist,epinephrine,0.05,Alpha-2C adrenergic receptor,GPCR,6.448550002,True,183.2044,-0.4295292850171321,True,8,4,0,2,72.72,3,4,4,1,26,0,1.0
DHFR,inhibitor,pralatrexate,3.11,Dihydrofolate reductase,Enzyme,7.35,True,477.4726,0.325347192902778,False,2,1,0,3,207.3,10,5,9,3,58,0,2.0
ALDH5A1,inhibitor,valproic acid,,"Succinate-semialdehyde dehydrogenase, mitochondrial",Enzyme,,True,144.2114,2.798451071,True,9,17,1,6,37.3,5,1,1,0,26,0,0.0
HDAC1,inhibitor,valproic acid,,Histone deacetylase 1,Enzyme,6.4,True,144.2114,2.798451071,True,9,17,1,6,37.3,5,1,1,0,26,0,0.0
KCNA10,blocker,verapamil,0.16,Potassium voltage-gated channel subfamily A member 10,Ion channel,4.3,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
TPCN2,blocker,verapamil,1.14,Two pore calcium channel protein 2,Unclassified,5.0,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
KCNA7,blocker,verapamil,0.14,Potassium voltage-gated channel subfamily A member 7,Ion channel,4.8,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
KCNH2,inhibitor,verapamil,0.02,Potassium voltage-gated channel subfamily H member 2,Ion channel,8.0,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
CACNA1H,inhibitor,verapamil,0.06,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,4.4854,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
TPCN1,blocker,verapamil,1.14,Two pore calcium channel protein 1,Unclassified,4.64,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
CYP3A4,inhibitor,verapamil,0.01,Cytochrome P450 3A4,Enzyme,6.22,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
ADRA1D,antagonist,verapamil,0.03,Alpha-1D adrenergic receptor,GPCR,6.07211659,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
SLC29A4,inhibitor,verapamil,0.1,Equilibrative nucleoside transporter 4,Transporter,4.73,True,454.6016,5.0431858210000025,False,11,10,2,12,63.95,13,0,6,2,71,0,1.0
KDR,inhibitor,cabozantinib,0.21,Vascular endothelial growth factor receptor 2,Kinase,10.4559316635132,True,501.514,4.658062448,False,3,3,0,0,98.78,8,2,6,5,61,0,0.0
KIT,inhibitor,cabozantinib,0.23,Mast/stem cell growth factor receptor Kit,Kinase,8.33724212646484,True,501.514,4.658062448,False,3,3,0,0,98.78,8,2,6,5,61,0,0.0
HTR1A,agonist,lofexidine,0.04,5-hydroxytryptamine receptor 1A,GPCR,6.9,True,259.132,2.663057541333333,True,6,3,0,2,33.62,3,1,3,2,28,0,1.0
SLC18A2,inhibitor,tetrabenazine,4.01,Synaptic vesicular amine transporter,Transporter,7.0,True,317.4226,3.4010616590000007,True,2,2,0,0,38.77,4,0,4,3,50,0,2.0
DRD2,inhibitor,tetrabenazine,0.05,D(2) dopamine receptor,GPCR,5.6778,True,317.4226,3.4010616590000007,True,2,2,0,0,38.77,4,0,4,3,50,0,2.0
SLC18A1,inhibitor,tetrabenazine,1.62,Chromaffin granule amine transporter,Transporter,4.7,True,317.4226,3.4010616590000007,True,2,2,0,0,38.77,4,0,4,3,50,0,2.0
PTGER1,agonist,iloprost,1.08,Prostaglandin E2 receptor EP1 subtype,GPCR,7.7,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
PTGER4,agonist,iloprost,0.19,Prostaglandin E2 receptor EP4 subtype,GPCR,6.68,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
TBXA2R,agonist,iloprost,0.16,Thromboxane A2 receptor,GPCR,5.2,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
PTGER3,agonist,iloprost,0.21,Prostaglandin E2 receptor EP3 subtype,GPCR,7.3,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
PTGFR,agonist,iloprost,0.22,Prostaglandin F2-alpha receptor,GPCR,6.2,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
PTGER2,agonist,iloprost,0.45,Prostaglandin E2 receptor EP2 subtype,GPCR,5.7,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
PTGDR,agonist,iloprost,0.27,Prostaglandin D2 receptor,GPCR,6.6,True,360.494,3.5643785116666664,True,8,0,0,3,77.76,8,3,3,2,58,0,6.0
DRD1,antagonist,loxapine,0.04,D(1A) dopamine receptor,GPCR,7.26760625839233,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HRH1,binder,loxapine,0.02,Histamine H1 receptor,GPCR,8.2,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
DRD2,antagonist,loxapine,0.11,D(2) dopamine receptor,GPCR,7.68,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
CHRM5,binder,loxapine,0.02,Muscarinic acetylcholine receptor M5,GPCR,6.82947063446045,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
DRD4,binder,loxapine,0.07,D(4) dopamine receptor,GPCR,8.31,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR6,binder,loxapine,0.07,5-hydroxytryptamine receptor 6,GPCR,7.82,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR2C,antagonist,loxapine,0.05,5-hydroxytryptamine receptor 2C,GPCR,8.0,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
ADRA2B,binder,loxapine,0.02,Alpha-2B adrenergic receptor,GPCR,6.96738195419312,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
KCNT1,activator,loxapine,0.43,Potassium channel subfamily T member 1,Ion channel,5.36,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
DRD3,binder,loxapine,0.05,D(3) dopamine receptor,GPCR,7.66,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
SLC6A2,binder,loxapine,0.02,Sodium-dependent noradrenaline transporter,Transporter,5.244277555,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HRH2,binder,loxapine,0.05,Histamine H2 receptor,GPCR,6.6819367408752415,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HRH4,binder,loxapine,0.05,Histamine H4 receptor,GPCR,5.2968807220459,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR1E,binder,loxapine,0.05,5-hydroxytryptamine receptor 1E,GPCR,5.854182243347171,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
ADRA2A,binder,loxapine,0.01,Alpha-2A adrenergic receptor,GPCR,6.82131099700928,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR2A,antagonist,loxapine,0.05,5-hydroxytryptamine receptor 2A,GPCR,8.62,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
CHRM4,binder,loxapine,0.02,Muscarinic acetylcholine receptor M4,GPCR,6.087092399597171,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR1A,binder,loxapine,0.01,5-hydroxytryptamine receptor 1A,GPCR,5.6097717285156286,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR1D,binder,loxapine,0.03,5-hydroxytryptamine receptor 1D,GPCR,5.45992088317871,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
CHRM3,binder,loxapine,0.01,Muscarinic acetylcholine receptor M3,GPCR,6.913640022277829,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
ADRA1B,binder,loxapine,0.02,Alpha-1B adrenergic receptor,GPCR,7.27572393417358,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
CHRM2,binder,loxapine,0.01,Muscarinic acetylcholine receptor M2,GPCR,6.376013278961179,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR3A,binder,loxapine,0.03,5-hydroxytryptamine receptor 3A,Ion channel,6.721246242523191,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR5A,binder,loxapine,0.1,5-hydroxytryptamine receptor 5A,GPCR,6.1101384162902805,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HTR1B,binder,loxapine,0.02,5-hydroxytryptamine receptor 1B,GPCR,6.41116809844971,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
ADRA1A,binder,loxapine,0.01,Alpha-1A adrenergic receptor,GPCR,7.50863838195801,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
DRD5,binder,loxapine,0.05,D(1B) dopamine receptor,GPCR,7.12493896484375,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
ADRA2C,binder,loxapine,0.02,Alpha-2C adrenergic receptor,GPCR,7.097181797027591,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
CHRM1,binder,loxapine,0.01,Muscarinic acetylcholine receptor M1,GPCR,5.26,True,327.80800000000005,3.4606024319999995,True,33,0,0,0,28.07,0,0,4,4,41,0,0.0
HRH1,antagonist,cariprazine,0.09,Histamine H1 receptor,GPCR,7.630000114440921,True,427.41,4.056449686666667,True,6,2,0,0,38.82,5,1,3,3,60,0,2.0
HTR2A,antagonist,cariprazine,0.09,5-hydroxytryptamine receptor 2A,GPCR,7.73000001907349,True,427.41,4.056449686666667,True,6,2,0,0,38.82,5,1,3,3,60,0,2.0
HTR1A,"agonist,partial agonist",cariprazine,0.11,5-hydroxytryptamine receptor 1A,GPCR,8.590000152587889,True,427.41,4.056449686666667,True,6,2,0,0,38.82,5,1,3,3,60,0,2.0
HTR2B,antagonist,cariprazine,0.2,5-hydroxytryptamine receptor 2B,GPCR,9.23999977111816,True,427.41,4.056449686666667,True,6,2,0,0,38.82,5,1,3,3,60,0,2.0
ADRA2C,agonist,dexmedetomidine,0.07,Alpha-2C adrenergic receptor,GPCR,9.3,True,200.2795,3.390314838666667,True,1,4,0,0,28.68,2,1,1,2,31,0,1.0
ADRA2B,agonist,dexmedetomidine,0.08,Alpha-2B adrenergic receptor,GPCR,9.7,True,200.2795,3.390314838666667,True,1,4,0,0,28.68,2,1,1,2,31,0,1.0
CYSLTR1,antagonist,cinalukast,8.28,Cysteinyl leukotriene receptor 1,GPCR,,False,412.545,5.482244516178102,False,1,0,0,0,79.29,9,2,4,3,57,0,0.0
CACNA1C,blocker,diltiazem,0.24,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,7.3188,True,414.518,2.7272518843333327,True,2,6,2,1,59.08,6,0,6,3,55,0,2.0
CACNA1S,blocker,diltiazem,0.12,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,6.42,True,414.518,2.7272518843333327,True,2,6,2,1,59.08,6,0,6,3,55,0,2.0
PTH2R,agonist,teriparatide,6.31,Parathyroid hormone 2 receptor,GPCR,7.8,True,4117.715,,False,1,0,0,0,1757.65,144,58,57,6,580,0,34.0
KCNA5,blocker,flecainide,0.27,Potassium voltage-gated channel subfamily A member 5,Ion channel,4.0,True,414.3427,3.188141905333333,True,4,3,2,2,59.59,7,2,4,2,48,0,1.0
SCN4A,inhibitor,flecainide,0.17,Sodium channel protein type 4 subunit alpha,Ion channel,4.7447,True,414.3427,3.188141905333333,True,4,3,2,2,59.59,7,2,4,2,48,0,1.0
KCNA7,blocker,flecainide,0.71,Potassium voltage-gated channel subfamily A member 7,Ion channel,5.1,True,414.3427,3.188141905333333,True,4,3,2,2,59.59,7,2,4,2,48,0,1.0
KCNH2,inhibitor,flecainide,0.03,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.41,True,414.3427,3.188141905333333,True,4,3,2,2,59.59,7,2,4,2,48,0,1.0
NR3C2,antagonist,nimodipine,0.37,Mineralocorticoid receptor,Nuclear hormone receptor,6.8,True,418.4403,2.541901752666668,True,10,1,0,0,117.0,8,1,8,2,56,0,1.0
CACNA1S,blocker,nimodipine,0.61,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,6.0,True,418.4403,2.541901752666668,True,10,1,0,0,117.0,8,1,8,2,56,0,1.0
CACNA1F,inhibitor,nimodipine,0.68,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,6.0,True,418.4403,2.541901752666668,True,10,1,0,0,117.0,8,1,8,2,56,0,1.0
CACNA1D,blocker,nimodipine,0.64,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,,True,418.4403,2.541901752666668,True,10,1,0,0,117.0,8,1,8,2,56,0,1.0
HRH1,antagonist,ketotifen,0.93,Histamine H1 receptor,GPCR,9.5086,True,309.425,3.3478693229999994,True,2,0,0,0,20.31,0,0,3,4,41,0,0.0
GABRA3,allosteric modulator,flumazenil,0.17,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,8.090000152587889,True,303.2884,0.3279000000000002,True,4,0,0,0,64.43,2,0,5,3,36,0,0.0
GABRA1,antagonist,flumazenil,0.19,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,8.699999809265138,True,303.2884,0.3279000000000002,True,4,0,0,0,64.43,2,0,5,3,36,0,0.0
HTR2B,antagonist,methysergide,0.12,5-hydroxytryptamine receptor 2B,GPCR,9.34000015258789,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR2A,antagonist,methysergide,0.16,5-hydroxytryptamine receptor 2A,GPCR,9.44999980926514,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR1E,binder,methysergide,0.29,5-hydroxytryptamine receptor 1E,GPCR,6.8,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR1D,antagonist,methysergide,0.05,5-hydroxytryptamine receptor 1D,GPCR,8.9,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR5A,antagonist,methysergide,0.2,5-hydroxytryptamine receptor 5A,GPCR,7.0,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR6,antagonist,methysergide,0.07,5-hydroxytryptamine receptor 6,GPCR,6.8,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR1B,antagonist,methysergide,0.13,5-hydroxytryptamine receptor 1B,GPCR,7.6,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
HTR1F,antagonist,methysergide,0.33,5-hydroxytryptamine receptor 1F,GPCR,8.2,True,353.458,1.816894446333333,True,8,1,0,0,57.5,4,2,4,4,53,0,3.0
KIT,inhibitor,midostaurin,0.29,Mast/stem cell growth factor receptor Kit,Kinase,8.11,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKCD,inhibitor,midostaurin,0.06,Protein kinase C delta type,Kinase,6.5,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
KDR,inhibitor,midostaurin,0.06,Vascular endothelial growth factor receptor 2,Kinase,6.6,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKCA,inhibitor,midostaurin,0.3,Protein kinase C alpha type,Kinase,6.14,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKCE,inhibitor,midostaurin,0.14,Protein kinase C epsilon type,Kinase,6.27,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PDGFRA,"antagonist,inhibitor",midostaurin,0.13,Platelet-derived growth factor receptor alpha,Kinase,6.75,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PDGFRB,inhibitor,midostaurin,0.08,Platelet-derived growth factor receptor beta,Kinase,6.96,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKCQ,inhibitor,midostaurin,0.11,Protein kinase C theta type,Kinase,6.04,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKCH,inhibitor,midostaurin,0.22,Protein kinase C eta type,Kinase,6.54,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
PRKD3,inhibitor,midostaurin,0.06,Serine/threonine-protein kinase D3,Kinase,5.5,True,570.649,5.433789877666666,False,6,12,0,0,77.73,3,1,6,9,73,0,4.0
AR,agonist,testosterone propionate,,Androgen receptor,Nuclear hormone receptor,9.6,True,344.4877,4.507084555000001,True,1,4,2,1,43.37,2,0,3,4,57,0,6.0
ACE,inhibitor,spirapril,8.0,Angiotensin-converting enzyme,Enzyme,9.1,True,466.614,1.6036345915656902,True,1,0,0,2,95.94,9,2,7,3,61,0,3.0
ESR1,"agonist,antagonist",tamoxifen,0.08,Estrogen receptor,Nuclear hormone receptor,7.51,True,371.5146,6.351221955666668,False,10,23,2,5,12.47,8,0,2,3,57,0,0.0
KCNH2,inhibitor,tamoxifen,0.0,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.8,True,371.5146,6.351221955666668,False,10,23,2,5,12.47,8,0,2,3,57,0,0.0
GPER1,agonist,tamoxifen,0.11,G-protein coupled estrogen receptor 1,GPCR,7.5,True,371.5146,6.351221955666668,False,10,23,2,5,12.47,8,0,2,3,57,0,0.0
EBP,inhibitor,tamoxifen,1.7,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,8.301,True,371.5146,6.351221955666668,False,10,23,2,5,12.47,8,0,2,3,57,0,0.0
CACNA1G,inhibitor,trimethadione,5.07,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,,True,143.1406,0.5041463303333331,True,1,5,0,0,46.61,0,0,3,1,19,0,0.0
CFTR,potentiator,ivacaftor,7.57,Cystic fibrosis transmembrane conductance regulator,Ion channel,8.52,True,392.4907,5.758022158000001,False,1,2,2,1,82.45,2,3,4,3,57,0,0.0
HTR1A,partial agonist,yohimbine,0.08,5-hydroxytryptamine receptor 1A,GPCR,7.3,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR7,antagonist,yohimbine,0.05,5-hydroxytryptamine receptor 7,GPCR,5.6,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR2B,antagonist,yohimbine,0.15,5-hydroxytryptamine receptor 2B,GPCR,7.9,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR1D,antagonist,yohimbine,0.13,5-hydroxytryptamine receptor 1D,GPCR,7.7,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
ADRA2C,antagonist,yohimbine,0.31,Alpha-2C adrenergic receptor,GPCR,9.3,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR5A,antagonist,yohimbine,0.18,5-hydroxytryptamine receptor 5A,GPCR,5.3,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
ADRA2B,antagonist,yohimbine,0.36,Alpha-2B adrenergic receptor,GPCR,8.7,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR1F,antagonist,yohimbine,0.1,5-hydroxytryptamine receptor 1F,GPCR,7.0,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
DRD3,antagonist,yohimbine,0.06,D(3) dopamine receptor,GPCR,5.603975103,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR1B,antagonist,yohimbine,0.16,5-hydroxytryptamine receptor 1B,GPCR,7.6,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
HTR1E,antagonist,yohimbine,0.09,5-hydroxytryptamine receptor 1E,GPCR,5.9,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
DRD2,antagonist,yohimbine,0.03,D(2) dopamine receptor,GPCR,6.163043263,True,354.4427,2.09865826,True,12,2,0,0,65.56,1,2,4,5,52,0,5.0
SLC6A4,inhibitor,levomilnacipran,0.64,Sodium-dependent serotonin transporter,Transporter,7.95078182220459,True,246.348,1.4217066229999988,True,2,5,0,1,46.33,5,1,2,2,40,0,2.0
SLC6A3,inhibitor,levomilnacipran,0.23,Sodium-dependent dopamine transporter,Transporter,5.49,True,246.348,1.4217066229999988,True,2,5,0,1,46.33,5,1,2,2,40,0,2.0
SLC6A2,inhibitor,levomilnacipran,0.73,Sodium-dependent noradrenaline transporter,Transporter,7.0352692604064915,True,246.348,1.4217066229999988,True,2,5,0,1,46.33,5,1,2,2,40,0,2.0
DRD4,agonist,dopamine,0.07,D(4) dopamine receptor,GPCR,9.0,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
DRD5,agonist,dopamine,0.14,D(1B) dopamine receptor,GPCR,9.0,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
DRD1,agonist,dopamine,0.09,D(1A) dopamine receptor,GPCR,8.15,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
SLC6A3,inducer,dopamine,0.04,Sodium-dependent dopamine transporter,Transporter,5.19,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
DRD3,agonist,dopamine,0.05,D(3) dopamine receptor,GPCR,9.0,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
DBH,ligand,dopamine,1.33,Dopamine beta-hydroxylase,Enzyme,3.0,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
HTR1A,binder,dopamine,0.04,5-hydroxytryptamine receptor 1A,GPCR,5.08365154266357,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
SLC6A2,inhibitor,dopamine,0.05,Sodium-dependent noradrenaline transporter,Transporter,8.18,True,153.1784,0.029550238796553663,True,16,4,0,5,66.48,2,3,3,1,22,0,0.0
HTR6,agonist,ergotamine,0.07,5-hydroxytryptamine receptor 6,GPCR,8.6,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR2B,agonist,ergotamine,0.12,5-hydroxytryptamine receptor 2B,GPCR,8.9,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR1B,agonist,ergotamine,0.3,5-hydroxytryptamine receptor 1B,GPCR,8.68,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
ADRA2A,partial agonist,ergotamine,0.1,Alpha-2A adrenergic receptor,GPCR,9.099086932,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR2C,agonist,ergotamine,0.08,5-hydroxytryptamine receptor 2C,GPCR,8.7,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR1E,agonist,ergotamine,0.1,5-hydroxytryptamine receptor 1E,GPCR,6.3,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR5A,antagonist,ergotamine,0.2,5-hydroxytryptamine receptor 5A,GPCR,7.85,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
DRD1,agonist,ergotamine,0.04,D(1A) dopamine receptor,GPCR,6.063486257999999,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR1F,agonist,ergotamine,0.33,5-hydroxytryptamine receptor 1F,GPCR,6.8,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR2A,agonist,ergotamine,0.09,5-hydroxytryptamine receptor 2A,GPCR,9.0,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
ADRA1D,partial agonist,ergotamine,0.09,Alpha-1D adrenergic receptor,GPCR,8.486782400000001,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
DRD2,agonist,ergotamine,0.05,D(2) dopamine receptor,GPCR,8.844663963,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
ADRA1A,partial agonist,ergotamine,0.08,Alpha-1A adrenergic receptor,GPCR,,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
HTR1A,agonist,ergotamine,0.04,5-hydroxytryptamine receptor 1A,GPCR,9.353596274,True,581.6615,2.597697310346601,False,14,1,0,1,118.21,4,3,6,8,78,0,6.0
TLR7,agonist,imiquimod,15.29,Toll-like receptor 7,Membrane receptor,4.97,True,240.3036,2.6506694719999997,True,2,1,0,0,56.73,2,1,4,3,34,0,0.0
PTGS1,inhibitor,nepafenac,1.29,Prostaglandin G/H synthase 1,Enzyme,6.6,True,254.2839,2.0844785749999994,True,2,0,0,0,86.18,4,2,3,2,33,0,0.0
CRBN,inhibitor,pomalidomide,14.2,Protein cereblon,Cytosolic other,6.57708215713501,True,273.2441,-0.16321859799999985,True,3,2,0,1,109.57,1,2,5,3,31,0,1.0
GNRHR,antagonist,ganirelix,7.47,Gonadotropin-releasing hormone receptor,GPCR,,True,1570.35,1.6180238152835371,False,1,0,0,0,451.49,44,16,16,6,225,0,10.0
OPRD1,antagonist,methylnaltrexone,0.23,Delta-type opioid receptor,GPCR,6.05,True,356.441,-2.492788006471746,True,2,0,0,0,66.76,2,2,4,6,52,1,5.0
OPRM1,antagonist,methylnaltrexone,0.52,Mu-type opioid receptor,GPCR,7.55,True,356.441,-2.492788006471746,True,2,0,0,0,66.76,2,2,4,6,52,1,5.0
OPRK1,antagonist,methylnaltrexone,0.51,Kappa-type opioid receptor,GPCR,6.65,True,356.441,-2.492788006471746,True,2,0,0,0,66.76,2,2,4,6,52,1,5.0
CDK8,inhibitor,ponatinib,0.09,Cyclin-dependent kinase 8,Kinase,8.17,True,532.5595,4.965714124000001,False,15,4,0,2,65.77,4,1,6,5,66,0,0.0
KDR,inhibitor,ponatinib,0.04,Vascular endothelial growth factor receptor 2,Kinase,8.82390880584717,True,532.5595,4.965714124000001,False,15,4,0,2,65.77,4,1,6,5,66,0,0.0
LYN,inhibitor,ponatinib,0.08,Tyrosine-protein kinase Lyn,Kinase,9.61978912353516,True,532.5595,4.965714124000001,False,15,4,0,2,65.77,4,1,6,5,66,0,0.0
PDGFRA,inhibitor,ponatinib,0.22,Platelet-derived growth factor receptor alpha,Kinase,8.95860767364502,True,532.5595,4.965714124000001,False,15,4,0,2,65.77,4,1,6,5,66,0,0.0
CDK19,inhibitor,ponatinib,0.17,Cyclin-dependent kinase 19,Kinase,7.92,True,532.5595,4.965714124000001,False,15,4,0,2,65.77,4,1,6,5,66,0,0.0
DRD2,antagonist,iloperidone,0.12,D(2) dopamine receptor,GPCR,8.9687,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
HTR1A,antagonist,iloperidone,0.09,5-hydroxytryptamine receptor 1A,GPCR,7.1809,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
HRH1,antagonist,iloperidone,0.06,Histamine H1 receptor,GPCR,7.91,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
HTR6,antagonist,iloperidone,0.28,5-hydroxytryptamine receptor 6,GPCR,7.37,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
ADRA2C,antagonist,iloperidone,0.07,Alpha-2C adrenergic receptor,GPCR,7.7902,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
HTR2A,antagonist,iloperidone,0.11,5-hydroxytryptamine receptor 2A,GPCR,9.8594,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
DRD3,antagonist,iloperidone,0.11,D(3) dopamine receptor,GPCR,8.15,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
DRD4,antagonist,iloperidone,0.1,D(4) dopamine receptor,GPCR,7.6,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
ADRA1A,antagonist,iloperidone,0.06,Alpha-1A adrenergic receptor,GPCR,7.44,True,426.4806,3.221352625333332,True,11,5,0,0,64.8,8,0,6,4,58,0,0.0
RAF1,inhibitor,vemurafenib,0.07,RAF proto-oncogene serine/threonine-protein kinase,Kinase,7.32,True,489.922,4.622483135000001,True,1,6,2,3,91.92,7,2,4,4,51,0,0.0
SLC6A3,inhibitor,cocaine,0.29,Dopamine transporter,Unclassified,7.19,True,303.3529,2.2821080089999994,True,8,5,1,2,55.84,3,0,5,3,43,0,4.0
SIGMAR1,agonist,cocaine,0.5,Sigma non-opioid intracellular receptor 1,Membrane receptor,5.05,True,303.3529,2.2821080089999994,True,8,5,1,2,55.84,3,0,5,3,43,0,4.0
MAP2K2,allosteric modulator,cobimetinib,0.57,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,6.7,True,531.318,5.035852919333332,False,1,2,0,4,64.6,4,3,4,4,51,0,1.0
MAP2K1,inhibitor,cobimetinib,0.98,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,9.04575729370117,True,531.318,5.035852919333332,False,1,2,0,4,64.6,4,3,4,4,51,0,1.0
HDAC2,inhibitor,belinostat,0.46,Histone deacetylase 2,Enzyme,9.07,True,318.35,1.813627203,True,1,5,0,1,95.5,5,3,4,2,36,0,0.0
HDAC7,inhibitor,belinostat,0.77,Histone deacetylase 7,Enzyme,7.29,True,318.35,1.813627203,True,1,5,0,1,95.5,5,3,4,2,36,0,0.0
HDAC8,inhibitor,belinostat,0.51,Histone deacetylase 8,Enzyme,7.66,True,318.35,1.813627203,True,1,5,0,1,95.5,5,3,4,2,36,0,0.0
HDAC9,inhibitor,belinostat,0.72,Histone deacetylase 9,Enzyme,7.62,True,318.35,1.813627203,True,1,5,0,1,95.5,5,3,4,2,36,0,0.0
HDAC11,inhibitor,belinostat,0.52,Histone deacetylase 11,Enzyme,7.57,True,318.35,1.813627203,True,1,5,0,1,95.5,5,3,4,2,36,0,0.0
HTR2A,antagonist,epinastine,0.13,5-hydroxytryptamine receptor 2A,GPCR,,True,249.3104,3.073111085666667,True,6,3,0,1,39.12,0,2,1,4,34,0,1.0
HRH2,antagonist,epinastine,0.9,Histamine H2 receptor,GPCR,,True,249.3104,3.073111085666667,True,6,3,0,1,39.12,0,2,1,4,34,0,1.0
ADORA3,inhibitor,enprofylline,0.45,Adenosine receptor A3,GPCR,4.03,True,194.1906,-0.11366737333333345,True,6,0,0,0,83.54,2,2,4,2,24,0,0.0
PDE4B,inhibitor,enprofylline,1.47,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,,True,194.1906,-0.11366737333333345,True,6,0,0,0,83.54,2,2,4,2,24,0,0.0
ADORA2A,inhibitor,enprofylline,0.32,Adenosine A2a receptor,Unclassified,4.04,True,194.1906,-0.11366737333333345,True,6,0,0,0,83.54,2,2,4,2,24,0,0.0
ADORA1,inhibitor,enprofylline,0.33,Adenosine receptor A1,GPCR,4.38,True,194.1906,-0.11366737333333345,True,6,0,0,0,83.54,2,2,4,2,24,0,0.0
ADORA2B,antagonist,enprofylline,0.73,Adenosine receptor A2b,GPCR,5.33,True,194.1906,-0.11366737333333345,True,6,0,0,0,83.54,2,2,4,2,24,0,0.0
HTR1D,agonist,zolmitriptan,1.6,5-hydroxytryptamine receptor 1D,GPCR,8.9,True,287.3568,2.0428752876666683,True,8,2,0,1,57.36,5,2,3,3,42,0,1.0
HTR1F,agonist,zolmitriptan,2.52,5-hydroxytryptamine receptor 1F,GPCR,7.45,True,287.3568,2.0428752876666683,True,8,2,0,1,57.36,5,2,3,3,42,0,1.0
HTR1E,agonist,zolmitriptan,0.72,5-hydroxytryptamine receptor 1E,GPCR,7.7,True,287.3568,2.0428752876666683,True,8,2,0,1,57.36,5,2,3,3,42,0,1.0
HTR1B,agonist,zolmitriptan,1.39,5-hydroxytryptamine receptor 1B,GPCR,7.7,True,287.3568,2.0428752876666683,True,8,2,0,1,57.36,5,2,3,3,42,0,1.0
S1PR5,modulator,fingolimod,5.68,Sphingosine 1-phosphate receptor 5,GPCR,9.52,True,307.4708,4.060977925999999,True,5,3,0,4,66.48,12,3,3,1,55,0,0.0
S1PR4,modulator,fingolimod,1.62,Sphingosine 1-phosphate receptor 4,GPCR,9.52,True,307.4708,4.060977925999999,True,5,3,0,4,66.48,12,3,3,1,55,0,0.0
S1PR3,modulator,fingolimod,2.84,Sphingosine 1-phosphate receptor 3,GPCR,8.52,True,307.4708,4.060977925999999,True,5,3,0,4,66.48,12,3,3,1,55,0,0.0
HTR2A,antagonist,thioridazine,0.14,5-hydroxytryptamine receptor 2A,GPCR,8.0,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
KCNH2,inhibitor,thioridazine,0.03,Potassium voltage-gated channel subfamily H member 2,Ion channel,7.0,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
DRD4,antagonist,thioridazine,0.04,D(4) dopamine receptor,GPCR,7.97881078720093,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
DRD5,antagonist,thioridazine,0.07,D(1B) dopamine receptor,GPCR,5.6,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
HRH1,antagonist,thioridazine,0.01,Histamine H1 receptor,GPCR,7.7,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
HTR6,antagonist,thioridazine,0.05,5-hydroxytryptamine receptor 6,GPCR,7.2,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
HTR1A,antagonist,thioridazine,0.02,5-hydroxytryptamine receptor 1A,GPCR,7.1,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
DRD3,antagonist,thioridazine,0.03,D(3) dopamine receptor,GPCR,7.3,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
HTR2C,antagonist,thioridazine,0.04,5-hydroxytryptamine receptor 2C,GPCR,7.3,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
ADRA1B,antagonist,thioridazine,0.05,Alpha-1B adrenergic receptor,GPCR,8.61978912353516,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
HTR7,antagonist,thioridazine,0.04,5-hydroxytryptamine receptor 7,GPCR,7.15,True,370.575,5.4693059060000015,False,6,3,0,0,6.48,4,0,4,4,51,0,1.0
AVPR2,agonist,vasopressin,1.36,Vasopressin V2 receptor,GPCR,8.48,True,2140.46,-7.249321714160335,False,4,0,0,1,463.93,19,14,16,4,140,0,8.0
OXTR,agonist,vasopressin,0.18,Oxytocin receptor,GPCR,8.78,True,2140.46,-7.249321714160335,False,4,0,0,1,463.93,19,14,16,4,140,0,8.0
SLC12A3,inhibitor,indapamide,3.94,Solute carrier family 12 member 3,Transporter,7.54,True,365.835,2.639544322333333,True,1,2,3,0,92.5,3,2,4,3,40,0,1.0
PDE4A,antagonist,apremilast,1.99,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,7.85,True,460.5,1.3102076129999998,True,1,3,0,1,119.08,8,1,7,3,56,0,1.0
PDE4D,inhibitor,apremilast,0.86,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,7.1307682991027805,True,460.5,1.3102076129999998,True,1,3,0,1,119.08,8,1,7,3,56,0,1.0
PDE4C,inhibitor,apremilast,1.0,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,6.93,True,460.5,1.3102076129999998,True,1,3,0,1,119.08,8,1,7,3,56,0,1.0
IMPDH2,inhibitor,ribavirin,0.86,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,6.0,True,244.2047,-2.7682973950000003,True,5,2,0,2,143.72,3,4,8,2,29,0,4.0
HDAC1,inhibitor,romidepsin,0.48,Histone deacetylase 1,Enzyme,7.0,True,540.69,1.0779514013333338,False,5,5,0,2,142.7,2,4,8,2,72,0,4.0
HDAC4,inhibitor,romidepsin,0.41,Histone deacetylase 4,Enzyme,6.2924,True,540.69,1.0779514013333338,False,5,5,0,2,142.7,2,4,8,2,72,0,4.0
HDAC9,inhibitor,romidepsin,0.25,Histone deacetylase 9,Enzyme,5.96,True,540.69,1.0779514013333338,False,5,5,0,2,142.7,2,4,8,2,72,0,4.0
HDAC8,inhibitor,romidepsin,0.3,Histone deacetylase 8,Enzyme,9.82,True,540.69,1.0779514013333338,False,5,5,0,2,142.7,2,4,8,2,72,0,4.0
HDAC7,inhibitor,romidepsin,0.31,Histone deacetylase 7,Enzyme,5.9,True,540.69,1.0779514013333338,False,5,5,0,2,142.7,2,4,8,2,72,0,4.0
DPYD,inhibitor,gimeracil,7.57,Dihydropyrimidine dehydrogenase [NADP(+)],Enzyme,6.6382722854614284,True,145.54,0.12644476800000015,True,1,0,0,0,53.09,0,2,2,1,13,0,0.0
BDKRB1,antagonist,icatibant,1.72,B1 bradykinin receptor,GPCR,7.0,True,1304.54,-7.6640031383219505,False,2,0,0,0,523.72,30,15,17,7,181,0,12.0
ATP1A1,inhibitor,digoxin,0.67,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,6.3,True,780.9385,2.366680672000001,False,1,1,0,7,203.06,7,6,14,8,119,0,21.0
ATP1A2,inhibitor,digoxin,0.28,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,5.783306401,True,780.9385,2.366680672000001,False,1,1,0,7,203.06,7,6,14,8,119,0,21.0
OPRK1,agonist,tramadol,0.11,Kappa-type opioid receptor,GPCR,7.85,True,263.3752,2.4498614993333323,True,15,4,0,0,32.7,4,1,3,2,44,0,2.0
OPRD1,agonist,tramadol,0.15,Delta-type opioid receptor,GPCR,8.03,True,263.3752,2.4498614993333323,True,15,4,0,0,32.7,4,1,3,2,44,0,2.0
ADRA2A,agonist,clonidine,0.49,Alpha-2A adrenergic receptor,GPCR,8.7,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
SLC22A1,inhibitor,clonidine,0.29,Solute carrier family 22 member 1,Transporter,4.65,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
ADRA2B,agonist,clonidine,0.28,Alpha-2B adrenergic receptor,GPCR,7.5,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
ADRA2C,agonist,clonidine,0.29,Alpha-2C adrenergic receptor,GPCR,6.7,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
ADRA1A,agonist,clonidine,0.05,Alpha-1A adrenergic receptor,GPCR,6.499999953,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
ADRA1B,agonist,clonidine,0.08,Alpha-1B adrenergic receptor,GPCR,6.5,True,230.094,2.485088703666668,True,6,5,1,3,36.42,1,2,1,2,23,0,0.0
DRD5,"antagonist,ligand,partial agonist",aripiprazole,0.1,D(1B) dopamine receptor,GPCR,5.681212902069089,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR1A,partial agonist,aripiprazole,0.09,5-hydroxytryptamine receptor 1A,GPCR,8.15,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR1B,"antagonist,ligand",aripiprazole,0.06,5-hydroxytryptamine receptor 1B,GPCR,6.1,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRA1A,antagonist,aripiprazole,0.02,Alpha-1A adrenergic receptor,GPCR,7.244,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
SLC6A3,modulator,aripiprazole,0.03,Sodium-dependent dopamine transporter,Transporter,5.49248170852661,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HRH1,antagonist,aripiprazole,0.03,Histamine H1 receptor,GPCR,7.2147,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
DRD2,agonist,aripiprazole,0.22,D(2) dopamine receptor,GPCR,8.71,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR7,"antagonist,partial agonist",aripiprazole,0.06,5-hydroxytryptamine receptor 7,GPCR,7.69,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
CHRM1,ligand,aripiprazole,0.02,Muscarinic acetylcholine receptor M1,GPCR,5.1688985824585005,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR6,antagonist,aripiprazole,0.07,5-hydroxytryptamine receptor 6,GPCR,6.51,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
DRD1,"antagonist,ligand,partial agonist",aripiprazole,0.02,D(1A) dopamine receptor,GPCR,6.060016632080081,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR2A,antagonist,aripiprazole,0.06,5-hydroxytryptamine receptor 2A,GPCR,7.9,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR1D,"antagonist,ligand",aripiprazole,0.07,5-hydroxytryptamine receptor 1D,GPCR,7.2,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
DRD3,"antagonist,partial agonist",aripiprazole,0.04,D(3) dopamine receptor,GPCR,8.53,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
CHRM4,ligand,aripiprazole,0.04,Muscarinic acetylcholine receptor M4,GPCR,5.8180136680603,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
CHRM5,ligand,aripiprazole,0.04,Muscarinic acetylcholine receptor M5,GPCR,5.63292407989502,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRB1,ligand,aripiprazole,0.02,Beta-1 adrenergic receptor,GPCR,6.8507809638977095,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR2C,agonist,aripiprazole,0.04,5-hydroxytryptamine receptor 2C,GPCR,7.36,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR3A,antagonist,aripiprazole,0.04,5-hydroxytryptamine receptor 3A,Ion channel,6.2020401954650906,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
DRD4,"antagonist,partial agonist",aripiprazole,0.05,D(4) dopamine receptor,GPCR,6.65,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRA2C,antagonist,aripiprazole,0.03,Alpha-2C adrenergic receptor,GPCR,7.42136096954346,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRA2B,"antagonist,ligand",aripiprazole,0.04,Alpha-2B adrenergic receptor,GPCR,6.991399765014651,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
SLC6A4,modulator,aripiprazole,0.03,Sodium-dependent serotonin transporter,Transporter,6.83,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR1E,"antagonist,ligand",aripiprazole,0.1,5-hydroxytryptamine receptor 1E,GPCR,5.09690999984741,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR5A,ligand,aripiprazole,0.07,5-hydroxytryptamine receptor 5A,GPCR,5.9064030647277805,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRA1B,antagonist,aripiprazole,0.03,Alpha-1B adrenergic receptor,GPCR,7.46347093582153,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
CHRM3,ligand,aripiprazole,0.03,Muscarinic acetylcholine receptor M3,GPCR,5.33003282546997,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
HTR2B,inverse agonist,aripiprazole,0.03,5-hydroxytryptamine receptor 2B,GPCR,9.44369792938232,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
CHRM2,ligand,aripiprazole,0.03,Muscarinic acetylcholine receptor M2,GPCR,5.45487833023071,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRA2A,antagonist,aripiprazole,0.03,Alpha-2A adrenergic receptor,GPCR,7.1307682991027805,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
ADRB2,ligand,aripiprazole,0.01,Beta-2 adrenergic receptor,GPCR,6.7878123960000005,True,448.385,4.901243659333332,True,38,4,1,0,44.81,7,1,4,4,57,0,0.0
SI,inhibitor,acarbose,10.82,"Sucrase-isomaltase, intestinal",Enzyme,6.609065055847171,True,645.6080000000002,-8.250380201666667,False,4,0,0,0,321.17,9,14,19,4,87,0,19.0
EDNRA,antagonist,bosentan,8.22,Endothelin-1 receptor,GPCR,8.12,True,551.614,4.941747168000001,False,2,2,0,1,145.65,10,2,10,4,68,0,0.0
CHRM2,antagonist,propantheline,0.08,Muscarinic acetylcholine receptor M2,GPCR,9.5,True,368.4892,0.3637936438615875,True,1,0,0,0,35.53,6,0,3,3,57,1,0.0
CHRM4,antagonist,propantheline,0.12,Muscarinic acetylcholine receptor M4,GPCR,10.2,True,368.4892,0.3637936438615875,True,1,0,0,0,35.53,6,0,3,3,57,1,0.0
CHRM3,antagonist,propantheline,0.07,Muscarinic acetylcholine receptor M3,GPCR,10.0,True,368.4892,0.3637936438615875,True,1,0,0,0,35.53,6,0,3,3,57,1,0.0
PTGS2,inhibitor,nimesulide,0.15,Prostaglandin G/H synthase 2,Enzyme,6.4,True,308.31,1.7866563706666665,True,3,1,0,0,98.54,5,1,5,2,33,0,0.0
PTGS1,inhibitor,nimesulide,0.03,Prostaglandin G/H synthase 1,Enzyme,5.21,True,308.31,1.7866563706666665,True,3,1,0,0,98.54,5,1,5,2,33,0,0.0
ACHE,inhibitor,neostigmine,10.02,Acetylcholinesterase,Enzyme,7.59,True,223.2915,-2.2459823888050785,True,1,1,0,0,29.54,2,0,2,1,35,1,0.0
ADRA1A,antagonist,risperidone,0.04,Alpha-1A adrenergic receptor,GPCR,8.5528,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HRH1,antagonist,risperidone,0.03,Histamine H1 receptor,GPCR,7.4815,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
ADRA1B,antagonist,risperidone,0.07,Alpha-1B adrenergic receptor,GPCR,8.48,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
ADRA2C,antagonist,risperidone,0.03,Alpha-2C adrenergic receptor,GPCR,8.4949,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR1B,antagonist,risperidone,0.01,5-hydroxytryptamine receptor 1B,GPCR,7.49,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
DRD2,antagonist,risperidone,0.27,D(2) dopamine receptor,GPCR,8.49,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR1F,antagonist,risperidone,0.03,5-hydroxytryptamine receptor 1F,GPCR,5.9,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR2C,antagonist,risperidone,0.12,5-hydroxytryptamine receptor 2C,GPCR,7.7,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
ADRA1D,antagonist,risperidone,0.01,Alpha-1D adrenergic receptor,GPCR,7.4,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR1D,antagonist,risperidone,0.04,5-hydroxytryptamine receptor 1D,GPCR,7.6,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR6,antagonist,risperidone,0.05,5-hydroxytryptamine receptor 6,GPCR,6.65,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR7,antagonist,risperidone,0.04,5-hydroxytryptamine receptor 7,GPCR,8.47,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
ADRA2B,antagonist,risperidone,0.04,Alpha-2B adrenergic receptor,GPCR,7.77,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
HTR1E,antagonist,risperidone,0.02,5-hydroxytryptamine receptor 1E,GPCR,5.9,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
DRD1,antagonist,risperidone,0.01,D(1A) dopamine receptor,GPCR,7.68,True,410.4845,2.6276210843333327,True,13,2,2,1,64.16,4,0,6,5,57,0,0.0
CASR,agonist,etelcalcetide,14.95,Extracellular calcium-sensing receptor,GPCR,4.6,True,1048.26,-11.436233233227105,False,1,0,0,0,567.71,36,18,16,0,144,0,8.0
HRH1,antagonist,alimemazine,1.85,Histamine H1 receptor,GPCR,,True,298.446,4.410279125333334,True,1,0,0,0,6.48,4,0,3,3,43,0,1.0
HTR2A,antagonist,brexpiprazole,0.17,5-hydroxytryptamine receptor 2A,GPCR,9.327901840209961,True,433.57,4.6497025926666655,True,5,2,0,0,48.57,7,1,5,5,58,0,0.0
ADRA1B,antagonist,brexpiprazole,0.15,Alpha-1B adrenergic receptor,GPCR,9.769551277160641,True,433.57,4.6497025926666655,True,5,2,0,0,48.57,7,1,5,5,58,0,0.0
DRD2,partial agonist,brexpiprazole,0.23,D(2) dopamine receptor,GPCR,9.52287864685059,True,433.57,4.6497025926666655,True,5,2,0,0,48.57,7,1,5,5,58,0,0.0
ADRA2C,antagonist,brexpiprazole,0.15,Alpha-2C adrenergic receptor,GPCR,9.22914791107178,True,433.57,4.6497025926666655,True,5,2,0,0,48.57,7,1,5,5,58,0,0.0
HTR1A,partial agonist,brexpiprazole,0.27,5-hydroxytryptamine receptor 1A,GPCR,9.92081832885742,True,433.57,4.6497025926666655,True,5,2,0,0,48.57,7,1,5,5,58,0,0.0
CNR1,agonist,dronabinol,1.65,Cannabinoid receptor 1,GPCR,8.54,True,314.4617,5.944157107333332,False,2,3,0,2,29.46,4,1,2,3,53,0,2.0
HTR2A,antagonist,cyclobenzaprine,0.16,5-hydroxytryptamine receptor 2A,GPCR,7.5409,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
HTR2B,antagonist,cyclobenzaprine,0.11,5-hydroxytryptamine receptor 2B,GPCR,6.8125,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
SLC6A4,inhibitor,cyclobenzaprine,0.1,Sodium-dependent serotonin transporter,Transporter,6.9666,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
HTR6,antagonist,cyclobenzaprine,0.17,5-hydroxytryptamine receptor 6,GPCR,6.8386,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
HTR7,antagonist,cyclobenzaprine,0.13,5-hydroxytryptamine receptor 7,GPCR,6.8210000000000015,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
AOX1,inhibitor,cyclobenzaprine,1.25,Aldehyde oxidase,Enzyme,5.5086,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
HTR2C,antagonist,cyclobenzaprine,0.07,5-hydroxytryptamine receptor 2C,GPCR,7.2441,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
SLC6A2,inhibitor,cyclobenzaprine,0.11,Sodium-dependent noradrenaline transporter,Transporter,7.4437,True,275.3874,4.613013258333333,True,9,5,1,0,3.24,3,0,1,3,42,0,0.0
DRD2,agonist,rotigotine,0.23,D(2) dopamine receptor,GPCR,10.22,True,315.48,4.339127960423522,True,7,2,0,0,23.47,6,1,3,3,47,0,1.0
DRD4,agonist,rotigotine,0.56,D(4) dopamine receptor,GPCR,7.26,True,315.48,4.339127960423522,True,7,2,0,0,23.47,6,1,3,3,47,0,1.0
DRD5,agonist,rotigotine,0.66,D(1B) dopamine receptor,GPCR,6.0,True,315.48,4.339127960423522,True,7,2,0,0,23.47,6,1,3,3,47,0,1.0
DRD3,agonist,rotigotine,0.4,D(3) dopamine receptor,GPCR,8.4,True,315.48,4.339127960423522,True,7,2,0,0,23.47,6,1,3,3,47,0,1.0
DRD1,agonist,rotigotine,0.18,D(1A) dopamine receptor,GPCR,5.6,True,315.48,4.339127960423522,True,7,2,0,0,23.47,6,1,3,3,47,0,1.0
HRH1,antagonist,amitriptyline,0.04,Histamine H1 receptor,GPCR,9.3,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
CHRM1,antagonist,amitriptyline,0.05,Muscarinic acetylcholine receptor M1,GPCR,7.83,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
CHRM2,antagonist,amitriptyline,0.02,Muscarinic acetylcholine receptor M2,GPCR,8.1,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
ADRA1A,"antagonist,inhibitor",amitriptyline,0.02,Alpha-1A adrenergic receptor,GPCR,7.9,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
SLC6A4,inhibitor,amitriptyline,0.19,Sodium-dependent serotonin transporter,Transporter,8.3665,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HTR7,antagonist,amitriptyline,0.06,5-hydroxytryptamine receptor 7,GPCR,6.4,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
SLC6A2,inhibitor,amitriptyline,0.12,Sodium-dependent noradrenaline transporter,Transporter,7.4559,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
SIGMAR1,agonist,amitriptyline,0.19,Sigma non-opioid intracellular receptor 1,Membrane receptor,6.25,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HTR2A,antagonist,amitriptyline,0.03,5-hydroxytryptamine receptor 2A,GPCR,7.96,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HTR2C,antagonist,amitriptyline,0.03,5-hydroxytryptamine receptor 2C,GPCR,8.1,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HRH2,blocker,amitriptyline,0.12,Histamine H2 receptor,GPCR,6.8,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HTR6,antagonist,amitriptyline,0.11,5-hydroxytryptamine receptor 6,GPCR,7.05,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HRH4,binder,amitriptyline,0.12,Histamine H4 receptor,GPCR,8.14,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
CHRM5,antagonist,amitriptyline,0.03,Muscarinic acetylcholine receptor M5,GPCR,7.8,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
KCNH2,blocker,amitriptyline,0.01,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.0,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
ADRA2A,"agonist,antagonist",amitriptyline,0.06,Alpha-2A adrenergic receptor,GPCR,6.879426069,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
CHRM3,antagonist,amitriptyline,0.02,Muscarinic acetylcholine receptor M3,GPCR,7.89,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
ADRA1D,antagonist,amitriptyline,0.04,Alpha-1D adrenergic receptor,GPCR,8.251811972999999,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
CHRM4,antagonist,amitriptyline,0.03,Muscarinic acetylcholine receptor M4,GPCR,8.14,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
HTR1A,"inhibitor,inducer",amitriptyline,0.05,5-hydroxytryptamine receptor 1A,GPCR,6.7212,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
NTRK1,"agonist,activator",amitriptyline,0.09,High affinity nerve growth factor receptor,Kinase,4.2199997901916495,True,277.4033,4.809534915,True,28,10,2,1,3.24,3,0,1,3,44,0,0.0
FLT1,inhibitor,axitinib,0.45,Vascular endothelial growth factor receptor 1,Kinase,8.24,True,386.47,4.148864336333333,True,3,5,0,2,70.67,5,2,4,4,46,0,0.0
FLT4,inhibitor,axitinib,0.36,Vascular endothelial growth factor receptor 3,Kinase,6.77,True,386.47,4.148864336333333,True,3,5,0,2,70.67,5,2,4,4,46,0,0.0
KDR,inhibitor,axitinib,0.32,Vascular endothelial growth factor receptor 2,Kinase,8.23,True,386.47,4.148864336333333,True,3,5,0,2,70.67,5,2,4,4,46,0,0.0
PDGFRB,inhibitor,axitinib,0.14,Platelet-derived growth factor receptor beta,Kinase,9.24,True,386.47,4.148864336333333,True,3,5,0,2,70.67,5,2,4,4,46,0,0.0
PLK4,inhibitor,axitinib,0.14,Serine/threonine-protein kinase PLK4,Kinase,8.38,True,386.47,4.148864336333333,True,3,5,0,2,70.67,5,2,4,4,46,0,0.0
HRH1,agonist,histamine,0.18,Histamine H1 receptor,GPCR,4.1,True,111.1451,-0.7009711443333334,True,5,1,0,4,54.7,2,2,2,1,17,0,0.0
HRH3,agonist,histamine,0.6,Histamine H3 receptor,GPCR,8.28,True,111.1451,-0.7009711443333334,True,5,1,0,4,54.7,2,2,2,1,17,0,0.0
HRH4,agonist,histamine,1.08,Histamine H4 receptor,GPCR,8.1,True,111.1451,-0.7009711443333334,True,5,1,0,4,54.7,2,2,2,1,17,0,0.0
ESR2,antagonist,bazedoxifene,0.57,Estrogen receptor beta,Nuclear hormone receptor,8.42,True,470.61300000000006,6.005592582323557,False,2,3,0,0,57.86,7,2,5,5,69,0,0.0
ESR1,antagonist,bazedoxifene,0.28,Estrogen receptor,Nuclear hormone receptor,9.22,True,470.61300000000006,6.005592582323557,False,2,3,0,0,57.86,7,2,5,5,69,0,0.0
SCN9A,blocker,carbamazepine,0.02,Sodium channel protein type 9 subunit alpha,Ion channel,4.66,True,236.2686,2.766030386333333,True,3,11,0,3,46.33,0,1,1,3,30,0,0.0
SCN4A,blocker,carbamazepine,0.02,Sodium channel protein type 4 subunit alpha,Ion channel,4.28,True,236.2686,2.766030386333333,True,3,11,0,3,46.33,0,1,1,3,30,0,0.0
KEAP1,binder,dimethyl fumarate,,Kelch-like ECH-associated protein 1,Cytosolic other,,True,144.1253,0.7175404473333331,True,2,0,0,0,52.6,2,0,4,0,18,0,0.0
ADORA3,antagonist,istradefylline,0.34,Adenosine receptor A3,GPCR,5.35,True,384.436,2.417824491333333,True,2,10,2,8,80.28,6,0,8,3,52,0,0.0
ADORA2A,antagonist,istradefylline,1.44,Adenosine receptor A2a,GPCR,8.66,True,384.436,2.417824491333333,True,2,10,2,8,80.28,6,0,8,3,52,0,0.0
ADORA1,antagonist,istradefylline,0.75,Adenosine receptor A1,GPCR,6.08,True,384.436,2.417824491333333,True,2,10,2,8,80.28,6,0,8,3,52,0,0.0
HCRTR2,antagonist,suvorexant,14.2,Orexin receptor type 2,GPCR,9.45593166351318,True,450.93,4.039400000000001,True,2,1,0,1,80.29,3,0,7,5,55,0,1.0
HCRTR1,antagonist,suvorexant,10.14,Orexin receptor type 1,GPCR,9.259636878967287,True,450.93,4.039400000000001,True,2,1,0,1,80.29,3,0,7,5,55,0,1.0
HTR6,antagonist,amoxapine,0.12,5-hydroxytryptamine receptor 6,GPCR,7.3,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HTR3A,antagonist,amoxapine,0.06,5-hydroxytryptamine receptor 3A,Ion channel,6.57024772,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
CHRM1,antagonist,amoxapine,0.05,Muscarinic acetylcholine receptor M1,GPCR,6.542118103,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
DRD1,antagonist,amoxapine,0.04,D(1A) dopamine receptor,GPCR,6.7077439289999985,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
DRD4,antagonist,amoxapine,0.08,D(4) dopamine receptor,GPCR,7.47,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HTR2A,antagonist,amoxapine,0.02,5-hydroxytryptamine receptor 2A,GPCR,8.75,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
DRD2,antagonist,amoxapine,0.04,D(2) dopamine receptor,GPCR,7.79587984085083,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
SLC6A2,inhibitor,amoxapine,0.18,Sodium-dependent noradrenaline transporter,Transporter,7.886056647999999,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
ADRA2A,antagonist,amoxapine,0.04,Alpha-2A adrenergic receptor,GPCR,6.307153081,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
DRD3,antagonist,amoxapine,0.06,D(3) dopamine receptor,GPCR,7.73362302780151,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
SLC6A3,binder,amoxapine,0.02,Sodium-dependent dopamine transporter,Transporter,5.3655,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HTR7,antagonist,amoxapine,0.06,5-hydroxytryptamine receptor 7,GPCR,6.3,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HRH1,antagonist,amoxapine,0.02,Histamine H1 receptor,GPCR,7.958607315,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HTR2B,antagonist,amoxapine,0.05,5-hydroxytryptamine receptor 2B,GPCR,8.18243463,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
HTR1A,antagonist,amoxapine,0.03,5-hydroxytryptamine receptor 1A,GPCR,6.66,True,313.781,3.077554494666667,True,25,1,1,0,36.86,0,1,4,4,38,0,0.0
ESR2,agonist,estrone,0.21,Estrogen receptor beta,Nuclear hormone receptor,8.68,True,270.3661,4.309029034000003,True,5,8,1,6,37.3,0,1,2,4,42,0,4.0
ESR1,agonist,estrone,0.21,Estrogen receptor,Nuclear hormone receptor,9.15,True,270.3661,4.309029034000003,True,5,8,1,6,37.3,0,1,2,4,42,0,4.0
GLRA1,potentiator,enflurane,0.35,Glycine receptor subunit alpha-1,Ion channel,,True,184.492,2.7992093016666666,True,7,1,1,0,9.23,3,0,1,0,12,0,1.0
HDAC4,inhibitor,panobinostat,0.32,Histone deacetylase 4,Enzyme,9.22,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC3,inhibitor,panobinostat,0.4,Histone deacetylase 3,Enzyme,8.96,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC6,inhibitor,panobinostat,0.38,Histone deacetylase 6,Enzyme,9.15,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC1,inhibitor,panobinostat,0.69,Histone deacetylase 1,Enzyme,9.0,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC8,inhibitor,panobinostat,0.21,Histone deacetylase 8,Enzyme,7.66,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC5,inhibitor,panobinostat,0.18,Histone deacetylase 5,Enzyme,9.15,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
HDAC9,inhibitor,panobinostat,0.39,Histone deacetylase 9,Enzyme,8.92,True,349.434,2.4776242830059205,True,1,2,0,1,77.15,7,4,3,3,49,0,0.0
AVPR2,antagonist,atosiban,2.1,Vasopressin V2 receptor,GPCR,6.48,True,994.19,-4.606656255666666,False,4,0,0,0,365.67,18,11,15,3,135,0,9.0
AVPR1B,antagonist,atosiban,3.16,Vasopressin V1b receptor,GPCR,7.36,True,994.19,-4.606656255666666,False,4,0,0,0,365.67,18,11,15,3,135,0,9.0
AVPR1A,antagonist,atosiban,2.37,Vasopressin V1a receptor,GPCR,9.82,True,994.19,-4.606656255666666,False,4,0,0,0,365.67,18,11,15,3,135,0,9.0
SCN5A,inhibitor,encainide,4.89,Sodium channel protein type 5 subunit alpha,Ion channel,,True,352.4699,4.492219194666667,True,1,1,0,0,41.57,6,1,3,3,54,0,1.0
CA14,inhibitor,acetazolamide,0.94,Carbonic anhydrase 14,Enzyme,7.39,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
CA1,inhibitor,acetazolamide,1.34,Carbonic anhydrase 1,Enzyme,7.92,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
CA3,inhibitor,acetazolamide,1.25,Carbonic anhydrase 3,Enzyme,4.08,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
CA4,inhibitor,acetazolamide,0.95,Carbonic anhydrase 4,Enzyme,7.96,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
CA7,inhibitor,acetazolamide,0.82,Carbonic anhydrase 7,Enzyme,8.6,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
AQP1,inhibitor,acetazolamide,6.12,Aquaporin-1,Transporter,,True,222.245,-1.039466954,True,8,1,0,1,115.04,2,2,6,1,19,0,0.0
DDR2,inhibitor,nilotinib,1.46,Discoidin domain-containing receptor 2,Kinase,8.22,True,529.5158,5.361539851000001,False,2,5,0,4,97.62,6,2,7,5,61,0,0.0
KIT,antagonist,nilotinib,1.26,Mast/stem cell growth factor receptor Kit,Kinase,7.77,True,529.5158,5.361539851000001,False,2,5,0,4,97.62,6,2,7,5,61,0,0.0
PDGFRA,inhibitor,nilotinib,0.19,Platelet-derived growth factor receptor alpha,Kinase,7.13,True,529.5158,5.361539851000001,False,2,5,0,4,97.62,6,2,7,5,61,0,0.0
DDR1,inhibitor,nilotinib,1.09,Epithelial discoidin domain-containing receptor 1,Kinase,8.96,True,529.5158,5.361539851000001,False,2,5,0,4,97.62,6,2,7,5,61,0,0.0
MAOB,inhibitor,isocarboxazid,1.67,Amine oxidase [flavin-containing] B,Enzyme,,True,231.2505,1.4255166486666668,True,2,0,0,0,67.16,4,2,4,2,30,0,0.0
MAOA,inhibitor,isocarboxazid,3.22,Amine oxidase [flavin-containing] A,Enzyme,,True,231.2505,1.4255166486666668,True,2,0,0,0,67.16,4,2,4,2,30,0,0.0
HTR2C,antagonist,sarpogrelate,0.33,5-hydroxytryptamine receptor 2C,GPCR,7.4,False,429.513,1.122808987977464,True,2,0,0,0,85.3,13,1,6,2,62,0,1.0
HTR2B,antagonist,sarpogrelate,0.18,5-hydroxytryptamine receptor 2B,GPCR,6.6,False,429.513,1.122808987977464,True,2,0,0,0,85.3,13,1,6,2,62,0,1.0
PDE4D,inhibitor,roflumilast,1.29,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,9.57,True,403.207,4.447540533,True,4,1,0,0,60.45,7,1,4,3,40,0,0.0
PDE4A,inhibitor,roflumilast,1.87,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,9.46,True,403.207,4.447540533,True,4,1,0,0,60.45,7,1,4,3,40,0,0.0
PDE4B,inhibitor,roflumilast,1.58,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,9.4,True,403.207,4.447540533,True,4,1,0,0,60.45,7,1,4,3,40,0,0.0
PSMB8,inhibitor,carfilzomib,0.75,Proteasome subunit beta type-8,Enzyme,7.85,True,719.9099,4.197719256666663,False,6,0,0,1,158.47,20,4,8,4,109,0,5.0
PSMB5,inhibitor,carfilzomib,0.82,Proteasome subunit beta type-5,Enzyme,8.221848487854,True,719.9099,4.197719256666663,False,6,0,0,1,158.47,20,4,8,4,109,0,5.0
DHODH,inhibitor,teriflunomide,9.04,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,7.52,True,270.2073,2.1388831993333333,True,1,2,0,2,69.96,3,1,3,1,28,0,0.0
NR1I2,activator,ritonavir,0.08,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,,True,720.944,5.2217820329999975,False,2,10,2,9,145.78,17,4,9,4,98,0,4.0
NR3C2,antagonist,progesterone,0.18,Mineralocorticoid receptor,Nuclear hormone receptor,11.0,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
TRPC5,blocker,progesterone,0.05,Short transient receptor potential channel 5,Ion channel,5.3,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
CATSPER4,activator,progesterone,0.18,Cation channel sperm-associated protein 4,Ion channel,8.11,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
NR3C1,partial agonist,progesterone,0.02,Glucocorticoid receptor,Nuclear hormone receptor,7.52,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
SHBG,"potentiator,binder",progesterone,0.1,Sex hormone-binding globulin,Secreted,6.94,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
CATSPER3,activator,progesterone,0.18,Cation channel sperm-associated protein 3,Ion channel,8.11,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
CATSPER1,activator,progesterone,0.18,Cation channel sperm-associated protein 1,Ion channel,8.11,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
CATSPER2,activator,progesterone,0.18,Cation channel sperm-associated protein 2,Ion channel,8.11,True,314.4617,4.148604400666668,True,10,10,0,10,34.14,1,0,2,4,53,0,6.0
CYP11B1,inhibitor,mitotane,4.13,"Cytochrome P450 11B1, mitochondrial",Enzyme,,True,320.041,6.110364791333335,False,5,1,3,1,0.0,3,0,0,2,28,0,1.0
CYP11A1,inhibitor,mitotane,5.16,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,,True,320.041,6.110364791333335,False,5,1,3,1,0.0,3,0,0,2,28,0,1.0
SLC6A4,inhibitor,venlafaxine,0.56,Sodium-dependent serotonin transporter,Transporter,8.0506,True,277.4018,2.7385227043333327,True,3,2,0,2,32.7,5,1,3,2,47,0,1.0
SLC6A3,inhibitor,venlafaxine,0.22,Sodium-dependent dopamine transporter,Transporter,5.44,True,277.4018,2.7385227043333327,True,3,2,0,2,32.7,5,1,3,2,47,0,1.0
HTR1E,agonist,ergometrine,0.32,5-hydroxytryptamine receptor 1E,GPCR,7.7,True,325.4048,1.0706959856666662,True,1,1,0,1,68.36,3,3,3,4,47,0,3.0
,negative modulator,uracil mustard,,DNA,DNA,,True,252.098,0.40531176,True,1,0,0,0,68.96,5,2,3,1,26,0,0.0
ADORA3,antagonist,nicardipine,0.05,Adenosine receptor A3,GPCR,5.49,True,479.525,3.558611921333333,True,15,8,0,3,111.01,9,1,8,3,64,0,1.0
PGR,agonist,norgestimate,1.58,Progesterone receptor,Nuclear hormone receptor,,True,369.4971,4.112401798666666,True,3,4,2,2,55.73,3,0,4,4,58,0,6.0
HTR1B,agonist,oxymetazoline,0.06,5-hydroxytryptamine receptor 1B,GPCR,9.52,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
HTR1D,agonist,oxymetazoline,0.07,5-hydroxytryptamine receptor 1D,GPCR,9.4,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
ADRA2B,binder,oxymetazoline,0.21,Alpha-2B adrenergic receptor,GPCR,6.2,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
HTR2C,agonist,oxymetazoline,0.04,5-hydroxytryptamine receptor 2C,GPCR,6.8,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
ADRA1B,agonist,oxymetazoline,0.21,Alpha-1B adrenergic receptor,GPCR,6.5,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
ADRA2C,agonist,oxymetazoline,0.14,Alpha-2C adrenergic receptor,GPCR,9.0,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
ADRA1D,agonist,oxymetazoline,0.33,Alpha-1D adrenergic receptor,GPCR,6.4,True,260.3746,3.0323152052087035,True,10,2,0,0,44.62,2,2,3,2,43,0,0.0
CHRM2,agonist,cevimeline,0.09,Muscarinic acetylcholine receptor M2,GPCR,5.983,True,199.313,0.9964063116666658,True,2,3,0,0,12.47,0,0,3,4,30,0,2.0
CHRM3,agonist,cevimeline,0.74,Muscarinic acetylcholine receptor M3,GPCR,7.3188,True,199.313,0.9964063116666658,True,2,3,0,0,12.47,0,0,3,4,30,0,2.0
CHRM4,agonist,cevimeline,0.14,Muscarinic acetylcholine receptor M4,GPCR,5.8827,True,199.313,0.9964063116666658,True,2,3,0,0,12.47,0,0,3,4,30,0,2.0
GPR35,agonist,furosemide,1.19,G-protein coupled receptor 35,GPCR,5.49,True,330.744,1.7484020586666662,True,3,2,2,6,122.63,5,3,5,2,32,0,0.0
CA2,inhibitor,furosemide,0.22,Carbonic anhydrase 2,Enzyme,7.19,True,330.744,1.7484020586666662,True,3,2,2,6,122.63,5,3,5,2,32,0,0.0
SLC12A2,inhibitor,furosemide,0.81,Solute carrier family 12 member 2,Transporter,5.13,True,330.744,1.7484020586666662,True,3,2,2,6,122.63,5,3,5,2,32,0,0.0
SLC6A2,inhibitor,milnacipran,0.73,Sodium-dependent noradrenaline transporter,Transporter,7.6,True,246.354,1.4217066229999988,True,3,1,0,0,46.33,5,1,2,2,40,0,2.0
SLC6A4,inhibitor,milnacipran,0.64,Sodium-dependent serotonin transporter,Transporter,7.29,True,246.354,1.4217066229999988,True,3,1,0,0,46.33,5,1,2,2,40,0,2.0
ADORA2B,antagonist,caffeine,0.2,Adenosine receptor A2b,GPCR,4.77,True,194.1906,-0.5456455916666669,True,14,8,0,1,61.82,0,0,6,2,24,0,0.0
ADORA1,antagonist,caffeine,0.32,Adenosine receptor A1,GPCR,4.97,True,194.1906,-0.5456455916666669,True,14,8,0,1,61.82,0,0,6,2,24,0,0.0
ADORA3,antagonist,caffeine,0.15,Adenosine receptor A3,GPCR,4.33,True,194.1906,-0.5456455916666669,True,14,8,0,1,61.82,0,0,6,2,24,0,0.0
PIK3CD,inhibitor,caffeine,0.05,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,4.12,True,194.1906,-0.5456455916666669,True,14,8,0,1,61.82,0,0,6,2,24,0,0.0
ACE,inhibitor,captopril,1.6,Angiotensin-converting enzyme,Enzyme,8.7,True,217.285,0.7269212306666664,True,5,0,1,3,57.61,3,2,3,1,29,0,2.0
LTA4H,inhibitor,captopril,0.25,Leukotriene A-4 hydrolase,Enzyme,7.15,True,217.285,0.7269212306666664,True,5,0,1,3,57.61,3,2,3,1,29,0,2.0
GUCY2C,agonist,linaclotide,85.21,Heat-stable enterotoxin receptor,Enzyme,8.90657806396484,True,1526.736,-10.775399084955938,False,1,0,0,0,573.91,13,19,26,6,180,0,14.0
SLC6A3,inhibitor,diethylpropion,1.73,Sodium-dependent dopamine transporter,Transporter,,True,205.2961,2.7047719746666665,True,2,0,0,0,20.31,5,0,2,1,34,0,1.0
SLC5A1,inhibitor,dapagliflozin,1.46,Sodium/glucose cotransporter 1,Transporter,8.49,True,408.8730000000001,2.1109003033333336,True,1,9,0,1,99.38,6,4,6,3,53,0,5.0
SLC6A15,inhibitor,loratadine,10.02,Sodium-dependent neutral amino acid transporter B(0)AT2,Transporter,5.400000095367429,True,382.883,4.554579307,True,2,13,0,2,42.43,1,0,3,4,50,0,0.0
KCNH2,antagonist,loratadine,0.03,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.77,True,382.883,4.554579307,True,2,13,0,2,42.43,1,0,3,4,50,0,0.0
CACNA1C,blocker,mibefradil,0.24,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,4.9,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CACNA1H,blocker,mibefradil,0.72,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,6.6021,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CATSPER2,blocker,mibefradil,0.59,Cation channel sperm-associated protein 2,Ion channel,4.5,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CACNA1I,inhibitor,mibefradil,0.53,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,6.9,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CATSPER4,blocker,mibefradil,0.59,Cation channel sperm-associated protein 4,Ion channel,4.5,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CACNA1G,blocker,mibefradil,0.68,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,6.7,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CATSPER3,blocker,mibefradil,0.59,Cation channel sperm-associated protein 3,Ion channel,4.5,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
CATSPER1,blocker,mibefradil,0.59,Cation channel sperm-associated protein 1,Ion channel,4.5,False,495.6287,5.156992555666666,False,11,7,0,1,67.45,11,1,5,4,74,0,2.0
HRH1,antagonist,trifluoperazine,0.01,Histamine H1 receptor,GPCR,7.2,True,407.496,4.655923626666667,True,6,3,0,1,9.72,4,0,4,4,52,0,0.0
HTR2A,antagonist,trifluoperazine,0.01,5-hydroxytryptamine receptor 2A,GPCR,7.9,True,407.496,4.655923626666667,True,6,3,0,1,9.72,4,0,4,4,52,0,0.0
DRD4,antagonist,trifluoperazine,0.03,D(4) dopamine receptor,GPCR,7.377243518829348,True,407.496,4.655923626666667,True,6,3,0,1,9.72,4,0,4,4,52,0,0.0
HTR2C,antagonist,trifluoperazine,0.01,5-hydroxytryptamine receptor 2C,GPCR,6.4,True,407.496,4.655923626666667,True,6,3,0,1,9.72,4,0,4,4,52,0,0.0
TRPV1,activator,capsaicin,0.5,Transient receptor potential cation channel subfamily V member 1,Ion channel,8.22,True,305.4119,3.749669544333333,True,2,9,0,0,58.56,9,2,3,1,49,0,0.0
HTR6,agonist,bromocriptine,0.03,5-hydroxytryptamine receptor 6,GPCR,7.5,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR2A,agonist,bromocriptine,0.05,5-hydroxytryptamine receptor 2A,GPCR,7.0,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
DRD3,agonist,bromocriptine,0.09,D(3) dopamine receptor,GPCR,7.5,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
DRD5,agonist,bromocriptine,0.14,D(1B) dopamine receptor,GPCR,6.3,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR2C,agonist,bromocriptine,0.07,5-hydroxytryptamine receptor 2C,GPCR,6.1,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR1A,agonist,bromocriptine,0.05,5-hydroxytryptamine receptor 1A,GPCR,7.9,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA2B,antagonist,bromocriptine,0.1,Alpha-2B adrenergic receptor,GPCR,7.5,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR2B,antagonist,bromocriptine,0.11,5-hydroxytryptamine receptor 2B,GPCR,7.3,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA1A,"agonist,antagonist",bromocriptine,0.03,Alpha-1A adrenergic receptor,GPCR,8.38,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
DRD1,agonist,bromocriptine,0.04,D(1A) dopamine receptor,GPCR,6.2,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA1D,agonist,bromocriptine,0.05,Alpha-1D adrenergic receptor,GPCR,8.549750892,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA2A,agonist,bromocriptine,0.07,Alpha-2A adrenergic receptor,GPCR,8.0,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA2C,antagonist,bromocriptine,0.08,Alpha-2C adrenergic receptor,GPCR,7.6,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR1D,agonist,bromocriptine,0.11,5-hydroxytryptamine receptor 1D,GPCR,8.0,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
ADRA1B,"agonist,antagonist",bromocriptine,0.05,Alpha-1B adrenergic receptor,GPCR,8.86,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
HTR1B,agonist,bromocriptine,0.09,5-hydroxytryptamine receptor 1B,GPCR,6.5,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
DRD4,antagonist,bromocriptine,0.07,D(4) dopamine receptor,GPCR,6.4,True,654.595,3.887167808333333,False,18,1,0,1,118.21,5,3,6,7,83,0,6.0
KCNK2,activator,isoflurane,0.31,Potassium channel subfamily K member 2,Ion channel,,True,184.492,2.8359380043333333,True,10,3,1,0,9.23,2,0,1,0,12,0,1.0
CHRM5,antagonist,solifenacin,0.54,Muscarinic acetylcholine receptor M5,GPCR,7.2,True,362.473,3.960605752666667,True,5,3,1,0,32.78,2,0,3,6,53,0,4.0
CHRM4,antagonist,solifenacin,0.55,Muscarinic acetylcholine receptor M4,GPCR,6.8,True,362.473,3.960605752666667,True,5,3,1,0,32.78,2,0,3,6,53,0,4.0
CHRM2,antagonist,solifenacin,0.47,Muscarinic acetylcholine receptor M2,GPCR,6.24,True,362.473,3.960605752666667,True,5,3,1,0,32.78,2,0,3,6,53,0,4.0
ADORA3,antagonist,dexniguldipine,0.68,Adenosine receptor A3,GPCR,5.72,False,609.7230000000002,5.599138836333333,False,1,1,0,0,111.01,10,1,8,5,84,0,1.0
ABCB1,inhibitor,dexniguldipine,0.22,Multidrug resistance protein 1,Transporter,7.4318,False,609.7230000000002,5.599138836333333,False,1,1,0,0,111.01,10,1,8,5,84,0,1.0
ACHE,inhibitor,ranitidine,0.28,Acetylcholinesterase,Enzyme,6.19,True,314.4,0.9907784663333328,True,2,4,0,4,83.91,9,1,6,1,43,0,0.0
GPER1,agonist,fulvestrant,0.51,G-protein coupled estrogen receptor 1,GPCR,7.0,True,606.78,7.57184088,False,1,2,0,0,57.53,14,2,3,4,88,0,7.0
,negative modulator,topotecan,,ORF 73,Unclassified,5.67,True,421.4458,-0.35709507722102324,True,3,0,0,4,104.89,3,2,8,5,54,0,1.0
BCHE,inhibitor,physostigmine,0.26,Cholinesterase,Enzyme,5.3,True,275.3461,2.2325330733333337,True,3,0,0,0,44.81,1,1,4,3,41,0,2.0
CYSLTR1,antagonist,zafirlukast,2.71,Cysteinyl leukotriene receptor 1,GPCR,9.52,True,575.675,6.4037449089999985,False,1,7,0,1,115.73,8,2,7,5,74,0,0.0
CYSLTR2,antagonist,zafirlukast,0.42,Cysteinyl leukotriene receptor 2,GPCR,5.15,True,575.675,6.4037449089999985,False,1,7,0,1,115.73,8,2,7,5,74,0,0.0
CACNA1S,blocker,nifedipine,0.07,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,6.3,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
CACNA1C,blocker,nifedipine,0.09,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,9.0,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
CACNA1F,blocker,nifedipine,0.07,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,6.0,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
GLRB,antagonist,nifedipine,0.06,Glycine receptor subunit beta,Ion channel,5.9,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
KCNA5,blocker,nifedipine,0.05,Potassium voltage-gated channel subfamily A member 5,Ion channel,5.21,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
CACNA1D,blocker,nifedipine,0.15,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,7.7,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
GLRA3,antagonist,nifedipine,0.08,Glycine receptor subunit alpha-3,Ion channel,4.5,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
GLRA1,antagonist,nifedipine,0.03,Glycine receptor subunit alpha-1,Ion channel,5.48,True,346.3346,1.8154942816666664,True,8,10,2,5,107.77,4,1,7,2,43,0,0.0
HTR1D,agonist,almotriptan,3.39,5-hydroxytryptamine receptor 1D,GPCR,7.5,True,335.464,1.5233823820000003,True,2,7,0,0,56.41,6,1,3,3,48,0,0.0
HTR1B,agonist,almotriptan,3.69,5-hydroxytryptamine receptor 1B,GPCR,8.0,True,335.464,1.5233823820000003,True,2,7,0,0,56.41,6,1,3,3,48,0,0.0
,modulator,pentetic acid,,lead,Inorganic material,,True,393.349,-6.273562251913113,False,1,0,1,0,196.22,16,5,8,0,50,0,0.0
PIK3CD,inhibitor,idelalisib,0.87,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,8.60206031799316,True,415.432,3.361083963333334,True,1,9,0,4,101.38,5,2,7,5,49,0,1.0
PIK3CG,inhibitor,idelalisib,0.09,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,7.0506100654602095,True,415.432,3.361083963333334,True,1,9,0,4,101.38,5,2,7,5,49,0,1.0
PIK3CB,inhibitor,idelalisib,0.14,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,6.24795150756836,True,415.432,3.361083963333334,True,1,9,0,4,101.38,5,2,7,5,49,0,1.0
TACR1,antagonist,casopitant,2.43,Substance-P receptor,GPCR,9.9,False,616.625,4.9687990630000005,False,2,0,0,0,47.1,4,0,3,4,78,0,3.0
NR1I2,agonist,clotrimazole,0.08,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,,True,344.837,5.839451670666668,False,5,8,0,4,17.82,4,0,2,4,42,0,0.0
NR1I3,antagonist,clotrimazole,0.18,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,6.16,True,344.837,5.839451670666668,False,5,8,0,4,17.82,4,0,2,4,42,0,0.0
KCNN4,inhibitor,clotrimazole,1.35,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,7.15,True,344.837,5.839451670666668,False,5,8,0,4,17.82,4,0,2,4,42,0,0.0
CHRM2,antagonist,dosulepin,0.12,Muscarinic acetylcholine receptor M2,GPCR,6.9625,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
SLC6A2,inhibitor,dosulepin,0.24,Sodium-dependent noradrenaline transporter,Transporter,7.3372,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
CHRM4,antagonist,dosulepin,0.17,Muscarinic acetylcholine receptor M4,GPCR,7.2147,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
HRH1,antagonist,dosulepin,0.08,Histamine H1 receptor,GPCR,8.699,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
HTR2A,antagonist,dosulepin,0.05,5-hydroxytryptamine receptor 2A,GPCR,6.5884,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
SLC6A4,inhibitor,dosulepin,0.21,Sodium-dependent serotonin transporter,Transporter,8.0655,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
CHRM1,antagonist,dosulepin,0.09,Muscarinic acetylcholine receptor M1,GPCR,7.744,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
CHRM3,antagonist,dosulepin,0.1,Muscarinic acetylcholine receptor M3,GPCR,7.4202,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
CHRM5,antagonist,dosulepin,0.17,Muscarinic acetylcholine receptor M5,GPCR,7.0362,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
ADRA1A,antagonist,dosulepin,0.03,Alpha-1A adrenergic receptor,GPCR,6.3778,True,295.44,4.522084514333333,True,12,4,0,0,3.24,3,0,2,3,42,0,0.0
PTGER2,agonist,alprostadil,1.88,Prostaglandin E2 receptor EP2 subtype,GPCR,8.0,True,354.487,3.5871917936666664,True,3,0,0,6,94.83,13,3,4,1,59,0,4.0
DRD4,agonist,fenoldopam,0.06,D(4) dopamine receptor,GPCR,6.5,True,305.756,1.920520197192234,True,8,0,0,0,72.72,1,4,4,3,37,0,1.0
ADRB1,"antagonist,partial agonist",penbutolol,0.9,Beta-1 adrenergic receptor,GPCR,8.8,True,291.4284,3.545216419,True,4,1,1,0,41.49,6,2,3,2,50,0,1.0
HTR1A,antagonist,penbutolol,0.28,5-hydroxytryptamine receptor 1A,GPCR,7.92,True,291.4284,3.545216419,True,4,1,1,0,41.49,6,2,3,2,50,0,1.0
ADRA2B,antagonist,carvedilol,0.04,Alpha-2B adrenergic receptor,GPCR,7.366531544,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRB2,antagonist,carvedilol,0.16,Beta-2 adrenergic receptor,GPCR,9.9,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
KCNH2,inhibitor,carvedilol,0.01,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.46,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRA2A,antagonist,carvedilol,0.03,Alpha-2A adrenergic receptor,GPCR,7.397940009,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRA1A,inhibitor,carvedilol,0.08,Alpha-1A adrenergic receptor,GPCR,8.66,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRA2C,antagonist,carvedilol,0.03,Alpha-2C adrenergic receptor,GPCR,7.886056647999999,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRB3,antagonist,carvedilol,0.03,Beta-3 adrenergic receptor,GPCR,9.4,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
ADRA1D,antagonist,carvedilol,0.08,Alpha-1D adrenergic receptor,GPCR,9.054039296000001,True,406.4742,3.4248544080000003,True,19,10,1,1,75.74,10,3,5,4,56,0,1.0
CA7,inhibitor,methazolamide,1.42,Carbonic anhydrase 7,Enzyme,8.68,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
CA4,inhibitor,methazolamide,0.99,Carbonic anhydrase 4,Enzyme,6.62,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
CA3,inhibitor,methazolamide,0.81,Carbonic anhydrase 3,Enzyme,8.96,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
CA2,inhibitor,methazolamide,0.23,Carbonic anhydrase,Unclassified,6.88,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
CA1,inhibitor,methazolamide,1.6,Carbonic anhydrase 1,Enzyme,7.85,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
CA14,inhibitor,methazolamide,0.41,Carbonic anhydrase 14,Enzyme,7.37,True,236.26,-0.593433132,True,5,0,0,1,107.41,1,1,6,1,22,0,0.0
ASIC3,blocker,diclofenac,0.3,Acid-sensing ion channel 3,Ion channel,4.0,True,296.149,4.259009233333334,True,2,14,2,13,49.33,4,2,2,2,30,0,0.0
PTGS2,inhibitor,diclofenac,0.23,Prostaglandin G/H synthase 2,Enzyme,7.22,True,296.149,4.259009233333334,True,2,14,2,13,49.33,4,2,2,2,30,0,0.0
PTGS1,inhibitor,diclofenac,0.24,Prostaglandin G/H synthase 1,Enzyme,8.52,True,296.149,4.259009233333334,True,2,14,2,13,49.33,4,2,2,2,30,0,0.0
PPARG,antagonist,diclofenac,0.01,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,6.2,True,296.149,4.259009233333334,True,2,14,2,13,49.33,4,2,2,2,30,0,0.0
DRD1,agonist,levodopa,0.06,D(1A) dopamine receptor,GPCR,,True,197.1879,-1.7921814507627931,True,5,1,1,4,103.78,3,4,4,1,25,0,1.0
KDM1A,inhibitor,tranylcypromine,3.79,Lysine-specific histone demethylase 1A,Enzyme,4.6,True,133.194,1.338882470333333,True,2,6,0,0,26.02,1,1,1,2,21,0,2.0
HTR2A,antagonist,amisulpride,0.05,5-hydroxytryptamine receptor 2A,GPCR,5.080712659,True,369.479,0.2512876846666668,True,4,0,0,0,101.73,7,2,6,2,52,0,1.0
HTR7,antagonist,amisulpride,0.16,5-hydroxytryptamine receptor 7,GPCR,7.93930216,True,369.479,0.2512876846666668,True,4,0,0,0,101.73,7,2,6,2,52,0,1.0
TLR7,antagonist,hydroxychloroquine,2.55,Toll-like receptor 7,Membrane receptor,5.56,True,335.872,2.886971174666668,True,4,3,2,2,48.39,9,2,4,2,49,0,1.0
TLR9,antagonist,hydroxychloroquine,1.39,Toll-like receptor 9,Membrane receptor,7.1,True,335.872,2.886971174666668,True,4,3,2,2,48.39,9,2,4,2,49,0,1.0
,inhibitor,hydroxychloroquine,,SARS-CoV-2,Virus,5.35,True,335.872,2.886971174666668,True,4,3,2,2,48.39,9,2,4,2,49,0,1.0
ADRA1A,agonist,mephentermine,0.53,Alpha-1A adrenergic receptor,GPCR,,True,163.2594,2.5174075436666663,True,2,0,0,0,12.03,3,1,1,1,29,0,0.0
CA2,inhibitor,bendroflumethiazide,0.63,Carbonic anhydrase 2,Enzyme,,True,421.415,1.6983960133333331,True,5,1,0,0,118.36,3,3,5,3,41,0,1.0
CA1,inhibitor,bendroflumethiazide,1.21,Carbonic anhydrase 1,Enzyme,,True,421.415,1.6983960133333331,True,5,1,0,0,118.36,3,3,5,3,41,0,1.0
SLC12A3,inhibitor,bendroflumethiazide,4.21,Solute carrier family 12 member 3,Transporter,8.3,True,421.415,1.6983960133333331,True,5,1,0,0,118.36,3,3,5,3,41,0,1.0
KCNMA1,inducer,bendroflumethiazide,1.05,Calcium-activated potassium channel subunit alpha-1,Ion channel,,True,421.415,1.6983960133333331,True,5,1,0,0,118.36,3,3,5,3,41,0,1.0
CA4,inhibitor,bendroflumethiazide,2.06,Carbonic anhydrase 4,Enzyme,,True,421.415,1.6983960133333331,True,5,1,0,0,118.36,3,3,5,3,41,0,1.0
HTR2B,agonist,cabergoline,0.25,5-hydroxytryptamine receptor 2B,GPCR,8.85,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
DRD1,agonist,cabergoline,0.11,D(1A) dopamine receptor,GPCR,6.7,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
DRD5,agonist,cabergoline,0.38,D(1B) dopamine receptor,GPCR,7.7,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA1B,binder,cabergoline,0.05,Alpha-1B adrenergic receptor,GPCR,7.22,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA2A,antagonist,cabergoline,0.11,Alpha-2A adrenergic receptor,GPCR,7.9,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
HTR2C,agonist,cabergoline,0.13,5-hydroxytryptamine receptor 2C,GPCR,6.2,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
HTR1D,agonist,cabergoline,0.17,5-hydroxytryptamine receptor 1D,GPCR,8.1,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA2C,antagonist,cabergoline,0.14,Alpha-2C adrenergic receptor,GPCR,7.7,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA1A,antagonist,cabergoline,0.05,Alpha-1A adrenergic receptor,GPCR,6.5,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA2B,antagonist,cabergoline,0.19,Alpha-2B adrenergic receptor,GPCR,7.1,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
HTR2A,agonist,cabergoline,0.09,5-hydroxytryptamine receptor 2A,GPCR,8.2,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
DRD4,agonist,cabergoline,0.16,D(4) dopamine receptor,GPCR,7.3,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
HTR1A,agonist,cabergoline,0.09,5-hydroxytryptamine receptor 1A,GPCR,7.7,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
HTR1B,agonist,cabergoline,0.15,5-hydroxytryptamine receptor 1B,GPCR,6.3,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
ADRA1D,binder,cabergoline,0.08,Alpha-1D adrenergic receptor,GPCR,6.78,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
DRD3,agonist,cabergoline,0.14,D(3) dopamine receptor,GPCR,9.1,True,451.6043,2.578516268,True,21,1,0,1,71.68,8,2,4,4,70,0,3.0
SLC6A4,inhibitor,paroxetine,0.23,Sodium-dependent serotonin transporter,Transporter,10.4,True,329.3654,3.1482486886666656,True,12,6,0,1,39.72,4,1,4,4,44,0,2.0
P2RX4,antagonist,paroxetine,0.56,P2X purinoceptor 4,Ion channel,5.33,True,329.3654,3.1482486886666656,True,12,6,0,1,39.72,4,1,4,4,44,0,2.0
SLC6A2,inhibitor,paroxetine,0.11,Sodium-dependent noradrenaline transporter,Transporter,7.3979,True,329.3654,3.1482486886666656,True,12,6,0,1,39.72,4,1,4,4,44,0,2.0
ADRB1,inhibitor,paroxetine,0.03,Beta-1 adrenergic receptor,GPCR,5.0,True,329.3654,3.1482486886666656,True,12,6,0,1,39.72,4,1,4,4,44,0,2.0
CHRM1,inhibitor,paroxetine,0.05,Muscarinic acetylcholine receptor M1,GPCR,7.4559319560000015,True,329.3654,3.1482486886666656,True,12,6,0,1,39.72,4,1,4,4,44,0,2.0
PTGFR,agonist,sulprostone,1.11,Prostaglandin F2-alpha receptor,GPCR,6.7,False,465.56,1.3329879033333332,True,0,0,0,0,130.0,12,3,7,2,63,0,4.0
PTGER1,agonist,sulprostone,0.9,Prostaglandin E2 receptor EP1 subtype,GPCR,7.0,False,465.56,1.3329879033333332,True,0,0,0,0,130.0,12,3,7,2,63,0,4.0
PTGER3,agonist,sulprostone,1.05,Prostaglandin E2 receptor EP3 subtype,GPCR,9.46,False,465.56,1.3329879033333332,True,0,0,0,0,130.0,12,3,7,2,63,0,4.0
MTNR1B,multitarget,ramelteon,77.09,Melatonin receptor type 1B,GPCR,10.39,True,259.3434,2.5705583956666667,True,2,4,0,0,38.33,4,1,2,3,40,0,1.0
MTNR1A,agonist,ramelteon,59.96,Melatonin receptor type 1A,GPCR,10.9,True,259.3434,2.5705583956666667,True,2,4,0,0,38.33,4,1,2,3,40,0,1.0
SCN5A,blocker,oxcarbazepine,0.18,Sodium channel protein type 5 subunit alpha,Ion channel,,True,252.268,1.8181766893333329,True,1,9,1,1,63.4,0,1,2,3,31,0,0.0
CHRM5,antagonist,desipramine,0.05,Muscarinic acetylcholine receptor M5,GPCR,6.84,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
SLC6A2,inhibitor,desipramine,0.39,Sodium-dependent noradrenaline transporter,Transporter,9.0809,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
ADRA1A,antagonist,desipramine,0.02,Alpha-1A adrenergic receptor,GPCR,7.0,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
HTR2C,binder,desipramine,0.03,5-hydroxytryptamine receptor 2C,GPCR,6.5,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
HTR1A,binder,desipramine,0.03,5-hydroxytryptamine receptor 1A,GPCR,5.19381999969482,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
DRD2,binder,desipramine,0.02,D(2) dopamine receptor,GPCR,5.63126468658447,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
SLC6A4,inhibitor,desipramine,0.22,Sodium-dependent serotonin transporter,Transporter,7.7545,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
ADRA2A,binder,desipramine,0.03,Alpha-2A adrenergic receptor,GPCR,5.860435734,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
CHRM4,antagonist,desipramine,0.05,Muscarinic acetylcholine receptor M4,GPCR,6.8,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
HTR2A,antagonist,desipramine,0.02,5-hydroxytryptamine receptor 2A,GPCR,6.7959,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
SLC29A4,inhibitor,desipramine,0.2,Equilibrative nucleoside transporter 4,Transporter,4.49,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
CHRM3,antagonist,desipramine,0.03,Muscarinic acetylcholine receptor M3,GPCR,6.68,True,266.3807,3.895520857,True,17,5,1,6,15.27,4,1,2,3,42,0,0.0
CA2,inhibitor,trichlormethiazide,0.65,Carbonic anhydrase 2,Enzyme,7.04,True,380.656,0.9733494586666664,True,5,1,0,0,118.36,2,3,5,2,28,0,1.0
SLC12A3,inhibitor,trichlormethiazide,2.71,Solute carrier family 12 member 3,Transporter,7.0,True,380.656,0.9733494586666664,True,5,1,0,0,118.36,2,3,5,2,28,0,1.0
CA1,inhibitor,trichlormethiazide,1.25,Carbonic anhydrase 1,Enzyme,6.46,True,380.656,0.9733494586666664,True,5,1,0,0,118.36,2,3,5,2,28,0,1.0
CHRM3,allosteric modulator,vincamine,0.08,Muscarinic acetylcholine receptor M3,GPCR,5.7,False,354.45,3.3907502936666667,True,0,0,0,0,54.7,2,1,5,5,52,0,3.0
CHRM1,allosteric modulator,vincamine,0.07,Muscarinic acetylcholine receptor M1,GPCR,4.8,False,354.45,3.3907502936666667,True,0,0,0,0,54.7,2,1,5,5,52,0,3.0
CHRM4,allosteric modulator,vincamine,0.14,Muscarinic acetylcholine receptor M4,GPCR,4.2,False,354.45,3.3907502936666667,True,0,0,0,0,54.7,2,1,5,5,52,0,3.0
CHRM2,allosteric modulator,vincamine,0.09,Muscarinic acetylcholine receptor M2,GPCR,5.1,False,354.45,3.3907502936666667,True,0,0,0,0,54.7,2,1,5,5,52,0,3.0
ADRA1B,antagonist,terazosin,0.29,Alpha-1B adrenergic receptor,GPCR,9.08,True,387.4329,1.1797275923333332,True,7,0,0,1,103.04,4,1,8,4,53,0,1.0
KCNH2,inhibitor,terazosin,0.02,Potassium voltage-gated channel subfamily H member 2,Ion channel,4.75,True,387.4329,1.1797275923333332,True,7,0,0,1,103.04,4,1,8,4,53,0,1.0
PTGS2,inhibitor,mefenamic acid,0.37,Prostaglandin G/H synthase 2,Enzyme,6.83,True,241.2851,5.397597278000001,False,2,5,1,0,49.33,3,2,2,2,33,0,0.0
KCNH2,inhibitor,procainamide,0.06,Potassium voltage-gated channel subfamily H member 2,Ion channel,3.86,True,235.3253,0.9508966536666662,True,3,2,0,7,58.36,6,2,3,1,38,0,0.0
ADRB2,agonist,olodaterol,1.73,Beta-2 adrenergic receptor,GPCR,9.14000034332275,True,386.448,1.1931407006669257,True,1,2,0,0,100.05,7,4,6,3,54,0,1.0
GABRA2,agonist,zolpidem,0.57,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,6.389999866485598,True,307.3895,3.0176268213333337,True,4,5,0,0,37.61,3,0,3,3,44,0,0.0
CNGA1,blocker,dequalinium,16.23,cGMP-gated cation channel alpha-1,Unclassified,6.7,True,456.6654,-3.5914346982768235,True,5,0,0,0,61.04,11,2,2,4,74,2,0.0
CNGA1,blocker,dequalinium,16.23,cGMP-gated cation channel alpha-1,Unclassified,6.7,True,456.6654,-3.5914346982768235,True,5,0,0,0,61.04,11,2,2,4,74,2,0.0
KCNN3,blocker,dequalinium,2.03,Small conductance calcium-activated potassium channel protein 3,Ion channel,5.89,True,456.6654,-3.5914346982768235,True,5,0,0,0,61.04,11,2,2,4,74,2,0.0
KCNN3,blocker,dequalinium,2.03,Small conductance calcium-activated potassium channel protein 3,Ion channel,5.89,True,456.6654,-3.5914346982768235,True,5,0,0,0,61.04,11,2,2,4,74,2,0.0
PCNA,antagonist,liothyronine,3.16,Proliferating cell nuclear antigen,Unclassified,5.44,True,650.9735,2.7985049745109825,False,3,1,3,11,92.78,5,3,4,2,35,0,1.0
THRA,agonist,liothyronine,4.63,Thyroid hormone receptor alpha,Nuclear hormone receptor,10.24,True,650.9735,2.7985049745109825,False,3,1,3,11,92.78,5,3,4,2,35,0,1.0
CFTR,activator,felodipine,0.09,Cystic fibrosis transmembrane conductance regulator,Ion channel,8.4,True,384.254,3.4404073996666664,True,13,6,0,2,64.63,4,1,5,2,44,0,1.0
CACNA1H,inhibitor,felodipine,0.23,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,5.1675,True,384.254,3.4404073996666664,True,13,6,0,2,64.63,4,1,5,2,44,0,1.0
ADRB2,antagonist,timolol,1.39,Beta-2 adrenergic receptor,GPCR,9.7,True,316.42,1.3357059456666662,True,3,2,0,1,79.74,6,2,8,2,45,0,1.0
HTR2C,agonist,apomorphine,0.07,5-hydroxytryptamine receptor 2C,GPCR,7.0,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
DRD5,agonist,apomorphine,0.38,D(1B) dopamine receptor,GPCR,7.8,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
ADRA2A,agonist,apomorphine,0.05,Alpha-2A adrenergic receptor,GPCR,6.9,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
ADRA2B,antagonist,apomorphine,0.08,Alpha-2B adrenergic receptor,GPCR,7.2,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
HTR1B,agonist,apomorphine,0.06,5-hydroxytryptamine receptor 1B,GPCR,5.53,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
ADRA2C,antagonist,apomorphine,0.07,Alpha-2C adrenergic receptor,GPCR,7.4,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
HTR1D,agonist,apomorphine,0.07,5-hydroxytryptamine receptor 1D,GPCR,5.91,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
HTR1A,agonist,apomorphine,0.06,5-hydroxytryptamine receptor 1A,GPCR,6.53,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
TRPA1,activator,apomorphine,0.07,Transient receptor potential cation channel subfamily A member 1,Ion channel,5.1,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
HTR2A,agonist,apomorphine,0.05,5-hydroxytryptamine receptor 2A,GPCR,6.9,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
HTR2B,antagonist,apomorphine,0.12,5-hydroxytryptamine receptor 2B,GPCR,6.9,True,267.3224,2.8666352302639715,True,14,11,1,1,43.7,0,2,3,4,37,0,1.0
ADRB3,antagonist,propranolol,0.23,Beta-3 adrenergic receptor,GPCR,6.22,True,259.3434,2.583695929333333,True,5,8,2,2,41.49,6,2,3,2,40,0,1.0
PDE3B,inhibitor,cilostazol,0.36,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,6.42,True,369.4607,3.3055661830000007,True,1,6,0,0,81.93,7,1,6,4,54,0,0.0
PDE3A,inhibitor,cilostazol,1.92,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,6.7,True,369.4607,3.3055661830000007,True,1,6,0,0,81.93,7,1,6,4,54,0,0.0
CHRM1,binder,terfenadine,0.04,Muscarinic acetylcholine receptor M1,GPCR,5.54,True,471.6734,6.479109075999999,False,7,6,0,2,43.7,8,2,3,4,76,0,1.0
KCNH1,blocker,terfenadine,0.24,Potassium voltage-gated channel subfamily H member 1,Ion channel,7.8,True,471.6734,6.479109075999999,False,7,6,0,2,43.7,8,2,3,4,76,0,1.0
NR3C2,antagonist,drospirenone,4.7,Mineralocorticoid receptor,Nuclear hormone receptor,10.5,True,366.4932,3.3667613656666666,True,4,3,0,0,43.37,0,0,3,7,57,0,10.0
PGR,agonist,drospirenone,1.74,Progesterone receptor,Nuclear hormone receptor,10.5,True,366.4932,3.3667613656666666,True,4,3,0,0,43.37,0,0,3,7,57,0,10.0
PTGS2,antagonist,thalidomide,0.1,Prostaglandin G/H synthase 2,Enzyme,6.3,True,258.2295,0.01570735600000027,True,7,5,0,0,83.55,1,1,4,3,29,0,1.0
CRBN,inhibitor,thalidomide,1.05,Protein cereblon,Cytosolic other,6.3929738998413095,True,258.2295,0.01570735600000027,True,7,5,0,0,83.55,1,1,4,3,29,0,1.0
HRH1,antagonist,prochlorperazine,0.04,Histamine H1 receptor,GPCR,7.7228,True,373.943,4.382119821333332,True,4,1,0,0,9.72,4,0,4,4,49,0,0.0
DRD4,antagonist,prochlorperazine,0.03,D(4) dopamine receptor,GPCR,7.17,True,373.943,4.382119821333332,True,4,1,0,0,9.72,4,0,4,4,49,0,0.0
ADRA1A,antagonist,prochlorperazine,0.02,Alpha-1A adrenergic receptor,GPCR,7.6216,True,373.943,4.382119821333332,True,4,1,0,0,9.72,4,0,4,4,49,0,0.0
DRD3,antagonist,prochlorperazine,0.02,D(3) dopamine receptor,GPCR,8.611,True,373.943,4.382119821333332,True,4,1,0,0,9.72,4,0,4,4,49,0,0.0
ADRA2A,antagonist,prochlorperazine,0.03,Alpha-2A adrenergic receptor,GPCR,7.200659451,True,373.943,4.382119821333332,True,4,1,0,0,9.72,4,0,4,4,49,0,0.0
CACNA1H,inhibitor,nitrendipine,0.36,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,5.0555,True,360.3612,2.172302236333333,True,7,3,0,2,107.77,5,1,7,2,46,0,1.0
KCNN4,blocker,nitrendipine,0.62,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,7.6,True,360.3612,2.172302236333333,True,7,3,0,2,107.77,5,1,7,2,46,0,1.0
CACNA1D,inhibitor,nitrendipine,0.51,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,8.4,True,360.3612,2.172302236333333,True,7,3,0,2,107.77,5,1,7,2,46,0,1.0
CACNA1F,inhibitor,nitrendipine,0.16,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,6.0,True,360.3612,2.172302236333333,True,7,3,0,2,107.77,5,1,7,2,46,0,1.0
CACNA1C,inhibitor,nitrendipine,0.23,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,,True,360.3612,2.172302236333333,True,7,3,0,2,107.77,5,1,7,2,46,0,1.0
,inhibitor,celecoxib,,Carbonic anhydrase,Enzyme,4.41,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
PTGS2,inhibitor,celecoxib,0.11,Prostaglandin G/H synthase 2,Enzyme,7.24,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
CA3,inhibitor,celecoxib,0.12,Carbonic anhydrase 3,Enzyme,5.13,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
PDPK1,inhibitor,celecoxib,0.21,3-phosphoinositide-dependent protein kinase 1,Kinase,4.32,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
PTGS1,inhibitor,celecoxib,0.01,Prostaglandin G/H synthase 1,Enzyme,8.43,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
CA2,inhibitor,celecoxib,0.03,Carbonic anhydrase 2,Enzyme,7.68,True,381.372,4.009441774333332,True,5,4,0,4,77.98,3,1,4,3,40,0,0.0
BCHE,inhibitor,galantamine,2.15,Cholinesterase,Enzyme,6.72,True,287.3535,1.1630428036666671,True,4,2,0,1,41.93,1,1,4,4,42,0,3.0
SCN9A,blocker,lidocaine,0.32,Sodium channel protein type 9 subunit alpha,Ion channel,4.54,True,234.3373,2.842913359666667,True,7,9,0,2,32.34,5,1,2,1,39,0,0.0
SCN2A,blocker,lidocaine,0.05,Sodium channel protein type 2 subunit alpha,Ion channel,,True,234.3373,2.842913359666667,True,7,9,0,2,32.34,5,1,2,1,39,0,0.0
SCN3A,blocker,lidocaine,0.05,Sodium channel protein type 3 subunit alpha,Ion channel,4.98,True,234.3373,2.842913359666667,True,7,9,0,2,32.34,5,1,2,1,39,0,0.0
HDAC5,inhibitor,vorinostat,0.35,Histone deacetylase 5,Enzyme,7.48,True,264.3202,2.003969249333333,True,6,0,0,0,78.43,8,3,3,1,39,0,0.0
HTR1F,agonist,eletriptan,1.58,5-hydroxytryptamine receptor 1F,GPCR,8.0,True,382.519,3.7732624000000015,True,4,6,0,1,53.17,6,1,3,4,53,0,1.0
HTR1D,agonist,eletriptan,1.55,5-hydroxytryptamine receptor 1D,GPCR,9.05,True,382.519,3.7732624000000015,True,4,6,0,1,53.17,6,1,3,4,53,0,1.0
HTR1E,agonist,eletriptan,0.81,5-hydroxytryptamine receptor 1E,GPCR,7.2,True,382.519,3.7732624000000015,True,4,6,0,1,53.17,6,1,3,4,53,0,1.0
HTR1A,agonist,eletriptan,0.19,5-hydroxytryptamine receptor 1A,GPCR,7.4,True,382.519,3.7732624000000015,True,4,6,0,1,53.17,6,1,3,4,53,0,1.0
CACNA1D,inhibitor,amlodipine,0.29,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,7.0,True,408.876,1.6355954516666678,True,8,6,0,1,99.88,8,2,7,2,53,0,1.0
CACNA1C,inhibitor,amlodipine,0.29,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,,True,408.876,1.6355954516666678,True,8,6,0,1,99.88,8,2,7,2,53,0,1.0
CA1,inhibitor,amlodipine,0.34,Carbonic anhydrase 1,Enzyme,,True,408.876,1.6355954516666678,True,8,6,0,1,99.88,8,2,7,2,53,0,1.0
KCNH2,blocker,disopyramide,0.1,Potassium voltage-gated channel subfamily H member 2,Ion channel,4.0362,True,339.4745,3.4684364846666664,True,8,2,1,2,59.22,8,1,3,2,54,0,1.0
CHRM2,antagonist,disopyramide,0.16,Muscarinic acetylcholine receptor M2,GPCR,,True,339.4745,3.4684364846666664,True,8,2,1,2,59.22,8,1,3,2,54,0,1.0
CHRM3,antagonist,disopyramide,0.09,Muscarinic acetylcholine receptor M3,GPCR,,True,339.4745,3.4684364846666664,True,8,2,1,2,59.22,8,1,3,2,54,0,1.0
CHRM1,antagonist,disopyramide,0.12,Muscarinic acetylcholine receptor M1,GPCR,,True,339.4745,3.4684364846666664,True,8,2,1,2,59.22,8,1,3,2,54,0,1.0
PTGS1,inhibitor,oxaprozin,1.38,Prostaglandin G/H synthase 1,Enzyme,6.067526235,True,293.3166,3.4633668516666667,True,2,0,0,0,63.33,5,1,3,3,37,0,0.0
,modulator,succimer,,lead,Inorganic material,,True,182.21,0.25882704599999995,True,4,0,0,0,74.6,3,4,4,0,16,0,2.0
HRH1,antagonist,doxylamine,0.54,Histamine H1 receptor,GPCR,,True,270.3694,2.9619422236666666,True,3,1,0,0,25.36,6,0,3,2,42,0,1.0
RARG,agonist,tretinoin,0.76,Retinoic acid receptor gamma,Nuclear hormone receptor,6.7,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
RXRG,agonist,tretinoin,0.86,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,8.85,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
NR2C2,agonist,tretinoin,0.65,Nuclear receptor subfamily 2 group C member 2,Unclassified,4.62,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
RARA,agonist,tretinoin,0.37,Retinoic acid receptor alpha,Nuclear hormone receptor,6.7,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
PPARD,agonist,tretinoin,0.01,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,7.8,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
RORB,"agonist,antagonist",tretinoin,0.65,Nuclear receptor ROR-beta,Nuclear hormone receptor,9.82,True,300.442,5.014367711,False,18,10,1,2,37.3,5,1,1,1,50,0,0.0
DHFR,inhibitor,pemetrexed,2.54,Dihydrofolate reductase,Enzyme,5.1805,True,427.4106,1.2039798977830458,False,4,2,0,1,191.26,9,6,6,3,52,0,1.0
,inhibitor,pemetrexed,,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,6.37,True,427.4106,1.2039798977830458,False,4,2,0,1,191.26,9,6,6,3,52,0,1.0
CHRM5,agonist,xanomeline,0.05,Muscarinic acetylcholine receptor M5,GPCR,7.1,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1B,agonist,xanomeline,0.05,5-hydroxytryptamine receptor 1B,GPCR,7.3,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR2A,antagonist,xanomeline,0.02,5-hydroxytryptamine receptor 2A,GPCR,6.9,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR2C,antagonist,xanomeline,0.03,5-hydroxytryptamine receptor 2C,GPCR,7.4,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
CHRM2,agonist,xanomeline,0.03,Muscarinic acetylcholine receptor M2,GPCR,6.92,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
CHRM3,agonist,xanomeline,0.03,Muscarinic acetylcholine receptor M3,GPCR,7.89,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR6,agonist,xanomeline,0.07,5-hydroxytryptamine receptor 6,GPCR,5.9,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
CHRM4,agonist,xanomeline,0.05,Muscarinic acetylcholine receptor M4,GPCR,7.14,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1F,agonist,xanomeline,0.13,5-hydroxytryptamine receptor 1F,GPCR,6.5,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1A,agonist,xanomeline,0.03,5-hydroxytryptamine receptor 1A,GPCR,7.2,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
CHRM1,agonist,xanomeline,0.02,Muscarinic acetylcholine receptor M1,GPCR,7.38,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR2B,antagonist,xanomeline,0.05,5-hydroxytryptamine receptor 2B,GPCR,7.7,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1D,agonist,xanomeline,0.06,5-hydroxytryptamine receptor 1D,GPCR,8.2,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1E,agonist,xanomeline,0.11,5-hydroxytryptamine receptor 1E,GPCR,5.6,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR7,agonist,xanomeline,0.06,5-hydroxytryptamine receptor 7,GPCR,6.9,False,281.42,3.7685445506666673,True,0,0,0,0,38.25,7,0,5,2,42,0,0.0
HTR1D,agonist,frovatriptan,4.52,5-hydroxytryptamine receptor 1D,GPCR,8.36,True,243.3043,1.0779760430000005,True,2,1,0,0,70.91,2,3,2,3,35,0,1.0
HTR1A,agonist,frovatriptan,0.13,5-hydroxytryptamine receptor 1A,GPCR,7.21,True,243.3043,1.0779760430000005,True,2,1,0,0,70.91,2,3,2,3,35,0,1.0
PTGS1,inhibitor,ketorolac,1.55,Prostaglandin G/H synthase 1,Enzyme,9.72,True,255.2686,2.2833629636666672,True,2,3,0,0,59.3,3,1,3,3,32,0,1.0
PTGS2,inhibitor,ketorolac,1.54,Prostaglandin G/H synthase 2,Enzyme,6.9,True,255.2686,2.2833629636666672,True,2,3,0,0,59.3,3,1,3,3,32,0,1.0
GLP1R,agonist,lixisenatide,1.49,Glucagon-like peptide 1 receptor,GPCR,8.844663619995119,True,4858.56,-33.10335576809145,False,1,0,0,0,2062.66,169,69,71,8,689,0,42.0
ADRB1,antagonist,nebivolol,0.9,Beta-1 adrenergic receptor,GPCR,8.5,True,405.435,3.2084032136666663,True,3,3,1,0,70.95,6,3,5,4,54,0,4.0
ADRB2,antagonist,nebivolol,0.26,Beta-2 adrenergic receptor,GPCR,7.5,True,405.435,3.2084032136666663,True,3,3,1,0,70.95,6,3,5,4,54,0,4.0
HTR1A,partial agonist,aripiprazole lauroxil,,5-hydroxytryptamine receptor 1A,GPCR,8.76955127716065,True,660.72,9.328087900666663,False,25,4,1,0,62.32,19,0,6,4,96,0,0.0
DRD2,partial agonist,aripiprazole lauroxil,,D(2) dopamine receptor,GPCR,9.46852111816406,True,660.72,9.328087900666663,False,25,4,1,0,62.32,19,0,6,4,96,0,0.0
HRH1,antagonist,aripiprazole lauroxil,,Histamine H1 receptor,GPCR,7.21467018127441,True,660.72,9.328087900666663,False,25,4,1,0,62.32,19,0,6,4,96,0,0.0
HTR2A,antagonist,aripiprazole lauroxil,0.1,5-hydroxytryptamine receptor 2A,GPCR,8.46852111816406,True,660.72,9.328087900666663,False,25,4,1,0,62.32,19,0,6,4,96,0,0.0
NR3C2,agonist,prednisolone,0.08,Mineralocorticoid receptor,Nuclear hormone receptor,9.54,True,360.444,1.2729899243333325,True,1,1,2,2,94.83,2,3,5,4,54,0,7.0
NR3C1,agonist,prednisolone,0.11,Glucocorticoid receptor,Nuclear hormone receptor,7.8,True,360.444,1.2729899243333325,True,1,1,2,2,94.83,2,3,5,4,54,0,7.0
ADRA1A,antagonist,flupentixol,0.13,Alpha-1A adrenergic receptor,GPCR,,True,434.52,4.496787735333333,True,8,2,0,1,26.71,5,1,4,4,55,0,0.0
DRD3,antagonist,flupentixol,0.06,D(3) dopamine receptor,GPCR,8.96,True,434.52,4.496787735333333,True,8,2,0,1,26.71,5,1,4,4,55,0,0.0
HTR2A,antagonist,flupentixol,0.06,5-hydroxytryptamine receptor 2A,GPCR,7.0579919470000005,True,434.52,4.496787735333333,True,8,2,0,1,26.71,5,1,4,4,55,0,0.0
DRD2,antagonist,flupentixol,0.3,D(2) dopamine receptor,GPCR,8.82,True,434.52,4.496787735333333,True,8,2,0,1,26.71,5,1,4,4,55,0,0.0
DRD5,antagonist,flupentixol,0.15,D(1B) dopamine receptor,GPCR,8.1,True,434.52,4.496787735333333,True,8,2,0,1,26.71,5,1,4,4,55,0,0.0
CACNA1A,inhibitor,loperamide,0.95,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,,True,477.038,4.7711908586666665,True,7,4,0,1,43.78,7,1,3,4,67,0,0.0
OPRD1,agonist,loperamide,0.23,Delta-type opioid receptor,GPCR,6.9101,True,477.038,4.7711908586666665,True,7,4,0,1,43.78,7,1,3,4,67,0,0.0
OPRK1,agonist,loperamide,0.07,Kappa-type opioid receptor,GPCR,6.8097,True,477.038,4.7711908586666665,True,7,4,0,1,43.78,7,1,3,4,67,0,0.0
CHRM1,antagonist,diphenidol,0.45,Muscarinic acetylcholine receptor M1,GPCR,7.107905397000001,True,309.4452,4.221518408333333,True,3,0,0,0,23.47,6,1,2,3,50,0,0.0
KCNA7,blocker,amiodarone,0.26,Potassium voltage-gated channel subfamily A member 7,Ion channel,6.0,True,645.3116,7.635421424666668,False,8,9,1,3,42.68,11,0,4,3,60,0,0.0
JAK1,inhibitor,tofacitinib,0.57,Tyrosine-protein kinase JAK1,Kinase,9.17,True,312.3696,1.2447144283333336,True,4,2,1,0,88.91,3,1,5,3,43,0,2.0
PKN1,inhibitor,tofacitinib,1.58,Serine/threonine-protein kinase N1,Kinase,6.77,True,312.3696,1.2447144283333336,True,4,2,1,0,88.91,3,1,5,3,43,0,2.0
EGFR,inhibitor,osimertinib,2.26,Epidermal growth factor receptor,Kinase,7.823908805847171,True,499.619,4.486981489333335,True,1,2,0,2,87.55,10,2,8,4,70,0,0.0
KCNH2,inhibitor,doxazosin,0.1,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.23,True,451.4751,2.135759032,True,4,4,0,2,112.27,4,1,9,5,58,0,1.0
AR,antagonist,bicalutamide,0.17,Androgen receptor,Nuclear hormone receptor,7.72,True,430.3730000000001,2.70929555,True,1,4,0,1,107.26,5,2,5,2,43,0,1.0
ADRA1D,binder,methoxamine,1.07,Alpha-1D adrenergic receptor,GPCR,4.9,True,211.2576,0.5699118033333335,True,3,0,0,0,64.71,4,2,4,1,32,0,2.0
ADRA1A,agonist,methoxamine,1.06,Alpha-1A adrenergic receptor,GPCR,5.1,True,211.2576,0.5699118033333335,True,3,0,0,0,64.71,4,2,4,1,32,0,2.0
CHRM3,antagonist,tolterodine,0.37,Muscarinic acetylcholine receptor M3,GPCR,8.49,True,325.4876,5.116408883863628,False,5,4,0,0,23.47,7,1,2,2,55,0,1.0
CHRM2,antagonist,tolterodine,0.38,Muscarinic acetylcholine receptor M2,GPCR,8.57,True,325.4876,5.116408883863628,False,5,4,0,0,23.47,7,1,2,2,55,0,1.0
PTGER1,agonist,limaprost,0.68,Prostaglandin E2 receptor EP1 subtype,GPCR,,False,380.525,4.3166030446666666,True,4,0,0,0,94.83,13,3,4,1,63,0,5.0
ESR1,"agonist,antagonist",raloxifene,0.13,Estrogen receptor,Nuclear hormone receptor,9.4,True,473.583,5.6926295073730415,False,4,8,2,7,70.0,7,2,6,5,61,0,0.0
GPER1,agonist,raloxifene,0.22,G-protein coupled estrogen receptor 1,GPCR,6.5,True,473.583,5.6926295073730415,False,4,8,2,7,70.0,7,2,6,5,61,0,0.0
HMGCR,inhibitor,lovastatin,1.08,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,7.67,True,404.5396,3.902186914333333,True,3,7,1,7,72.83,6,1,5,3,65,0,8.0
ITGAL,inhibitory allosteric modulator,lovastatin,0.2,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,4.89,True,404.5396,3.902186914333333,True,3,7,1,7,72.83,6,1,5,3,65,0,8.0
NR1I2,agonist,lovastatin,0.02,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,6.0,True,404.5396,3.902186914333333,True,3,7,1,7,72.83,6,1,5,3,65,0,8.0
OPRK1,antagonist,naltrexone,0.63,Kappa-type opioid receptor,GPCR,8.93,True,341.4009,1.3626752317227506,True,4,1,0,0,70.0,2,2,5,6,48,0,4.0
OPRM1,antagonist,naltrexone,1.07,Mu-type opioid receptor,GPCR,9.38,True,341.4009,1.3626752317227506,True,4,1,0,0,70.0,2,2,5,6,48,0,4.0
ADRA2C,binder,tolazoline,0.23,Alpha-2C adrenergic receptor,GPCR,5.43,True,160.2157,1.2036401929999996,True,6,0,0,0,24.39,2,1,2,2,24,0,0.0
ADRA2B,antagonist,tolazoline,0.26,Alpha-2B adrenergic receptor,GPCR,5.5,True,160.2157,1.2036401929999996,True,6,0,0,0,24.39,2,1,2,2,24,0,0.0
ADRA1A,antagonist,tolazoline,0.32,Alpha-1A adrenergic receptor,GPCR,5.5,True,160.2157,1.2036401929999996,True,6,0,0,0,24.39,2,1,2,2,24,0,0.0
ADRA2A,antagonist,tolazoline,0.18,Alpha-2A adrenergic receptor,GPCR,6.64,True,160.2157,1.2036401929999996,True,6,0,0,0,24.39,2,1,2,2,24,0,0.0
SLC6A3,inhibitor,bupropion,0.55,Sodium-dependent dopamine transporter,Transporter,6.28,True,239.741,3.2661124519999998,True,4,4,1,1,29.1,3,1,2,1,34,0,1.0
SLC6A2,inhibitor,bupropion,0.38,Sodium-dependent noradrenaline transporter,Transporter,5.16,True,239.741,3.2661124519999998,True,4,4,1,1,29.1,3,1,2,1,34,0,1.0
NR1I2,agonist,rifampicin,0.17,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,5.64,True,822.9402,2.7698967809531,False,2,13,2,13,220.15,4,6,15,6,117,0,9.0
SLCO1A2,inhibitor,rifampicin,0.77,Solute carrier organic anion transporter family member 1A2,Unclassified,4.29,True,822.9402,2.7698967809531,False,2,13,2,13,220.15,4,6,15,6,117,0,9.0
SLCO1B1,inhibitor,rifampicin,0.34,Solute carrier organic anion transporter family member 1B1,Transporter,5.96,True,822.9402,2.7698967809531,False,2,13,2,13,220.15,4,6,15,6,117,0,9.0
SLCO1B3,inhibitor,rifampicin,0.2,Solute carrier organic anion transporter family member 1B3,Transporter,5.8,True,822.9402,2.7698967809531,False,2,13,2,13,220.15,4,6,15,6,117,0,9.0
DRD1,antagonist,methylergometrine,0.28,D(1A) dopamine receptor,GPCR,6.268411235,True,339.4314,1.5932183806666669,True,2,1,0,0,68.36,4,3,3,4,50,0,3.0
HTR7,ligand,quetiapine,0.04,5-hydroxytryptamine receptor 7,GPCR,6.51201391220093,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
ADRA2A,antagonist,quetiapine,0.05,Alpha-2A adrenergic receptor,GPCR,5.4400935173034695,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR6,antagonist,quetiapine,0.07,5-hydroxytryptamine receptor 6,GPCR,5.85,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HRH1,antagonist,quetiapine,0.03,Histamine H1 receptor,GPCR,8.35,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR1E,agonist,quetiapine,0.11,5-hydroxytryptamine receptor 1E,GPCR,5.9,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
CHRM4,ligand,quetiapine,0.05,Muscarinic acetylcholine receptor M4,GPCR,6.2660007476806605,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
SLC6A2,inhibitor,quetiapine,0.02,Sodium-dependent noradrenaline transporter,Transporter,6.03,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR1A,"antagonist,partial agonist",quetiapine,0.08,5-hydroxytryptamine receptor 1A,GPCR,6.8297,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
DRD4,ligand,quetiapine,0.05,D(4) dopamine receptor,GPCR,5.8,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR2C,ligand,quetiapine,0.07,5-hydroxytryptamine receptor 2C,GPCR,7.0,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
DRD3,ligand,quetiapine,0.07,D(3) dopamine receptor,GPCR,6.49,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
CHRM1,antagonist,quetiapine,0.02,Muscarinic acetylcholine receptor M1,GPCR,7.25,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
ADRA2C,antagonist,quetiapine,0.05,Alpha-2C adrenergic receptor,GPCR,6.2410000000000005,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR1D,ligand,quetiapine,0.07,5-hydroxytryptamine receptor 1D,GPCR,5.7,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
CHRM3,antagonist,quetiapine,0.04,Muscarinic acetylcholine receptor M3,GPCR,5.79547643661499,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
CHRM5,ligand,quetiapine,0.04,Muscarinic acetylcholine receptor M5,GPCR,5.524328708648679,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
DRD5,ligand,quetiapine,0.1,D(1B) dopamine receptor,GPCR,5.79005575180054,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
CHRM2,ligand,quetiapine,0.03,Muscarinic acetylcholine receptor M2,GPCR,6.03693962097168,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR1B,ligand,quetiapine,0.03,5-hydroxytryptamine receptor 1B,GPCR,5.82165718078613,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
ADRA2B,antagonist,quetiapine,0.07,Alpha-2B adrenergic receptor,GPCR,6.126912117004402,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
ADRA1A,antagonist,quetiapine,0.03,Alpha-1A adrenergic receptor,GPCR,7.0269,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
HTR1F,agonist,quetiapine,0.04,5-hydroxytryptamine receptor 1F,GPCR,5.6,True,383.507,2.807942516,True,24,5,0,1,48.3,5,1,6,4,52,0,0.0
EDNRA,antagonist,sitaxentan,14.95,Endothelin-1 receptor,GPCR,9.37,True,454.905,3.091685922,True,2,3,0,0,107.73,6,1,8,4,44,0,0.0
EDNRB,antagonist,sitaxentan,20.66,Endothelin B receptor,GPCR,5.01,True,454.905,3.091685922,True,2,3,0,0,107.73,6,1,8,4,44,0,0.0
VDR,agonist,doxercalciferol,0.74,Vitamin D3 receptor,Nuclear hormone receptor,,True,412.6478,5.746953121333334,False,1,1,0,0,40.46,5,2,2,3,74,0,7.0
PRKCD,ligand,ingenol mebutate,,Protein kinase C delta type,Kinase,8.32790184020996,True,430.541,2.505605261,True,2,0,0,0,104.06,3,3,6,4,65,0,8.0
PRKCA,activator,ingenol mebutate,,Protein kinase C alpha type,Kinase,6.19722604751587,True,430.541,2.505605261,True,2,0,0,0,104.06,3,3,6,4,65,0,8.0
CDK4,inhibitor,palbociclib,0.62,Cyclin-dependent kinase 4,Kinase,7.95860719680786,True,447.5328,2.770733063666668,True,2,2,1,3,105.04,5,2,9,5,62,0,0.0
CDK6,inhibitor,palbociclib,0.51,Cyclin-dependent kinase 6,Kinase,7.823908805847171,True,447.5328,2.770733063666668,True,2,2,1,3,105.04,5,2,9,5,62,0,0.0
PDE5A,inhibitor,vardenafil,7.36,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,9.1549,True,488.603,1.3251205046367571,True,3,2,0,1,112.9,8,1,8,4,66,0,0.0
ADRB1,agonist,norepinephrine,0.17,Beta-1 adrenergic receptor,GPCR,6.4,True,169.1778,-0.6835133951859955,True,12,0,0,6,86.71,2,4,4,1,23,0,1.0
ADRA1D,agonist,norepinephrine,0.33,Alpha-1D adrenergic receptor,GPCR,7.4,True,169.1778,-0.6835133951859955,True,12,0,0,6,86.71,2,4,4,1,23,0,1.0
ADRA1B,agonist,norepinephrine,0.21,Alpha-1B adrenergic receptor,GPCR,4.69,True,169.1778,-0.6835133951859955,True,12,0,0,6,86.71,2,4,4,1,23,0,1.0
ADRB2,agonist,norepinephrine,0.14,Beta-2 adrenergic receptor,GPCR,5.22,True,169.1778,-0.6835133951859955,True,12,0,0,6,86.71,2,4,4,1,23,0,1.0
ADRB3,agonist,norepinephrine,0.28,Beta-3 adrenergic receptor,GPCR,5.366531544,True,169.1778,-0.6835133951859955,True,12,0,0,6,86.71,2,4,4,1,23,0,1.0
ITK,inhibitor,ibrutinib,0.11,Tyrosine-protein kinase ITK/TSK,Kinase,8.309804,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
FYN,inhibitor,ibrutinib,0.06,Tyrosine-protein kinase Fyn,Kinase,7.5376020000000015,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
LYN,inhibitor,ibrutinib,0.16,Tyrosine-protein kinase Lyn,Kinase,7.85387182235718,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
SRC,inhibitor,ibrutinib,0.03,Proto-oncogene tyrosine-protein kinase Src,Kinase,7.721246000000002,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
ERBB2,inhibitor,ibrutinib,0.08,Receptor tyrosine-protein kinase erbB-2,Kinase,8.19382,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
YES1,inhibitor,ibrutinib,0.02,Tyrosine-protein kinase Yes,Kinase,8.387216,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
ERBB4,inhibitor,ibrutinib,0.06,Receptor tyrosine-protein kinase erbB-4,Kinase,8.468521,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
TXK,inhibitor,ibrutinib,0.41,Tyrosine-protein kinase TXK,Kinase,8.69897,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
LCK,inhibitor,ibrutinib,0.04,Tyrosine-protein kinase Lck,Kinase,8.200659,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
BLK,inhibitor,ibrutinib,0.06,Tyrosine-protein kinase Blk,Kinase,10.0,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
TEC,inhibitor,ibrutinib,0.41,Tyrosine-protein kinase Tec,Kinase,8.154902,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
JAK3,inhibitor,ibrutinib,0.04,Tyrosine-protein kinase JAK3,Kinase,7.49485,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
HCK,inhibitor,ibrutinib,0.1,Tyrosine-protein kinase HCK,Kinase,7.5376020000000015,True,440.507,3.630226299333334,True,1,3,2,0,99.16,5,1,7,5,57,0,1.0
HTR1A,agonist,vortioxetine,0.17,5-hydroxytryptamine receptor 1A,GPCR,7.823908805847171,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
ADRB1,ligand,vortioxetine,0.08,Beta-1 adrenergic receptor,GPCR,7.34,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
HTR7,antagonist,vortioxetine,0.32,5-hydroxytryptamine receptor 7,GPCR,7.721246242523191,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
HTR1B,agonist,vortioxetine,0.27,5-hydroxytryptamine receptor 1B,GPCR,7.48148584365845,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
HTR2A,antagonist,vortioxetine,0.03,5-hydroxytryptamine receptor 2A,GPCR,6.74,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
HTR6,antagonist,vortioxetine,0.1,5-hydroxytryptamine receptor 6,GPCR,6.48,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
HTR5A,antagonist,vortioxetine,0.3,5-hydroxytryptamine receptor 5A,GPCR,6.66,True,298.45,4.7609535586666665,True,7,8,0,0,15.27,3,1,3,3,43,0,0.0
CDK6,inhibitor,ribociclib,1.68,Cyclin-dependent kinase 6,Kinase,7.408935546875,True,434.548,2.3799433863333337,True,2,1,0,0,91.21,5,2,8,5,62,0,0.0
CDK4,inhibitor,ribociclib,1.29,Cyclin-dependent kinase 4,Kinase,8.0,True,434.548,2.3799433863333337,True,2,1,0,0,91.21,5,2,8,5,62,0,0.0
,binder,trabectedin,,DNA,DNA,,True,761.837,3.9873105634094035,False,1,6,0,0,168.72,3,4,15,10,97,0,7.0
,modulator,procarbazine,,DNA,DNA,,True,221.2988,0.9857342426666668,True,2,1,0,0,53.16,5,3,3,1,35,0,0.0
HSD11B1,inhibitor,carbenoxolone,0.2,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,7.08,False,570.7566,6.297316193666665,False,2,0,0,0,117.97,5,2,5,5,91,0,9.0
HRH1,antagonist,azatadine,2.78,Histamine H1 receptor,GPCR,,True,290.4021,3.7475412023333328,True,1,1,0,0,16.13,0,0,2,4,44,0,0.0
F2,inhibitor,ximelagatran,6.16,Prothrombin,Enzyme,6.4318,True,473.5652,0.8693069373333331,True,1,1,0,0,143.85,10,5,7,3,69,0,2.0
SCN9A,blocker,lamotrigine,0.02,Sodium channel protein type 9 subunit alpha,Ion channel,4.77,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN3A,blocker,lamotrigine,0.02,Sodium channel protein type 3 subunit alpha,Ion channel,4.77,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN10A,blocker,lamotrigine,0.02,Sodium channel protein type 10 subunit alpha,Ion channel,4.02,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN8A,blocker,lamotrigine,0.02,Sodium channel protein type 8 subunit alpha,Ion channel,,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN5A,blocker,lamotrigine,0.01,Sodium channel protein type 5 subunit alpha,Ion channel,4.21,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN4A,blocker,lamotrigine,0.02,Sodium channel protein type 4 subunit alpha,Ion channel,4.77,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
HTR3A,inhibitor,lamotrigine,0.04,5-hydroxytryptamine receptor 3A,Ion channel,4.744,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
SCN1A,blocker,lamotrigine,0.15,Sodium channel protein type 1 subunit alpha,Ion channel,,True,256.091,1.9265221886666664,True,17,2,1,3,90.71,1,2,5,2,23,0,0.0
GUCY1B3,positive modulator,riociguat,3.25,Guanylate cyclase soluble subunit beta-1,Enzyme,7.522878646850589,True,422.4157,2.6855664843333336,True,1,4,2,1,138.07,4,2,9,4,50,0,0.0
VKORC1,inhibitor,phenindione,25.82,Vitamin K epoxide reductase complex subunit 1,Enzyme,,True,222.2387,2.8809052646666657,True,1,0,0,0,34.14,1,0,2,3,27,0,0.0
SLC6A4,inhibitor,clomipramine,0.49,Sodium-dependent serotonin transporter,Transporter,9.70335674285889,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
HTR2A,antagonist,clomipramine,0.11,5-hydroxytryptamine receptor 2A,GPCR,7.449771881103518,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
HTR2B,antagonist,clomipramine,0.17,5-hydroxytryptamine receptor 2B,GPCR,6.818156412,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
SLC6A3,inhibitor,clomipramine,0.04,Sodium-dependent dopamine transporter,Transporter,5.56,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
HTR2C,antagonist,clomipramine,0.1,5-hydroxytryptamine receptor 2C,GPCR,7.1897673606872585,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
GSTP1,inhibitor,clomipramine,0.23,Glutathione S-transferase P,Enzyme,,True,314.8520000000001,4.882613470666668,True,6,4,1,1,6.48,4,0,2,3,45,0,0.0
CYP51A1,inhibitor,itraconazole,4.13,Lanosterol 14-alpha demethylase,Enzyme,5.44,True,705.633,7.311371119666668,False,2,6,0,2,104.7,11,0,12,7,87,0,3.0
ESR1,antagonist,hexestrol,0.17,Estrogen receptor,Nuclear hormone receptor,10.3,False,270.3661,5.3656533873333325,False,4,0,0,0,40.46,5,2,2,2,42,0,2.0
DRD3,antagonist,buspirone,0.11,D(3) dopamine receptor,GPCR,6.18,True,385.5031,1.7767331956666652,True,5,4,2,1,69.64,6,0,6,4,59,0,0.0
HTR1A,partial agonist,buspirone,0.45,5-hydroxytryptamine receptor 1A,GPCR,7.25,True,385.5031,1.7767331956666652,True,5,4,2,1,69.64,6,0,6,4,59,0,0.0
ADRA1A,partial agonist,buspirone,0.06,Alpha-1A adrenergic receptor,GPCR,6.4353,True,385.5031,1.7767331956666652,True,5,4,2,1,69.64,6,0,6,4,59,0,0.0
DRD4,antagonist,buspirone,0.16,D(4) dopamine receptor,GPCR,7.0,True,385.5031,1.7767331956666652,True,5,4,2,1,69.64,6,0,6,4,59,0,0.0
GABRA1,agonist,etomidate,0.31,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,4.96000003814697,True,244.289,2.4997860430000003,True,3,2,1,0,44.12,4,0,4,2,34,0,1.0
TAAR1,agonist,tyramine,1.22,Trace amine-associated receptor 1,GPCR,7.16,False,137.179,0.6797131598312175,True,0,0,0,1,46.25,2,2,2,1,21,0,0.0
PSMA1,inhibitor,bortezomib,0.5,Proteasome subunit alpha type-1,Enzyme,9.2076,True,384.237,1.5303000000000004,True,2,5,0,2,124.44,9,4,6,2,53,0,2.0
PSMB8,inhibitor,bortezomib,0.32,Proteasome subunit beta type-8,Enzyme,8.09,True,384.237,1.5303000000000004,True,2,5,0,2,124.44,9,4,6,2,53,0,2.0
PSMD1,inhibitor,bortezomib,0.95,26S proteasome non-ATPase regulatory subunit 1,Cytosolic other,7.7447,True,384.237,1.5303000000000004,True,2,5,0,2,124.44,9,4,6,2,53,0,2.0
NISCH,agonist,moxonidine,14.2,Nischarin,Membrane receptor,8.38,True,241.677,1.5387770663333329,True,2,0,0,0,71.43,2,2,4,2,28,0,0.0
ADRA2A,agonist,moxonidine,0.74,Alpha-2A adrenergic receptor,GPCR,6.82,True,241.677,1.5387770663333329,True,2,0,0,0,71.43,2,2,4,2,28,0,0.0
ADRA2C,agonist,apraclonidine,0.14,Alpha-2C adrenergic receptor,GPCR,7.52,True,245.109,1.6561627496666669,True,3,0,0,0,62.44,1,3,2,2,25,0,0.0
ADRA2B,agonist,apraclonidine,0.31,Alpha-2B adrenergic receptor,GPCR,7.93839359283447,True,245.109,1.6561627496666669,True,3,0,0,0,62.44,1,3,2,2,25,0,0.0
CHRM5,antagonist,promethazine,0.14,Muscarinic acetylcholine receptor M5,GPCR,8.480172006,True,284.4190000000001,4.287570851666667,True,13,3,1,3,6.48,3,0,3,3,40,0,1.0
ADRA1A,antagonist,promethazine,0.06,Alpha-1A adrenergic receptor,GPCR,,True,284.4190000000001,4.287570851666667,True,13,3,1,3,6.48,3,0,3,3,40,0,1.0
HRH1,antagonist,promethazine,0.19,Histamine H1 receptor,GPCR,9.6198,True,284.4190000000001,4.287570851666667,True,13,3,1,3,6.48,3,0,3,3,40,0,1.0
DRD2,antagonist,promethazine,0.03,D(2) dopamine receptor,GPCR,6.6094,True,284.4190000000001,4.287570851666667,True,13,3,1,3,6.48,3,0,3,3,40,0,1.0
HRH2,antagonist,promethazine,0.16,Histamine H2 receptor,GPCR,5.940815382,True,284.4190000000001,4.287570851666667,True,13,3,1,3,6.48,3,0,3,3,40,0,1.0
HTR2B,antagonist,trazodone,0.05,5-hydroxytryptamine receptor 2B,GPCR,7.08,True,371.864,3.1318566039999984,True,8,4,0,1,45.78,5,0,6,4,48,0,0.0
HTR2A,antagonist,trazodone,0.26,5-hydroxytryptamine receptor 2A,GPCR,7.35,True,371.864,3.1318566039999984,True,8,4,0,1,45.78,5,0,6,4,48,0,0.0
HTR2C,agonist,trazodone,0.25,5-hydroxytryptamine receptor 2C,GPCR,6.65,True,371.864,3.1318566039999984,True,8,4,0,1,45.78,5,0,6,4,48,0,0.0
SLC6A4,inhibitor,trazodone,0.23,Sodium-dependent serotonin transporter,Transporter,6.8,True,371.864,3.1318566039999984,True,8,4,0,1,45.78,5,0,6,4,48,0,0.0
PARP1,inhibitor,rucaparib,0.52,Poly [ADP-ribose] polymerase 1,Enzyme,8.5,True,323.371,2.454489927,True,3,10,0,10,56.92,3,3,2,4,42,0,0.0
PARP2,antagonist,rucaparib,1.23,Poly [ADP-ribose] polymerase 2,Enzyme,7.550000190734861,True,323.371,2.454489927,True,3,10,0,10,56.92,3,3,2,4,42,0,0.0
SLC22A8,inhibitor,probenecid,4.62,Solute carrier family 22 member 8,Transporter,,True,285.3590000000001,2.442872324333333,True,5,4,1,22,74.68,7,1,3,1,38,0,0.0
SLC22A6,inhibitor,probenecid,4.54,Solute carrier family 22 member 6,Transporter,4.9,True,285.3590000000001,2.442872324333333,True,5,4,1,22,74.68,7,1,3,1,38,0,0.0
CA14,inhibitor,brinzolamide,0.58,Carbonic anhydrase 14,Enzyme,7.62,True,383.507,-0.6745202669020238,True,5,1,0,0,118.8,7,2,7,2,44,0,1.0
CA2,inhibitor,brinzolamide,1.19,Carbonic anhydrase 2,Enzyme,9.9,True,383.507,-0.6745202669020238,True,5,1,0,0,118.8,7,2,7,2,44,0,1.0
CA5A,inhibitor,brinzolamide,2.03,"Carbonic anhydrase 5A, mitochondrial",Enzyme,7.3,True,383.507,-0.6745202669020238,True,5,1,0,0,118.8,7,2,7,2,44,0,1.0
CA1,inhibitor,brinzolamide,0.83,Carbonic anhydrase 1,Enzyme,8.52,True,383.507,-0.6745202669020238,True,5,1,0,0,118.8,7,2,7,2,44,0,1.0
CA7,inhibitor,brinzolamide,0.51,Carbonic anhydrase 7,Enzyme,8.55,True,383.507,-0.6745202669020238,True,5,1,0,0,118.8,7,2,7,2,44,0,1.0
GPR35,agonist,bumetanide,0.22,G-protein coupled receptor 35,GPCR,5.54,True,364.416,2.423461698376048,True,5,1,0,6,118.72,8,3,5,2,45,0,0.0
HRH1,antagonist,diphenhydramine,0.46,Histamine H1 receptor,GPCR,7.81,True,255.3547,3.651907262,True,2,4,0,2,12.47,6,0,2,2,40,0,0.0
CHRM2,antagonist,diphenhydramine,0.12,Muscarinic acetylcholine receptor M2,GPCR,6.9208,True,255.3547,3.651907262,True,2,4,0,2,12.47,6,0,2,2,40,0,0.0
CHRM3,antagonist,oxybutynin,0.82,Muscarinic acetylcholine receptor M3,GPCR,9.11,True,357.4864,4.438075326666665,True,3,4,2,0,49.77,7,1,4,2,57,0,1.0
CHRM1,antagonist,oxybutynin,0.53,Muscarinic acetylcholine receptor M1,GPCR,9.0,True,357.4864,4.438075326666665,True,3,4,2,0,49.77,7,1,4,2,57,0,1.0
CHRM5,antagonist,oxybutynin,0.1,Muscarinic acetylcholine receptor M5,GPCR,7.85,True,357.4864,4.438075326666665,True,3,4,2,0,49.77,7,1,4,2,57,0,1.0
CHRM4,antagonist,oxybutynin,0.1,Muscarinic acetylcholine receptor M4,GPCR,8.44,True,357.4864,4.438075326666665,True,3,4,2,0,49.77,7,1,4,2,57,0,1.0
ADRA2C,agonist,guanabenz,0.14,Alpha-2C adrenergic receptor,GPCR,6.793174124,True,231.082,1.713098971,True,2,1,0,0,74.26,2,3,2,1,22,0,0.0
ADRA2B,agonist,guanabenz,0.46,Alpha-2B adrenergic receptor,GPCR,7.167491087,True,231.082,1.713098971,True,2,1,0,0,74.26,2,3,2,1,22,0,0.0
RXRG,agonist,bexarotene,7.1,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,8.08,True,348.4779,6.940537397666668,False,3,2,0,0,37.3,3,1,1,3,54,0,0.0
RXRB,agonist,bexarotene,6.04,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,8.23,True,348.4779,6.940537397666668,False,3,2,0,0,37.3,3,1,1,3,54,0,0.0
PPARG,antagonist,bexarotene,0.03,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,5.52,True,348.4779,6.940537397666668,False,3,2,0,0,37.3,3,1,1,3,54,0,0.0
TYR,inhibitor,mequinol,4.73,Tyrosinase,Enzyme,,True,124.1372,1.5120092286666669,True,0,0,0,0,29.46,1,1,2,1,17,0,0.0
CHRM3,antagonist,cyproheptadine,0.06,Muscarinic acetylcholine receptor M3,GPCR,8.0,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
ADRA1B,antagonist,cyproheptadine,0.04,Alpha-1B adrenergic receptor,GPCR,7.6,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
CHRM1,antagonist,cyproheptadine,0.06,Muscarinic acetylcholine receptor M1,GPCR,8.0,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
HTR2A,antagonist,cyproheptadine,0.18,5-hydroxytryptamine receptor 2A,GPCR,8.4192,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
ADRA1A,antagonist,cyproheptadine,0.02,Alpha-1A adrenergic receptor,GPCR,7.4,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
HTR6,antagonist,cyproheptadine,0.09,5-hydroxytryptamine receptor 6,GPCR,6.8,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
HTR2C,antagonist,cyproheptadine,0.07,5-hydroxytryptamine receptor 2C,GPCR,8.6517,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
CHRM2,antagonist,cyproheptadine,0.07,Muscarinic acetylcholine receptor M2,GPCR,8.0,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
ADRA1D,antagonist,cyproheptadine,0.06,Alpha-1D adrenergic receptor,GPCR,6.9,True,287.3981,4.382841646999999,True,7,1,0,0,3.24,0,0,1,4,43,0,0.0
ACHE,inhibitor,tacrine,2.27,Acetylcholinesterase,Enzyme,7.14,True,198.2637,2.628144685,True,3,1,0,1,38.91,0,1,2,3,29,0,0.0
BCHE,inhibitor,tacrine,1.32,Cholinesterase,Enzyme,8.61,True,198.2637,2.628144685,True,3,1,0,1,38.91,0,1,2,3,29,0,0.0
PTGS2,inhibitor,piroxicam,0.42,Prostaglandin G/H synthase 2,Enzyme,4.7,True,331.346,0.5998838320211013,True,2,2,1,4,96.44,2,1,5,3,36,0,0.0
SLC6A3,inhibitor,atomoxetine,0.17,Sodium-dependent dopamine transporter,Transporter,5.97,True,255.3547,3.8087924510000004,True,5,2,3,0,21.26,6,1,2,2,40,0,1.0
SLC6A4,inhibitor,atomoxetine,0.4,Sodium-dependent serotonin transporter,Transporter,8.05,True,255.3547,3.8087924510000004,True,5,2,3,0,21.26,6,1,2,2,40,0,1.0
BRAF,inhibitor,regorafenib,0.18,Serine/threonine-protein kinase B-raf,Kinase,7.55,True,482.815,4.486031697,True,18,6,0,2,92.35,5,3,4,3,48,0,0.0
KDR,inhibitor,regorafenib,0.14,Vascular endothelial growth factor receptor 2,Kinase,7.9,True,482.815,4.486031697,True,18,6,0,2,92.35,5,3,4,3,48,0,0.0
ADRA2B,antagonist,mirtazapine,0.06,Alpha-2B adrenergic receptor,GPCR,6.65,True,265.3529,3.207982755,True,7,3,0,1,19.37,0,0,3,4,39,0,1.0
HTR2A,antagonist,mirtazapine,0.18,5-hydroxytryptamine receptor 2A,GPCR,7.16,True,265.3529,3.207982755,True,7,3,0,1,19.37,0,0,3,4,39,0,1.0
ADRA2C,antagonist,mirtazapine,0.1,Alpha-2C adrenergic receptor,GPCR,7.74,True,265.3529,3.207982755,True,7,3,0,1,19.37,0,0,3,4,39,0,1.0
HRH1,antagonist,mirtazapine,0.07,Histamine H1 receptor,GPCR,8.7959,True,265.3529,3.207982755,True,7,3,0,1,19.37,0,0,3,4,39,0,1.0
ADRA1A,antagonist,mirtazapine,0.09,Alpha-1A adrenergic receptor,GPCR,5.5,True,265.3529,3.207982755,True,7,3,0,1,19.37,0,0,3,4,39,0,1.0
SLC29A4,inhibitor,quinine,0.43,Equilibrative nucleoside transporter 4,Transporter,4.57,True,324.4168,2.5134639506666683,True,3,10,0,7,45.59,4,1,4,5,48,0,5.0
KCNB2,blocker,quinine,0.95,Potassium voltage-gated channel subfamily B member 2,Ion channel,4.9,True,324.4168,2.5134639506666683,True,3,10,0,7,45.59,4,1,4,5,48,0,5.0
ADRB1,antagonist,nadolol,1.26,Beta-1 adrenergic receptor,GPCR,6.9,True,309.4006,0.8654279130000008,True,2,0,1,5,81.95,5,4,5,2,49,0,3.0
ADRB2,antagonist,nadolol,0.9,Beta-2 adrenergic receptor,GPCR,8.6,True,309.4006,0.8654279130000008,True,2,0,1,5,81.95,5,4,5,2,49,0,3.0
ADRB3,antagonist,nadolol,0.22,Beta-3 adrenergic receptor,GPCR,6.3,True,309.4006,0.8654279130000008,True,2,0,1,5,81.95,5,4,5,2,49,0,3.0
KCNH2,blocker,ibutilide,0.14,Potassium voltage-gated channel subfamily H member 2,Ion channel,8.0,True,384.576,2.542652195191505,True,10,0,0,0,69.64,14,2,4,1,62,0,1.0
BCHE,antagonist,pyridostigmine,0.96,Cholinesterase,Enzyme,5.46,True,181.2117,-3.4667273988050784,True,3,0,0,0,33.42,1,0,2,1,26,1,0.0
ACHE,"antagonist,inhibitor",pyridostigmine,1.15,Acetylcholinesterase,Enzyme,4.71,True,181.2117,-3.4667273988050784,True,3,0,0,0,33.42,1,0,2,1,26,1,0.0
AVPR1B,agonist,desmopressin,6.31,Vasopressin V1b receptor,GPCR,9.43,True,1069.22,-6.128255121522684,False,3,2,0,0,437.91,19,13,15,4,138,0,7.0
AVPR2,agonist,desmopressin,3.68,Vasopressin V2 receptor,GPCR,8.3,True,1069.22,-6.128255121522684,False,3,2,0,0,437.91,19,13,15,4,138,0,7.0
OPRM1,antagonist,pentazocine,0.78,Mu-type opioid receptor,GPCR,8.408999999999999,True,285.4238,3.893620046077092,True,3,0,0,1,23.47,2,1,2,3,48,0,3.0
SIGMAR1,agonist,pentazocine,3.87,Sigma non-opioid intracellular receptor 1,Membrane receptor,8.76,True,285.4238,3.893620046077092,True,3,0,0,1,23.47,2,1,2,3,48,0,3.0
DNMT1,inhibitor,azacitidine,0.97,DNA (cytosine-5)-methyltransferase 1,Enzyme,,True,244.2047,-3.065332952,True,3,1,0,0,143.72,2,4,9,2,29,0,4.0
DNMT3A,inhibitor,azacitidine,0.28,DNA (cytosine-5)-methyltransferase 3A,Enzyme,,True,244.2047,-3.065332952,True,3,1,0,0,143.72,2,4,9,2,29,0,4.0
CACNA1I,inhibitor,flunarizine,1.64,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,6.08,True,404.4948,6.165795012666668,False,5,6,0,0,6.48,6,0,2,4,56,0,0.0
CACNA1G,inhibitor,flunarizine,1.58,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,6.28,True,404.4948,6.165795012666668,False,5,6,0,0,6.48,6,0,2,4,56,0,0.0
FDPS,inhibitor,zoledronic acid,2.84,Farnesyl pyrophosphate synthase,Enzyme,10.15,True,272.0896,-3.851108564002269,True,3,0,0,1,153.11,4,5,5,1,26,0,0.0
GGPS1,inhibitor,zoledronic acid,,Geranylgeranyl pyrophosphate synthase,Enzyme,5.57,True,272.0896,-3.851108564002269,True,3,0,0,1,153.11,4,5,5,1,26,0,0.0
DRD4,antagonist,perospirone,0.33,D(4) dopamine receptor,GPCR,10.05,False,426.58,3.7354490443333335,True,6,4,0,0,56.75,6,0,6,5,60,0,2.0
DRD2,antagonist,perospirone,0.12,D(2) dopamine receptor,GPCR,9.22,False,426.58,3.7354490443333335,True,6,4,0,0,56.75,6,0,6,5,60,0,2.0
DRD3,antagonist,perospirone,0.08,D(3) dopamine receptor,GPCR,9.55,False,426.58,3.7354490443333335,True,6,4,0,0,56.75,6,0,6,5,60,0,2.0
FKBP1A,potentiator,pimecrolimus,3.99,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,9.0,True,810.46,6.808131370666668,False,2,1,0,0,158.13,6,2,11,4,124,0,14.0
RARG,agonist,tamibarotene,0.65,Retinoic acid receptor gamma,Nuclear hormone receptor,6.23,False,351.4388,5.349100168333335,False,2,0,1,0,66.4,3,2,2,3,51,0,0.0
ADRA1B,antagonist,silodosin,0.51,Alpha-1B adrenergic receptor,GPCR,7.7,True,495.5345,3.04673584,True,3,2,0,2,97.05,13,3,6,3,67,0,1.0
ADRA1D,antagonist,silodosin,0.8,Alpha-1D adrenergic receptor,GPCR,8.7,True,495.5345,3.04673584,True,3,2,0,2,97.05,13,3,6,3,67,0,1.0
DDC,inhibitor,benserazide,5.68,Aromatic-L-amino-acid decarboxylase,Enzyme,,True,257.246,-1.9020041327408348,False,1,0,0,0,148.07,5,7,7,1,33,0,1.0
BTK,inhibitor,acalabrutinib,0.32,Tyrosine-protein kinase BTK,Kinase,8.29243,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
ERBB4,inhibitor,acalabrutinib,0.1,Receptor tyrosine-protein kinase erbB-4,Kinase,7.79588,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
LYN,inhibitor,acalabrutinib,0.09,Tyrosine-protein kinase Lyn,Kinase,6.0,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
TEC,inhibitor,acalabrutinib,0.68,Tyrosine-protein kinase Tec,Kinase,7.031517,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
TXK,inhibitor,acalabrutinib,0.68,Tyrosine-protein kinase TXK,Kinase,6.434152,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
BMX,inhibitor,acalabrutinib,0.68,Cytoplasmic tyrosine-protein kinase BMX,Kinase,7.337242,True,465.517,2.561967257666668,True,1,3,2,0,118.51,5,2,7,5,58,0,1.0
SLC22A12,inhibitor,sulfinpyrazone,2.37,Solute carrier family 22 member 12,Transporter,4.0,True,404.482,3.187408559666668,True,4,4,1,7,64.23,6,1,5,4,49,0,1.0
MTOR,inhibitor,temsirolimus,0.4,Serine/threonine-protein kinase mTOR,Kinase,5.75,True,1030.2871,7.129959347000002,False,1,4,0,1,241.96,10,4,16,4,160,0,15.0
FKBP1A,inhibitor,temsirolimus,0.2,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,,True,1030.2871,7.129959347000002,False,1,4,0,1,241.96,10,4,16,4,160,0,15.0
ESR2,agonist,ethinylestradiol,0.04,Estrogen receptor beta,Nuclear hormone receptor,8.09,True,296.4034,3.897353088000002,True,2,14,2,5,40.46,0,2,2,4,46,0,5.0
ESR1,agonist,ethinylestradiol,0.19,Estrogen receptor,Nuclear hormone receptor,9.83,True,296.4034,3.897353088000002,True,2,14,2,5,40.46,0,2,2,4,46,0,5.0
NR3C1,agonist,methylprednisolone,0.23,Glucocorticoid receptor,Nuclear hormone receptor,8.5,True,374.4706,1.5600090206666664,True,2,10,1,1,94.83,2,3,5,4,57,0,8.0
KCNH1,blocker,astemizole,0.95,Potassium voltage-gated channel subfamily H member 1,Ion channel,6.7,True,458.5703,5.389652434333334,False,4,5,0,2,42.32,8,1,5,5,65,0,0.0
FKBP1A,inhibitor,tacrolimus,0.62,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,9.398,True,804.0182,5.594120193333335,False,1,2,2,3,178.36,7,3,12,4,126,0,14.0
AVPR1A,agonist,oxytocin,0.53,Vasopressin V1a receptor,GPCR,6.9101,True,1007.187,,False,1,2,1,1,399.53,17,12,15,3,135,0,9.0
AVPR2,agonist,oxytocin,0.47,Vasopressin V2 receptor,GPCR,6.1,True,1007.187,,False,1,2,1,1,399.53,17,12,15,3,135,0,9.0
HRH1,inverse agonist,hydroxyzine,0.42,Histamine H1 receptor,GPCR,8.699,True,374.904,3.4129695053333338,True,2,3,1,1,35.94,8,1,4,3,53,0,1.0
PPARA,agonist,clofibrate,0.49,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,4.25,True,242.699,3.401834674,True,1,5,1,0,35.53,4,0,3,1,31,0,0.0
HTR1A,agonist,vilazodone,0.32,5-hydroxytryptamine receptor 1A,GPCR,9.7,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
DRD2,agonist,vilazodone,0.04,D(2) dopamine receptor,GPCR,6.18,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
DRD3,agonist,vilazodone,0.08,D(3) dopamine receptor,GPCR,7.15,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
HRH1,agonist,vilazodone,0.04,Histamine H1 receptor,GPCR,6.5,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
HTR4,agonist,vilazodone,0.23,5-hydroxytryptamine receptor 4,GPCR,6.6,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
SLC6A4,inhibitor,vilazodone,0.46,Sodium-dependent serotonin transporter,Transporter,9.3,True,441.5249,3.715303905999999,True,2,3,0,0,102.29,7,2,5,5,60,0,0.0
ADRB1,agonist,xamoterol,1.35,Beta-1 adrenergic receptor,GPCR,7.75,True,339.392,-0.8208274645547786,True,1,0,0,0,103.29,8,4,6,2,49,0,1.0
ELANE,inhibitor,sivelestat,12.91,Neutrophil elastase,Enzyme,6.7,False,434.46,2.4200081700000005,True,0,0,0,0,138.87,7,3,6,2,52,0,0.0
NR3C1,agonist,dexamethasone,0.06,Glucocorticoid receptor,Nuclear hormone receptor,8.88,True,392.4611,1.6815696796666673,True,5,15,1,6,94.83,2,3,5,4,57,0,8.0
NR3C2,agonist,dexamethasone,0.02,Mineralocorticoid receptor,Nuclear hormone receptor,9.0,True,392.4611,1.6815696796666673,True,5,15,1,6,94.83,2,3,5,4,57,0,8.0
ANXA1,agonist,dexamethasone,0.18,Annexin A1,Cytosolic other,,True,392.4611,1.6815696796666673,True,5,15,1,6,94.83,2,3,5,4,57,0,8.0
KCNH1,blocker,dofetilide,0.39,Potassium voltage-gated channel subfamily H member 1,Ion channel,7.5,True,441.565,0.2379157528062352,True,3,1,0,1,104.81,11,2,6,2,56,0,0.0
ADRB2,antagonist,sotalol,0.31,Beta-2 adrenergic receptor,GPCR,6.24,True,272.36400000000003,-0.3950640027108308,True,3,1,0,0,78.43,6,3,4,1,38,0,1.0
NR3C1,agonist,clobetasol propionate,,Glucocorticoid receptor,Nuclear hormone receptor,9.179142011,True,466.97,4.177822793000002,True,3,2,2,0,80.67,4,1,5,4,64,0,8.0
ANXA1,inducer,clobetasol propionate,,Annexin A1,Cytosolic other,,True,466.97,4.177822793000002,True,3,2,2,0,80.67,4,1,5,4,64,0,8.0
PTGS2,inhibitor,diflunisal,1.02,Prostaglandin G/H synthase 2,Enzyme,5.09,True,250.1976,3.909892637,True,2,2,2,1,57.53,2,2,2,2,26,0,0.0
ALOX5,inhibitor,sulfasalazine,0.26,Arachidonate 5-lipoxygenase,Enzyme,,True,398.393,4.247607462666666,True,10,0,0,6,141.31,6,3,7,3,42,0,0.0
TBXAS1,antagonist,sulfasalazine,0.65,Thromboxane-A synthase,Enzyme,4.70688063,True,398.393,4.247607462666666,True,10,0,0,6,141.31,6,3,7,3,42,0,0.0
SLC7A11,inhibitor,sulfasalazine,0.84,Cystine/glutamate transporter,Transporter,4.52,True,398.393,4.247607462666666,True,10,0,0,6,141.31,6,3,7,3,42,0,0.0
SLC46A1,inhibitor,sulfasalazine,0.49,Proton-coupled folate transporter,Transporter,4.2,True,398.393,4.247607462666666,True,10,0,0,6,141.31,6,3,7,3,42,0,0.0
CACNA1C,inhibitor,nisoldipine,0.4,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,7.1,True,388.4144,3.059797457666667,True,5,3,0,1,107.77,6,1,7,2,52,0,1.0
CACNA1D,inhibitor,nisoldipine,0.29,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,,True,388.4144,3.059797457666667,True,5,3,0,1,107.77,6,1,7,2,52,0,1.0
NISCH,agonist,tizanidine,12.62,Nischarin,Membrane receptor,7.55,True,253.711,2.024673073,True,3,1,0,0,62.2,1,2,4,3,24,0,0.0
CA1,inhibitor,benzthiazide,0.73,Carbonic anhydrase 1,Enzyme,,True,431.937,1.840787007666666,True,7,0,0,0,118.69,5,2,6,3,40,0,0.0
SLC12A3,inhibitor,benzthiazide,3.16,Solute carrier family 12 member 3,Transporter,8.17,True,431.937,1.840787007666666,True,7,0,0,0,118.69,5,2,6,3,40,0,0.0
CA4,inhibitor,benzthiazide,0.93,Carbonic anhydrase 4,Enzyme,,True,431.937,1.840787007666666,True,7,0,0,0,118.69,5,2,6,3,40,0,0.0
ALDH2,inhibitor,disulfiram,0.97,"Aldehyde dehydrogenase, mitochondrial",Enzyme,,True,296.539,4.159758921999999,True,2,3,0,1,6.48,4,0,4,0,36,0,0.0
PTGS1,inhibitor,naproxen,0.34,Prostaglandin G/H synthase 1,Enzyme,4.96,True,230.2592,2.9857858746666657,True,3,10,1,5,46.53,3,1,2,2,31,0,1.0
PTGS2,inhibitor,naproxen,0.58,Prostaglandin G/H synthase 2,Enzyme,5.6,True,230.2592,2.9857858746666657,True,3,10,1,5,46.53,3,1,2,2,31,0,1.0
NR3C2,antagonist,spironolactone,1.05,Mineralocorticoid receptor,Nuclear hormone receptor,9.8844,True,416.573,3.636754577333333,True,10,2,2,4,60.44,1,0,5,5,61,0,7.0
AR,antagonist,spironolactone,0.01,Androgen receptor,Nuclear hormone receptor,7.4,True,416.573,3.636754577333333,True,10,2,2,4,60.44,1,0,5,5,61,0,7.0
PGR,agonist,spironolactone,0.06,Progesterone receptor,Transcription factor,6.663140179,True,416.573,3.636754577333333,True,10,2,2,4,60.44,1,0,5,5,61,0,7.0
NR3C1,antagonist,spironolactone,0.03,Glucocorticoid receptor,Nuclear hormone receptor,6.2272,True,416.573,3.636754577333333,True,10,2,2,4,60.44,1,0,5,5,61,0,7.0
PTGIR,agonist,beraprost,4.21,Prostacyclin receptor,GPCR,8.37,False,420.4738,3.5970807350000005,True,1,1,0,0,86.99,8,3,4,3,59,0,6.0
PTGER4,agonist,beraprost,0.95,Prostaglandin E2 receptor EP4 subtype,GPCR,5.14,False,420.4738,3.5970807350000005,True,1,1,0,0,86.99,8,3,4,3,59,0,6.0
PTGER3,agonist,beraprost,1.05,Prostaglandin E2 receptor EP3 subtype,GPCR,6.17,False,420.4738,3.5970807350000005,True,1,1,0,0,86.99,8,3,4,3,59,0,6.0
SLC18A2,inducer,benzphetamine,0.67,Synaptic vesicular amine transporter,Transporter,,True,239.3553,4.34435193,True,4,3,0,0,3.24,5,0,1,2,39,0,1.0
CPT1A,inhibitor,perhexiline,23.67,"Carnitine O-palmitoyltransferase 1, liver isoform",Enzyme,,True,277.4879,5.5313085483333335,False,3,3,0,0,12.03,4,1,1,3,55,0,1.0
CHRM1,antagonist,tropicamide,0.19,Muscarinic acetylcholine receptor M1,GPCR,7.167491087,True,284.3529,1.3772273896666662,True,4,0,0,0,53.43,6,1,3,2,41,0,1.0
CHRM2,antagonist,tropicamide,0.24,Muscarinic acetylcholine receptor M2,GPCR,7.431798276,True,284.3529,1.3772273896666662,True,4,0,0,0,53.43,6,1,3,2,41,0,1.0
CHRM3,antagonist,tropicamide,0.41,Muscarinic acetylcholine receptor M3,GPCR,7.522878745,True,284.3529,1.3772273896666662,True,4,0,0,0,53.43,6,1,3,2,41,0,1.0
SSTR2,agonist,lanreotide,1.89,Somatostatin receptor type 2,GPCR,9.6,True,1096.33,-0.3327616914464849,False,2,1,0,0,355.08,17,13,14,6,146,0,9.0
SSTR3,agonist,lanreotide,0.87,Somatostatin receptor type 3,GPCR,8.0,True,1096.33,-0.3327616914464849,False,2,1,0,0,355.08,17,13,14,6,146,0,9.0
CYP2B6,inhibitor,ticlopidine,0.25,Cytochrome P450 2B6,Enzyme,6.7,True,263.786,4.195930255999999,True,1,8,0,0,3.24,2,0,2,3,31,0,0.0
OPRK1,agonist,nalfurafine,0.51,Kappa-type opioid receptor,GPCR,9.75,False,476.573,2.238659811787697,True,0,0,0,0,86.38,5,2,6,7,67,0,5.0
OPRM1,agonist,eluxadoline,0.65,Mu-type opioid receptor,GPCR,8.76955127716065,True,569.6619999999998,1.7984149328863572,False,3,0,0,3,164.63,11,4,6,4,77,0,2.0
OPRK1,agonist,eluxadoline,0.17,Kappa-type opioid receptor,GPCR,7.259637355804441,True,569.6619999999998,1.7984149328863572,False,3,0,0,3,164.63,11,4,6,4,77,0,2.0
ADRB1,antagonist,propafenone,0.12,Beta-1 adrenergic receptor,GPCR,6.6882461389999985,True,341.444,3.5367225463333334,True,4,3,0,1,58.56,11,2,4,2,52,0,1.0
ADRB2,antagonist,propafenone,0.09,Beta-2 adrenergic receptor,GPCR,7.443697499,True,341.444,3.5367225463333334,True,4,3,0,1,58.56,11,2,4,2,52,0,1.0
KCNA5,blocker,propafenone,0.25,Potassium voltage-gated channel subfamily A member 5,Ion channel,4.4,True,341.444,3.5367225463333334,True,4,3,0,1,58.56,11,2,4,2,52,0,1.0
PPARG,agonist,rosiglitazone,0.23,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,7.04,True,357.427,2.4463478986056937,True,7,7,1,2,78.45,7,2,6,3,44,0,1.0
FFAR1,agonist,rosiglitazone,0.13,Free fatty acid receptor 1,GPCR,5.6,True,357.427,2.4463478986056937,True,7,7,1,2,78.45,7,2,6,3,44,0,1.0
TRPC5,activator,rosiglitazone,0.12,Short transient receptor potential channel 5,Ion channel,4.51,True,357.427,2.4463478986056937,True,7,7,1,2,78.45,7,2,6,3,44,0,1.0
DRD3,antagonist,pimozide,0.07,D(3) dopamine receptor,GPCR,9.0455,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
HTR2A,antagonist,pimozide,0.02,5-hydroxytryptamine receptor 2A,GPCR,7.5585,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
DRD2,antagonist,pimozide,0.12,D(2) dopamine receptor,GPCR,8.8623,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
HTR1A,antagonist,pimozide,0.01,5-hydroxytryptamine receptor 1A,GPCR,6.63,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
DRD4,antagonist,pimozide,0.03,D(4) dopamine receptor,GPCR,8.7447,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
CACNA1I,blocker,pimozide,0.07,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,7.5,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
HRH1,antagonist,pimozide,0.01,Histamine H1 receptor,GPCR,6.71,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
KCNA10,blocker,pimozide,0.26,Potassium voltage-gated channel subfamily A member 10,Ion channel,6.5,True,461.5462,5.825713467999999,False,4,5,0,1,41.03,7,1,3,5,63,0,0.0
ALOX5,inhibitor,balsalazide,1.49,Arachidonate 5-lipoxygenase,Enzyme,,True,357.3175,3.172469480333333,True,4,1,0,0,148.65,7,4,6,2,41,0,0.0
ADRA2B,agonist,brimonidine,0.41,Alpha-2B adrenergic receptor,GPCR,7.2596,True,292.135,1.3715845303333332,True,3,1,0,0,62.2,1,2,3,3,27,0,0.0
HTR3A,antagonist,palonosetron,5.11,5-hydroxytryptamine receptor 3A,Ion channel,10.5,True,296.414,2.5460127283333343,True,1,3,0,0,23.55,1,0,2,6,46,0,4.0
ADRA1A,antagonist,zuclopenthixol,0.07,Alpha-1A adrenergic receptor,GPCR,,True,400.965,4.22298393,True,7,2,0,0,26.71,5,1,4,4,52,0,0.0
HTR2A,antagonist,zuclopenthixol,0.13,5-hydroxytryptamine receptor 2A,GPCR,,True,400.965,4.22298393,True,7,2,0,0,26.71,5,1,4,4,52,0,0.0
ADRB2,agonist,ephedrine,0.42,Beta-2 adrenergic receptor,GPCR,5.6,True,165.2322,1.3178347283333334,True,4,2,1,1,32.26,3,2,2,1,27,0,2.0
ACE,inhibitor,zofenopril,2.4,Angiotensin-converting enzyme,Enzyme,9.4,True,429.55,4.3085359773333325,True,1,0,0,0,74.68,7,1,5,3,52,0,3.0
RARB,agonist,adapalene,4.54,Retinoic acid receptor beta,Nuclear hormone receptor,7.47,True,412.5201,6.458501423666665,False,9,0,0,0,46.53,4,1,2,7,59,0,0.0
RARG,agonist,adapalene,3.1,Retinoic acid receptor gamma,Nuclear hormone receptor,6.89,True,412.5201,6.458501423666665,False,9,0,0,0,46.53,4,1,2,7,59,0,0.0
RAF1,"antagonist,inhibitor",dabrafenib,0.09,RAF proto-oncogene serine/threonine-protein kinase,Kinase,6.82,True,519.562,5.459618017333335,False,5,6,0,6,110.86,5,2,7,4,55,0,0.0
PTGS1,inhibitor,meclofenamic acid,0.62,Prostaglandin G/H synthase 1,Enzyme,7.3,True,296.149,6.092265241333332,False,5,0,1,2,49.33,3,2,2,2,30,0,0.0
SMO,antagonist,sonidegib,9.85,Smoothened homolog,GPCR,8.221848487854,True,485.507,6.756367518666668,False,1,1,0,0,63.69,5,1,5,4,61,0,2.0
ESR2,agonist,estriol,0.43,Estrogen receptor beta,Nuclear hormone receptor,8.4,True,288.3814,2.6705977213333343,True,3,0,0,2,60.69,0,3,3,4,45,0,6.0
CA7,inhibitor,topiramate,0.08,Carbonic anhydrase 7,Enzyme,9.06,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
CA4,inhibitor,topiramate,0.48,Carbonic anhydrase 4,Enzyme,5.31,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
CA1,inhibitor,topiramate,0.13,Carbonic anhydrase 1,Enzyme,6.6,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
SCN5A,blocker,topiramate,0.01,Sodium channel protein type 5 subunit alpha,Ion channel,,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
CA2,inhibitor,topiramate,0.15,Carbonic anhydrase 2,Enzyme,8.3,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
SCN1A,blocker,topiramate,0.15,Sodium channel protein type 1 subunit alpha,Ion channel,,True,339.362,0.12695973433333307,True,9,2,1,2,115.54,3,1,8,3,43,0,4.0
HMGCR,inhibitor,pravastatin,0.85,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,7.52,True,424.5277,1.6470916203333337,True,2,0,0,13,124.29,10,4,6,2,66,0,8.0
EDNRA,antagonist,macitentan,11.96,Endothelin-1 receptor,GPCR,9.30103015899658,True,588.273,3.6851263283333338,False,2,2,1,0,128.22,11,2,8,3,52,0,0.0
EDNRB,antagonist,macitentan,20.66,Endothelin B receptor,GPCR,6.407823085784909,True,588.273,3.6851263283333338,False,2,2,1,0,128.22,11,2,8,3,52,0,0.0
HCN3,blocker,ivabradine,3.16,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,Ion channel,5.7,True,468.594,2.7224452983333336,True,1,1,0,0,60.47,10,0,6,4,70,0,1.0
HCN2,inhibitor,ivabradine,1.89,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,,True,468.594,2.7224452983333336,True,1,1,0,0,60.47,10,0,6,4,70,0,1.0
HCN4,blocker,ivabradine,1.89,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,5.37,True,468.594,2.7224452983333336,True,1,1,0,0,60.47,10,0,6,4,70,0,1.0
HCN1,blocker,ivabradine,2.37,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,5.7,True,468.594,2.7224452983333336,True,1,1,0,0,60.47,10,0,6,4,70,0,1.0
ROCK1,inhibitor,ripasudil,0.84,Rho-associated protein kinase 1,Kinase,7.2924299240112305,False,323.39,0.8817413883333332,True,2,0,0,0,62.3,2,1,4,3,40,0,1.0
ROCK2,inhibitor,ripasudil,0.77,Rho-associated protein kinase 2,Kinase,7.721246242523191,False,323.39,0.8817413883333332,True,2,0,0,0,62.3,2,1,4,3,40,0,1.0
ADRA1D,antagonist,alfuzosin,1.49,Alpha-1D adrenergic receptor,GPCR,8.44,True,389.4488,1.1875362089999997,True,4,1,2,1,111.83,8,2,8,3,55,0,1.0
ADRA1A,antagonist,alfuzosin,0.68,Alpha-1A adrenergic receptor,GPCR,7.64,True,389.4488,1.1875362089999997,True,4,1,2,1,111.83,8,2,8,3,55,0,1.0
PARP1,inhibitor,niraparib,1.92,Poly [ADP-ribose] polymerase 1,Enzyme,8.42,True,320.396,2.4680503419999997,True,2,2,0,0,72.94,3,2,4,4,44,0,1.0
PARP2,inhibitor,niraparib,6.31,Poly [ADP-ribose] polymerase 2,Enzyme,8.68,True,320.396,2.4680503419999997,True,2,2,0,0,72.94,3,2,4,4,44,0,1.0
CHRM1,antagonist,scopolamine,0.32,Muscarinic acetylcholine receptor M1,GPCR,9.0,True,303.3529,0.8949522950000002,True,8,1,0,0,62.3,4,1,5,4,43,0,6.0
CHRM3,antagonist,scopolamine,0.15,Muscarinic acetylcholine receptor M3,GPCR,9.4,True,303.3529,0.8949522950000002,True,8,1,0,0,62.3,4,1,5,4,43,0,6.0
CHRM2,antagonist,scopolamine,0.3,Muscarinic acetylcholine receptor M2,GPCR,8.86,True,303.3529,0.8949522950000002,True,8,1,0,0,62.3,4,1,5,4,43,0,6.0
CHRM4,antagonist,scopolamine,0.26,Muscarinic acetylcholine receptor M4,GPCR,9.37,True,303.3529,0.8949522950000002,True,8,1,0,0,62.3,4,1,5,4,43,0,6.0
CHRM5,antagonist,scopolamine,0.17,Muscarinic acetylcholine receptor M5,GPCR,7.75,True,303.3529,0.8949522950000002,True,8,1,0,0,62.3,4,1,5,4,43,0,6.0
ATP1A2,inhibitor,ouabain,1.72,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,6.168770306,True,584.6525,-2.781805889666668,False,3,0,0,6,206.6,4,8,12,6,85,0,15.0
DRD2,antagonist,perphenazine,0.16,D(2) dopamine receptor,GPCR,9.32,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
HTR2A,antagonist,perphenazine,0.01,5-hydroxytryptamine receptor 2A,GPCR,8.2518,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
HTR2C,antagonist,perphenazine,0.02,5-hydroxytryptamine receptor 2C,GPCR,6.8794,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
HRH1,antagonist,perphenazine,0.01,Histamine H1 receptor,GPCR,8.0881,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
HTR7,antagonist,perphenazine,0.04,5-hydroxytryptamine receptor 7,GPCR,7.6383,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
HTR6,antagonist,perphenazine,0.05,5-hydroxytryptamine receptor 6,GPCR,7.55,True,403.969,3.6920178093333327,True,3,7,0,0,29.95,6,1,5,4,53,0,0.0
CHRM2,agonist,pilocarpine,0.24,Muscarinic acetylcholine receptor M2,GPCR,6.949999809265139,True,208.2569,0.949751419333334,True,4,2,0,0,44.12,3,0,4,2,31,0,2.0
CHRM4,partial agonist,pilocarpine,0.15,Muscarinic acetylcholine receptor M4,GPCR,7.150000095367429,True,208.2569,0.949751419333334,True,4,2,0,0,44.12,3,0,4,2,31,0,2.0
CHRM5,agonist,pilocarpine,0.1,Muscarinic acetylcholine receptor M5,GPCR,7.0,True,208.2569,0.949751419333334,True,4,2,0,0,44.12,3,0,4,2,31,0,2.0
DPP4,inhibitor,sitagliptin,5.55,Dipeptidyl peptidase 4,Enzyme,7.774,True,407.3136,1.257216275666667,True,1,2,0,2,77.04,4,1,5,3,43,0,1.0
IMPDH2,inhibitor,mycophenolic acid,,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,8.22,True,320.3371,3.5275974476666656,True,2,5,0,0,93.06,6,2,5,2,43,0,0.0
GRIN2C,blocker,dextromethorphan,0.08,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,6.33,True,271.404,3.4937743506666674,True,16,10,0,0,12.47,1,0,2,4,45,0,3.0
SLC6A4,inhibitor,dextromethorphan,0.16,Sodium-dependent serotonin transporter,Transporter,8.841637508,True,271.404,3.4937743506666674,True,16,10,0,0,12.47,1,0,2,4,45,0,3.0
SIGMAR1,agonist,dextromethorphan,1.55,Sigma non-opioid intracellular receptor 1,Membrane receptor,6.4584,True,271.404,3.4937743506666674,True,16,10,0,0,12.47,1,0,2,4,45,0,3.0
OPRK1,agonist,butorphanol,1.01,Kappa-type opioid receptor,GPCR,9.92,True,327.4605,2.8903292922420443,True,3,0,0,0,43.7,2,2,3,5,53,0,3.0
OPRD1,agonist,butorphanol,1.17,Delta-type opioid receptor,GPCR,7.92,True,327.4605,2.8903292922420443,True,3,0,0,0,43.7,2,2,3,5,53,0,3.0
CMPK1,inhibitor,gemcitabine,1.39,UMP-CMP kinase,Kinase,,True,263.1981,-1.466539628,True,4,2,0,6,110.6,2,3,7,2,29,0,3.0
TYMS,inhibitor,gemcitabine,0.12,Thymidylate synthase,Enzyme,,True,263.1981,-1.466539628,True,4,2,0,6,110.6,2,3,7,2,29,0,3.0
CHRM2,antagonist,atropine,0.35,Muscarinic acetylcholine receptor M2,GPCR,8.97,True,289.3694,1.571241016666666,True,8,0,0,1,49.77,4,1,4,3,44,0,4.0
CHRM5,antagonist,atropine,0.41,Muscarinic acetylcholine receptor M5,GPCR,9.29,True,289.3694,1.571241016666666,True,8,0,0,1,49.77,4,1,4,3,44,0,4.0
CHRM3,antagonist,atropine,0.22,Muscarinic acetylcholine receptor M3,GPCR,9.5,True,289.3694,1.571241016666666,True,8,0,0,1,49.77,4,1,4,3,44,0,4.0
HTR2A,antagonist,flibanserin,0.21,5-hydroxytryptamine receptor 2A,GPCR,7.309803962707519,True,390.4021,3.8251415389999996,True,3,1,0,1,44.27,4,1,4,4,49,0,0.0
HTR1A,agonist,flibanserin,0.26,5-hydroxytryptamine receptor 1A,GPCR,9.0,True,390.4021,3.8251415389999996,True,3,1,0,1,44.27,4,1,4,4,49,0,0.0
DRD4,"agonist,antagonist",flibanserin,0.31,D(4) dopamine receptor,GPCR,8.39793968200684,True,390.4021,3.8251415389999996,True,3,1,0,1,44.27,4,1,4,4,49,0,0.0
ADRB3,agonist,mirabegron,1.64,Beta-3 adrenergic receptor,GPCR,7.64975214004517,True,396.506,2.8864113700000003,True,1,3,2,2,100.27,9,4,6,3,52,0,1.0
GLP1R,agonist,glucagon,0.2,Glucagon-like peptide 1 receptor,GPCR,7.0,True,3767.1,,False,3,0,0,0,1543.74,113,53,51,7,471,0,31.0
GCGR,agonist,glucagon,6.46,Glucagon receptor,GPCR,9.0,True,3767.1,,False,3,0,0,0,1543.74,113,53,51,7,471,0,31.0
HTR2B,agonist,fenfluramine,0.82,5-hydroxytryptamine receptor 2B,GPCR,6.397940009,True,231.2573,3.4714873116666665,True,7,7,0,1,12.03,4,1,1,1,32,0,1.0
SLC6A4,inhibitor,fenfluramine,0.64,Sodium-dependent serotonin transporter,Transporter,6.175874166,True,231.2573,3.4714873116666665,True,7,7,0,1,12.03,4,1,1,1,32,0,1.0
HTR2C,agonist,fenfluramine,0.44,5-hydroxytryptamine receptor 2C,GPCR,5.790484985,True,231.2573,3.4714873116666665,True,7,7,0,1,12.03,4,1,1,1,32,0,1.0
CHRNA3,blocker,mecamylamine,0.17,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,6.41,True,167.2911,2.3736397596666663,True,4,0,0,0,12.03,1,1,1,2,33,0,3.0
CHRNA1,blocker,mecamylamine,0.23,Acetylcholine receptor subunit alpha,Ion channel,5.82,True,167.2911,2.3736397596666663,True,4,0,0,0,12.03,1,1,1,2,33,0,3.0
CHRNA6,blocker,mecamylamine,0.74,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,4.96,True,167.2911,2.3736397596666663,True,4,0,0,0,12.03,1,1,1,2,33,0,3.0
,modulator,cyclophosphamide,,DNA,DNA,,True,261.086,0.09654768666666612,True,2,8,0,0,41.57,5,1,2,1,29,0,1.0
CNR1,agonist,nabilone,7.93,Cannabinoid receptor 1,GPCR,8.4,True,372.5408,6.359703313333332,False,2,3,0,0,46.53,6,1,3,3,63,0,2.0
ACE,inhibitor,trandolapril,2.4,Angiotensin-converting enzyme,Enzyme,8.12,True,430.5372,1.9473587942916133,True,1,1,0,2,95.94,9,2,5,3,65,0,5.0
FFAR4,agonist,oleic acid,,Free fatty acid receptor 4,GPCR,4.7,True,282.4614,6.783798451000003,False,5,0,6,0,37.3,15,1,1,0,54,0,0.0
FFAR1,agonist,oleic acid,,Free fatty acid receptor 1,GPCR,5.7,True,282.4614,6.783798451000003,False,5,0,6,0,37.3,15,1,1,0,54,0,0.0
PPARG,ligand,oleic acid,0.13,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,5.39,True,282.4614,6.783798451000003,False,5,0,6,0,37.3,15,1,1,0,54,0,0.0
ACE,inhibitor,enalaprilat,1.2,Angiotensin-converting enzyme,Enzyme,7.5,True,348.3936,-1.0502586259696762,True,2,0,0,0,106.94,8,3,4,2,49,0,3.0
MC5R,agonist,afamelanotide,3.55,Melanocortin receptor 5,GPCR,9.0,True,1646.8452,-8.175742803850767,False,1,0,0,0,645.48,50,22,21,6,229,0,12.0
MC4R,agonist,afamelanotide,0.79,Melanocortin receptor 4,GPCR,8.8,True,1646.8452,-8.175742803850767,False,1,0,0,0,645.48,50,22,21,6,229,0,12.0
MC3R,agonist,afamelanotide,2.84,Melanocortin receptor 3,GPCR,8.9,True,1646.8452,-8.175742803850767,False,1,0,0,0,645.48,50,22,21,6,229,0,12.0
DRD3,antagonist,domperidone,0.28,D(3) dopamine receptor,GPCR,8.46,True,425.911,2.900103093,True,2,7,0,1,78.82,5,2,5,5,54,0,0.0
CLCNKB,activator,niflumic acid,,Chloride channel protein ClC-Kb,Ion channel,5.0,False,282.218,3.1187293407963845,True,6,1,0,2,62.22,3,2,3,2,29,0,0.0
CLCNKA,inducer,niflumic acid,6.31,Chloride channel protein ClC-Ka,Ion channel,5.0,False,282.218,3.1187293407963845,True,6,1,0,2,62.22,3,2,3,2,29,0,0.0
KCNT2,activator,niflumic acid,,Potassium channel subfamily T member 2,Ion channel,8.68,False,282.218,3.1187293407963845,True,6,1,0,2,62.22,3,2,3,2,29,0,0.0
AGTR1,antagonist,azilsartan medoxomil,,Type-1 angiotensin II receptor,GPCR,,True,568.5336,6.0344982279999995,False,1,0,0,0,155.59,9,1,11,6,66,0,0.0
SCN4A,blocker,mexiletine,0.17,Sodium channel protein type 4 subunit alpha,Ion channel,4.38,True,179.2588,2.462008545,True,2,5,0,0,35.25,3,1,2,1,30,0,1.0
GABRA3,allosteric modulator,flunitrazepam,0.42,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,7.8,True,313.2832,2.554728016666667,True,2,9,0,0,75.81,2,0,4,3,35,0,0.0
GABRA1,ligand,flunitrazepam,0.2,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,8.28,True,313.2832,2.554728016666667,True,2,9,0,0,75.81,2,0,4,3,35,0,0.0
ADRA1A,agonist,xylometazoline,0.14,Alpha-1A adrenergic receptor,GPCR,7.04,True,244.3752,3.7755392423333323,True,6,0,0,0,24.39,2,1,2,2,42,0,0.0
ADRA2B,agonist,xylometazoline,0.18,Alpha-2B adrenergic receptor,GPCR,5.98000001907349,True,244.3752,3.7755392423333323,True,6,0,0,0,24.39,2,1,2,2,42,0,0.0
ADRA2A,agonist,xylometazoline,0.18,Alpha-2A adrenergic receptor,GPCR,7.82000017166138,True,244.3752,3.7755392423333323,True,6,0,0,0,24.39,2,1,2,2,42,0,0.0
ADRB1,agonist,salbutamol,0.11,Beta-1 adrenergic receptor,GPCR,5.612610340118411,True,239.3107,0.3444161509994905,True,3,1,0,0,72.72,4,4,4,1,38,0,1.0
SCN10A,inhibitor,benzocaine,2.95,Sodium channel protein type 10 subunit alpha,Ion channel,,True,165.1891,1.5046047806666665,True,1,1,0,1,52.32,2,1,3,1,23,0,0.0
HTR1A,antagonist,molindone,0.11,5-hydroxytryptamine receptor 1A,GPCR,5.42055940628052,True,276.374,2.035115026333333,True,4,0,0,0,45.33,3,1,3,3,44,0,1.0
HTR2A,antagonist,molindone,0.13,5-hydroxytryptamine receptor 2A,GPCR,6.5,True,276.374,2.035115026333333,True,4,0,0,0,45.33,3,1,3,3,44,0,1.0
HRH1,antagonist,molindone,0.04,Histamine H1 receptor,GPCR,5.7,True,276.374,2.035115026333333,True,4,0,0,0,45.33,3,1,3,3,44,0,1.0
RRM2,inhibitor,clofarabine,0.84,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,8.3,True,303.677,-0.2913217523333334,True,3,1,0,1,119.31,2,3,8,3,31,0,4.0
KCNN4,activator,riluzole,0.35,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,5.7,True,234.198,3.3999074026666665,True,2,2,0,1,48.14,1,1,4,2,20,0,0.0
KCNN3,activator,riluzole,0.62,Small conductance calcium-activated potassium channel protein 3,Ion channel,4.9,True,234.198,3.3999074026666665,True,2,2,0,1,48.14,1,1,4,2,20,0,0.0
KCNN1,activator,riluzole,0.49,Small conductance calcium-activated potassium channel protein 1,Ion channel,4.68,True,234.198,3.3999074026666665,True,2,2,0,1,48.14,1,1,4,2,20,0,0.0
CHRM1,antagonist,oxyphenonium,1.49,Muscarinic acetylcholine receptor M1,GPCR,,True,348.4996,-0.19810528447174525,True,1,0,0,0,46.53,8,1,3,2,59,1,1.0
PDE4B,inhibitor,papaverine,0.55,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,,True,339.385,3.0800750716666663,True,2,0,0,0,49.81,6,0,5,3,46,0,0.0
PDE10A,inhibitor,papaverine,0.55,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,7.77,True,339.385,3.0800750716666663,True,2,0,0,0,49.81,6,0,5,3,46,0,0.0
HTR1A,antagonist,lurasidone,0.31,5-hydroxytryptamine receptor 1A,GPCR,8.195178985595701,True,492.676,4.556549749333332,True,6,1,0,0,56.75,5,0,6,7,71,0,6.0
HTR2A,antagonist,lurasidone,0.15,5-hydroxytryptamine receptor 2A,GPCR,9.327901840209961,True,492.676,4.556549749333332,True,6,1,0,0,56.75,5,0,6,7,71,0,6.0
HTR7,antagonist,lurasidone,0.58,5-hydroxytryptamine receptor 7,GPCR,9.30539512634277,True,492.676,4.556549749333332,True,6,1,0,0,56.75,5,0,6,7,71,0,6.0
ADRA2C,antagonist,lurasidone,0.36,Alpha-2C adrenergic receptor,GPCR,7.966576099395749,True,492.676,4.556549749333332,True,6,1,0,0,56.75,5,0,6,7,71,0,6.0
ADRA2A,antagonist,lurasidone,0.21,Alpha-2A adrenergic receptor,GPCR,7.39040565490723,True,492.676,4.556549749333332,True,6,1,0,0,56.75,5,0,6,7,71,0,6.0
SLC6A4,inhibitor,dexfenfluramine,2.55,Sodium-dependent serotonin transporter,Transporter,6.17587423324585,True,231.2573,3.4714873116666665,True,2,3,0,0,12.03,4,1,1,1,32,0,1.0
HTR2C,agonist,dexfenfluramine,1.33,5-hydroxytryptamine receptor 2C,GPCR,5.79048490524292,True,231.2573,3.4714873116666665,True,2,3,0,0,12.03,4,1,1,1,32,0,1.0
F2,inhibitor,bivalirudin,8.21,Prothrombin,Enzyme,8.6,True,2180.2853,-14.345512778557275,False,1,1,0,0,904.07,66,27,29,6,293,0,16.0
ADRB1,agonist,formoterol,0.18,Beta-1 adrenergic receptor,GPCR,6.5,True,344.4049,1.0566727363571802,True,3,9,1,4,90.82,9,4,5,2,49,0,2.0
ADRB3,agonist,formoterol,0.44,Beta-3 adrenergic receptor,GPCR,7.6,True,344.4049,1.0566727363571802,True,3,9,1,4,90.82,9,4,5,2,49,0,2.0
VDR,agonist,alfacalcidol,0.16,Vitamin D3 receptor,Nuclear hormone receptor,,True,400.6371,5.821855681666667,False,3,0,1,0,40.46,6,2,2,3,73,0,6.0
OPRD1,antagonist,alvimopan,0.91,Delta-type opioid receptor,GPCR,7.92,True,424.5326,0.8221535913906884,True,3,0,0,0,89.87,8,3,4,3,63,0,3.0
OPRM1,antagonist,alvimopan,1.43,Mu-type opioid receptor,GPCR,9.3979,True,424.5326,0.8221535913906884,True,3,0,0,0,89.87,8,3,4,3,63,0,3.0
OPRK1,antagonist,alvimopan,0.68,Kappa-type opioid receptor,GPCR,7.0,True,424.5326,0.8221535913906884,True,3,0,0,0,89.87,8,3,4,3,63,0,3.0
JAK3,inhibitor,baricitinib,0.26,Tyrosine-protein kinase JAK3,Kinase,6.1,True,371.42,-0.18857415466666694,True,4,1,0,7,120.56,5,1,7,4,43,0,0.0
JAK2,inhibitor,baricitinib,0.55,Tyrosine-protein kinase JAK2,Kinase,8.24412536621094,True,371.42,-0.18857415466666694,True,4,1,0,7,120.56,5,1,7,4,43,0,0.0
TYK2,inhibitor,baricitinib,0.22,Non-receptor tyrosine-protein kinase TYK2,Kinase,7.27572393417358,True,371.42,-0.18857415466666694,True,4,1,0,7,120.56,5,1,7,4,43,0,0.0
NR1I2,agonist,rifaximin,3.11,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,5.66,True,785.8785,4.3720907210402435,False,2,3,0,0,198.38,2,5,13,6,108,0,9.0
OPRD1,antagonist,naloxone,0.59,Delta-type opioid receptor,GPCR,7.27,True,327.3743,1.620221160000001,True,7,2,1,2,70.0,2,2,5,5,45,0,4.0
OPRM1,antagonist,naloxone,0.52,Mu-type opioid receptor,GPCR,8.81,True,327.3743,1.620221160000001,True,7,2,1,2,70.0,2,2,5,5,45,0,4.0
OPRK1,antagonist,naloxone,0.2,Kappa-type opioid receptor,GPCR,8.5,True,327.3743,1.620221160000001,True,7,2,1,2,70.0,2,2,5,5,45,0,4.0
IDH2,inhibitor,enasidenib,52.07,"Isocitrate dehydrogenase [NADP], mitochondrial",Enzyme,7.0,True,473.383,4.586206418333333,True,1,13,0,7,108.74,6,3,8,3,50,0,0.0
HTR1A,agonist,naratriptan,0.38,5-hydroxytryptamine receptor 1A,GPCR,7.35,True,335.464,1.440624933,True,4,1,0,0,65.2,5,2,3,3,48,0,0.0
HTR1B,agonist,naratriptan,2.21,5-hydroxytryptamine receptor 1B,GPCR,8.48,True,335.464,1.440624933,True,4,1,0,0,65.2,5,2,3,3,48,0,0.0
HTR1D,agonist,naratriptan,2.71,5-hydroxytryptamine receptor 1D,GPCR,8.7959,True,335.464,1.440624933,True,4,1,0,0,65.2,5,2,3,3,48,0,0.0
HTR1E,agonist,naratriptan,0.32,5-hydroxytryptamine receptor 1E,GPCR,7.7,True,335.464,1.440624933,True,4,1,0,0,65.2,5,2,3,3,48,0,0.0
OPRM1,agonist,ketobemidone,0.29,Mu-type opioid receptor,GPCR,9.0,False,247.3327,2.4890444393991444,True,4,7,0,0,40.54,3,1,3,2,39,0,0.0
OPRD1,agonist,ketobemidone,0.34,Delta-type opioid receptor,GPCR,6.844664,False,247.3327,2.4890444393991444,True,4,7,0,0,40.54,3,1,3,2,39,0,0.0
OPRK1,agonist,ketobemidone,0.25,Kappa-type opioid receptor,GPCR,6.2225730000000015,False,247.3327,2.4890444393991444,True,4,7,0,0,40.54,3,1,3,2,39,0,0.0
NTSR2,agonist,levocabastine,47.34,Neurotensin receptor type 2,GPCR,6.8,True,420.528,2.499427576992052,True,2,0,0,0,64.33,4,1,3,4,60,0,4.0
PGR,agonist,etonogestrel,1.78,Progesterone receptor,Nuclear hormone receptor,,True,324.4565,3.601169887666668,True,1,1,2,0,37.3,1,1,2,4,52,0,6.0
ACHE,inhibitor,ambenonium,9.19,Acetylcholinesterase,Enzyme,9.92,True,537.565,-3.6334014476101566,False,1,1,0,0,58.2,14,2,2,2,78,2,0.0
KCNQ4,blocker,bepridil,0.39,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,5.0,True,366.5396,5.487299518666665,False,10,2,0,1,15.71,10,0,3,3,61,0,1.0
KCNH2,inhibitor,bepridil,0.02,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.26,True,366.5396,5.487299518666665,False,10,2,0,1,15.71,10,0,3,3,61,0,1.0
CACNA1A,inhibitor,bepridil,1.33,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,6.6,True,366.5396,5.487299518666665,False,10,2,0,1,15.71,10,0,3,3,61,0,1.0
CACNA1H,inhibitor,bepridil,0.3,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,5.1487,True,366.5396,5.487299518666665,False,10,2,0,1,15.71,10,0,3,3,61,0,1.0
HMGCR,inhibitor,rosuvastatin,1.88,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,9.05,True,481.538,1.9229604620000005,True,2,1,1,11,140.92,10,3,7,2,61,0,2.0
PTGS1,inhibitor,tiaprofenic acid,0.86,Prostaglandin G/H synthase 1,Enzyme,5.9,True,260.308,3.658654214,True,2,0,0,0,54.37,4,1,3,2,30,0,1.0
RARA,agonist,etretinate,1.83,Retinoic acid receptor alpha,Nuclear hormone receptor,,False,354.4825,6.3230840696666695,False,6,1,1,0,35.53,7,0,3,1,56,0,0.0
RXRG,agonist,etretinate,3.38,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,,False,354.4825,6.3230840696666695,False,6,1,1,0,35.53,7,0,3,1,56,0,0.0
NR3C1,agonist,betamethasone phosphate,0.37,Glucocorticoid receptor,Nuclear hormone receptor,8.428291168,True,472.446,1.5580036483333335,True,2,2,2,3,141.36,4,4,6,4,62,0,8.0
ADRA1B,antagonist,indoramin,0.17,Alpha-1B adrenergic receptor,GPCR,7.6,True,347.4534,3.1862646183333334,True,1,0,0,0,48.13,5,2,2,4,51,0,0.0
ADRA1D,antagonist,indoramin,0.27,Alpha-1D adrenergic receptor,GPCR,6.96,True,347.4534,3.1862646183333334,True,1,0,0,0,48.13,5,2,2,4,51,0,0.0
ADRA1A,antagonist,indoramin,0.43,Alpha-1A adrenergic receptor,GPCR,7.92,True,347.4534,3.1862646183333334,True,1,0,0,0,48.13,5,2,2,4,51,0,0.0
ADRA2A,antagonist,phentolamine,0.45,Alpha-2A adrenergic receptor,GPCR,9.03,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
ADRA1D,antagonist,phentolamine,0.25,Alpha-1D adrenergic receptor,GPCR,7.71,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
ADRA1B,antagonist,phentolamine,0.12,Alpha-1B adrenergic receptor,GPCR,7.32,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
ADRA2C,antagonist,phentolamine,0.04,Alpha-2C adrenergic receptor,GPCR,8.08,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
ADRA2B,antagonist,phentolamine,0.05,Alpha-2B adrenergic receptor,GPCR,8.12,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
ADRA1A,antagonist,phentolamine,0.15,Alpha-1A adrenergic receptor,GPCR,8.17,True,281.3523,2.515108176294385,True,4,0,0,0,47.86,4,2,4,3,40,0,0.0
IMPDH1,"inhibitor,inducer",mycophenolate mofetil,,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,7.48148584365845,True,433.4947,3.4736355743333323,True,3,12,0,5,94.53,9,1,8,3,62,0,0.0
CHRNA3,agonist,nicotine,0.35,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,7.349999904632571,True,162.2316,1.1625346926666664,True,13,13,0,5,16.13,1,0,2,2,26,0,1.0
TRPA1,activator,nicotine,0.03,Transient receptor potential cation channel subfamily A member 1,Ion channel,4.8,True,162.2316,1.1625346926666664,True,13,13,0,5,16.13,1,0,2,2,26,0,1.0
ABAT,inhibitor,vigabatrin,18.94,"4-aminobutyrate aminotransferase, mitochondrial",Enzyme,,True,129.157,-2.0949147846992218,True,1,1,0,1,63.32,4,2,2,0,20,0,1.0
TSSK1B,inhibitor,ceritinib,1.58,Testis-specific serine/threonine-protein kinase 1,Kinase,7.6382722854614284,True,558.135,5.8052708939835584,False,1,2,0,1,105.24,9,3,8,4,74,0,0.0
FLT3,inhibitor,ceritinib,0.05,Receptor-type tyrosine-protein kinase FLT3,Kinase,7.22,True,558.135,5.8052708939835584,False,1,2,0,1,105.24,9,3,8,4,74,0,0.0
ESR1,agonist,estradiol acetate,0.23,Estrogen receptor,Nuclear hormone receptor,,True,314.4186,3.656327624333334,True,10,10,3,14,46.53,1,1,3,4,49,0,5.0
PPARG,agonist,linoleic acid,,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,5.21,True,280.4455,6.421876794333332,False,0,0,0,0,37.3,14,1,1,0,52,0,0.0
FFAR1,agonist,linoleic acid,,Free fatty acid receptor 1,GPCR,5.7,True,280.4455,6.421876794333332,False,0,0,0,0,37.3,14,1,1,0,52,0,0.0
KCNB1,"blocker,activator",linoleic acid,,Potassium voltage-gated channel subfamily B member 1,Ion channel,5.6,True,280.4455,6.421876794333332,False,0,0,0,0,37.3,14,1,1,0,52,0,0.0
FFAR4,agonist,linoleic acid,,Free fatty acid receptor 4,GPCR,5.89,True,280.4455,6.421876794333332,False,0,0,0,0,37.3,14,1,1,0,52,0,0.0
OPRM1,agonist,diphenoxylate,1.56,Mu-type opioid receptor,GPCR,7.1674,True,452.5873,5.884015037999999,False,2,0,0,0,53.33,8,0,4,4,66,0,0.0
SSTR3,agonist,octreotide,0.36,Somatostatin receptor type 3,GPCR,8.3,True,1019.25,-1.4112649113972529,False,1,2,1,2,332.22,17,13,14,5,137,0,10.0
SSTR3,agonist,octreotide,0.36,Somatostatin receptor type 3,GPCR,8.3,True,1019.25,-1.4112649113972529,False,1,2,1,2,332.22,17,13,14,5,137,0,10.0
HTR1E,agonist,dihydroergotamine,0.16,5-hydroxytryptamine receptor 1E,GPCR,5.6,True,583.6774,2.7116222909811363,False,4,1,0,1,118.21,4,3,6,8,80,0,7.0
HTR2B,agonist,dihydroergotamine,0.21,5-hydroxytryptamine receptor 2B,GPCR,8.363512104,True,583.6774,2.7116222909811363,False,4,1,0,1,118.21,4,3,6,8,80,0,7.0
HTR7,antagonist,dihydroergotamine,0.09,5-hydroxytryptamine receptor 7,GPCR,8.0,True,583.6774,2.7116222909811363,False,4,1,0,1,118.21,4,3,6,8,80,0,7.0
ADRA2A,agonist,dihydroergotamine,0.08,Alpha-2A adrenergic receptor,GPCR,9.412289035,True,583.6774,2.7116222909811363,False,4,1,0,1,118.21,4,3,6,8,80,0,7.0
HTR1F,agonist,dihydroergotamine,0.19,5-hydroxytryptamine receptor 1F,GPCR,7.1,True,583.6774,2.7116222909811363,False,4,1,0,1,118.21,4,3,6,8,80,0,7.0
CHRM2,agonist,bethanechol,0.66,Muscarinic acetylcholine receptor M2,GPCR,4.0,True,161.2221,-4.138114261471746,True,4,0,0,0,52.32,3,1,2,0,28,1,1.0
CHRM4,agonist,bethanechol,0.42,Muscarinic acetylcholine receptor M4,GPCR,4.0,True,161.2221,-4.138114261471746,True,4,0,0,0,52.32,3,1,2,0,28,1,1.0
PTGS2,inhibitor,carprofen,2.77,Prostaglandin G/H synthase 2,Enzyme,7.0,True,273.714,3.8756649333333333,True,2,0,0,1,53.09,2,2,1,3,31,0,1.0
PTGS1,inhibitor,carprofen,0.52,Prostaglandin G/H synthase 1,Enzyme,4.88,True,273.714,3.8756649333333333,True,2,0,0,1,53.09,2,2,1,3,31,0,1.0
ACHE,inhibitor,minaprine,0.28,Acetylcholinesterase,Enzyme,4.07,True,298.3828,2.1896802423333326,True,9,1,0,0,50.28,5,1,5,3,44,0,0.0
CHRM1,agonist,minaprine,0.12,Muscarinic acetylcholine receptor M1,GPCR,4.77,True,298.3828,2.1896802423333326,True,9,1,0,0,50.28,5,1,5,3,44,0,0.0
HRH1,antagonist,carbinoxamine,1.39,Histamine H1 receptor,GPCR,,True,290.788,3.2719406193333334,True,1,0,0,0,25.36,6,0,3,2,39,0,1.0
P2RY12,agonist,epoprostenol,2.39,P2Y purinoceptor 12,GPCR,,True,352.4651,2.415704516333332,True,3,0,0,0,86.99,10,3,4,2,57,0,5.0
SLC6A3,inhibitor,methylphenidate,0.32,Sodium-dependent dopamine transporter,Transporter,6.96,True,233.3062,2.254935081666666,True,3,1,0,0,38.33,3,1,3,2,36,0,2.0
PTGS1,inhibitor,flurbiprofen,0.95,Prostaglandin G/H synthase 1,Enzyme,6.0,True,244.2609,3.943907682,True,2,6,1,2,37.3,3,1,1,2,31,0,1.0
UGCG,inhibitor,miglustat,113.61,Ceramide glucosyltransferase,Enzyme,5.13,True,219.278,-1.178796231,True,1,0,0,0,84.16,4,4,5,1,36,0,4.0
NR3C1,agonist,difluprednate,0.87,Glucocorticoid receptor,Nuclear hormone receptor,,True,508.5515,3.0042328929999984,False,1,1,0,0,106.97,6,1,7,4,70,0,8.0
PGR,agonist,dydrogesterone,3.16,Progesterone receptor,Nuclear hormone receptor,6.9,True,312.4458,3.7866827440000006,True,1,1,0,0,34.14,1,0,2,4,51,0,6.0
ESR1,modulator,ospemifene,0.34,Estrogen receptor,Nuclear hormone receptor,6.0824943,True,378.891,5.560388660666667,False,1,5,0,0,29.46,8,1,2,3,50,0,0.0
PTGFR,agonist,bimatoprost,14.48,Prostaglandin F2-alpha receptor,GPCR,5.3,True,415.5656,2.629262466666666,True,3,2,0,0,89.79,12,4,4,2,67,0,5.0
HDAC2,inhibitor,atorvastatin,0.03,Histone deacetylase 2,Enzyme,4.65,True,558.6398,5.387146767000001,False,5,10,1,10,111.79,12,4,5,4,76,0,2.0
HMGCR,inhibitor,atorvastatin,0.63,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,8.0,True,558.6398,5.387146767000001,False,5,10,1,10,111.79,12,4,5,4,76,0,2.0
NR1I3,ligand,atorvastatin,0.07,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,,True,558.6398,5.387146767000001,False,5,10,1,10,111.79,12,4,5,4,76,0,2.0
ESR2,agonist,lasofoxifene,0.57,Estrogen receptor beta,Nuclear hormone receptor,8.74,True,413.5512,5.9722240382087834,False,3,0,0,0,32.7,6,1,3,5,62,0,2.0
ESR1,agonist,lasofoxifene,0.38,Estrogen receptor,Nuclear hormone receptor,8.89,True,413.5512,5.9722240382087834,False,3,0,0,0,32.7,6,1,3,5,62,0,2.0
PDE10A,inhibitor,dipyridamole,0.57,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,6.0,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
PDE4A,inhibitor,dipyridamole,0.14,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,5.80161787,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
PDE8A,inhibitor,dipyridamole,0.53,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,5.1,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
SLC29A1,inhibitor,dipyridamole,0.13,Equilibrative nucleoside transporter 1,Transporter,8.5,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
PDE7B,inhibitor,dipyridamole,0.53,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,6.0,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
PDE2A,inhibitor,dipyridamole,0.11,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,5.49,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
PDE8B,inhibitor,dipyridamole,0.7,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",Enzyme,4.3,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
SLC29A4,inhibitor,dipyridamole,0.1,Equilibrative nucleoside transporter 4,Transporter,5.9,True,504.6256,1.806389258,False,6,0,0,7,145.44,12,4,12,4,76,0,0.0
MAOB,antagonist,moclobemide,1.04,Amine oxidase [flavin-containing] B,Enzyme,5.97,True,268.73900000000003,1.451750923,True,3,5,0,0,41.57,4,1,3,2,35,0,0.0
NR3C1,agonist,hydrocortisone cypionate,0.37,Glucocorticoid receptor,Nuclear hormone receptor,,True,486.649,4.0183955456666665,True,4,4,2,4,100.9,6,2,6,5,77,0,7.0
HRH1,antagonist,triprolidine,2.32,Histamine H1 receptor,GPCR,9.9,True,278.3914,4.045153588666668,True,1,0,0,0,16.13,4,0,2,3,43,0,0.0
PDE3A,inhibitor,amrinone,0.91,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,4.78,True,187.198,-0.568917207,True,5,0,0,0,71.77,1,2,3,2,23,0,0.0
PDE3B,inhibitor,amrinone,1.18,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,4.51,True,187.198,-0.568917207,True,5,0,0,0,71.77,1,2,3,2,23,0,0.0
PNLIP,inhibitor,orlistat,14.91,Pancreatic triacylglycerol lipase,Enzyme,8.9,True,495.7348,8.106577767000001,False,3,2,0,0,81.7,23,1,5,1,88,0,4.0
ABHD12,inhibitor,orlistat,5.68,Monoacylglycerol lipase ABHD12,Enzyme,7.1,True,495.7348,8.106577767000001,False,3,2,0,0,81.7,23,1,5,1,88,0,4.0
DAGLA,inhibitor,orlistat,8.52,Sn1-specific diacylglycerol lipase alpha,Enzyme,8.0,True,495.7348,8.106577767000001,False,3,2,0,0,81.7,23,1,5,1,88,0,4.0
LIPF,inhibitor,orlistat,31.24,Gastric triacylglycerol lipase,Enzyme,,True,495.7348,8.106577767000001,False,3,2,0,0,81.7,23,1,5,1,88,0,4.0
NR3C1,agonist,triamcinolone,0.15,Glucocorticoid receptor,Nuclear hormone receptor,7.585026652000001,True,394.4339,0.241693246333333,True,1,5,2,0,115.06,2,4,6,4,55,0,8.0
GLRB,antagonist,tropisetron,0.36,Glycine receptor subunit beta,Ion channel,5.3,True,284.3529,2.6276225066666665,True,1,0,0,0,45.33,2,1,3,4,41,0,3.0
GLRA2,antagonist,tropisetron,0.41,Glycine receptor subunit alpha-2,Ion channel,4.9,True,284.3529,2.6276225066666665,True,1,0,0,0,45.33,2,1,3,4,41,0,3.0
GLRA1,antagonist,tropisetron,0.17,Glycine receptor subunit alpha-1,Ion channel,4.1,True,284.3529,2.6276225066666665,True,1,0,0,0,45.33,2,1,3,4,41,0,3.0
HTR3A,antagonist,tropisetron,0.18,5-hydroxytryptamine receptor 3A,Ion channel,7.52,True,284.3529,2.6276225066666665,True,1,0,0,0,45.33,2,1,3,4,41,0,3.0
NR3C1,agonist,hydrocortisone butyrate,0.12,Glucocorticoid receptor,Nuclear hormone receptor,,True,432.557,2.8613963570000016,True,4,6,2,4,100.9,5,2,6,4,67,0,7.0
DIO1,inhibitor,propylthiouracil,6.68,Type I iodothyronine deiodinase,Enzyme,,True,170.232,1.203742354333333,True,1,3,0,0,48.65,2,2,2,1,21,0,0.0
TPO,inhibitor,propylthiouracil,5.73,Thyroid peroxidase,Enzyme,5.06,True,170.232,1.203742354333333,True,1,3,0,0,48.65,2,2,2,1,21,0,0.0
CHRM2,agonist,acetylcholine,0.18,Muscarinic acetylcholine receptor M2,GPCR,6.5,True,146.2074,-4.221143752471746,True,6,0,0,2,26.3,3,0,2,0,26,1,0.0
CHRM5,agonist,acetylcholine,0.08,Muscarinic acetylcholine receptor M5,GPCR,6.1,True,146.2074,-4.221143752471746,True,6,0,0,2,26.3,3,0,2,0,26,1,0.0
CHRM4,agonist,acetylcholine,0.26,Muscarinic acetylcholine receptor M4,GPCR,5.6,True,146.2074,-4.221143752471746,True,6,0,0,2,26.3,3,0,2,0,26,1,0.0
P2RY12,inhibitor,ticagrelor,3.36,P2Y purinoceptor 12,GPCR,7.85,True,522.568,2.278667876,False,1,2,1,1,138.44,10,4,11,5,64,0,6.0
SLC29A1,inhibitor,ticagrelor,0.44,Equilibrative nucleoside transporter 1,Transporter,7.3,True,522.568,2.278667876,False,1,2,1,1,138.44,10,4,11,5,64,0,6.0
PRSS1,inhibitor,nafamostat,0.22,Trypsin-1,Enzyme,7.77,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
KLK1,inhibitor,nafamostat,0.89,Kallikrein-1,Enzyme,6.19,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
ASIC2,blocker,nafamostat,0.71,Acid-sensing ion channel 2,Ion channel,4.2,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
ASIC3,blocker,nafamostat,0.44,Acid-sensing ion channel 3,Ion channel,5.6,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
F10,inhibitor,nafamostat,0.13,Coagulation factor X,Enzyme,4.68,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
TPSAB1,inhibitor,nafamostat,0.59,Tryptase alpha/beta-1,Enzyme,10.0,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
F2,inhibitor,nafamostat,0.09,Prothrombin,Enzyme,6.54,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
C1R,inhibitor,nafamostat,0.71,Complement C1r subcomponent,Enzyme,6.0,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
ASIC1,blocker,nafamostat,0.71,Acid-sensing ion channel 1,Ion channel,4.9,False,347.3780000000001,2.5186194733333327,True,6,0,0,2,140.57,4,4,4,3,43,0,0.0
DDC,inhibitor,methyldopa,0.12,Aromatic-L-amino-acid decarboxylase,Enzyme,,True,211.2145,-1.3594803166154474,True,2,1,0,1,103.78,3,4,4,1,28,0,1.0
PTGS1,inhibitor,tenoxicam,0.83,Prostaglandin G/H synthase 1,Enzyme,5.943095149,True,337.37,-0.11589946271036078,True,2,1,0,1,96.44,2,1,6,3,33,0,0.0
PARP2,inhibitor,olaparib,1.62,Poly [ADP-ribose] polymerase 2,Enzyme,9.0,True,434.4628,1.9638784226666663,True,3,3,0,2,86.37,4,1,4,5,55,0,0.0
PARP3,inhibitor,olaparib,0.81,Poly [ADP-ribose] polymerase 3,Enzyme,7.34,True,434.4628,1.9638784226666663,True,3,3,0,2,86.37,4,1,4,5,55,0,0.0
ADRB2,agonist,orciprenaline,3.81,Beta-2 adrenergic receptor,GPCR,5.04,True,211.2576,0.21496194252848475,True,1,0,0,0,72.72,4,4,4,1,32,0,1.0
SRD5A2,inhibitor,dutasteride,92.31,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,9.2,True,528.5297,5.792817784000001,False,2,1,2,2,58.2,2,2,2,5,67,0,7.0
SRD5A1,inhibitor,dutasteride,26.37,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,8.49,True,528.5297,5.792817784000001,False,2,1,2,2,58.2,2,2,2,5,67,0,7.0
DRD4,antagonist,droperidol,0.11,D(4) dopamine receptor,GPCR,9.07572078704834,True,379.4274,3.014257972,True,2,0,0,0,58.1,6,1,4,4,50,0,0.0
DRD3,antagonist,droperidol,0.08,D(3) dopamine receptor,GPCR,9.027334408,True,379.4274,3.014257972,True,2,0,0,0,58.1,6,1,4,4,50,0,0.0
HTR2A,antagonist,droperidol,0.04,5-hydroxytryptamine receptor 2A,GPCR,9.131943638,True,379.4274,3.014257972,True,2,0,0,0,58.1,6,1,4,4,50,0,0.0
SLC6A2,inhibitor,citalopram,0.02,Sodium-dependent noradrenaline transporter,Transporter,5.21,True,324.3919,3.764304206333334,True,2,4,0,1,36.26,5,0,3,3,45,0,1.0
HRH1,binder,citalopram,0.02,Histamine H1 receptor,GPCR,6.4559,True,324.3919,3.764304206333334,True,2,4,0,1,36.26,5,0,3,3,45,0,1.0
SLC18A2,inhibitor,deutetrabenazine,2.51,Synaptic vesicular amine transporter,Transporter,,True,323.466,3.4010616590000007,True,1,6,0,0,38.77,6,0,4,3,50,0,2.0
DNMT1,inhibitor,decitabine,2.6,DNA (cytosine-5)-methyltransferase 1,Enzyme,,True,228.2053,-2.164694889,True,4,4,0,1,123.49,2,3,8,2,28,0,3.0
SLC5A8,inhibitor,fenoprofen,3.79,Sodium-coupled monocarboxylate transporter 1,Transporter,4.57,True,242.2699,3.6542675666666655,True,4,0,1,0,46.53,4,1,2,2,32,0,1.0
PGR,modulator,levonorgestrel,1.58,Progesterone receptor,Nuclear hormone receptor,12.7959,True,312.4458,3.6617966023333337,True,6,2,0,0,37.3,1,1,2,4,51,0,6.0
SHBG,"binder,inhibitor",levonorgestrel,1.58,Sex hormone-binding globulin,Secreted,8.91,True,312.4458,3.6617966023333337,True,6,2,0,0,37.3,1,1,2,4,51,0,6.0
NR3C1,binder,levonorgestrel,0.12,Glucocorticoid receptor,Nuclear hormone receptor,7.167491087,True,312.4458,3.6617966023333337,True,6,2,0,0,37.3,1,1,2,4,51,0,6.0
F10,inhibitor,betrixaban,9.3,Coagulation factor X,Enzyme,8.82390880584717,True,451.91,3.0280569612513357,True,1,1,0,2,107.41,6,3,5,3,54,0,0.0
TYR,inhibitor,monobenzone,6.31,Tyrosinase,Enzyme,,True,200.2332,3.2364823460000003,True,1,0,0,0,29.46,3,1,2,2,27,0,0.0
METAP2,inhibitor,nitroxoline,0.51,Methionine aminopeptidase 2,Enzyme,7.26,False,190.1555,1.7673193390000002,True,3,0,0,0,76.26,1,1,4,2,20,0,0.0
HTR3A,antagonist,memantine,0.27,5-hydroxytryptamine receptor 3A,Ion channel,,True,179.3018,2.066041788333333,True,7,3,0,4,26.02,0,1,1,4,34,0,2.0
TPH1,inhibitor,telotristat ethyl,,Tryptophan 5-hydroxylase 1,Enzyme,7.79587984085083,True,574.99,5.537098499666667,False,2,0,0,0,131.17,9,2,9,4,66,0,2.0
ADRB1,antagonist,atenolol,0.41,Beta-1 adrenergic receptor,GPCR,7.62,True,266.3361,0.4250248483333329,True,2,1,1,1,84.58,8,3,4,1,41,0,1.0
MAOB,inhibitor,pioglitazone,0.1,Amine oxidase [flavin-containing] B,Enzyme,6.3,True,356.439,3.3282486998862546,True,2,3,1,2,75.21,7,2,5,3,45,0,1.0
SLC6A2,inhibitor,orphenadrine,0.21,Sodium-dependent noradrenaline transporter,Transporter,5.577902837000001,True,269.3813,4.165328651333335,True,7,5,0,0,12.47,6,0,2,2,43,0,1.0
SCN10A,inhibitor,orphenadrine,0.21,Sodium channel protein type 10 subunit alpha,Ion channel,5.2007,True,269.3813,4.165328651333335,True,7,5,0,0,12.47,6,0,2,2,43,0,1.0
PPARA,agonist,gemfibrozil,0.57,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,4.23,True,250.3334,4.389643824,True,5,11,1,0,46.53,6,1,2,1,40,0,0.0
CHRM1,antagonist,cycrimine,2.97,Muscarinic acetylcholine receptor M1,GPCR,,True,287.4397,3.7881168286666655,True,1,0,0,0,23.47,5,1,2,3,50,0,1.0
CACNA1C,blocker,isradipine,0.78,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,,True,371.3871,1.9989157586666682,True,7,1,0,1,103.55,4,1,8,3,48,0,1.0
CACNA1H,inhibitor,isradipine,0.47,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,5.50863,True,371.3871,1.9989157586666682,True,7,1,0,1,103.55,4,1,8,3,48,0,1.0
CACNA1D,blocker,isradipine,0.84,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,9.3,True,371.3871,1.9989157586666682,True,7,1,0,1,103.55,4,1,8,3,48,0,1.0
SLC18A2,inhibitor,reserpine,0.96,Synaptic vesicular amine transporter,Transporter,7.9,True,608.6787,3.531495942666668,False,3,1,0,7,117.78,8,1,10,6,84,0,6.0
SLC18A1,inhibitor,reserpine,0.94,Chromaffin granule amine transporter,Transporter,7.45,True,608.6787,3.531495942666668,False,3,1,0,7,117.78,8,1,10,6,84,0,6.0
NR3C1,agonist,prednicarbate,0.46,Glucocorticoid receptor,Nuclear hormone receptor,,True,488.577,3.8318756826666673,True,1,1,0,0,116.2,6,1,8,4,71,0,7.0
PGR,modulator,ulipristal,1.58,Progesterone receptor,Nuclear hormone receptor,9.7,True,433.592,4.180761779333334,True,3,2,2,0,63.68,4,0,5,5,72,0,5.0
PPARG,partial agonist,telmisartan,0.32,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,5.82,True,514.6169,6.040852203862812,False,2,2,0,4,72.94,7,1,5,6,69,0,0.0
PTGS2,inhibitor,nabumetone,0.73,Prostaglandin G/H synthase 2,Enzyme,,True,228.2863,3.2169937839999996,True,2,7,1,0,26.3,4,0,2,2,33,0,0.0
ADRA1A,antagonist,piribedil,0.03,Alpha-1A adrenergic receptor,GPCR,6.1,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
DRD2,agonist,piribedil,0.07,D(2) dopamine receptor,GPCR,6.9,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
DRD4,antagonist,piribedil,0.06,D(4) dopamine receptor,GPCR,6.5,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
HTR2B,antagonist,piribedil,0.06,5-hydroxytryptamine receptor 2B,GPCR,5.9,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
ADRA2C,antagonist,piribedil,0.05,Alpha-2C adrenergic receptor,GPCR,7.2,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
DRD3,agonist,piribedil,0.14,D(3) dopamine receptor,GPCR,6.6,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
HTR1A,agonist,piribedil,0.03,5-hydroxytryptamine receptor 1A,GPCR,6.4,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
ADRA2A,antagonist,piribedil,0.04,Alpha-2A adrenergic receptor,GPCR,7.1,False,298.346,2.031391500666667,True,2,0,0,0,50.72,3,0,6,4,40,0,0.0
HTR2A,agonist,lorcaserin,0.1,5-hydroxytryptamine receptor 2A,GPCR,7.036211967468259,True,195.69,2.829161859666667,True,1,8,0,0,12.03,0,1,1,2,27,0,1.0
HTR2B,agonist,lorcaserin,0.23,5-hydroxytryptamine receptor 2B,GPCR,6.83268260955811,True,195.69,2.829161859666667,True,1,8,0,0,12.03,0,1,1,2,27,0,1.0
RARG,agonist,tazarotene,3.55,Retinoic acid receptor gamma,Nuclear hormone receptor,7.4,True,351.462,5.2187405516666665,False,4,1,0,0,39.19,2,0,4,3,46,0,0.0
RARA,agonist,tazarotene,2.52,Retinoic acid receptor alpha,Nuclear hormone receptor,7.2,True,351.462,5.2187405516666665,False,4,1,0,0,39.19,2,0,4,3,46,0,0.0
RARB,agonist,tazarotene,4.26,Retinoic acid receptor beta,Nuclear hormone receptor,9.1,True,351.462,5.2187405516666665,False,4,1,0,0,39.19,2,0,4,3,46,0,0.0
HRH1,antagonist,fluphenazine,0.02,Histamine H1 receptor,GPCR,7.7934,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
DRD1,antagonist,fluphenazine,0.15,D(1A) dopamine receptor,GPCR,7.6488,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
HTR6,antagonist,fluphenazine,0.06,5-hydroxytryptamine receptor 6,GPCR,7.4644,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
HTR7,antagonist,fluphenazine,0.05,5-hydroxytryptamine receptor 7,GPCR,8.0969,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
HTR2A,antagonist,fluphenazine,0.05,5-hydroxytryptamine receptor 2A,GPCR,8.0443,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
DRD5,antagonist,fluphenazine,0.09,D(1B) dopamine receptor,GPCR,7.8873,True,437.522,3.9658216146666656,True,6,2,0,1,29.95,6,1,5,4,56,0,0.0
ADRB2,agonist,dobutamine,0.12,Beta-2 adrenergic receptor,GPCR,6.2,True,301.3801,2.616255192047479,True,4,1,0,0,72.72,7,4,4,2,45,0,1.0
TUBB4B,inhibitor,colchicine,0.22,Tubulin beta-4B chain,Structural,5.2403,True,399.437,1.4619885703333333,True,1,4,1,1,83.09,5,1,6,3,54,0,1.0
TUBB,"binder,inhibitor",colchicine,0.35,Tubulin beta chain,Structural,5.2403,True,399.437,1.4619885703333333,True,1,4,1,1,83.09,5,1,6,3,54,0,1.0
GLRA1,antagonist,colchicine,0.04,Glycine receptor subunit alpha-1,Ion channel,3.4895,True,399.437,1.4619885703333333,True,1,4,1,1,83.09,5,1,6,3,54,0,1.0
GLRA2,antagonist,colchicine,0.08,Glycine receptor subunit alpha-2,Ion channel,4.1938,True,399.437,1.4619885703333333,True,1,4,1,1,83.09,5,1,6,3,54,0,1.0
TUBB2B,inhibitor,colchicine,0.25,Tubulin beta-2B chain,Structural,6.11,True,399.437,1.4619885703333333,True,1,4,1,1,83.09,5,1,6,3,54,0,1.0
DRD4,agonist,pramipexole,1.25,D(4) dopamine receptor,GPCR,9.31,True,211.327,1.7642826546666668,True,5,0,0,3,50.94,3,2,4,2,31,0,1.0
DRD2,agonist,pramipexole,0.6,D(2) dopamine receptor,GPCR,8.8,True,211.327,1.7642826546666668,True,5,0,0,3,50.94,3,2,4,2,31,0,1.0
HTR1A,agonist,pramipexole,0.45,5-hydroxytryptamine receptor 1A,GPCR,6.16,True,211.327,1.7642826546666668,True,5,0,0,3,50.94,3,2,4,2,31,0,1.0
ADRA2A,agonist,pramipexole,0.5,Alpha-2A adrenergic receptor,GPCR,7.12090412,True,211.327,1.7642826546666668,True,5,0,0,3,50.94,3,2,4,2,31,0,1.0
GPER1,binder,estradiol,1.04,G-protein coupled estrogen receptor 1,GPCR,9.52,True,272.382,3.745501328333334,True,7,13,3,10,40.46,0,2,2,4,44,0,5.0
ESR1,agonist,estradiol,0.13,Estrogen receptor,Nuclear hormone receptor,10.3,True,272.382,3.745501328333334,True,7,13,3,10,40.46,0,2,2,4,44,0,5.0
SLC6A2,inhibitor,pseudoephedrine,0.13,Sodium-dependent noradrenaline transporter,Transporter,,True,165.2322,1.3178347283333334,True,12,1,1,3,32.26,3,2,2,1,27,0,2.0
SLC6A4,inhibitor,sibutramine,1.6,Sodium-dependent serotonin transporter,Transporter,6.5257,True,279.848,5.201850084,False,3,1,0,0,3.24,5,0,1,2,45,0,1.0
PDE4B,inhibitor,ibudilast,0.46,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,7.19,False,230.3055,3.6792449313333337,True,5,0,0,0,34.37,3,0,3,2,35,0,0.0
PDE4C,inhibitor,ibudilast,1.09,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,6.62,False,230.3055,3.6792449313333337,True,5,0,0,0,34.37,3,0,3,2,35,0,0.0
PDE4D,inhibitor,ibudilast,0.23,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,6.78,False,230.3055,3.6792449313333337,True,5,0,0,0,34.37,3,0,3,2,35,0,0.0
MAOB,inhibitor,rasagiline,3.9,Amine oxidase [flavin-containing] B,Enzyme,6.15,True,171.2383,2.303901933,True,2,1,0,0,12.03,2,1,1,2,26,0,1.0
SLC12A3,inhibitor,metolazone,7.36,Solute carrier family 12 member 3,Transporter,,True,365.835,2.9435805356666664,True,1,0,0,0,92.5,2,2,4,3,40,0,1.0
MTOR,inhibitor,sirolimus,0.16,Serine/threonine-protein kinase mTOR,Kinase,10.0,True,914.187,7.45083982266667,False,3,3,0,3,195.43,6,3,13,4,144,0,15.0
FPR1,antagonist,deoxycholic acid,,fMet-Leu-Phe receptor,GPCR,4.0,True,392.572,3.791259253666668,True,11,0,0,4,77.76,4,3,3,4,68,0,10.0
PTGS1,inhibitor,dexibuprofen,0.08,Prostaglandin G/H synthase 1,Enzyme,7.01,True,206.2808,3.843558199333335,True,12,9,1,8,37.3,4,1,1,1,33,0,1.0
HPD,inhibitor,nitisinone,312.43,4-hydroxyphenylpyruvate dioxygenase,Enzyme,7.398,True,329.2281,3.1276615006666666,True,1,0,0,0,97.51,3,1,5,2,33,0,0.0
MGAM,"antagonist,inhibitor",miglitol,10.22,"Maltase-glucoamylase, intestinal",Enzyme,6.0,True,207.2243,-3.1927972576666668,True,4,1,0,0,104.39,3,5,6,1,31,0,4.0
GAA,inhibitor,miglitol,1.17,Lysosomal alpha-glucosidase,Enzyme,6.46,True,207.2243,-3.1927972576666668,True,4,1,0,0,104.39,3,5,6,1,31,0,4.0
MAOA,inhibitor,selegiline,1.07,Amine oxidase [flavin-containing] A,Enzyme,5.04,True,187.286,2.847961858666666,True,2,8,0,1,3.24,4,0,1,1,31,0,1.0
MAOB,inhibitor,selegiline,1.95,Amine oxidase [flavin-containing] B,Enzyme,6.01,True,187.286,2.847961858666666,True,2,8,0,1,3.24,4,0,1,1,31,0,1.0
SLC5A1,inhibitor,ipragliflozin,2.18,Sodium/glucose cotransporter 1,Transporter,5.72676706314087,False,404.45,2.4588850906666666,True,0,0,0,0,90.15,4,4,6,4,49,0,5.0
PGR,agonist,dienogest,0.79,Progesterone receptor,Nuclear hormone receptor,,True,311.425,2.3128524966666664,True,2,1,0,0,61.09,1,1,3,4,48,0,4.0
KCNJ8,inducer,levosimendan,2.37,ATP-sensitive inward rectifier potassium channel 8,Ion channel,,True,280.2847,2.161618159333333,True,4,0,0,0,113.76,3,1,6,2,33,0,1.0
PDE3A,inhibitor,levosimendan,1.14,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,,True,280.2847,2.161618159333333,True,4,0,0,0,113.76,3,1,6,2,33,0,1.0
TOP2A,inhibitor,amsacrine,0.59,DNA topoisomerase 2-alpha,Enzyme,5.0,True,393.459,3.1616212456666672,True,5,0,0,1,80.32,5,2,5,4,47,0,0.0
KCNH2,inhibitor,amsacrine,0.02,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.68,True,393.459,3.1616212456666672,True,5,0,0,1,80.32,5,2,5,4,47,0,0.0
HRH1,antagonist,mizolastine,0.31,Histamine H1 receptor,GPCR,8.84,True,432.503,3.733408288,True,0,1,0,0,70.05,5,1,6,5,57,0,0.0
PDE3B,inhibitor,milrinone,0.95,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,6.55,True,211.2194,0.32901938366666683,True,1,0,0,0,69.54,1,1,3,2,25,0,0.0
PDE5A,inhibitor,milrinone,0.42,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,6.13,True,211.2194,0.32901938366666683,True,1,0,0,0,69.54,1,1,3,2,25,0,0.0
HTR4,"antagonist,partial agonist",tegaserod,2.92,5-hydroxytryptamine receptor 4,GPCR,8.4,True,301.394,2.9544107576666665,True,4,4,0,3,87.79,7,3,3,2,45,0,0.0
HTR2B,antagonist,tegaserod,0.7,5-hydroxytryptamine receptor 2B,GPCR,8.4,True,301.394,2.9544107576666665,True,4,4,0,3,87.79,7,3,3,2,45,0,0.0
KCNJ1,inducer,minoxidil,2.43,ATP-sensitive inward rectifier potassium channel 1,Ion channel,6.97,True,209.2483,0.0007928796666662741,True,3,1,0,0,95.11,1,2,5,2,30,0,0.0
GRIN2A,antagonist,felbamate,0.47,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,,True,238.2399,0.6795679436666664,True,2,4,0,0,104.64,5,2,4,1,31,0,0.0
GRIN2B,antagonist,felbamate,0.8,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,4.284,True,238.2399,0.6795679436666664,True,2,4,0,0,104.64,5,2,4,1,31,0,0.0
ROCK2,inhibitor,netarsudil,1.02,Rho-associated protein kinase 2,Kinase,8.376750999999999,True,453.542,4.727226517666668,True,3,0,0,0,94.31,11,2,5,4,61,0,1.0
HTR7,antagonist,cyamemazine,0.22,5-hydroxytryptamine receptor 7,GPCR,7.2,False,323.455,4.266375313666666,True,0,0,0,0,30.27,4,0,4,3,44,0,1.0
HTR2C,antagonist,cyamemazine,0.11,5-hydroxytryptamine receptor 2C,GPCR,7.9,False,323.455,4.266375313666666,True,0,0,0,0,30.27,4,0,4,3,44,0,1.0
HTR2A,antagonist,cyamemazine,0.07,5-hydroxytryptamine receptor 2A,GPCR,8.8,False,323.455,4.266375313666666,True,0,0,0,0,30.27,4,0,4,3,44,0,1.0
HTR1A,antagonist,cyamemazine,0.09,5-hydroxytryptamine receptor 1A,GPCR,6.3,False,323.455,4.266375313666666,True,0,0,0,0,30.27,4,0,4,3,44,0,1.0
CCKBR,agonist,pentagastrin,27.05,Gastrin/cholecystokinin type B receptor,GPCR,7.84,True,767.9,1.0496471596666672,False,1,1,0,0,250.91,20,8,9,3,103,0,4.0
SLC6A3,"binder,inhibitor",sertraline,0.2,Sodium-dependent dopamine transporter,Transporter,7.6,True,306.23,5.1492999736666665,False,5,9,1,1,12.03,2,1,1,3,37,0,2.0
SLC6A2,"negative modulator,inhibitor",sertraline,0.09,Sodium-dependent noradrenaline transporter,Transporter,6.38,True,306.23,5.1492999736666665,False,5,9,1,1,12.03,2,1,1,3,37,0,2.0
SLC6A2,inhibitor,reboxetine,5.83,Sodium-dependent noradrenaline transporter,Transporter,8.96,True,313.397,3.27581463,True,1,2,0,1,39.72,6,1,4,3,46,0,2.0
GLRA1,agonist,methoxyflurane,0.33,Glycine receptor subunit alpha-1,Ion channel,,True,164.96599999999995,2.305878239333333,True,7,7,0,0,9.23,2,0,1,0,12,0,0.0
SLC6A2,inhibitor,protriptyline,0.83,Sodium-dependent noradrenaline transporter,Transporter,8.39,True,263.3767,4.496811469000001,True,2,0,0,1,12.03,4,1,1,3,41,0,0.0
SLC6A4,inhibitor,protriptyline,0.91,Sodium-dependent serotonin transporter,Transporter,7.34,True,263.3767,4.496811469000001,True,2,0,0,1,12.03,4,1,1,3,41,0,0.0
PDE3A,inhibitor,anagrelide,18.18,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,7.27,True,256.088,1.94393082,True,1,1,0,0,44.7,0,1,3,3,23,0,0.0
VDR,agonist,ergocalciferol,0.34,Vitamin D3 receptor,Nuclear hormone receptor,,True,396.6484,7.050558194333334,False,2,6,1,0,20.23,5,1,1,3,73,0,6.0
CACNA2D2,modulator,gabapentin,1.18,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,6.92811822891235,True,171.2368,-1.2730330706628037,True,6,1,0,1,63.32,3,2,2,1,29,0,0.0
ADORA1,agonist,gabapentin,0.16,Adenosine receptor A1,GPCR,,True,171.2368,-1.2730330706628037,True,6,1,0,1,63.32,3,2,2,1,29,0,0.0
,modulator,busulfan,,DNA,DNA,,True,246.302,-0.7590282259999991,True,1,6,0,0,86.74,7,0,6,0,28,0,0.0
OPRK1,antagonist,dezocine,2.28,Kappa-type opioid receptor,GPCR,,True,245.3599,3.2300964295828267,True,2,0,0,0,46.25,0,2,2,3,41,0,3.0
OPRM1,partial agonist,dezocine,1.95,Mu-type opioid receptor,GPCR,7.42,True,245.3599,3.2300964295828267,True,2,0,0,0,46.25,0,2,2,3,41,0,3.0
HTR1A,agonist,tandospirone,0.38,5-hydroxytryptamine receptor 1A,GPCR,7.49,False,383.496,1.4968144959999998,True,0,0,0,0,69.64,6,0,6,5,57,0,4.0
,negative modulator,ganciclovir,,DNA polymerase catalytic subunit,Enzyme,,True,255.2306,-2.1799025086666672,True,3,0,0,6,139.28,5,4,8,2,31,0,0.0
CHRM2,antagonist,hyoscyamine,0.38,Muscarinic acetylcholine receptor M2,GPCR,9.3,True,289.3694,1.571241016666666,True,5,0,0,0,49.77,4,1,4,3,44,0,4.0
CHRM4,antagonist,hyoscyamine,0.28,Muscarinic acetylcholine receptor M4,GPCR,9.9,True,289.3694,1.571241016666666,True,5,0,0,0,49.77,4,1,4,3,44,0,4.0
CHRM3,antagonist,hyoscyamine,0.16,Muscarinic acetylcholine receptor M3,GPCR,9.8,True,289.3694,1.571241016666666,True,5,0,0,0,49.77,4,1,4,3,44,0,4.0
CHRM1,antagonist,hyoscyamine,0.3,Muscarinic acetylcholine receptor M1,GPCR,9.0,True,289.3694,1.571241016666666,True,5,0,0,0,49.77,4,1,4,3,44,0,4.0
PTGER2,agonist,treprostinil,0.37,Prostaglandin E2 receptor EP2 subtype,GPCR,8.4,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGIR,agonist,treprostinil,2.81,Prostacyclin receptor,GPCR,8.72,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGDR,agonist,treprostinil,0.45,Prostaglandin D2 receptor,GPCR,8.4,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGER3,agonist,treprostinil,0.35,Prostaglandin E2 receptor EP3 subtype,GPCR,5.6,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGER4,agonist,treprostinil,0.32,Prostaglandin E2 receptor EP4 subtype,GPCR,6.7,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGER1,agonist,treprostinil,0.3,Prostaglandin E2 receptor EP1 subtype,GPCR,6.7,True,390.5131,4.004209447,True,3,1,0,0,86.99,10,3,4,3,62,0,5.0
PTGFR,agonist,tafluprost,16.71,Prostaglandin F2-alpha receptor,GPCR,,True,452.5313,4.2923223713333325,True,1,1,0,0,75.99,12,2,5,2,66,0,4.0
HTR5A,antagonist,ketanserin,0.17,5-hydroxytryptamine receptor 5A,GPCR,4.7,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
ADRA1D,antagonist,ketanserin,0.04,Alpha-1D adrenergic receptor,GPCR,7.8,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
HTR1A,antagonist,ketanserin,0.02,5-hydroxytryptamine receptor 1A,GPCR,5.0,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
HTR2B,antagonist,ketanserin,0.04,5-hydroxytryptamine receptor 2B,GPCR,6.7,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
HTR2C,antagonist,ketanserin,0.02,5-hydroxytryptamine receptor 2C,GPCR,7.5,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
DRD5,antagonist,ketanserin,0.08,D(1B) dopamine receptor,GPCR,5.6,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
SLC18A2,inhibitor,ketanserin,0.08,Synaptic vesicular amine transporter,Transporter,6.1549,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
HTR1B,antagonist,ketanserin,0.04,5-hydroxytryptamine receptor 1B,GPCR,5.19,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
ADRA1B,antagonist,ketanserin,0.03,Alpha-1B adrenergic receptor,GPCR,8.2,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
SLC18A1,inhibitor,ketanserin,0.41,Chromaffin granule amine transporter,Transporter,5.8,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
HTR1D,antagonist,ketanserin,0.04,5-hydroxytryptamine receptor 1D,GPCR,6.59,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
ADRA1A,antagonist,ketanserin,0.02,Alpha-1A adrenergic receptor,GPCR,8.2,False,395.434,3.609319796,True,1,0,0,0,75.17,5,1,5,4,51,0,0.0
SLC6A3,inhibitor,benzatropine,0.81,Sodium-dependent dopamine transporter,Transporter,7.2533,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
SLC6A19,inhibitor,benzatropine,4.73,Sodium-dependent neutral amino acid transporter B(0)AT1,Unclassified,4.36,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
SLC6A2,inhibitor,benzatropine,0.24,Sodium-dependent noradrenaline transporter,Transporter,5.860435734,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
HRH1,antagonist,benzatropine,0.1,Histamine H1 receptor,GPCR,8.9586,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
CHRM1,antagonist,benzatropine,0.25,Muscarinic acetylcholine receptor M1,GPCR,9.6364,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
SLC6A4,inhibitor,benzatropine,0.21,Sodium-dependent serotonin transporter,Transporter,4.62,True,307.4293,4.185400473333332,True,5,0,1,0,12.47,4,0,2,4,48,0,3.0
MTNR1A,agonist,tasimelteon,18.94,Melatonin receptor type 1A,GPCR,9.44999980926514,True,245.322,1.977541167666668,True,2,2,0,0,38.33,4,1,2,3,37,0,2.0
ESR2,modulator,chlorotrianisene,0.11,Estrogen receptor beta,Nuclear hormone receptor,,False,380.864,5.427334731,False,1,1,0,0,27.69,6,0,3,3,48,0,0.0
CHRM1,antagonist,trospium,0.74,Muscarinic acetylcholine receptor M1,GPCR,,True,392.518,-0.5009602721384119,True,2,1,0,0,46.53,4,1,3,5,59,1,3.0
HTR2B,antagonist,fluoxetine,0.02,5-hydroxytryptamine receptor 2B,GPCR,5.3,True,309.3261,4.1732195433333334,True,7,8,2,1,21.26,6,1,2,2,40,0,1.0
KCNH2,inhibitor,fluoxetine,0.02,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.1549,True,309.3261,4.1732195433333334,True,7,8,2,1,21.26,6,1,2,2,40,0,1.0
SLC29A4,inhibitor,fluoxetine,0.15,Equilibrative nucleoside transporter 4,Transporter,4.64,True,309.3261,4.1732195433333334,True,7,8,2,1,21.26,6,1,2,2,40,0,1.0
HTR2C,antagonist,fluoxetine,0.05,5-hydroxytryptamine receptor 2C,GPCR,6.4,True,309.3261,4.1732195433333334,True,7,8,2,1,21.26,6,1,2,2,40,0,1.0
SCN9A,blocker,lacosamide,0.21,Sodium channel protein type 9 subunit alpha,Ion channel,6.74,True,250.2936,-0.02244160533333384,True,3,3,0,0,67.43,6,2,3,1,36,0,1.0
TOP2A,inhibitor,etoposide,0.66,DNA topoisomerase 2-alpha,Enzyme,7.3,True,588.5566,1.1604304576666673,False,2,9,0,7,160.83,5,3,13,7,74,0,10.0
CHRM1,binder,cinnarizine,0.04,Muscarinic acetylcholine receptor M1,GPCR,6.218244625,True,368.524,,False,11,7,0,0,6.48,6,0,2,4,56,0,0.0
KCNH1,blocker,quinidine,0.2,Potassium voltage-gated channel subfamily H member 1,Ion channel,5.8,True,324.4168,2.5134639506666683,True,7,9,2,10,45.59,4,1,4,5,48,0,5.0
KCNA5,blocker,quinidine,0.11,Potassium voltage-gated channel subfamily A member 5,Ion channel,5.2,True,324.4168,2.5134639506666683,True,7,9,2,10,45.59,4,1,4,5,48,0,5.0
KCNH2,inhibitor,quinidine,0.06,Potassium voltage-gated channel subfamily H member 2,Ion channel,6.49,True,324.4168,2.5134639506666683,True,7,9,2,10,45.59,4,1,4,5,48,0,5.0
KCNA7,blocker,quinidine,0.3,Potassium voltage-gated channel subfamily A member 7,Ion channel,4.8,True,324.4168,2.5134639506666683,True,7,9,2,10,45.59,4,1,4,5,48,0,5.0
SLC29A4,inhibitor,quinidine,0.22,Equilibrative nucleoside transporter 4,Transporter,4.6,True,324.4168,2.5134639506666683,True,7,9,2,10,45.59,4,1,4,5,48,0,5.0
HTR2A,agonist,cisapride,0.2,5-hydroxytryptamine receptor 2A,GPCR,8.14,True,465.945,2.4913588646666662,True,4,9,0,0,86.05,9,2,6,3,61,0,2.0
KCNH2,inhibitor,cisapride,0.23,Potassium voltage-gated channel subfamily H member 2,Ion channel,8.19,True,465.945,2.4913588646666662,True,4,9,0,0,86.05,9,2,6,3,61,0,2.0
THRA,agonist,tiratricol,1.51,Thyroid hormone receptor alpha,Nuclear hormone receptor,9.85,False,621.9323,5.594549401666666,False,1,0,0,0,66.76,4,2,3,2,30,0,0.0
MAOA,inhibitor,pirlindole,1.21,Amine oxidase [flavin-containing] A,Enzyme,7.408935546875,False,226.323,3.104723180333333,True,3,1,0,0,16.96,0,1,2,4,35,0,1.0
OPRM1,agonist,sufentanil,0.72,Mu-type opioid receptor,GPCR,8.13,True,386.551,3.6051731266666662,True,3,1,0,0,32.78,8,0,4,3,57,0,0.0
OPRD1,agonist,sufentanil,0.39,Delta-type opioid receptor,GPCR,7.301030158996579,True,386.551,3.6051731266666662,True,3,1,0,0,32.78,8,0,4,3,57,0,0.0
ADRA2C,agonist,paliperidone,0.05,Alpha-2C adrenergic receptor,GPCR,8.195202827453612,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
HTR2A,antagonist,paliperidone,0.14,5-hydroxytryptamine receptor 2A,GPCR,8.95860767364502,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
HTR1D,antagonist,paliperidone,0.08,5-hydroxytryptamine receptor 1D,GPCR,7.721246242523191,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
ADRA2A,antagonist,paliperidone,0.04,Alpha-2A adrenergic receptor,GPCR,7.92539024353027,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
HTR1A,antagonist,paliperidone,0.04,5-hydroxytryptamine receptor 1A,GPCR,6.2176790237426784,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
ADRA2B,antagonist,paliperidone,0.06,Alpha-2B adrenergic receptor,GPCR,7.635498523712161,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
HTR2C,antagonist,paliperidone,0.04,5-hydroxytryptamine receptor 2C,GPCR,7.3187589645385716,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
HRH1,antagonist,paliperidone,0.09,Histamine H1 receptor,GPCR,8.25103759765625,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
ADRA1B,antagonist,paliperidone,0.22,Alpha-1B adrenergic receptor,GPCR,9.1549015045166,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
DRD3,antagonist,paliperidone,0.08,D(3) dopamine receptor,GPCR,9.04575729370117,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
DRD4,antagonist,paliperidone,0.11,D(4) dopamine receptor,GPCR,7.26520013809204,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
ADRA1A,antagonist,paliperidone,0.14,Alpha-1A adrenergic receptor,GPCR,8.5528,True,426.4839,1.7565551636666674,True,15,3,0,1,84.39,4,1,7,5,58,0,1.0
NR1H4,agonist,obeticholic acid,,Bile acid receptor,Nuclear hormone receptor,7.004364967346191,True,420.6252,4.522847015000002,True,1,1,0,1,77.76,5,3,3,4,74,0,11.0
OPRK1,agonist,hydrocodone,0.17,Kappa-type opioid receptor,GPCR,6.59,True,299.3642,1.9603039676666665,True,3,4,0,0,38.77,1,0,4,5,43,0,4.0
CYP19A1,inhibitor,testolactone,5.21,Aromatase,Enzyme,4.46,True,300.3921,3.2313274366666658,True,1,0,0,0,43.37,0,0,3,4,46,0,5.0
CHRM4,antagonist,fesoterodine,0.2,Muscarinic acetylcholine receptor M4,GPCR,6.1871,True,411.5769,5.698894813000001,False,5,2,0,1,49.77,10,1,4,2,67,0,1.0
CHRM5,antagonist,fesoterodine,0.19,Muscarinic acetylcholine receptor M5,GPCR,5.9788,True,411.5769,5.698894813000001,False,5,2,0,1,49.77,10,1,4,2,67,0,1.0
VDR,agonist,calcifediol,0.2,Vitamin D3 receptor,Nuclear hormone receptor,,True,400.6371,5.654346069666669,False,1,2,0,0,40.46,6,2,2,3,73,0,5.0
SLC6A3,inhibitor,modafinil,0.57,Sodium-dependent dopamine transporter,Transporter,5.836838625,True,273.35,1.5328344403333334,True,2,7,0,0,60.16,5,1,2,2,34,0,1.0
ADRA1B,partial agonist,modafinil,0.09,Alpha-1B adrenergic receptor,GPCR,,True,273.35,1.5328344403333334,True,2,7,0,0,60.16,5,1,2,2,34,0,1.0
MTNR1A,agonist,melatonin,2.23,Melatonin receptor type 1A,GPCR,9.4,True,232.2783,1.1476127873333333,True,10,9,0,1,54.12,4,2,2,2,33,0,0.0
HTR2B,antagonist,melatonin,0.02,5-hydroxytryptamine receptor 2B,GPCR,5.2,True,232.2783,1.1476127873333333,True,10,9,0,1,54.12,4,2,2,2,33,0,0.0
MTNR1B,agonist,melatonin,2.39,Melatonin receptor type 1B,GPCR,9.7,True,232.2783,1.1476127873333333,True,10,9,0,1,54.12,4,2,2,2,33,0,0.0
HRH1,antagonist,diphenylpyraline,1.13,Histamine H1 receptor,GPCR,8.0757,True,281.392,3.6600688666666654,True,2,0,0,0,12.47,4,0,2,3,44,0,0.0
SLC6A3,inhibitor,diphenylpyraline,0.46,Sodium-dependent dopamine transporter,Transporter,6.3767,True,281.392,3.6600688666666654,True,2,0,0,0,12.47,4,0,2,3,44,0,0.0
MLNR,agonist,azithromycin,0.65,Motilin receptor,GPCR,5.5,True,748.9845,2.444781599333332,False,2,1,0,2,180.08,7,5,14,3,124,0,18.0
AR,agonist,danazol,0.03,Androgen receptor,Nuclear hormone receptor,,True,337.4553,3.462082191666666,True,6,2,1,0,46.26,0,1,3,5,52,0,6.0
PGR,agonist,danazol,0.28,Progesterone receptor,Nuclear hormone receptor,,True,337.4553,3.462082191666666,True,6,2,1,0,46.26,0,1,3,5,52,0,6.0
CHRM1,antagonist,tridihexethyl,0.46,Muscarinic acetylcholine receptor M1,GPCR,,False,318.5166,0.2904066095282539,True,3,0,0,0,20.23,8,1,1,2,59,1,1.0
ACE,inhibitor,cilazapril,19.2,Angiotensin-converting enzyme,Enzyme,8.7,True,417.4986,-0.007882287847574103,True,1,0,0,3,99.18,8,2,6,3,61,0,3.0
NR3C1,agonist,fluocinonide,0.46,Glucocorticoid receptor,Nuclear hormone receptor,8.621602099,True,494.5249,2.0455239793333324,True,2,2,1,0,99.13,3,1,7,5,67,0,9.0
HRH1,antagonist,cyclizine,1.08,Histamine H1 receptor,GPCR,8.35261703,True,266.3807,3.5460023493333326,True,2,1,0,0,6.48,3,0,2,3,42,0,0.0
TBXA2R,antagonist,ramatroban,0.99,Thromboxane A2 receptor,GPCR,9.24,False,416.47,3.3045409183333327,True,1,0,0,0,88.4,6,2,4,4,50,0,1.0
BLVRB,product of,riboflavin,7.1,Flavin reductase (NADPH),Enzyme,,True,376.3639,-0.9165402600000004,True,3,2,0,1,161.56,5,5,9,3,47,0,3.0
RFK,ligand,riboflavin,24.85,Riboflavin kinase,Kinase,,True,376.3639,-0.9165402600000004,True,3,2,0,1,161.56,5,5,9,3,47,0,3.0
CA1,inhibitor,dorzolamide,1.04,Carbonic anhydrase 1,Enzyme,6.3,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
CA2,inhibitor,dorzolamide,1.41,Carbonic anhydrase 2,Enzyme,9.7,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
CA4,inhibitor,dorzolamide,0.71,Carbonic anhydrase 4,Enzyme,7.37,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
CA7,inhibitor,dorzolamide,0.51,Carbonic anhydrase 7,Enzyme,8.46,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
CA3,inhibitor,dorzolamide,1.16,Carbonic anhydrase 3,Enzyme,5.1,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
CA14,inhibitor,dorzolamide,0.58,Carbonic anhydrase 14,Enzyme,7.57,True,324.44,-0.15111351272826434,True,4,4,0,0,106.33,3,2,6,2,35,0,2.0
GRIN3A,antagonist,profenamine,1.18,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,,True,312.472,5.0011867610000005,False,3,1,0,0,6.48,5,0,3,3,46,0,1.0
CHRM1,antagonist,profenamine,0.43,Muscarinic acetylcholine receptor M1,GPCR,,True,312.472,5.0011867610000005,False,3,1,0,0,6.48,5,0,3,3,46,0,1.0
OPRD1,agonist,levorphanol,0.34,Delta-type opioid receptor,GPCR,8.38,True,257.3706,2.9030437913342864,True,3,0,0,0,23.47,0,1,2,4,42,0,3.0
OPRK1,agonist,levorphanol,0.25,Kappa-type opioid receptor,GPCR,8.64,True,257.3706,2.9030437913342864,True,3,0,0,0,23.47,0,1,2,4,42,0,3.0
PIK3CD,inhibitor,copanlisib,0.24,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,9.1549015045166,True,480.529,0.3192440660000002,False,2,4,1,3,139.79,10,2,11,5,63,0,0.0
PIK3CA,inhibitor,copanlisib,0.23,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,9.30103015899658,True,480.529,0.3192440660000002,False,2,4,1,3,139.79,10,2,11,5,63,0,0.0
PIK3CG,inhibitor,copanlisib,0.11,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,8.19381999969482,True,480.529,0.3192440660000002,False,2,4,1,3,139.79,10,2,11,5,63,0,0.0
PIK3CB,inhibitor,copanlisib,0.19,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,8.431797981262209,True,480.529,0.3192440660000002,False,2,4,1,3,139.79,10,2,11,5,63,0,0.0
SCN10A,inhibitor,procaine,0.45,Sodium channel protein type 10 subunit alpha,Ion channel,,True,236.3101,1.8800572576666656,True,11,1,0,3,55.56,6,1,4,1,37,0,0.0
RYR1,blocker,procaine,0.26,Ryanodine receptor 1,Ion channel,2.2218,True,236.3101,1.8800572576666656,True,11,1,0,3,55.56,6,1,4,1,37,0,0.0
GRIN3A,antagonist,procaine,0.55,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,3.5287,True,236.3101,1.8800572576666656,True,11,1,0,3,55.56,6,1,4,1,37,0,0.0
AKR1B1,inhibitor,tolrestat,2.61,Aldose reductase,Enzyme,8.5086,False,357.347,3.348745107,True,3,0,0,0,49.77,4,1,3,2,38,0,0.0
HRH2,antagonist,famotidine,7.1,Histamine H2 receptor,GPCR,7.93,True,337.445,-1.9500818776783029,True,1,1,0,4,173.33,7,5,6,1,35,0,0.0
GAA,inhibitor,migalastat,0.42,Lysosomal alpha-glucosidase,Enzyme,5.21999979019165,True,163.1717,-2.885743183,True,1,1,0,0,92.95,1,5,5,1,24,0,4.0
KCNK9,inhibitor,doxapram,9.47,Potassium channel subfamily K member 9,Ion channel,,True,378.5072,3.230592205,True,2,0,0,0,32.78,6,0,3,4,58,0,1.0
KCNK3,inhibitor,doxapram,8.42,Potassium channel subfamily K member 3,Ion channel,,True,378.5072,3.230592205,True,2,0,0,0,32.78,6,0,3,4,58,0,1.0
HTR2B,antagonist,agomelatine,0.23,5-hydroxytryptamine receptor 2B,GPCR,6.6,True,243.301,2.038327551,True,3,2,0,0,38.33,4,1,2,2,35,0,0.0
MTNR1A,agonist,agomelatine,4.21,Melatonin receptor type 1A,GPCR,10.22,True,243.301,2.038327551,True,3,2,0,0,38.33,4,1,2,2,35,0,0.0
HTR2C,antagonist,agomelatine,0.3,5-hydroxytryptamine receptor 2C,GPCR,6.2,True,243.301,2.038327551,True,3,2,0,0,38.33,4,1,2,2,35,0,0.0
HTR2A,antagonist,agomelatine,0.05,5-hydroxytryptamine receptor 2A,GPCR,5.4,True,243.301,2.038327551,True,3,2,0,0,38.33,4,1,2,2,35,0,0.0
OPRD1,agonist,morphine,0.24,Delta-type opioid receptor,GPCR,6.62,True,285.3377,0.8952108197005768,True,4,8,1,1,52.93,0,2,4,5,40,0,5.0
OPRM1,agonist,morphine,0.16,Mu-type opioid receptor,GPCR,9.3,True,285.3377,0.8952108197005768,True,4,8,1,1,52.93,0,2,4,5,40,0,5.0
PTGS1,antagonist,acemetacin,0.26,Prostaglandin G/H synthase 1,Enzyme,,True,415.83,3.153551744,True,2,1,0,1,94.83,6,1,6,3,47,0,0.0
PTGS2,antagonist,acemetacin,0.23,Prostaglandin G/H synthase 2,Enzyme,,True,415.83,3.153551744,True,2,1,0,1,94.83,6,1,6,3,47,0,0.0
METAP2,ligand,fumagillin,3.55,Methionine aminopeptidase 2,Enzyme,9.2,False,458.551,4.048655004333334,True,1,0,0,0,97.89,10,1,6,3,67,0,6.0
CHRM1,antagonist,clidinium,1.3,Muscarinic acetylcholine receptor M1,GPCR,,True,352.4467,-1.0832464701384124,True,1,0,0,0,46.53,4,1,3,5,52,1,1.0
CHRM3,antagonist,clidinium,0.2,Muscarinic acetylcholine receptor M3,GPCR,9.6,True,352.4467,-1.0832464701384124,True,1,0,0,0,46.53,4,1,3,5,52,1,1.0
SLC12A1,inhibitor,piretanide,1.89,Solute carrier family 12 member 1,Transporter,8.3,True,362.4,2.2509880019999997,True,1,0,0,0,109.93,5,2,5,3,43,0,0.0
SLC12A2,inhibitor,piretanide,1.89,Solute carrier family 12 member 2,Transporter,5.62,True,362.4,2.2509880019999997,True,1,0,0,0,109.93,5,2,5,3,43,0,0.0
AVPR1A,antagonist,conivaptan,17.75,Vasopressin V1a receptor,GPCR,9.37,True,498.5744,5.4371654173333335,False,2,1,0,1,78.09,4,2,3,6,64,0,0.0
HTR2B,"agonist,antagonist",pindolol,0.09,5-hydroxytryptamine receptor 2B,GPCR,5.7,True,248.3208,1.692981165666667,True,5,1,0,0,57.28,6,3,3,2,38,0,1.0
HTR1A,antagonist,pindolol,0.38,5-hydroxytryptamine receptor 1A,GPCR,8.1,True,248.3208,1.692981165666667,True,5,1,0,0,57.28,6,3,3,2,38,0,1.0
HTR2A,"agonist,antagonist",pindolol,0.04,5-hydroxytryptamine receptor 2A,GPCR,5.0,True,248.3208,1.692981165666667,True,5,1,0,0,57.28,6,3,3,2,38,0,1.0
ADRB3,agonist,pindolol,0.41,Beta-3 adrenergic receptor,GPCR,6.78,True,248.3208,1.692981165666667,True,5,1,0,0,57.28,6,3,3,2,38,0,1.0
MMP8,inhibitor,doxycycline,0.25,Neutrophil collagenase,Enzyme,4.6,True,444.4346,-3.337123924710148,False,1,1,0,2,181.62,2,6,9,4,56,0,6.0
MMP7,inhibitor,doxycycline,0.51,Matrilysin,Unclassified,4.14,True,444.4346,-3.337123924710148,False,1,1,0,2,181.62,2,6,9,4,56,0,6.0
,modulator,lomustine,,DNA,DNA,,True,233.695,2.15743697,True,2,2,0,0,61.77,4,1,3,1,31,0,0.0
CACNA1G,blocker,ethosuximide,3.65,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,,True,141.1677,0.5500976843333328,True,1,3,0,0,46.17,1,1,2,1,21,0,1.0
AR,antagonist,cyproterone acetate,,Androgen receptor,Nuclear hormone receptor,7.432,True,416.9380000000001,3.638856937333333,True,2,2,0,0,60.44,2,0,4,5,58,0,8.0
NR3C2,agonist,desoxycorticosterone acetate,2.94,Mineralocorticoid receptor,Nuclear hormone receptor,,True,372.505,3.7724817650000015,True,1,1,0,0,60.44,3,0,4,4,59,0,6.0
ADRA2B,antagonist,phenoxybenzamine,0.13,Alpha-2B adrenergic receptor,GPCR,8.45593166351318,True,303.826,4.6397570586666665,True,8,0,0,3,12.47,8,0,2,2,43,0,1.0
ADRA1A,antagonist,phenoxybenzamine,0.18,Alpha-1A adrenergic receptor,GPCR,7.27,True,303.826,4.6397570586666665,True,8,0,0,3,12.47,8,0,2,2,43,0,1.0
ADRA2A,antagonist,phenoxybenzamine,0.06,Alpha-2A adrenergic receptor,GPCR,6.28,True,303.826,4.6397570586666665,True,8,0,0,3,12.47,8,0,2,2,43,0,1.0
NR3C1,agonist,hydrocortisone,0.12,Glucocorticoid receptor,Nuclear hormone receptor,8.5,True,362.4599,1.2751664346666671,True,2,15,2,3,94.83,2,3,5,4,56,0,7.0
PTGS1,antagonist,tolfenamic acid,0.19,Prostaglandin G/H synthase 1,Enzyme,6.24,True,261.704,5.488220565,False,2,1,0,0,49.33,3,2,2,2,30,0,0.0
PTGS2,antagonist,tolfenamic acid,0.17,Prostaglandin G/H synthase 2,Enzyme,8.3,True,261.704,5.488220565,False,2,1,0,0,49.33,3,2,2,2,30,0,0.0
AKR1C3,inhibitor,tolfenamic acid,,Aldo-keto reductase family 1 member C3,Enzyme,8.1,True,261.704,5.488220565,False,2,1,0,0,49.33,3,2,2,2,30,0,0.0
RARA,agonist,isotretinoin,1.5,Retinoic acid receptor alpha,Nuclear hormone receptor,8.2291,True,300.4351,5.014367711,False,2,1,1,0,37.3,5,1,1,1,50,0,0.0
RARB,agonist,isotretinoin,0.34,Retinoic acid receptor beta,Nuclear hormone receptor,,True,300.4351,5.014367711,False,2,1,1,0,37.3,5,1,1,1,50,0,0.0
PTGFR,agonist,latanoprostene bunod,6.68,Prostaglandin F2-alpha receptor,GPCR,8.6,True,507.624,3.7933643519999993,False,1,0,0,1,139.36,23,3,8,2,77,0,5.0
HRH2,antagonist,cimetidine,1.21,Histamine H2 receptor,GPCR,6.14,True,252.33900000000003,-0.10935610666666697,True,1,11,1,13,88.89,5,3,4,1,33,0,0.0
SLC47A1,inhibitor,cimetidine,1.09,Multidrug and toxin extrusion protein 1,Transporter,5.92,True,252.33900000000003,-0.10935610666666697,True,1,11,1,13,88.89,5,3,4,1,33,0,0.0
SLC47A2,inhibitor,cimetidine,1.46,Multidrug and toxin extrusion protein 2,Transporter,5.1,True,252.33900000000003,-0.10935610666666697,True,1,11,1,13,88.89,5,3,4,1,33,0,0.0
TACR1,antagonist,rolapitant,5.83,Substance-P receptor,GPCR,9.18045616149902,True,500.485,5.003099035000001,False,1,2,0,2,50.36,5,2,3,4,61,0,3.0
PTGS1,antagonist,dexketoprofen,0.13,Prostaglandin G/H synthase 1,Enzyme,8.72,True,254.2806,3.613333421,True,2,2,0,0,54.37,4,1,2,2,33,0,1.0
PTGS2,antagonist,dexketoprofen,0.12,Prostaglandin G/H synthase 2,Enzyme,7.57,True,254.2806,3.613333421,True,2,2,0,0,54.37,4,1,2,2,33,0,1.0
THRA,inhibitor,dronedarone,0.26,Thyroid hormone receptor alpha,Nuclear hormone receptor,4.2291,True,556.756,5.277915882139469,False,24,4,1,6,88.85,18,1,6,3,83,0,0.0
ADRB2,agonist,vilanterol,1.39,Beta-2 adrenergic receptor,GPCR,9.4,True,486.43,3.598011515615924,True,1,1,0,0,91.18,16,4,6,2,65,0,1.0
PTGS2,inhibitor,bromfenac,1.39,Prostaglandin G/H synthase 2,Enzyme,8.4,True,334.165,3.660173814,True,2,1,0,0,80.39,4,2,3,2,32,0,0.0
SCN5A,inhibitor,cinchocaine,0.87,Sodium channel protein type 5 subunit alpha,Ion channel,,True,343.4632,3.6981625420000017,True,3,1,0,0,54.46,10,1,4,2,54,0,0.0
SCN10A,inhibitor,cinchocaine,0.74,Sodium channel protein type 10 subunit alpha,Ion channel,,True,343.4632,3.6981625420000017,True,3,1,0,0,54.46,10,1,4,2,54,0,0.0
HTR1A,antagonist,pizotifen,0.07,5-hydroxytryptamine receptor 1A,GPCR,7.4,True,295.44,4.492244676666665,True,16,1,0,0,3.24,0,0,2,4,42,0,0.0
HTR2B,antagonist,pizotifen,0.13,5-hydroxytryptamine receptor 2B,GPCR,8.7,True,295.44,4.492244676666665,True,16,1,0,0,3.24,0,0,2,4,42,0,0.0
HTR2A,antagonist,pizotifen,0.06,5-hydroxytryptamine receptor 2A,GPCR,8.12,True,295.44,4.492244676666665,True,16,1,0,0,3.24,0,0,2,4,42,0,0.0
CHRM1,antagonist,pizotifen,0.05,Muscarinic acetylcholine receptor M1,GPCR,8.7,True,295.44,4.492244676666665,True,16,1,0,0,3.24,0,0,2,4,42,0,0.0
HTR2C,antagonist,pizotifen,0.03,5-hydroxytryptamine receptor 2C,GPCR,8.85,True,295.44,4.492244676666665,True,16,1,0,0,3.24,0,0,2,4,42,0,0.0
NR3C1,agonist,meprednisone,0.37,Glucocorticoid receptor,Nuclear hormone receptor,,True,372.461,2.023477004333333,True,0,2,1,0,91.67,2,2,5,4,55,0,7.0
AGTR1,antagonist,candesartan cilexetil,,Type-1 angiotensin II receptor,GPCR,,True,610.6709999999998,7.531521166999999,False,1,4,0,1,143.34,10,1,11,6,79,0,1.0
CHRM3,antagonist,darifenacin,0.61,Muscarinic acetylcholine receptor M3,GPCR,9.52,True,426.55,4.540284133666668,True,5,2,0,0,55.56,7,1,3,5,62,0,1.0
CHRM5,antagonist,darifenacin,0.45,Muscarinic acetylcholine receptor M5,GPCR,8.64,True,426.55,4.540284133666668,True,5,2,0,0,55.56,7,1,3,5,62,0,1.0
CHRM2,antagonist,darifenacin,0.32,Muscarinic acetylcholine receptor M2,GPCR,7.6,True,426.55,4.540284133666668,True,5,2,0,0,55.56,7,1,3,5,62,0,1.0
CHRM1,antagonist,darifenacin,0.25,Muscarinic acetylcholine receptor M1,GPCR,8.3,True,426.55,4.540284133666668,True,5,2,0,0,55.56,7,1,3,5,62,0,1.0
CHRM4,antagonist,darifenacin,0.46,Muscarinic acetylcholine receptor M4,GPCR,8.1,True,426.55,4.540284133666668,True,5,2,0,0,55.56,7,1,3,5,62,0,1.0
CHRM3,antagonist,chlorprothixene,0.06,Muscarinic acetylcholine receptor M3,GPCR,7.657577319,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
DRD3,antagonist,chlorprothixene,0.3,D(3) dopamine receptor,GPCR,8.34,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
DRD1,antagonist,chlorprothixene,0.14,D(1A) dopamine receptor,GPCR,7.74,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
CHRM4,antagonist,chlorprothixene,0.11,Muscarinic acetylcholine receptor M4,GPCR,7.744727495,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
CHRM1,antagonist,chlorprothixene,0.06,Muscarinic acetylcholine receptor M1,GPCR,7.958607315,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
CHRM5,antagonist,chlorprothixene,0.1,Muscarinic acetylcholine receptor M5,GPCR,7.602059991,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
CHRM2,antagonist,chlorprothixene,0.07,Muscarinic acetylcholine receptor M2,GPCR,7.552841969,True,315.86,5.065966363,False,11,0,0,1,3.24,3,0,2,3,39,0,0.0
DPP4,inhibitor,teneligliptin,0.65,Dipeptidyl peptidase 4,Enzyme,9.43179798126221,False,426.578,1.4152378159999996,True,0,0,0,0,56.64,4,1,7,5,60,0,2.0
DPP8,inhibitor,teneligliptin,9.47,Dipeptidyl peptidase 8,Enzyme,6.585026741027829,False,426.578,1.4152378159999996,True,0,0,0,0,56.64,4,1,7,5,60,0,2.0
DPP9,inhibitor,teneligliptin,9.47,Dipeptidyl peptidase 9,Enzyme,6.26760625839233,False,426.578,1.4152378159999996,True,0,0,0,0,56.64,4,1,7,5,60,0,2.0
ADORA3,agonist,adenosine,1.35,Adenosine receptor A3,GPCR,6.54,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
ADORA1,agonist,adenosine,0.82,Adenosine receptor A1,GPCR,6.5086,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
ADORA2B,agonist,adenosine,1.46,Adenosine receptor A2b,GPCR,4.6198,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
ADORA2A,agonist,adenosine,0.96,Adenosine receptor A2a,GPCR,6.1549,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
PI4K2A,inhibitor,adenosine,5.16,Phosphatidylinositol 4-kinase type 2-alpha,Kinase,5.0,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
PI4K2B,inhibitor,adenosine,2.58,Phosphatidylinositol 4-kinase type 2-beta,Kinase,5.0,True,267.2413,-2.0909638716666668,True,4,2,0,1,139.54,2,4,9,3,32,0,4.0
F2R,antagonist,vorapaxar,5.57,Proteinase-activated receptor 1,GPCR,8.09151458740234,True,492.5817,5.036946574,False,1,2,0,1,77.52,5,1,5,5,69,0,7.0
SLC5A1,inhibitor,empagliflozin,1.46,Sodium/glucose cotransporter 1,Transporter,5.08092212677002,True,450.91,1.6553187060000008,True,1,4,0,5,108.61,6,4,7,4,58,0,6.0
SLC5A2,inhibitor,empagliflozin,6.31,Sodium/glucose cotransporter 2,Transporter,7.24412536621094,True,450.91,1.6553187060000008,True,1,4,0,5,108.61,6,4,7,4,58,0,6.0
PPARD,agonist,bezafibrate,0.17,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,4.45,True,361.819,3.9865833456666673,True,7,3,0,1,75.63,7,2,3,2,45,0,0.0
PPARG,agonist,bezafibrate,0.09,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,4.1778,True,361.819,3.9865833456666673,True,7,3,0,1,75.63,7,2,3,2,45,0,0.0
ESR1,"agonist,antagonist",tibolone,0.23,Estrogen receptor,Nuclear hormone receptor,6.907279355,True,312.453,3.100844062666668,True,1,4,0,0,37.3,0,1,2,4,51,0,6.0
CACNA2D1,modulator,gabapentin enacarbil,0.21,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,,True,329.3930000000001,2.7634692416666664,True,2,0,0,2,101.93,7,2,5,1,50,0,1.0
ACKR3,agonist,plerixafor,11.36,Atypical chemokine receptor 3,GPCR,6.85,True,502.782,-0.4335920706666668,False,1,0,0,0,78.66,4,6,8,3,90,0,0.0
PTGS1,inhibitor,lumiracoxib,0.62,Prostaglandin G/H synthase 1,Enzyme,8.15,True,293.721,4.311087882666666,True,2,4,0,0,49.33,4,2,2,2,33,0,0.0
ADRB1,antagonist,levobetaxolol,0.68,Beta-1 adrenergic receptor,GPCR,9.1,True,307.434,2.539234387333333,True,1,1,0,0,50.72,11,2,4,2,51,0,1.0
ADRB2,antagonist,levobetaxolol,0.17,Beta-2 adrenergic receptor,GPCR,7.49,True,307.434,2.539234387333333,True,1,1,0,0,50.72,11,2,4,2,51,0,1.0
ADRA1A,agonist,midodrine,0.24,Alpha-1A adrenergic receptor,GPCR,,True,254.2823,-0.9519464609999999,True,3,1,0,1,93.81,6,3,5,1,36,0,1.0
TBXAS1,inhibitor,ozagrel,9.47,Thromboxane-A synthase,Enzyme,7.96,False,228.251,1.1854363679880655,True,0,0,0,0,55.12,4,1,3,2,29,0,0.0
SSTR2,agonist,pasireotide,4.73,Somatostatin receptor type 2,GPCR,9.0,True,1047.2062,2.6765632471960648,False,4,1,0,0,281.2,17,9,11,8,143,0,7.0
SSTR1,agonist,pasireotide,6.55,Somatostatin receptor type 1,GPCR,8.0,True,1047.2062,2.6765632471960648,False,4,1,0,0,281.2,17,9,11,8,143,0,7.0
CYSLTR2,antagonist,pranlukast,1.01,Cysteinyl leukotriene receptor 2,GPCR,5.44,False,481.512,4.671582699000001,True,6,2,0,1,123.0,9,2,7,5,59,0,0.0
SLC6A2,inhibitor,phenmetrazine,2.55,Sodium-dependent noradrenaline transporter,Transporter,7.2976,True,177.2429,1.7894362886666664,True,2,0,0,0,21.26,1,1,2,2,28,0,2.0
PGR,agonist,megestrol acetate,0.2,Progesterone receptor,Nuclear hormone receptor,,True,384.516,3.723744303,True,2,1,0,1,60.44,2,0,4,4,60,0,6.0
NR3C1,agonist,megestrol acetate,,Glucocorticoid receptor,Nuclear hormone receptor,8.057000407,True,384.516,3.723744303,True,2,1,0,1,60.44,2,0,4,4,60,0,6.0
SQLE,inhibitor,naftifine,75.74,Squalene monooxygenase,Enzyme,,True,287.3981,5.238508130333333,False,1,0,0,0,3.24,5,0,1,3,43,0,0.0
HTR1A,antagonist,dihydroergocristine,0.11,5-hydroxytryptamine receptor 1A,GPCR,9.385102783999999,True,611.743,3.827820328867739,False,4,1,0,1,118.21,5,3,6,8,86,0,7.0
ADRA1A,"agonist,antagonist",dihydroergocristine,0.09,Alpha-1A adrenergic receptor,GPCR,,True,611.743,3.827820328867739,False,4,1,0,1,118.21,5,3,6,8,86,0,7.0
MC2R,agonist,corticotropin,4.06,Adrenocorticotropic hormone receptor,GPCR,,True,4541.0658,,False,2,4,0,0,1843.75,145,60,61,12,630,0,36.0
GPR35,agonist,lodoxamide,3.34,G-protein coupled receptor 35,GPCR,8.79317378997803,True,311.63,0.8279957053333333,True,0,0,0,0,156.59,2,4,5,1,27,0,0.0
SLC18A2,inhibitor,valbenazine,1.67,Synaptic vesicular amine transporter,Transporter,8.52287864685059,True,418.578,3.645750237666666,True,1,3,0,0,74.02,7,1,6,3,68,0,4.0
ADRB2,partial agonist,bopindolol,0.4,Beta-2 adrenergic receptor,GPCR,9.65,False,380.48,4.668419005666666,True,5,1,0,0,63.35,7,2,4,3,56,0,1.0
ADRB1,partial agonist,bopindolol,0.53,Beta-1 adrenergic receptor,GPCR,9.51,False,380.48,4.668419005666666,True,5,1,0,0,63.35,7,2,4,3,56,0,1.0
HSD11B1,antagonist,glycyrrhizic acid,0.62,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,8.22,True,822.942,3.130205821,False,5,0,4,1,267.04,7,8,13,7,120,0,19.0
OPRM1,agonist,tapentadol,0.22,Mu-type opioid receptor,GPCR,7.0177288055419895,True,221.3385,2.9585336273557528,True,6,5,0,0,23.47,5,1,2,1,39,0,2.0
SLC6A2,inhibitor,tapentadol,0.32,Sodium-dependent noradrenaline transporter,Transporter,6.3187589645385716,True,221.3385,2.9585336273557528,True,6,5,0,0,23.47,5,1,2,1,39,0,2.0
ADRA2A,antagonist,tiapride,0.14,Alpha-2A adrenergic receptor,GPCR,6.108462542000001,False,328.427,0.4624598843333341,True,5,0,0,0,75.71,8,1,5,1,46,0,0.0
DRD3,blocker,tiapride,0.19,D(3) dopamine receptor,GPCR,6.755865573883059,False,328.427,0.4624598843333341,True,5,0,0,0,75.71,8,1,5,1,46,0,0.0
HRH1,antagonist,methdilazine,3.09,Histamine H1 receptor,GPCR,,True,296.43,3.936746242333333,True,1,0,0,0,6.48,2,0,3,4,41,0,1.0
CHRM4,antagonist,procyclidine,1.25,Muscarinic acetylcholine receptor M4,GPCR,8.1549015045166,True,287.4397,3.7881168286666655,True,4,0,0,0,23.47,5,1,2,3,50,0,1.0
CHRM3,antagonist,procyclidine,0.25,Muscarinic acetylcholine receptor M3,GPCR,7.906578540801999,True,287.4397,3.7881168286666655,True,4,0,0,0,23.47,5,1,2,3,50,0,1.0
CHRM2,antagonist,procyclidine,0.85,Muscarinic acetylcholine receptor M2,GPCR,7.6020598411560085,True,287.4397,3.7881168286666655,True,4,0,0,0,23.47,5,1,2,3,50,0,1.0
NR3C1,agonist,mometasone furoate,0.07,Glucocorticoid receptor,Nuclear hormone receptor,,True,521.429,5.055208110333334,False,2,3,0,0,93.81,4,1,6,5,65,0,8.0
DRD1,antagonist,thiothixene,0.15,D(1A) dopamine receptor,GPCR,7.2924299240112305,True,443.625,3.3624241666666657,True,3,2,1,1,43.86,5,0,5,4,59,0,0.0
HTR2A,antagonist,thiothixene,0.25,5-hydroxytryptamine receptor 2A,GPCR,7.3,True,443.625,3.3624241666666657,True,3,2,1,1,43.86,5,0,5,4,59,0,0.0
DRD2,antagonist,thiothixene,0.46,D(2) dopamine receptor,GPCR,9.34678745269775,True,443.625,3.3624241666666657,True,3,2,1,1,43.86,5,0,5,4,59,0,0.0
HRH1,antagonist,thiothixene,0.05,Histamine H1 receptor,GPCR,8.4,True,443.625,3.3624241666666657,True,3,2,1,1,43.86,5,0,5,4,59,0,0.0
HTR2A,antagonist,pipamperone,0.07,5-hydroxytryptamine receptor 2A,GPCR,8.3,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
HRH1,antagonist,pipamperone,0.03,Histamine H1 receptor,GPCR,5.6,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
HTR1B,antagonist,pipamperone,0.06,5-hydroxytryptamine receptor 1B,GPCR,6.2,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
HTR1D,antagonist,pipamperone,0.07,5-hydroxytryptamine receptor 1D,GPCR,6.8,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
ADRA2A,antagonist,pipamperone,0.07,Alpha-2A adrenergic receptor,GPCR,6.06550168991089,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
DRD2,antagonist,pipamperone,0.05,D(2) dopamine receptor,GPCR,6.93971300125122,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
HTR1A,antagonist,pipamperone,0.03,5-hydroxytryptamine receptor 1A,GPCR,5.6,False,375.48800000000006,1.8671278030000005,True,8,0,0,0,66.64,7,1,4,3,57,0,0.0
SLC6A2,inhibitor,viloxazine,1.46,Sodium-dependent noradrenaline transporter,Transporter,6.81,True,237.299,1.4915744426666662,True,1,1,0,0,39.72,5,1,4,2,36,0,1.0
ACE,inhibitor,imidapril,0.2,Angiotensin-converting enzyme,Enzyme,5.0,False,405.4449,-0.23491832682730185,True,0,0,0,0,116.25,9,2,6,2,56,0,3.0
PPARA,agonist,fenofibrate,0.3,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,6.0,True,360.831,5.277762736000001,False,3,11,1,1,52.6,6,0,4,2,46,0,0.0
S100P,antagonist,cromoglicic acid,,Protein S100-P,Unclassified,,True,468.3665,1.4770116999999996,False,1,0,0,0,173.71,8,3,9,4,50,0,0.0
SLC6A3,inhibitor,dexmethylphenidate,3.46,Sodium-dependent dopamine transporter,Transporter,7.8,True,233.3062,2.254935081666666,True,3,1,0,0,38.33,3,1,3,2,36,0,2.0
SLC6A2,inhibitor,dexmethylphenidate,2.91,Sodium-dependent noradrenaline transporter,Transporter,,True,233.3062,2.254935081666666,True,3,1,0,0,38.33,3,1,3,2,36,0,2.0
CHRM1,antagonist,pirenzepine,0.32,Muscarinic acetylcholine receptor M1,GPCR,7.68,True,351.4023,0.8524512625648508,True,1,0,0,0,68.78,2,1,5,4,47,0,0.0
CHRM5,antagonist,pirenzepine,0.08,Muscarinic acetylcholine receptor M5,GPCR,6.55,True,351.4023,0.8524512625648508,True,1,0,0,0,68.78,2,1,5,4,47,0,0.0
CHRM3,antagonist,pirenzepine,0.05,Muscarinic acetylcholine receptor M3,GPCR,6.61,True,351.4023,0.8524512625648508,True,1,0,0,0,68.78,2,1,5,4,47,0,0.0
CHRM4,antagonist,pirenzepine,0.09,Muscarinic acetylcholine receptor M4,GPCR,7.12,True,351.4023,0.8524512625648508,True,1,0,0,0,68.78,2,1,5,4,47,0,0.0
CHRM2,antagonist,pirenzepine,0.06,Muscarinic acetylcholine receptor M2,GPCR,6.76,True,351.4023,0.8524512625648508,True,1,0,0,0,68.78,2,1,5,4,47,0,0.0
P2RY13,antagonist,cangrelor,7.1,P2Y purinoceptor 13,GPCR,8.3,True,776.35,-0.12444800635445567,False,1,0,0,0,255.91,15,7,15,3,69,0,6.0
SLC5A2,inhibitor,canagliflozin,5.05,Sodium/glucose cotransporter 2,Transporter,8.657577499999999,True,444.516,3.5206550853333343,True,1,3,1,3,90.15,5,4,6,4,56,0,5.0
SLC5A1,inhibitor,canagliflozin,2.91,Sodium/glucose cotransporter 1,Transporter,5.72,True,444.516,3.5206550853333343,True,1,3,1,3,90.15,5,4,6,4,56,0,5.0
,modulator,edetic acid,,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Unclassified,4.13,True,292.2426,-4.924670289588847,True,3,3,0,0,155.68,11,4,6,0,36,0,0.0
NR3C1,agonist,fluorometholone,1.36,Glucocorticoid receptor,Nuclear hormone receptor,8.801342913,True,376.4617,2.4208639956666667,True,1,2,1,0,74.6,1,2,4,4,56,0,8.0
OPRM1,agonist,dextropropoxyphene,0.78,Mu-type opioid receptor,GPCR,,True,339.4712,4.902155232666666,True,4,2,0,0,29.54,8,0,3,2,54,0,2.0
PTGS2,inhibitor,valdecoxib,1.73,Prostaglandin G/H synthase 2,Enzyme,8.3,True,314.3590000000001,2.8236843580000004,True,3,3,0,0,86.19,3,1,4,3,36,0,0.0
CA2,inhibitor,valdecoxib,0.38,Carbonic anhydrase,Unclassified,5.24,True,314.3590000000001,2.8236843580000004,True,3,3,0,0,86.19,3,1,4,3,36,0,0.0
CA3,inhibitor,valdecoxib,2.03,Carbonic anhydrase 3,Enzyme,4.11,True,314.3590000000001,2.8236843580000004,True,3,3,0,0,86.19,3,1,4,3,36,0,0.0
CHRM1,antagonist,biperiden,0.64,Muscarinic acetylcholine receptor M1,GPCR,9.32,True,311.4611,3.5365074619999994,True,1,1,0,0,23.47,5,1,2,4,52,0,4.0
CHRM2,antagonist,biperiden,0.07,Muscarinic acetylcholine receptor M2,GPCR,8.2,True,311.4611,3.5365074619999994,True,1,1,0,0,23.47,5,1,2,4,52,0,4.0
CHRM5,antagonist,biperiden,0.1,Muscarinic acetylcholine receptor M5,GPCR,8.20065975189209,True,311.4611,3.5365074619999994,True,1,1,0,0,23.47,5,1,2,4,52,0,4.0
CHRM4,antagonist,biperiden,0.1,Muscarinic acetylcholine receptor M4,GPCR,8.62,True,311.4611,3.5365074619999994,True,1,1,0,0,23.47,5,1,2,4,52,0,4.0
CHRM3,antagonist,biperiden,0.06,Muscarinic acetylcholine receptor M3,GPCR,8.41,True,311.4611,3.5365074619999994,True,1,1,0,0,23.47,5,1,2,4,52,0,4.0
ESR1,agonist,estradiol cypionate,0.11,Estrogen receptor,Nuclear hormone receptor,,True,396.5622,6.488730439333335,False,10,10,3,14,46.53,4,1,3,5,65,0,5.0
MAOA,inhibitor,linezolid,0.17,Amine oxidase [flavin-containing] A,Enzyme,5.1,True,337.3461,0.6366636523333332,True,1,2,0,0,71.11,4,1,5,3,44,0,1.0
MAOB,inhibitor,linezolid,0.12,Amine oxidase [flavin-containing] B,Enzyme,4.5,True,337.3461,0.6366636523333332,True,1,2,0,0,71.11,4,1,5,3,44,0,1.0
ESR1,agonist,dienestrol,0.37,Estrogen receptor,Nuclear hormone receptor,4.88,True,266.34,4.8319610913333335,True,2,0,0,0,40.46,3,2,2,2,38,0,0.0
GLP1R,agonist,semaglutide,2.24,Glucagon-like peptide 1 receptor,GPCR,9.420216403,True,4113.641,-17.292170184168903,False,1,4,1,0,1646.18,184,57,56,6,582,0,30.0
SLC22A12,inhibitor,lesinurad,9.47,Solute carrier family 22 member 12,Transporter,5.136677265167241,True,404.28,4.089902325,True,2,2,0,0,68.01,5,1,5,4,38,0,0.0
SLC22A11,inhibitor,lesinurad,2.71,Solute carrier family 22 member 11,Transporter,5.43179845809937,True,404.28,4.089902325,True,2,2,0,0,68.01,5,1,5,4,38,0,0.0
CYP19A1,inhibitor,aminoglutethimide,3.04,Aromatase,Enzyme,5.11,True,232.2783,1.2995443679999998,True,2,2,0,0,72.19,2,2,3,2,33,0,1.0
ADRB2,agonist,procaterol,1.91,Beta-2 adrenergic receptor,GPCR,8.43,True,290.3575,0.8841294780789967,True,1,0,0,0,85.35,5,4,4,2,43,0,2.0
F10,antagonist,rivaroxaban,3.44,Coagulation factor X,Enzyme,9.4,True,435.881,1.8976447186666672,True,1,3,0,2,88.18,5,1,6,4,47,0,1.0
HTR3A,antagonist,ondansetron,1.25,5-hydroxytryptamine receptor 3A,Ion channel,7.8,True,293.363,2.3499651703333324,True,5,7,0,0,39.82,2,0,4,4,41,0,1.0
AR,agonist,oxymetholone,0.03,Androgen receptor,Nuclear hormone receptor,,True,332.4840000000001,3.5527294793333324,True,2,7,2,0,57.53,1,2,3,4,56,0,7.0
VKORC1,inhibitor,dicoumarol,6.46,Vitamin K epoxide reductase complex subunit 1,Enzyme,5.5086383819580105,True,336.295,-1.5927893718444857,True,3,3,1,0,100.88,2,2,6,4,37,0,0.0
ATP1A2,inhibitor,digitoxin,0.53,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,6.647817482000001,True,764.9391,3.5974917390000014,False,1,2,1,3,182.83,7,5,13,8,118,0,20.0
CHRM3,agonist,methacholine,1.02,Muscarinic acetylcholine receptor M3,GPCR,,True,160.234,-3.8045687278050786,True,1,0,0,0,26.3,3,0,2,0,29,1,1.0
CHRM2,antagonist,dimetindene,0.47,Muscarinic acetylcholine receptor M2,GPCR,7.35,True,292.418,3.7387046103333343,True,2,0,0,0,16.13,5,0,2,3,46,0,1.0
HRH1,antagonist,dimetindene,0.62,Histamine H1 receptor,GPCR,9.16,True,292.418,3.7387046103333343,True,2,0,0,0,16.13,5,0,2,3,46,0,1.0
,negative modulator,epirubicin,,DNA,DNA,,True,543.5193,0.916421641538582,False,2,2,0,1,206.07,5,6,12,5,68,0,6.0
GHRHR,agonist,sermorelin,99.41,Growth hormone-releasing hormone receptor,GPCR,,True,3357.882,,False,1,0,0,0,1454.4,115,49,47,3,482,0,31.0
BCL2L1,antagonist,venetoclax,0.38,Bcl-2-like protein 1,Cytosolic other,7.3187589645385716,True,868.45,6.762158637639526,False,1,1,0,3,172.03,13,3,11,8,111,0,0.0
BCL2,antagonist,venetoclax,1.16,Apoptosis regulator Bcl-2,Cytosolic other,11.0,True,868.45,6.762158637639526,False,1,1,0,3,172.03,13,3,11,8,111,0,0.0
BCL2L2,antagonist,venetoclax,0.63,Apoptosis regulator Bcl-W,Cytosolic other,6.610834121704099,True,868.45,6.762158637639526,False,1,1,0,3,172.03,13,3,11,8,111,0,0.0
AGTR1,antagonist,eprosartan,17.82,Type-1 angiotensin II receptor,GPCR,8.7,True,424.513,3.7972303935904312,True,1,0,0,1,92.42,10,2,5,3,54,0,0.0
ABCA1,inhibitor,probucol,23.67,ATP-binding cassette sub-family A member 1,Transporter,,True,516.842,10.569524170333334,False,2,0,0,0,40.46,4,2,4,2,83,0,0.0
TPO,inhibitor,carbimazole,16.23,Thyroid peroxidase,Enzyme,,True,186.232,1.3485111993333334,True,1,1,0,0,36.16,1,0,5,1,22,0,0.0
RAC1,modulator,azathioprine,0.44,Ras-related C3 botulinum toxin substrate 1,Unclassified,,True,277.263,1.173143957666667,True,1,12,1,4,115.42,3,1,8,3,26,0,0.0
IKBKE,inhibitor,amlexanox,0.24,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,6.0,True,298.2934,3.654548958,True,4,0,0,0,106.42,2,2,5,3,36,0,0.0
TBK1,inhibitor,amlexanox,0.32,Serine/threonine-protein kinase TBK1,Kinase,6.0,True,298.2934,3.654548958,True,4,0,0,0,106.42,2,2,5,3,36,0,0.0
DRD2,antagonist,etoperidone,0.09,D(2) dopamine receptor,GPCR,5.6382722854614284,False,377.92,3.3657262419999987,True,6,0,0,3,46.3,7,0,6,3,54,0,0.0
OPRM1,agonist,methadone,0.13,Mu-type opioid receptor,GPCR,8.78,True,309.4452,5.007171635333333,False,8,10,2,1,20.31,7,0,2,2,50,0,1.0
KCNH2,inhibitor,halofantrine,0.61,Potassium voltage-gated channel subfamily H member 2,Ion channel,5.12,True,500.424,8.056956757,False,3,4,0,0,23.47,10,1,2,3,63,0,1.0
HCAR2,agonist,acipimox,7.1,Hydroxycarboxylic acid receptor 2,GPCR,5.6,True,154.125,-2.521175933019461,True,0,0,0,0,77.13,1,1,3,1,17,0,0.0
SQLE,inhibitor,terbinafine,21.3,Squalene monooxygenase,Enzyme,7.52,True,291.4299,5.527483033666665,False,2,7,2,1,3.24,4,0,1,2,47,0,0.0
OPRM1,agonist,fentanyl,0.18,Mu-type opioid receptor,GPCR,9.0014,True,336.4705,3.8154985483333332,True,4,2,2,1,23.55,6,0,2,3,53,0,0.0
OPRK1,agonist,fentanyl,0.06,Kappa-type opioid receptor,GPCR,6.71,True,336.4705,3.8154985483333332,True,4,2,2,1,23.55,6,0,2,3,53,0,0.0
SLC12A3,inhibitor,hydroflumethiazide,0.29,Solute carrier family 12 member 3,Transporter,7.37,True,331.292,-0.301813971,True,9,0,1,2,118.36,1,3,5,2,28,0,0.0
HRH1,antagonist,bilastine,0.62,Histamine H1 receptor,GPCR,7.1938199996948216,True,463.622,2.409230745583987,True,1,0,0,3,67.59,10,1,5,4,71,0,0.0
ABL1,antagonist,radotinib,1.51,Tyrosine-protein kinase ABL1,Kinase,7.514278411865232,False,530.515,4.529717749666665,False,1,0,0,0,110.51,6,2,8,5,60,0,0.0
MAOA,inhibitor,pargyline,4.23,Amine oxidase [flavin-containing] A,Enzyme,5.47,True,159.2276,2.142725628999999,True,2,0,0,0,3.24,3,0,1,1,25,0,0.0
MAOB,inhibitor,pargyline,7.52,Amine oxidase [flavin-containing] B,Enzyme,5.74,True,159.2276,2.142725628999999,True,2,0,0,0,3.24,3,0,1,1,25,0,0.0
SSTR4,agonist,somatostatin,4.26,Somatostatin receptor type 4,GPCR,9.23,True,1637.9,-8.234491845035745,False,5,1,0,1,613.23,26,22,23,6,219,0,15.0
SSTR2,agonist,somatostatin,1.89,Somatostatin receptor type 2,GPCR,10.46,True,1637.9,-8.234491845035745,False,5,1,0,1,613.23,26,22,23,6,219,0,15.0
SSTR1,agonist,somatostatin,2.62,Somatostatin receptor type 1,GPCR,9.54,True,1637.9,-8.234491845035745,False,5,1,0,1,613.23,26,22,23,6,219,0,15.0
SSTR3,agonist,somatostatin,4.37,Somatostatin receptor type 3,GPCR,10.0,True,1637.9,-8.234491845035745,False,5,1,0,1,613.23,26,22,23,6,219,0,15.0
SSTR5,agonist,somatostatin,2.27,Somatostatin receptor type 5,GPCR,9.85,True,1637.9,-8.234491845035745,False,5,1,0,1,613.23,26,22,23,6,219,0,15.0
SLC6A4,inhibitor,mazindol,0.21,Sodium-dependent serotonin transporter,Transporter,7.3,True,284.74,3.4352790006666662,True,4,0,0,0,35.83,1,1,3,4,33,0,1.0
SLC6A2,inhibitor,mazindol,0.97,Sodium-dependent noradrenaline transporter,Transporter,9.3,True,284.74,3.4352790006666662,True,4,0,0,0,35.83,1,1,3,4,33,0,1.0
SLC6A3,inhibitor,mazindol,1.27,Sodium-dependent dopamine transporter,Transporter,8.0,True,284.74,3.4352790006666662,True,4,0,0,0,35.83,1,1,3,4,33,0,1.0
CTSA,inhibitor,telaprevir,3.55,Lysosomal protective protein,Enzyme,7.0,True,679.8493,2.580292300333334,False,3,1,2,1,179.56,13,4,8,5,102,0,6.0
CELA1,inhibitor,telaprevir,1.42,Chymotrypsin-like elastase family member 1,Enzyme,7.52,True,679.8493,2.580292300333334,False,3,1,2,1,179.56,13,4,8,5,102,0,6.0
PDE11A,inhibitor,tadalafil,56.81,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,7.48,True,389.404,1.6393403350000002,True,2,2,0,0,74.87,1,1,4,6,48,0,2.0
PDE5A,inhibitor,tadalafil,6.84,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,8.0,True,389.404,1.6393403350000002,True,2,2,0,0,74.87,1,1,4,6,48,0,2.0
PDE3A,inhibitor,enoximone,3.98,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,5.3449,True,248.301,1.844280216,True,1,0,0,0,65.72,3,2,3,2,29,0,0.0
TACR1,antagonist,netupitant,2.91,Substance-P receptor,GPCR,9.022275924682619,True,578.6030000000002,7.256654907333332,False,1,4,0,1,39.68,5,0,4,4,73,0,0.0
DRD2,antagonist,bromopride,0.55,D(2) dopamine receptor,GPCR,7.85,False,344.247,1.5619780133333332,True,1,0,0,0,67.59,7,2,4,1,42,0,0.0
HRH1,antagonist,acrivastine,0.93,Histamine H1 receptor,GPCR,7.16,True,348.4382,1.710666395404386,True,1,0,0,0,53.43,6,1,3,3,50,0,0.0
P2RY1,antagonist,suramin,0.28,P2Y purinoceptor 1,GPCR,5.3,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
P2RY13,antagonist,suramin,0.36,P2Y purinoceptor 13,GPCR,5.6,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
P2RY2,antagonist,suramin,1.1,P2Y purinoceptor 2,GPCR,4.3,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
P2RY11,antagonist,suramin,0.24,P2Y purinoceptor 11,GPCR,6.0,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
P2RX3,antagonist,suramin,0.28,P2X purinoceptor 3,Ion channel,5.962573502000001,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
P2RY6,antagonist,suramin,0.71,P2Y purinoceptor 6,GPCR,4.0,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
SIRT5,inhibitor,suramin,0.89,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,4.85,False,1297.28,5.577430975666668,False,7,2,0,0,483.75,16,12,17,8,126,0,0.0
ADRB2,agonist,isoprenaline,0.21,Beta-2 adrenergic receptor,GPCR,6.87,True,211.2576,0.2402056821478119,True,9,1,0,0,72.72,4,4,4,1,32,0,1.0
ADRB1,agonist,isoprenaline,0.16,Beta-1 adrenergic receptor,GPCR,9.0,True,211.2576,0.2402056821478119,True,9,1,0,0,72.72,4,4,4,1,32,0,1.0
ADRB3,agonist,isoprenaline,0.13,Beta-3 adrenergic receptor,GPCR,8.5,True,211.2576,0.2402056821478119,True,9,1,0,0,72.72,4,4,4,1,32,0,1.0
DPP4,inhibitor,linagliptin,2.45,Dipeptidyl peptidase 4,Enzyme,10.0,True,472.5422,2.8026328140000007,True,1,1,0,4,116.86,4,1,10,5,63,0,1.0
GNRHR,agonist,goserelin,0.64,Gonadotropin-releasing hormone receptor,GPCR,,True,1269.4105,-5.17557331843203,False,2,0,0,0,495.89,31,17,16,6,175,0,9.0
P4HA1,cofactor,ascorbic acid,,Prolyl 4-hydroxylase subunit alpha-1,Enzyme,,True,176.1241,-1.9135588756666668,True,24,1,1,5,107.22,2,4,6,1,20,0,2.0
PLOD1,cofactor,ascorbic acid,,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",Enzyme,,True,176.1241,-1.9135588756666668,True,24,1,1,5,107.22,2,4,6,1,20,0,2.0
PAH,cofactor,sapropterin,12.78,Phenylalanine-4-hydroxylase,Enzyme,5.4,True,241.2471,-2.3211264380000003,False,4,1,0,0,136.29,2,6,7,2,32,0,3.0
DHODH,inhibitor,atovaquone,9.04,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,5.03,True,366.837,4.997646357666667,True,3,2,0,1,54.37,2,1,3,4,45,0,2.0
TRPM8,inducer,levomenthol,6.99,Transient receptor potential cation channel subfamily M member 8,Ion channel,4.6,True,156.2652,2.6642731470000007,True,5,1,0,0,20.23,1,1,1,1,31,0,3.0
TRPA1,inducer,levomenthol,1.67,Transient receptor potential cation channel subfamily A member 1,Ion channel,4.5,True,156.2652,2.6642731470000007,True,5,1,0,0,20.23,1,1,1,1,31,0,3.0
PTGER4,agonist,misoprostol,3.31,Prostaglandin E2 receptor EP4 subtype,GPCR,7.6,True,382.5341,3.857755057999998,True,4,0,0,0,83.83,13,2,5,1,65,0,4.0
PTGER2,agonist,misoprostol,3.34,Prostaglandin E2 receptor EP2 subtype,GPCR,7.5,True,382.5341,3.857755057999998,True,4,0,0,0,83.83,13,2,5,1,65,0,4.0
MPL,agonist,lusutrombopag,5.16,Thrombopoietin receptor,Membrane receptor,7.0757207139,True,591.54,8.555446220666669,False,1,1,0,2,97.75,13,2,6,3,71,0,1.0
ADRB2,antagonist,bisoprolol,0.69,Beta-2 adrenergic receptor,GPCR,5.94,True,325.443,2.19640338,True,2,1,0,1,59.95,12,2,5,1,54,0,1.0
CACNA1D,inhibitor,nilvadipine,0.48,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,,True,385.3707,2.2390465833333333,True,6,5,0,0,131.56,5,1,8,2,47,0,1.0
CACNA1C,inhibitor,nilvadipine,0.42,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,,True,385.3707,2.2390465833333333,True,6,5,0,0,131.56,5,1,8,2,47,0,1.0
PTGS2,antagonist,alclofenac,0.46,Prostaglandin G/H synthase 2,Enzyme,,True,226.66,2.788617339333333,True,1,0,0,0,46.53,5,1,2,1,26,0,0.0
PTGS1,inhibitor,diethylcarbamazine,0.52,Prostaglandin G/H synthase 1,Enzyme,,True,199.2932,0.0916058893333325,True,2,1,0,0,26.79,2,0,2,1,35,0,0.0
ALOX5,inhibitor,diethylcarbamazine,5.98,Arachidonate 5-lipoxygenase,Enzyme,,True,199.2932,0.0916058893333325,True,2,1,0,0,26.79,2,0,2,1,35,0,0.0
HTR1D,agonist,rizatriptan,2.37,5-hydroxytryptamine receptor 1D,GPCR,7.9,True,269.3449,1.7678793143333331,True,3,1,0,0,49.74,5,1,4,3,39,0,0.0
HTR1A,agonist,rizatriptan,0.08,5-hydroxytryptamine receptor 1A,GPCR,6.85,True,269.3449,1.7678793143333331,True,3,1,0,0,49.74,5,1,4,3,39,0,0.0
HTR1B,agonist,rizatriptan,1.62,5-hydroxytryptamine receptor 1B,GPCR,6.9,True,269.3449,1.7678793143333331,True,3,1,0,0,49.74,5,1,4,3,39,0,0.0
HTR1F,agonist,rizatriptan,2.65,5-hydroxytryptamine receptor 1F,GPCR,6.8,True,269.3449,1.7678793143333331,True,3,1,0,0,49.74,5,1,4,3,39,0,0.0
HTR1E,agonist,rizatriptan,0.32,5-hydroxytryptamine receptor 1E,GPCR,6.8,True,269.3449,1.7678793143333331,True,3,1,0,0,49.74,5,1,4,3,39,0,0.0
CDK4,inhibitor,abemaciclib,0.98,Cyclin-dependent kinase 4,Kinase,9.22184875,True,506.606,4.415418176,False,2,6,2,5,75.0,13,1,8,5,69,0,0.0
CDK6,inhibitor,abemaciclib,1.28,Cyclin-dependent kinase 6,Kinase,8.619788758,True,506.606,4.415418176,False,2,6,2,5,75.0,13,1,8,5,69,0,0.0
VKORC1,inhibitor,warfarin,23.31,Vitamin K epoxide reductase complex subunit 1,Enzyme,7.0,True,308.3279,2.7447073623333327,True,2,6,2,0,67.51,4,1,4,3,39,0,1.0
F2,inhibitor,dabigatran etexilate,,Prothrombin,Enzyme,8.35,True,627.7332,4.593332732,False,1,6,0,1,154.03,15,2,9,4,87,0,0.0
CYP11B1,inhibitor,metyrapone,34.08,"Cytochrome P450 11B1, mitochondrial",Enzyme,7.84,True,226.2738,2.028888880666667,True,2,5,0,1,42.85,3,0,3,2,31,0,0.0
HRH3,antagonist,pitolisant,1.41,Histamine H3 receptor,GPCR,9.79588031768799,True,295.85,4.115267491666666,True,2,4,2,1,12.47,8,0,2,2,46,0,0.0
HRH1,antagonist,pitolisant,0.05,Histamine H1 receptor,GPCR,5.94000005722046,True,295.85,4.115267491666666,True,2,4,2,1,12.47,8,0,2,2,46,0,0.0
OPRM1,antagonist,naldemedine,0.39,Mu-type opioid receptor,GPCR,,True,570.646,2.425656088235664,False,3,2,0,1,141.18,6,4,9,8,76,0,4.0
CHRM5,antagonist,trihexyphenidyl,0.29,Muscarinic acetylcholine receptor M5,GPCR,7.99,True,301.4662,4.232685493666667,True,5,0,1,0,23.47,5,1,2,3,53,0,1.0
CHRM4,antagonist,trihexyphenidyl,0.3,Muscarinic acetylcholine receptor M4,GPCR,8.17,True,301.4662,4.232685493666667,True,5,0,1,0,23.47,5,1,2,3,53,0,1.0
CHRM1,antagonist,trihexyphenidyl,0.69,Muscarinic acetylcholine receptor M1,GPCR,8.89,True,301.4662,4.232685493666667,True,5,0,1,0,23.47,5,1,2,3,53,0,1.0
CHRM2,antagonist,trihexyphenidyl,0.27,Muscarinic acetylcholine receptor M2,GPCR,7.73,True,301.4662,4.232685493666667,True,5,0,1,0,23.47,5,1,2,3,53,0,1.0
CHRM3,antagonist,trihexyphenidyl,0.23,Muscarinic acetylcholine receptor M3,GPCR,7.58,True,301.4662,4.232685493666667,True,5,0,1,0,23.47,5,1,2,3,53,0,1.0
SLC5A2,inhibitor,tofogliflozin,2.52,Sodium/glucose cotransporter 2,Transporter,8.53760242462158,False,386.444,2.4703787556666668,True,0,0,0,0,99.38,4,4,6,4,54,0,5.0
SLC5A1,inhibitor,tofogliflozin,1.46,Sodium/glucose cotransporter 1,Transporter,5.07345199584961,False,386.444,2.4703787556666668,True,0,0,0,0,99.38,4,4,6,4,54,0,5.0
ADRB2,agonist,levosalbutamol,0.52,Beta-2 adrenergic receptor,GPCR,5.42,True,239.3107,0.3444161509994905,True,1,0,0,2,72.72,4,4,4,1,38,0,1.0
CHRNA7,agonist,cytisine,0.5,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,5.85,False,190.2417,-0.27985360699999995,True,5,0,0,0,34.03,0,1,3,3,28,0,2.0
ADRB1,antagonist,bupranolol,0.75,Beta-1 adrenergic receptor,GPCR,9.0,False,271.783,2.9922619066666667,True,3,1,0,0,41.49,5,2,3,1,40,0,1.0
ADRB3,antagonist,bupranolol,1.46,Beta-3 adrenergic receptor,GPCR,7.3,False,271.783,2.9922619066666667,True,3,1,0,0,41.49,5,2,3,1,40,0,1.0
NEU2,inhibitor,zanamivir,37.87,Sialidase 2,Enzyme,4.77,True,332.3098,-5.827718904459089,False,3,0,0,0,200.72,6,7,7,1,43,0,5.0
CHRM3,antagonist,isopropamide,0.41,Muscarinic acetylcholine receptor M3,GPCR,,True,353.5209,0.13792196952825314,True,2,0,0,0,43.09,8,1,1,2,59,1,0.0
MLNR,agonist,erythromycin,1.42,Motilin receptor,GPCR,4.43,True,733.9268,2.596388847333333,False,3,3,0,6,193.91,7,5,14,3,118,0,18.0
KCNH2,inhibitor,erythromycin,0.05,Potassium voltage-gated channel subfamily H member 2,Ion channel,7.41,True,733.9268,2.596388847333333,False,3,3,0,6,193.91,7,5,14,3,118,0,18.0
CACNA2D2,modulator,pregabalin,0.16,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,7.259637355804441,True,159.2261,-1.3455846782464078,True,1,0,0,2,63.32,5,2,2,0,28,0,1.0
HTR4,agonist,prucalopride,3.25,5-hydroxytryptamine receptor 4,GPCR,8.6,True,367.87,0.7446884966666674,True,1,1,1,1,76.82,6,2,5,3,51,0,0.0
CHRM2,antagonist,homatropine,0.19,Muscarinic acetylcholine receptor M2,GPCR,7.124938737000001,True,275.348,1.593867434333332,True,5,1,0,0,49.77,3,1,4,3,41,0,4.0
CHRM4,antagonist,homatropine,0.28,Muscarinic acetylcholine receptor M4,GPCR,7.853871964,True,275.348,1.593867434333332,True,5,1,0,0,49.77,3,1,4,3,41,0,4.0
CHRM1,antagonist,homatropine,0.15,Muscarinic acetylcholine receptor M1,GPCR,7.494850022,True,275.348,1.593867434333332,True,5,1,0,0,49.77,3,1,4,3,41,0,4.0
CHRM3,antagonist,homatropine,0.16,Muscarinic acetylcholine receptor M3,GPCR,7.795880017000001,True,275.348,1.593867434333332,True,5,1,0,0,49.77,3,1,4,3,41,0,4.0
CHRM5,antagonist,homatropine,0.27,Muscarinic acetylcholine receptor M5,GPCR,7.408935392999999,True,275.348,1.593867434333332,True,5,1,0,0,49.77,3,1,4,3,41,0,4.0
ADRB1,agonist,clenbuterol,0.18,Beta-1 adrenergic receptor,GPCR,7.161150909,True,277.19,2.33438275,True,5,1,0,0,58.28,3,3,3,1,35,0,1.0
HRH1,"antagonist,inhibitor",levocetirizine,1.23,Histamine H1 receptor,GPCR,7.95,True,388.89,0.8736928308508121,True,1,1,1,1,53.01,8,1,4,3,52,0,1.0
ADORA2A,agonist,regadenoson,1.16,Adenosine receptor A2a,GPCR,5.8861,True,390.354,-2.2520429833333333,True,1,0,0,0,186.46,4,5,12,4,46,0,4.0
ADORA1,agonist,regadenoson,0.2,Adenosine receptor A1,GPCR,4.3979,True,390.354,-2.2520429833333333,True,1,0,0,0,186.46,4,5,12,4,46,0,4.0
GLRA2,agonist,ethanol,0.15,Glycine receptor subunit alpha-2,Ion channel,,True,46.0684,-0.1617691140000001,True,52,16,0,0,20.23,0,1,1,0,9,0,0.0
GRIN3A,antagonist,ethanol,0.08,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,,True,46.0684,-0.1617691140000001,True,52,16,0,0,20.23,0,1,1,0,9,0,0.0
GLRA1,agonist,ethanol,0.08,Glycine receptor subunit alpha-1,Ion channel,,True,46.0684,-0.1617691140000001,True,52,16,0,0,20.23,0,1,1,0,9,0,0.0
CPS1,positive modulator,carglumic acid,28.4,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",Enzyme,,True,190.154,-1.446560950333333,True,1,0,0,0,129.72,5,4,3,0,23,0,1.0
AR,agonist,nandrolone decanoate,0.25,Androgen receptor,Nuclear hormone receptor,,True,428.6472,7.31901809,False,1,3,0,0,43.37,9,0,3,4,75,0,6.0
KCNQ2,activator,flupirtine,0.3,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,5.0,False,304.3195,2.669325134,True,1,0,0,0,89.27,5,3,5,2,39,0,0.0
KCNN2,blocker,tubocurarine,2.37,Small conductance calcium-activated potassium channel protein 2,Ion channel,5.7,True,609.7312,3.144135107944982,False,4,1,0,2,80.62,2,2,7,8,86,1,2.0
ZACN,antagonist,tubocurarine,7.1,Zinc-activated ligand-gated ion channel,Ion channel,5.2,True,609.7312,3.144135107944982,False,4,1,0,2,80.62,2,2,7,8,86,1,2.0
KCNN3,blocker,tubocurarine,1.78,Small conductance calcium-activated potassium channel protein 3,Ion channel,4.5,True,609.7312,3.144135107944982,False,4,1,0,2,80.62,2,2,7,8,86,1,2.0
KCNN1,blocker,tubocurarine,1.42,Small conductance calcium-activated potassium channel protein 1,Ion channel,4.6,True,609.7312,3.144135107944982,False,4,1,0,2,80.62,2,2,7,8,86,1,2.0
HTR3A,antagonist,tubocurarine,0.68,5-hydroxytryptamine receptor 3A,Ion channel,7.0604,True,609.7312,3.144135107944982,False,4,1,0,2,80.62,2,2,7,8,86,1,2.0
NR3C1,agonist,prednisolone tebutate,0.37,Glucocorticoid receptor,Nuclear hormone receptor,9.28,True,458.587,3.4462860630000014,True,0,0,0,0,100.9,4,2,6,4,71,0,7.0
NR3C1,agonist,hydrocortisone valerate,0.12,Glucocorticoid receptor,Nuclear hormone receptor,,True,446.5763,3.305965022000002,True,4,6,2,4,100.9,6,2,6,4,70,0,7.0
ADRB2,agonist,arformoterol,1.13,Beta-2 adrenergic receptor,GPCR,8.53760242462158,True,344.4049,1.0566727363571802,True,1,4,0,0,90.82,9,4,5,2,49,0,2.0
ADRB1,agonist,arformoterol,0.11,Beta-1 adrenergic receptor,GPCR,6.94692134857178,True,344.4049,1.0566727363571802,True,1,4,0,0,90.82,9,4,5,2,49,0,2.0
SLC6A2,negative modulator,phendimetrazine,0.49,Sodium-dependent noradrenaline transporter,Transporter,,True,191.274,2.1724842260000004,True,3,0,0,0,12.47,1,0,2,2,31,0,2.0
ACE,inhibitor,perindopril,1.92,Angiotensin-converting enzyme,Enzyme,8.82,True,368.4678,0.6307438391420584,True,2,1,0,2,95.94,8,2,5,2,58,0,5.0
F10,inhibitor,edoxaban,4.13,Coagulation factor X,Enzyme,9.25181198120117,True,548.06,0.9016595426666651,False,1,0,0,1,136.63,5,3,8,4,67,0,3.0
PLAT,antagonist,aminocaproic acid,,Tissue-type plasminogen activator,Enzyme,,True,131.1729,-1.9971552340836567,True,3,1,0,0,63.32,5,2,2,0,22,0,0.0
,modulator,deferoxamine,,iron,Inorganic material,,True,560.684,-3.3651618251632973,False,3,1,0,0,205.84,23,6,9,0,87,0,0.0
PTGS2,inhibitor,rofecoxib,1.04,Prostaglandin G/H synthase 2,Enzyme,6.52,True,314.356,2.560910504,True,2,5,0,1,60.44,3,0,4,3,36,0,0.0
,modulator,chlorambucil,,DNA,DNA,,True,304.212,3.9371549819999987,True,1,1,0,1,40.54,9,1,2,1,38,0,0.0
PGR,agonist,hydroxyprogesterone caproate,0.2,Progesterone receptor,Nuclear hormone receptor,7.66354036331177,True,428.6041,5.876546530000002,False,1,3,0,0,60.44,6,0,4,4,71,0,6.0
SLC18A2,inhibitor,deserpidine,3.34,Synaptic vesicular amine transporter,Transporter,,True,578.6527,3.689167208333335,False,1,0,0,0,108.55,7,1,9,6,80,0,6.0
SLC25A6,inhibitor,clodronic acid,,ADP/ATP translocase 3,Enzyme,,True,244.892,-0.06669455533333335,True,4,1,0,0,115.06,2,4,2,0,15,0,0.0
SLC25A4,inhibitor,clodronic acid,,ADP/ATP translocase 1,Transporter,,True,244.892,-0.06669455533333335,True,4,1,0,0,115.06,2,4,2,0,15,0,0.0
SLC25A5,inhibitor,clodronic acid,,ADP/ATP translocase 2,Enzyme,,True,244.892,-0.06669455533333335,True,4,1,0,0,115.06,2,4,2,0,15,0,0.0
NR3C1,agonist,amcinonide,0.58,Glucocorticoid receptor,Nuclear hormone receptor,,True,502.5717,3.195263625666665,False,2,2,0,0,99.13,3,1,7,6,71,0,8.0
OPRM1,agonist,anileridine,2.33,Mu-type opioid receptor,GPCR,,True,352.4699,3.640008764333333,True,1,0,0,0,55.56,6,1,4,3,54,0,0.0
SLC47A1,inhibitor,pyrimethamine,1.18,Multidrug and toxin extrusion protein 1,Transporter,7.1,True,248.711,2.7483031543333327,True,3,1,0,2,77.82,2,2,4,2,30,0,0.0
PDXK,ligand,pyridoxine,21.3,Pyridoxal kinase,Kinase,,True,169.1778,-0.9513212983333332,True,1,4,1,1,73.58,2,3,4,1,23,0,0.0
CACNA1C,inhibitor,drotaverine,1.47,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,,True,397.5072,4.191374697333334,True,2,0,0,0,49.28,10,0,5,3,60,0,0.0
CHRNA7,agonist,varenicline,0.44,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,6.9,True,211.268,1.0076279959999996,True,5,0,0,1,37.81,0,1,3,4,29,0,2.0
SCN5A,blocker,ropivacaine,0.12,Sodium channel protein type 5 subunit alpha,Ion channel,4.56,True,274.4011,4.070950219333334,True,1,3,0,0,32.34,4,1,2,2,46,0,1.0
TPSAB1,inhibitor,gabexate,1.89,Tryptase alpha/beta-1,Enzyme,8.47,False,321.377,2.097702387,True,3,3,0,0,117.0,9,2,5,1,46,0,0.0
ESR1,agonist,mestranol,0.2,Estrogen receptor,Nuclear hormone receptor,8.282329497000001,True,310.4299,4.043247144,True,1,3,0,0,29.46,1,1,2,4,49,0,5.0
POLB,inhibitor,cytarabine,0.04,DNA polymerase beta,Enzyme,,True,243.2166,-2.7975172843333334,True,2,5,0,3,130.83,2,4,8,2,30,0,4.0
KCNA5,blocker,vernakalant,1.08,Potassium voltage-gated channel subfamily A member 5,Ion channel,4.87451887130737,True,349.471,2.513554538666666,True,4,1,0,0,51.16,7,1,5,3,56,0,3.0
FDPS,inhibitor,minodronic acid,,Farnesyl pyrophosphate synthase,Enzyme,8.52,False,322.1483,-3.4886604086283044,True,2,0,0,0,152.59,4,5,5,2,32,0,0.0
GGPS1,inhibitor,minodronic acid,,Geranylgeranyl pyrophosphate synthase,Enzyme,5.74,False,322.1483,-3.4886604086283044,True,2,0,0,0,152.59,4,5,5,2,32,0,0.0
OPRK1,agonist,nalorphine,0.17,Kappa-type opioid receptor,GPCR,7.82,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
OPRK1,agonist,nalorphine,0.17,Kappa-type opioid receptor,GPCR,7.82,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
OPRD1,agonist,nalorphine,0.23,Delta-type opioid receptor,GPCR,6.92,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
OPRD1,agonist,nalorphine,0.23,Delta-type opioid receptor,GPCR,6.92,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
OPRM1,antagonist,nalorphine,0.13,Mu-type opioid receptor,GPCR,9.72,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
OPRM1,antagonist,nalorphine,0.13,Mu-type opioid receptor,GPCR,9.72,False,311.381,1.6752604327019132,True,0,0,0,0,52.93,2,2,4,5,44,0,5.0
DRD2,antagonist,alizapride,1.37,D(2) dopamine receptor,GPCR,7.15,False,315.3702,1.1190993874086288,True,1,0,0,0,83.14,6,2,5,3,44,0,1.0
MMP2,inhibitor,tiludronic acid,,72 kDa type IV collagenase,Enzyme,5.14,True,318.608,1.322081915,True,6,0,1,0,115.06,4,4,3,1,26,0,0.0
HTR2A,antagonist,blonanserin,0.4,5-hydroxytryptamine receptor 2A,GPCR,9.09151458740234,False,367.512,5.6672371073333325,False,3,1,1,0,19.37,3,0,3,4,57,0,0.0
DRD2,antagonist,blonanserin,0.36,D(2) dopamine receptor,GPCR,9.85387229919434,False,367.512,5.6672371073333325,False,3,1,1,0,19.37,3,0,3,4,57,0,0.0
HTR3A,antagonist,granisetron,0.97,5-hydroxytryptamine receptor 3A,Ion channel,8.7,True,312.4170000000001,1.8768568383333333,True,1,2,0,0,50.16,2,1,4,4,47,0,3.0
NR3C1,agonist,desonide,0.74,Glucocorticoid receptor,Nuclear hormone receptor,,True,416.5073,1.9005109329999987,True,1,1,0,0,93.06,2,2,6,5,62,0,8.0
EGFR,inhibitor,icotinib,1.88,Epidermal growth factor receptor,Kinase,8.69896984100342,False,391.427,3.029462643,True,1,3,0,0,74.73,2,1,7,4,50,0,0.0
DRD4,antagonist,benperidol,0.26,D(4) dopamine receptor,GPCR,8.7,True,381.451,3.79126911,True,0,0,0,0,58.1,6,1,4,4,52,0,0.0
DRD2,antagonist,benperidol,0.09,D(2) dopamine receptor,GPCR,10.57,True,381.451,3.79126911,True,0,0,0,0,58.1,6,1,4,4,52,0,0.0
CHRNA6,blocker,hexamethonium,2.03,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,4.04,False,202.38,-6.64939950494349,True,1,0,0,0,0.0,7,0,0,0,44,2,0.0
CHRNA4,blocker,hexamethonium,0.25,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,5.17,False,202.38,-6.64939950494349,True,1,0,0,0,0.0,7,0,0,0,44,2,0.0
ADORA2A,antagonist,mefloquine,0.96,Adenosine receptor A2a,GPCR,6.90999984741211,True,378.3122,4.110594849666667,True,3,4,0,1,45.15,2,2,3,3,42,0,2.0
ADORA1,antagonist,mefloquine,0.33,Adenosine receptor A1,GPCR,5.90999984741211,True,378.3122,4.110594849666667,True,3,4,0,1,45.15,2,2,3,3,42,0,2.0
FDPS,inhibitor,alendronic acid,,Farnesyl pyrophosphate synthase,Enzyme,7.35,True,249.096,-4.190998026971535,False,6,0,0,0,161.31,5,6,4,0,27,0,0.0
TYR,inhibitor,mimosine,7.89,Tyrosinase,Enzyme,5.43,False,198.176,-2.9592000692311604,True,3,0,0,0,105.55,3,3,5,1,24,0,1.0
SHMT1,inhibitor,mimosine,9.47,"Serine hydroxymethyltransferase, cytosolic",Enzyme,,False,198.176,-2.9592000692311604,True,3,0,0,0,105.55,3,3,5,1,24,0,1.0
GNRHR,agonist,triptorelin,2.24,Gonadotropin-releasing hormone receptor,GPCR,9.025,True,1311.473,-3.5860375370969124,False,1,0,0,0,490.42,33,17,15,8,177,0,9.0
NQO2,inhibitor,primaquine,0.45,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,5.12,True,259.3467,1.6429209590000005,True,3,5,0,1,60.17,6,2,4,2,40,0,1.0
AGTR1,antagonist,irbesartan,1.76,Type-1 angiotensin II receptor,GPCR,9.1,True,428.5294,5.495261916666666,False,2,5,2,0,87.13,7,1,5,5,60,0,0.0
SLC10A1,inhibitor,irbesartan,4.73,Sodium/bile acid cotransporter,Transporter,4.92,True,428.5294,5.495261916666666,False,2,5,2,0,87.13,7,1,5,5,60,0,0.0
PSMB5,inhibitor,ixazomib,1.72,Proteasome subunit beta type-5,Enzyme,8.46852111816406,True,361.03,2.5677000000000003,True,0,7,0,0,98.66,7,4,4,1,42,0,1.0
NOD2,ligand,mifamurtide,9.47,Nucleotide-binding oligomerization domain-containing protein 2,Cytosolic other,,True,1277.515,5.566524969000003,False,2,0,0,0,376.1,52,10,18,1,194,0,11.0
NR3C1,agonist,hydrocortisone acetate,0.19,Glucocorticoid receptor,Nuclear hormone receptor,,True,404.4966,1.7162918449999998,True,4,6,2,4,100.9,3,2,6,4,61,0,7.0
REN,inhibitor,remikiren,33.41,Renin,Enzyme,9.1549015045166,False,630.8380000000002,2.368042855333332,False,1,0,0,0,161.48,15,5,7,4,94,0,5.0
AGTR1,antagonist,fimasartan,2.23,Type-1 angiotensin II receptor,GPCR,9.37675094604492,False,501.65,4.208753043333333,False,1,0,0,2,92.59,9,1,7,4,67,0,0.0
SLC18A2,inhibitor,rescinnamine,0.33,Synaptic vesicular amine transporter,Transporter,,True,634.716,4.070086811999999,False,1,0,0,0,117.78,9,1,10,6,88,0,6.0
HDAC6,inhibitor,bufexamac,0.65,Histone deacetylase 6,Enzyme,4.97,True,223.272,1.9670975133333333,True,4,0,0,0,58.56,6,2,3,1,33,0,0.0
HDAC10,inhibitor,bufexamac,0.81,Histone deacetylase 10,Enzyme,4.91,True,223.272,1.9670975133333333,True,4,0,0,0,58.56,6,2,3,1,33,0,0.0
,modulator,penicillamine,,copper,Inorganic material,,True,149.211,-2.146518265659755,True,1,0,0,1,63.32,2,3,3,0,20,0,1.0
CHRM2,antagonist,dexetimide,0.47,Muscarinic acetylcholine receptor M2,GPCR,8.9,False,362.4647,3.3830662353333327,True,0,0,0,0,49.41,4,1,3,4,53,0,1.0
MME,"antagonist,inhibitor",sacubitril,7.57,Neprilysin,Enzyme,,True,411.4980000000001,3.7877227776666658,True,1,0,0,2,92.7,11,2,4,2,59,0,2.0
KCNJ11,activator,nicorandil,0.36,ATP-sensitive inward rectifier potassium channel 11,Ion channel,5.8861,True,211.177,-0.1616976216666668,True,1,0,0,0,94.36,5,1,5,1,24,0,0.0
RARG,agonist,acitretin,0.76,Retinoic acid receptor gamma,Nuclear hormone receptor,,True,326.4293,5.5870487256666665,False,8,0,1,0,46.53,6,1,2,1,50,0,0.0
NR3C1,agonist,dexamethasone acetate,0.37,Glucocorticoid receptor,Nuclear hormone receptor,,True,434.4977,2.12269509,True,5,15,1,6,100.9,3,2,6,4,62,0,8.0
GNRHR,agonist,histrelin,2.24,Gonadotropin-releasing hormone receptor,GPCR,,True,1443.632,-2.138446574944563,False,1,0,0,0,449.36,34,15,16,8,182,0,9.0
TRPA1,activator,thymol,1.67,Transient receptor potential cation channel subfamily A member 1,Ion channel,5.22,True,150.2176,3.428111034333333,True,0,0,0,0,20.23,1,1,1,1,25,0,0.0
ADRB1,agonist,prenalterol,0.45,Beta-1 adrenergic receptor,GPCR,6.6,False,225.288,0.7999004997286241,True,0,0,0,0,61.72,6,3,4,1,35,0,1.0
PDE1A,inhibitor,vinpocetine,1.26,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,5.1,False,350.462,4.067020486333332,True,0,1,0,0,34.47,3,0,4,5,52,0,2.0
PDE1C,inhibitor,vinpocetine,3.79,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",Enzyme,4.3,False,350.462,4.067020486333332,True,0,1,0,0,34.47,3,0,4,5,52,0,2.0
RYR1,antagonist,dantrolene,5.2,Ryanodine receptor 1,Ion channel,6.7570000000000014,True,314.257,1.256485484666666,True,1,0,1,0,126.66,4,2,7,3,33,0,0.0
RYR3,antagonist,dantrolene,1.26,Ryanodine receptor 3,Ion channel,,True,314.257,1.256485484666666,True,1,0,1,0,126.66,4,2,7,3,33,0,0.0
BCHE,inhibitor,hexafluronium,4.61,Butyrylcholinesterase,Enzyme,6.47,True,502.745,-0.28401380361015754,False,1,0,0,0,0.0,9,0,0,6,80,2,0.0
PGR,agonist,norelgestromin,1.58,Progesterone receptor,Nuclear hormone receptor,,True,327.468,3.671276388333333,True,3,2,0,0,49.66,2,1,3,4,53,0,6.0
PTGS2,inhibitor,benzquinamide,0.05,Prostaglandin G/H synthase 2,Enzyme,8.32,False,404.4999,1.419519497333333,True,6,0,0,0,68.31,6,0,6,3,61,0,3.0
DRD2,agonist,benzquinamide,0.03,D(2) dopamine receptor,GPCR,5.4,False,404.4999,1.419519497333333,True,6,0,0,0,68.31,6,0,6,3,61,0,3.0
CHRM1,antagonist,imidafenacin,0.25,Muscarinic acetylcholine receptor M1,GPCR,8.3840503692627,False,319.408,2.764839751,True,3,2,2,0,60.91,6,1,3,3,45,0,0.0
CHRM3,antagonist,imidafenacin,0.27,Muscarinic acetylcholine receptor M3,GPCR,9.49894046783447,False,319.408,2.764839751,True,3,2,2,0,60.91,6,1,3,3,45,0,0.0
GPBAR1,agonist,cholic acid,,G-protein coupled bile acid receptor 1,GPCR,5.0,True,408.5714,2.482494456666666,True,23,0,1,13,97.99,4,4,4,4,69,0,11.0
NR3C1,agonist,norethisterone,0.07,Glucocorticoid receptor,Nuclear hormone receptor,6.705533774,True,298.4192,3.217227937333333,True,3,8,2,1,37.3,0,1,2,4,48,0,6.0
AR,agonist,norethisterone,0.02,Androgen receptor,Nuclear hormone receptor,7.12,True,298.4192,3.217227937333333,True,3,8,2,1,37.3,0,1,2,4,48,0,6.0
ATP6V1B2,inhibitor,enoxacin,6.31,"V-type proton ATPase subunit B, brain isoform",Enzyme,5.0,True,320.3189,-0.9830519373098778,True,3,1,0,0,87.46,3,2,6,3,40,0,0.0
ESR1,"agonist,antagonist",clomifene,0.79,Estrogen receptor,Nuclear hormone receptor,8.886056648,True,405.96,6.474937693999999,False,2,1,0,1,12.47,9,0,2,3,57,0,0.0
ADRB3,antagonist,tertatolol,0.27,Beta-3 adrenergic receptor,GPCR,8.6,False,295.44,2.8836921863333336,True,0,1,0,0,41.49,5,2,4,2,45,0,1.0
DHFR,inhibitor,trimetrexate,2.37,Dihydrofolate reductase,Enzyme,8.85,True,369.4176,2.2781130193333325,True,1,1,0,1,117.54,6,3,8,3,50,0,0.0
DRD2,antagonist,thioproperazine,0.32,D(2) dopamine receptor,GPCR,9.34678745269775,False,446.629,2.8314580459999985,True,4,0,1,0,47.1,6,0,6,4,60,0,0.0
SLC5A2,inhibitor,ertugliflozin,5.05,Sodium/glucose cotransporter 2,Transporter,9.057,True,436.89,2.316586535666666,True,1,4,1,2,108.61,12,4,7,4,55,0,5.0
SLC5A1,inhibitor,ertugliflozin,1.46,Sodium/glucose cotransporter 1,Transporter,5.707744,True,436.89,2.316586535666666,True,1,4,1,2,108.61,12,4,7,4,55,0,5.0
EGFR,inhibitor,olmutinib,1.88,Epidermal growth factor receptor,Kinase,8.03621196746826,False,486.59,5.474233900333334,False,1,0,0,0,82.62,7,2,8,5,61,0,0.0
CHRM3,antagonist,mepenzolate,0.33,Muscarinic acetylcholine receptor M3,GPCR,8.59,True,340.436,-0.9746864134717452,True,2,0,0,0,46.53,4,1,3,3,51,1,1.0
CHRM1,antagonist,mepenzolate,0.3,Muscarinic acetylcholine receptor M1,GPCR,,True,340.436,-0.9746864134717452,True,2,0,0,0,46.53,4,1,3,3,51,1,1.0
HRH2,antagonist,roxatidine acetate,3.16,Histamine H2 receptor,GPCR,7.6,False,348.4366,1.3130373466666667,True,1,0,0,0,67.87,9,1,5,2,53,0,0.0
,adduct,dactinomycin,,DNA,DNA,,True,1255.417,-0.09688245333333306,False,2,0,0,5,359.98,8,5,18,7,176,0,10.0
PTGS2,inhibitor,polmacoxib,0.46,Prostaglandin G/H synthase 2,Enzyme,8.08085155487061,False,361.39,2.944671925333333,True,0,0,0,0,86.46,3,1,4,3,41,0,0.0
NR3C1,agonist,rimexolone,0.3,Glucocorticoid receptor,Nuclear hormone receptor,,True,370.533,4.381232338666667,True,1,2,1,0,54.37,2,1,3,4,61,0,8.0
,modulator,dacarbazine,,DNA,DNA,,True,182.187,-0.4258889623333337,True,3,3,0,0,99.73,3,2,4,1,23,0,0.0
APEX1,inhibitor,lucanthone,0.16,DNA-(apurinic or apyrimidinic site) lyase,Enzyme,5.3000001907348615,False,340.482,5.016562449333335,False,4,0,0,0,32.34,6,1,4,3,48,0,0.0
ESR1,agonist,estradiol benzoate,0.09,Estrogen receptor,Nuclear hormone receptor,7.744727495,True,376.48800000000006,5.710502062666667,False,10,10,3,14,46.53,2,1,3,5,56,0,5.0
SCN5A,blocker,tetracaine,0.05,Sodium channel protein type 5 subunit alpha,Ion channel,6.28,True,264.369,2.7920444443333325,True,3,0,0,0,41.57,8,1,4,1,43,0,0.0
SCN2A,blocker,tetracaine,0.07,Sodium channel protein type 2 subunit alpha,Ion channel,5.96,True,264.369,2.7920444443333325,True,3,0,0,0,41.57,8,1,4,1,43,0,0.0
SCN9A,blocker,tetracaine,0.06,Sodium channel protein type 9 subunit alpha,Ion channel,6.3,True,264.369,2.7920444443333325,True,3,0,0,0,41.57,8,1,4,1,43,0,0.0
MC2R,antagonist,tetracosactide,63.12,Adrenocorticotropic hormone receptor,GPCR,8.26760578155518,True,2933.49,-14.065533676163854,False,1,0,0,0,1166.22,93,39,39,9,418,0,22.0
OPRM1,antagonist,naloxegol,0.78,Mu-type opioid receptor,GPCR,,True,651.794,1.3564175840257162,False,1,3,0,0,126.77,24,2,12,5,99,0,5.0
FBP1,"inhibitory allosteric modulator,antagonist",adenosine phosphate,1.58,"Fructose-1,6-bisphosphatase 1",Enzyme,6.85,True,347.2212,-4.788289391565842,True,14,2,0,0,186.07,4,5,10,3,37,0,4.0
,product of,adenosine phosphate,,Alcohol dehydrogenase,Enzyme,4.42,True,347.2212,-4.788289391565842,True,14,2,0,0,186.07,4,5,10,3,37,0,4.0
FFAR2,agonist,acetic acid,,Free fatty acid receptor 2,GPCR,4.6,True,60.052,-0.2233457143333334,True,0,0,0,2,0.0,0,0,0,0,8,0,0.0
CA6,antagonist,mafenide,7.1,Carbonic anhydrase 6,Enzyme,5.32,True,186.232,-0.543209136904693,True,1,0,0,0,86.18,2,2,3,1,22,0,0.0
,modulator,melphalan,,DNA,DNA,,True,305.2,0.25219622473316816,True,1,0,0,2,66.56,8,2,3,1,37,0,1.0
PDK1,inhibitor,dichloroacetic acid,16.23,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",Kinase,3.0,True,128.942,1.0581826133333334,True,2,0,0,0,37.3,1,1,1,0,8,0,0.0
GABRB3,positive modulator,pentobarbital,0.04,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,4.06,True,226.2722,1.8932512466666669,True,13,3,0,0,75.27,4,2,3,1,34,0,1.0
ACHE,activator,pralidoxime,3.76,Acetylcholinesterase,Enzyme,4.59,True,137.1592,-3.257118933138412,True,2,0,0,0,33.31,2,0,2,1,19,1,0.0
TPK1,substrate,thiamine,284.03,Thiamin pyrophosphokinase 1,Kinase,,True,265.355,-3.0974126491384126,True,1,4,1,5,75.91,4,2,5,2,35,1,0.0
KCNA5,blocker,bupivacaine,0.21,Potassium voltage-gated channel subfamily A member 5,Ion channel,5.4,True,288.4277,4.515518884333334,True,2,3,0,0,32.34,5,1,2,2,49,0,1.0
SCN5A,blocker,bupivacaine,0.05,Sodium channel protein type 5 subunit alpha,Ion channel,5.66,True,288.4277,4.515518884333334,True,2,3,0,0,32.34,5,1,2,2,49,0,1.0
SCN4A,blocker,bupivacaine,0.07,Sodium channel protein type 4 subunit alpha,Ion channel,6.0,True,288.4277,4.515518884333334,True,2,3,0,0,32.34,5,1,2,2,49,0,1.0
PTGS2,inhibitor,aceclofenac,0.31,Prostaglandin G/H synthase 2,Enzyme,,True,354.18,3.8828865976666656,True,2,1,0,0,75.63,6,2,4,2,36,0,0.0
SLC6A3,inhibitor,armodafinil,1.39,Sodium-dependent dopamine transporter,Transporter,5.4975,True,273.35,1.5328344403333334,True,1,6,0,0,60.16,5,1,2,2,34,0,1.0
AR,agonist,testosterone cypionate,,Androgen receptor,Nuclear hormone receptor,,True,412.614,6.108652408666665,False,3,14,2,8,43.37,4,0,3,5,70,0,6.0
FDPS,inhibitor,incadronic acid,1.42,Farnesyl pyrophosphate synthase,Enzyme,7.522878646850589,False,287.189,-1.3763154756938276,True,4,0,0,0,130.58,3,5,5,1,36,0,0.0
ESR1,agonist,estradiol valerate,0.08,Estrogen receptor,Nuclear hormone receptor,,True,356.4984,5.776299915666669,False,10,10,3,14,46.53,4,1,3,4,58,0,5.0
ADRA2A,agonist,naphazoline,0.42,Alpha-2A adrenergic receptor,GPCR,7.67999982833862,True,210.2744,2.1931169496666665,True,2,0,0,0,24.39,2,1,2,3,30,0,0.0
CTSA,inhibitor,boceprevir,3.55,Lysosomal protective protein,Enzyme,6.0,True,519.6767,1.7752963963333332,False,1,2,0,1,150.7,8,4,5,3,82,0,5.0
GRIN2B,antagonist,ifenprodil,0.54,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,7.7,False,325.4446,3.5710014461647885,True,5,0,0,0,43.7,5,2,3,3,51,0,2.0
HTR2B,agonist,dihydroergocryptine,0.18,5-hydroxytryptamine receptor 2B,GPCR,7.48,False,,,False,0,1,0,0,118.21,5,3,6,7,85,0,7.0
DRD2,antagonist,melperone,0.27,D(2) dopamine receptor,GPCR,6.9788,False,263.356,3.2281529286666664,True,1,1,0,0,20.31,5,0,2,2,41,0,0.0
TYMP,inhibitor,tipiracil,4.06,Thymidine phosphorylase,Enzyme,7.698969841003421,True,242.662,-1.9810753469509712,True,1,0,0,2,92.81,2,3,3,2,27,0,0.0
ACHE,inhibitor,echothiophate,0.84,Acetylcholinesterase,Enzyme,,True,256.323,-3.050055222805079,True,1,0,1,0,35.53,8,0,4,0,38,1,0.0
NR3C1,agonist,cortisone acetate,3.34,Glucocorticoid receptor,Nuclear hormone receptor,6.02,True,402.4807,2.1018060986666662,True,2,2,2,3,97.74,3,1,6,4,59,0,6.0
SLC6A4,"antagonist,inhibitor",butriptyline,0.85,Sodium-dependent serotonin transporter,Transporter,5.866461277008059,True,,5.4413538893333335,False,3,0,0,0,3.24,4,0,1,3,49,0,1.0
TYR,inhibitor,arbutin,14.2,Tyrosinase,Enzyme,4.52,True,272.2512,-0.9019529206666664,True,1,0,1,0,119.61,3,5,7,2,35,0,5.0
ACE,inhibitor,temocapril,1.6,Angiotensin-converting enzyme,Enzyme,8.44369792938232,False,476.609,2.042777061904141,True,1,0,0,2,95.94,10,2,7,3,60,0,3.0
ADRB2,agonist,celiprolol,0.1,Beta-2 adrenergic receptor,GPCR,6.8,True,379.501,1.4975762340000012,True,6,1,0,0,90.9,9,3,5,1,60,0,1.0
HPGDS,inhibitor,tranilast,1.41,Hematopoietic prostaglandin D synthase,Enzyme,4.94,False,327.3313,3.5626285343333333,True,1,2,0,0,84.86,6,2,4,2,41,0,0.0
TACR1,antagonist,fosaprepitant,1.46,Substance-P receptor,GPCR,8.92,True,614.4066,2.400678928653885,False,0,2,0,0,129.91,7,3,7,4,63,0,3.0
HMGCR,inhibitor,cerivastatin,4.56,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,8.0,True,459.5503,2.6681542381694316,True,1,8,0,5,99.88,11,3,5,2,67,0,2.0
MAOA,antagonist,toloxatone,1.21,Amine oxidase [flavin-containing] A,Enzyme,5.82,False,207.229,1.405874892,True,1,1,0,0,29.54,2,0,2,2,30,0,1.0
TBXA2R,antagonist,seratrodast,2.47,Thromboxane A2 receptor,GPCR,8.13,False,354.446,5.374309062666667,False,1,8,0,0,77.76,7,3,3,2,52,0,1.0
,modulator,thiotepa,,DNA,DNA,,True,189.218,-1.0273805153333335,True,1,3,0,0,9.03,3,0,1,3,23,0,0.0
SLC6A2,partial agonist,guanadrel,4.37,Sodium-dependent noradrenaline transporter,Transporter,,True,213.2768,0.6234137306666664,True,1,0,0,0,82.86,2,2,3,2,34,0,1.0
OPRM1,agonist,tianeptine,0.39,Mu-type opioid receptor,GPCR,6.4168012260000005,False,436.952,1.5311524937990022,True,4,1,0,0,86.71,8,2,4,3,54,0,1.0
ACHE,inhibitor,demecarium,1.25,Acetylcholinesterase,Enzyme,,True,556.7797,-1.4187553209434929,False,2,0,0,0,59.08,15,0,4,2,92,2,0.0
TYR,inhibitor,hexylresorcinol,0.68,Tyrosinase,Enzyme,6.25,True,194.2701,4.102379887,True,3,0,0,0,40.46,5,2,2,1,32,0,0.0
VDR,agonist,tacalcitol,0.12,Vitamin D3 receptor,Nuclear hormone receptor,8.5,False,416.646,4.513090884666667,True,0,0,0,0,60.69,6,3,3,3,74,0,7.0
ACHE,inhibitor,decamethonium,0.84,Acetylcholinesterase,Enzyme,5.23,True,258.4863,-4.87112484494349,True,4,1,0,0,0.0,11,0,0,0,56,2,0.0
NR3C1,agonist,fluprednisolone,0.19,Glucocorticoid receptor,Nuclear hormone receptor,,True,378.44,0.9332706313333324,True,0,1,0,0,94.83,2,3,5,4,54,0,8.0
SRD5A2,inhibitor,azelaic acid,,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,,True,188.2209,1.8243603576666665,True,5,0,0,0,74.6,8,2,2,0,29,0,0.0
PDE1A,inhibitor,crisaborole,1.05,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,5.21,True,251.05,3.3416999999999986,True,4,3,0,0,62.48,2,1,4,3,29,0,0.0
PDE7A,inhibitor,crisaborole,1.35,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",Enzyme,6.14,True,251.05,3.3416999999999986,True,4,3,0,0,62.48,2,1,4,3,29,0,0.0
MLNR,agonist,roxithromycin,0.71,Motilin receptor,GPCR,6.2,True,837.0465,2.9999792816666657,False,2,2,0,0,216.89,13,5,17,3,134,0,18.0
NR3C1,agonist,halcinonide,0.09,Glucocorticoid receptor,Nuclear hormone receptor,9.135488919,True,454.96,3.300886228333332,True,1,1,0,0,72.83,2,1,5,5,63,0,8.0
SHBG,antagonist,gestrinone,0.32,Sex hormone-binding globulin,Secreted,8.11,True,308.4141,2.8506376396666657,True,6,1,0,0,37.3,1,1,2,4,47,0,4.0
PTGDR2,agonist,dinoprost,4.73,Prostaglandin D2 receptor 2,GPCR,6.4,True,354.487,2.611054417333332,True,1,0,0,0,97.99,12,4,4,1,59,0,5.0
SCTR,ligand,secretin human,,Secretin receptor,GPCR,9.7,True,3039.44,,False,1,0,0,0,1411.22,105,47,43,2,434,0,26.0
PGR,agonist,norethynodrel,0.2,Progesterone receptor,Nuclear hormone receptor,,True,298.426,2.8138249663333337,True,3,1,0,0,37.3,0,1,2,4,48,0,5.0
ADRB2,agonist,protokylol,0.69,Beta-2 adrenergic receptor,GPCR,,True,331.36800000000005,1.4816013219288675,True,1,0,0,0,91.18,6,4,6,3,45,0,2.0
CPT1A,activator,levocarnitine,12.05,"Carnitine O-palmitoyltransferase 1, liver isoform",Enzyme,,True,161.1989,-4.8875060481384125,True,11,0,0,5,60.36,4,1,3,0,26,0,1.0
ALOX5,inhibitor,masoprocol,3.49,Arachidonate 5-lipoxygenase,Enzyme,7.6,True,302.3649,4.758522744,True,2,1,0,0,80.92,5,4,4,2,44,0,2.0
SIGMAR1,agonist,pentoxyverine,0.74,Sigma non-opioid intracellular receptor 1,Membrane receptor,7.71,True,333.472,3.966585092333333,True,5,0,0,0,38.77,10,0,4,2,55,0,0.0
